action_type;activity_comment;activity_id;activity_properties;assay_chembl_id;assay_description;assay_type;assay_variant_accession;assay_variant_mutation;bao_endpoint;bao_format;bao_label;canonical_smiles;data_validity_comment;data_validity_description;document_chembl_id;document_journal;document_year;ligand_efficiency;molecule_chembl_id;molecule_pref_name;parent_molecule_chembl_id;pchembl_value;potential_duplicate;qudt_units;record_id;relation;src_id;standard_flag;standard_relation;standard_text_value;standard_type;standard_units;standard_upper_value;standard_value;target_chembl_id;target_organism;target_pref_name;target_tax_id;text_value;toid;type;units;uo_units;upper_value;value
;;224312;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCN(C(C)C)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.39', 'le': '0.20', 'lle': '-0.89', 'sei': '16.64'};CHEMBL296979;;CHEMBL296979;5.92;0;http://www.openphacts.org/units/Nanomolar;82904;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1200.0
;;225577;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC3(CCCO3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.53', 'le': '0.20', 'lle': '-1.29', 'sei': '14.76'};CHEMBL3085129;;CHEMBL3085129;6.14;0;http://www.openphacts.org/units/Nanomolar;82913;=;1;1;=;;Ki;nM;;730.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;730.0
;;228175;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCC(c3ccc(F)cc3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '11.87', 'le': '0.23', 'lle': '-1.43', 'sei': '22.78'};CHEMBL296397;;CHEMBL296397;7.37;0;http://www.openphacts.org/units/Nanomolar;82907;=;1;1;=;;Ki;nM;;43.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;43.0
;;232020;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@H](N2CCCCC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '11.24', 'le': '0.22', 'lle': '-1.35', 'sei': '18.31'};CHEMBL3085124;;CHEMBL3085124;5.92;0;http://www.openphacts.org/units/Nanomolar;82903;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1200.0
;;232022;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC1CCN([C@H]2CC[C@](NC(=O)C(C)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)(c3ccccc3)CC2)CC1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '11.72', 'le': '0.23', 'lle': '-1.17', 'sei': '19.60'};CHEMBL3085128;;CHEMBL3085128;6.34;0;http://www.openphacts.org/units/Nanomolar;82902;=;1;1;=;;Ki;nM;;460.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;460.0
;;232024;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCC(=O)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '9.99', 'le': '0.19', 'lle': '-1.05', 'sei': '10.92'};CHEMBL431732;;CHEMBL431732;5.40;0;http://www.openphacts.org/units/Nanomolar;82914;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4000.0
;;234462;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCC3(CC2)OCCO3)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.26', 'le': '0.20', 'lle': '-0.62', 'sei': '11.81'};CHEMBL297344;;CHEMBL297344;6.00;0;http://www.openphacts.org/units/Nanomolar;82905;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1000.0
;;237051;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCC(O)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.79', 'le': '0.21', 'lle': '-0.39', 'sei': '11.14'};CHEMBL298858;;CHEMBL298858;5.85;0;http://www.openphacts.org/units/Nanomolar;82901;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1400.0
;;239775;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC3(CC2)CCC(C)(C)O3)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '9.86', 'le': '0.19', 'lle': '-2.19', 'sei': '14.49'};CHEMBL3085132;;CHEMBL3085132;6.02;0;http://www.openphacts.org/units/Nanomolar;82909;=;1;1;=;;Ki;nM;;950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;950.0
;;247790;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC(O)(Cc3ccccc3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.41', 'le': '0.20', 'lle': '-1.26', 'sei': '12.53'};CHEMBL3085130;;CHEMBL3085130;6.58;0;http://www.openphacts.org/units/Nanomolar;82900;=;1;1;=;;Ki;nM;;260.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;260.0
;;249252;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC3(CCOC3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.55', 'le': '0.20', 'lle': '-1.13', 'sei': '14.79'};CHEMBL3085127;;CHEMBL3085127;6.15;0;http://www.openphacts.org/units/Nanomolar;82912;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;710.0
;;250604;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC(C3CCOC3=O)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.33', 'le': '0.20', 'lle': '-0.75', 'sei': '10.76'};CHEMBL3085133;;CHEMBL3085133;6.31;0;http://www.openphacts.org/units/Nanomolar;82910;=;1;1;=;;Ki;nM;;490.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;490.0
;;250606;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@H](N2CCC(C3CCOC3(C)C)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '9.06', 'le': '0.18', 'lle': '-2.65', 'sei': '13.61'};CHEMBL3085131;;CHEMBL3085131;5.66;0;http://www.openphacts.org/units/Nanomolar;82908;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2200.0
;;258825;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)NC1(c2ccccc2)CCC(N2CCC(C3CCC(=O)O3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '10.48', 'le': '0.20', 'lle': '-0.80', 'sei': '10.91'};CHEMBL3085126;;CHEMBL3085126;6.40;0;http://www.openphacts.org/units/Nanomolar;82911;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;400.0
;;264101;[];CHEMBL824627;Compound was evaluated for the displacement of labelled MK-499 from the cloned channel expressed in HEK cells (Ikr channel);B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@H](N(C)C)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1135170;Bioorg Med Chem Lett;2002.0;{'bei': '11.76', 'le': '0.23', 'lle': '-0.62', 'sei': '17.69'};CHEMBL3085125;;CHEMBL3085125;5.72;0;http://www.openphacts.org/units/Nanomolar;82899;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1900.0
;;308221;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '13.64', 'le': '0.27', 'lle': '3.12', 'sei': '6.93'};CHEMBL22359;;CHEMBL22359;5.23;0;http://www.openphacts.org/units/Nanomolar;273687;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5900.0
;;308227;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '12.23', 'le': '0.23', 'lle': '1.98', 'sei': '5.19'};CHEMBL22679;;CHEMBL22679;4.40;0;http://www.openphacts.org/units/Nanomolar;273702;=;1;1;=;;Ki;nM;;40000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;40000.0
;;309675;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2cccc3ccccc23)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '11.72', 'le': '0.23', 'lle': '1.67', 'sei': '6.17'};CHEMBL3084949;;CHEMBL3084949;4.66;0;http://www.openphacts.org/units/Nanomolar;273685;=;1;1;=;;Ki;nM;;22000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;22000.0
;;319707;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '11.10', 'le': '0.23', 'lle': '2.71', 'sei': '4.82'};CHEMBL25437;;CHEMBL25437;4.46;0;http://www.openphacts.org/units/Nanomolar;273699;=;1;1;=;;Ki;nM;;35000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;35000.0
;;331197;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '11.67', 'le': '0.24', 'lle': '2.87', 'sei': '5.15'};CHEMBL23979;;CHEMBL23979;5.24;0;http://www.openphacts.org/units/Nanomolar;273700;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5700.0
;;336426;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)Nc2ccc(I)cc2)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '11.71', 'le': '0.30', 'lle': '2.89', 'sei': '6.54'};CHEMBL3084953;;CHEMBL3084953;5.72;0;http://www.openphacts.org/units/Nanomolar;273705;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1900.0
;;337685;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)c2cccc3ccccc23)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '12.57', 'le': '0.23', 'lle': '1.69', 'sei': '6.32'};CHEMBL3084944;;CHEMBL3084944;4.77;0;http://www.openphacts.org/units/Nanomolar;273694;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;17000.0
;;341677;[];CHEMBL768689;Binding affinity for Potassium channel HERG Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1146708;Bioorg Med Chem Lett;2004.0;{'bei': '11.88', 'le': '0.25', 'lle': '3.27', 'sei': '5.46'};CHEMBL25211;;CHEMBL25211;5.55;0;http://www.openphacts.org/units/Nanomolar;273711;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2800.0
;;432184;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '15.95', 'le': '0.30', 'lle': '2.13', 'sei': '14.21'};CHEMBL74355;VOLINANSERIN;CHEMBL74355;5.96;0;http://www.openphacts.org/units/Nanomolar;286536;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1100.0
;;432248;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)c(F)c1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '20.97', 'le': '0.39', 'lle': '2.38', 'sei': '221.02'};CHEMBL150210;;CHEMBL150210;7.16;0;http://www.openphacts.org/units/Nanomolar;286511;=;1;1;=;;Ki;nM;;69.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;69.0
;;433608;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '16.01', 'le': '0.32', 'lle': '2.93', 'sei': '10.22'};CHEMBL150220;;CHEMBL150220;6.25;0;http://www.openphacts.org/units/Nanomolar;286516;=;1;1;=;;Ki;nM;;560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;560.0
;;434769;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2ccc[n+]([O-])c2)c2ccc(OC(F)F)c(OC3CC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.58', 'le': '0.18', 'lle': '-0.09', 'sei': '5.57'};CHEMBL78439;;CHEMBL78439;4.38;0;http://www.openphacts.org/units/Nanomolar;143628;=;1;1;=;;Ki;nM;;42200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;42.2
;;434772;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ncc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC3CCC3)c2)s1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '8.88', 'le': '0.18', 'lle': '-0.68', 'sei': '5.39'};CHEMBL310303;;CHEMBL310303;4.23;0;http://www.openphacts.org/units/Nanomolar;143625;=;1;1;=;;Ki;nM;;58400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;58.4
;;437251;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][n+]1ccc(CC(c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)cc1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '8.20', 'le': '0.17', 'lle': '-0.93', 'sei': '5.96'};CHEMBL2112296;;CHEMBL2112296;4.68;0;http://www.openphacts.org/units/Nanomolar;143623;=;1;1;=;;Ki;nM;;21000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;21.0
;;437292;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '16.42', 'le': '0.33', 'lle': '2.55', 'sei': '16.05'};CHEMBL145939;;CHEMBL145939;6.00;0;http://www.openphacts.org/units/Nanomolar;286533;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1000.0
;;437358;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccccc3)[nH]c2c1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '17.28', 'le': '0.32', 'lle': '1.01', 'sei': '19.40'};CHEMBL504699;;CHEMBL504699;5.40;1;http://www.openphacts.org/units/Nanomolar;286512;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4000.0
;;438670;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC3CCC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.78', 'le': '0.18', 'lle': '-0.25', 'sei': '5.86'};CHEMBL78806;;CHEMBL78806;4.60;0;http://www.openphacts.org/units/Nanomolar;143616;=;1;1;=;;Ki;nM;;25000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;25.0
;;438674;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC3CC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '10.03', 'le': '0.19', 'lle': '0.12', 'sei': '5.83'};CHEMBL276559;;CHEMBL276559;4.58;0;http://www.openphacts.org/units/Nanomolar;143617;=;1;1;=;;Ki;nM;;26400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;26.4
;;438751;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)c1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '14.41', 'le': '0.29', 'lle': '3.35', 'sei': '7.31'};CHEMBL148058;;CHEMBL148058;5.89;0;http://www.openphacts.org/units/Nanomolar;286527;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1300.0
;;442747;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '14.65', 'le': '0.29', 'lle': '2.40', 'sei': '9.35'};CHEMBL147048;;CHEMBL147048;5.72;0;http://www.openphacts.org/units/Nanomolar;286515;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1900.0
;;445346;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][n+]1ccc(CC(c2ccc(OC(F)F)c(OC3CCC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)cc1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '7.56', 'le': '0.15', 'lle': '-1.58', 'sei': '5.63'};CHEMBL2112295;;CHEMBL2112295;4.42;0;http://www.openphacts.org/units/Nanomolar;143624;=;1;1;=;;Ki;nM;;38100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;38.1
;;445411;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;OC1c2ccccc2CCC12CCN(CCc1ccccc1)CC2;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '18.42', 'le': '0.34', 'lle': '1.93', 'sei': '25.23'};CHEMBL146144;;CHEMBL146144;5.92;0;http://www.openphacts.org/units/Nanomolar;286530;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1200.0
;;446816;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '16.04', 'le': '0.32', 'lle': '2.57', 'sei': '16.45'};CHEMBL358075;;CHEMBL358075;6.15;0;http://www.openphacts.org/units/Nanomolar;286529;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;710.0
;;450669;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '15.74', 'le': '0.30', 'lle': '3.00', 'sei': '15.27'};CHEMBL83894;FANANSERIN;CHEMBL83894;6.70;0;http://www.openphacts.org/units/Nanomolar;286504;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;200.0
;;451882;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)(c1ccccc1)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC(F)F)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '11.22', 'le': '0.21', 'lle': '0.38', 'sei': '7.55'};CHEMBL61191;;CHEMBL61191;5.93;0;http://www.openphacts.org/units/Nanomolar;143615;=;1;1;=;;Ki;nM;;1180.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.18
;;453176;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(CC2=CCC(=O)N=C2)c2ccc(OC(F)F)c(OC3CC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.32', 'le': '0.18', 'lle': '-0.65', 'sei': '5.25'};CHEMBL81491;;CHEMBL81491;4.25;0;http://www.openphacts.org/units/Nanomolar;143627;=;1;1;=;;Ki;nM;;55900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;55.9
;;454551;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2ccc[n+]([O-])c2)c2ccc(OC(F)F)c(OC3CC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.53', 'le': '0.18', 'lle': '-0.11', 'sei': '5.54'};CHEMBL78439;;CHEMBL78439;4.35;0;http://www.openphacts.org/units/Nanomolar;143618;=;1;1;=;;Ki;nM;;44700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;44.7
;;454554;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][n+]1cccc(C[C@H](c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)c1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '7.73', 'le': '0.16', 'lle': '-1.20', 'sei': '5.62'};CHEMBL383762;;CHEMBL383762;4.41;0;http://www.openphacts.org/units/Nanomolar;143621;=;1;1;=;;Ki;nM;;39000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;39.0
;;456019;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S1(=O)c2ccccc2CCC12CCN(CCc1ccc(F)cc1F)CC2;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '15.95', 'le': '0.32', 'lle': '2.48', 'sei': '16.70'};CHEMBL146595;;CHEMBL146595;6.24;0;http://www.openphacts.org/units/Nanomolar;286534;=;1;1;=;;Ki;nM;;570.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;570.0
;;457140;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC3CC3)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.60', 'le': '0.18', 'lle': '-0.08', 'sei': '5.58'};CHEMBL276559;;CHEMBL276559;4.38;0;http://www.openphacts.org/units/Nanomolar;143629;=;1;1;=;;Ki;nM;;41500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;41.5
;;458677;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)C1CCN(CCCc2ccccc2)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '16.31', 'le': '0.32', 'lle': '2.04', 'sei': '14.99'};CHEMBL148565;;CHEMBL148565;5.60;0;http://www.openphacts.org/units/Nanomolar;286509;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2500.0
;;461065;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC3CCC3)c2)cc1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.90', 'le': '0.19', 'lle': '-0.80', 'sei': '7.08'};CHEMBL2112294;;CHEMBL2112294;4.65;0;http://www.openphacts.org/units/Nanomolar;143626;=;1;1;=;;Ki;nM;;22400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;22.4
;;462285;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC(F)F)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.96', 'le': '0.19', 'lle': '0.12', 'sei': '5.91'};CHEMBL417776;;CHEMBL417776;4.64;0;http://www.openphacts.org/units/Nanomolar;143631;=;1;1;=;;Ki;nM;;22700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;22.7
;;464859;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)c(F)c1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '20.26', 'le': '0.38', 'lle': '2.59', 'sei': '55.80'};CHEMBL147431;;CHEMBL147431;6.96;0;http://www.openphacts.org/units/Nanomolar;286531;=;1;1;=;;Ki;nM;;110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;110.0
;;464876;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(CN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccc(F)cc1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '14.30', 'le': '0.28', 'lle': '2.22', 'sei': '9.49'};CHEMBL146620;;CHEMBL146620;5.17;0;http://www.openphacts.org/units/Nanomolar;286523;=;1;1;=;;Ki;nM;;6800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6800.0
;;466272;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)c1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '12.60', 'le': '0.25', 'lle': '2.61', 'sei': '6.40'};CHEMBL146485;;CHEMBL146485;5.15;0;http://www.openphacts.org/units/Nanomolar;286526;=;1;1;=;;Ki;nM;;7143.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7143.0
;;467497;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][n+]1cccc(C[C@@H](c2ccc(OC(F)F)c(OC3CC3)c2)c2cnc(C(O)(C(F)(F)F)C(F)(F)F)s2)c1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '7.38', 'le': '0.15', 'lle': '-1.40', 'sei': '5.36'};CHEMBL199015;;CHEMBL199015;4.21;0;http://www.openphacts.org/units/Nanomolar;143622;=;1;1;=;;Ki;nM;;61400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;61.4
;;467555;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(Cl)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '17.06', 'le': '0.36', 'lle': '2.72', 'sei': '18.26'};CHEMBL149429;;CHEMBL149429;6.82;0;http://www.openphacts.org/units/Nanomolar;286528;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;150.0
;;471890;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc2c(c1)CCC1(CCN(CCc3ccc(F)cc3F)CC1)O2;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '20.62', 'le': '0.39', 'lle': '3.32', 'sei': '35.48'};CHEMBL146233;;CHEMBL146233;7.70;0;http://www.openphacts.org/units/Nanomolar;286535;=;1;1;=;;Ki;nM;;20.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20.0
;;471920;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccccc1S(=O)(=O)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '13.82', 'le': '0.27', 'lle': '2.08', 'sei': '8.82'};CHEMBL146998;;CHEMBL146998;5.40;0;http://www.openphacts.org/units/Nanomolar;286514;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4000.0
;;473136;[];CHEMBL820996;In vitro displacement of [35S]-MK- 499 from HEK 293 cells stably transfected with hERG voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)c1ccc(C(Cc2cc[n+]([O-])cc2)c2ccc(OC(F)F)c(OC(F)F)c2)cn1;;;CHEMBL1145790;J Med Chem;2003.0;{'bei': '9.85', 'le': '0.19', 'lle': '0.08', 'sei': '5.85'};CHEMBL417776;;CHEMBL417776;4.59;0;http://www.openphacts.org/units/Nanomolar;143630;=;1;1;=;;Ki;nM;;25400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;25.4
;;473179;[];CHEMBL816205;Displacement of [3H]-dofetilide to HEK cells stably expressing hERG voltage-gated IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1;;;CHEMBL1135811;J Med Chem;2002.0;{'bei': '17.44', 'le': '0.34', 'lle': '2.57', 'sei': '15.37'};CHEMBL148280;;CHEMBL148280;5.75;0;http://www.openphacts.org/units/Nanomolar;286513;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1800.0
;;514110;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccc4ccccc34)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '19.20', 'le': '0.35', 'lle': '1.42', 'sei': '25.01'};CHEMBL496687;;CHEMBL496687;6.96;0;http://www.openphacts.org/units/Nanomolar;67950;=;1;1;=;;Ki;nM;;110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;110.0
;;517808;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(C3CCCCC3)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '16.54', 'le': '0.31', 'lle': '0.50', 'sei': '18.93'};CHEMBL507898;;CHEMBL507898;5.27;0;http://www.openphacts.org/units/Nanomolar;67936;=;1;1;=;;Ki;nM;;5400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5400.0
;;524438;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2c(Cl)cccc12;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.27', 'le': '0.34', 'lle': '0.78', 'sei': '20.41'};CHEMBL523585;;CHEMBL523585;5.68;0;http://www.openphacts.org/units/Nanomolar;67952;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2100.0
;;531129;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(-c2[nH]c3ccccc3c2C2CCNCC2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '18.97', 'le': '0.34', 'lle': '0.94', 'sei': '18.85'};CHEMBL295559;;CHEMBL295559;5.24;0;http://www.openphacts.org/units/Nanomolar;67957;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5700.0
;;533797;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccsc3)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '18.29', 'le': '0.36', 'lle': '1.37', 'sei': '20.93'};CHEMBL497054;;CHEMBL497054;5.82;0;http://www.openphacts.org/units/Nanomolar;67946;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1500.0
;;533807;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(-c2[nH]c3cc(F)ccc3c2C2CCCNC2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '18.84', 'le': '0.35', 'lle': '1.31', 'sei': '21.16'};CHEMBL296512;;CHEMBL296512;5.89;0;http://www.openphacts.org/units/Nanomolar;67932;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1300.0
;;535154;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccc4ccccc4c3)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.39', 'le': '0.32', 'lle': '0.76', 'sei': '22.65'};CHEMBL496860;;CHEMBL496860;6.30;0;http://www.openphacts.org/units/Nanomolar;67949;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;500.0
;;536499;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(CCN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '16.49', 'le': '0.30', 'lle': '0.02', 'sei': '32.98'};CHEMBL44310;;CHEMBL44310;6.28;0;http://www.openphacts.org/units/Nanomolar;67931;=;1;1;=;;Ki;nM;;530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;530.0
;;536504;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1cccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccccc3)[nH]c12;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.68', 'le': '0.33', 'lle': '1.13', 'sei': '19.85'};CHEMBL498729;;CHEMBL498729;5.52;0;http://www.openphacts.org/units/Nanomolar;67953;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3000.0
;;537849;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccccc3)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.28', 'le': '0.32', 'lle': '1.01', 'sei': '19.40'};CHEMBL504699;;CHEMBL504699;5.40;0;http://www.openphacts.org/units/Nanomolar;67937;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4000.0
;;539026;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(-c2[nH]c3cc(F)ccc3c2[C@@H]2CNCC[C@H]2F)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.54', 'le': '0.33', 'lle': '1.27', 'sei': '20.83'};CHEMBL523245;;CHEMBL523245;5.80;0;http://www.openphacts.org/units/Nanomolar;67933;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1600.0
;;540344;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccnc3)[nH]c2c1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.88', 'le': '0.33', 'lle': '1.82', 'sei': '13.76'};CHEMBL523760;;CHEMBL523760;5.60;0;http://www.openphacts.org/units/Nanomolar;67948;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2500.0
;;541651;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(CCN2[C@@H]3CC[C@H]2CC(c2c(-c4ccccc4)[nH]c4ccccc24)C3)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '19.05', 'le': '0.34', 'lle': '0.95', 'sei': '40.70'};CHEMBL2113667;;CHEMBL2113667;7.75;0;http://www.openphacts.org/units/Nanomolar;67928;=;1;1;=;;Ki;nM;;18.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18.0
;;545540;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(CCN2CCC(c3c(-c4ccccc4)[nH]c4ccccc34)CC2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '18.65', 'le': '0.33', 'lle': '0.84', 'sei': '37.29'};CHEMBL40584;;CHEMBL40584;7.10;0;http://www.openphacts.org/units/Nanomolar;67927;=;1;1;=;;Ki;nM;;80.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;80.0
;;548262;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCCC(c2c(-c3ccccc3)[nH]c3ccccc23)C1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.28', 'le': '0.31', 'lle': '0.38', 'sei': '26.37'};CHEMBL43819;;CHEMBL43819;5.02;0;http://www.openphacts.org/units/Nanomolar;67956;=;1;1;=;;Ki;nM;;9600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9600.0
;;549275;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.84', 'le': '0.32', 'lle': '0.33', 'sei': '34.35'};CHEMBL46523;;CHEMBL46523;6.54;0;http://www.openphacts.org/units/Nanomolar;67955;=;1;1;=;;Ki;nM;;290.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;290.0
;;550360;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCCCC1c1c(-c2ccccc2)[nH]c2ccccc12;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.75', 'le': '0.32', 'lle': '0.16', 'sei': '27.09'};CHEMBL43697;;CHEMBL43697;5.16;0;http://www.openphacts.org/units/Nanomolar;67930;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7000.0
;;550364;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2cc(Cl)ccc12;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '17.80', 'le': '0.35', 'lle': '0.95', 'sei': '21.04'};CHEMBL498048;;CHEMBL498048;5.85;0;http://www.openphacts.org/units/Nanomolar;67954;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1400.0
;;551582;[];CHEMBL768699;Displacement of [3H]dofetilide from HEK cells expressing hERG voltage dependent IKr potassium channel Kv11.1;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1;;;CHEMBL1134475;J Med Chem;2001.0;{'bei': '19.21', 'le': '0.35', 'lle': '1.01', 'sei': '19.09'};CHEMBL42557;;CHEMBL42557;5.31;0;http://www.openphacts.org/units/Nanomolar;67929;=;1;1;=;;Ki;nM;;4900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4900.0
;;671631;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '10.27', 'le': '0.21', 'lle': '2.61', 'sei': '4.66'};CHEMBL22310;;CHEMBL22310;4.31;0;http://www.openphacts.org/units/Nanomolar;31187;=;1;1;=;;Ki;nM;;49000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;49000.0
;;674222;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)C1CCCCC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '19.94', 'le': '0.41', 'lle': '3.12', 'sei': '9.83'};CHEMBL23223;;CHEMBL23223;4.55;0;http://www.openphacts.org/units/Nanomolar;31176;=;1;1;=;;Ki;nM;;28000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;28000.0
;;675583;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '13.64', 'le': '0.27', 'lle': '3.12', 'sei': '6.93'};CHEMBL22359;;CHEMBL22359;5.23;1;http://www.openphacts.org/units/Nanomolar;31204;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5900.0
;;675588;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.10', 'le': '0.23', 'lle': '2.71', 'sei': '4.82'};CHEMBL25437;;CHEMBL25437;4.46;1;http://www.openphacts.org/units/Nanomolar;31188;=;1;1;=;;Ki;nM;;35000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;35000.0
;;679299;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.17', 'le': '0.23', 'lle': '2.90', 'sei': '5.13'};CHEMBL281561;;CHEMBL281561;5.22;0;http://www.openphacts.org/units/Nanomolar;31192;=;1;1;=;;Ki;nM;;6000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6000.0
;;679302;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '10.21', 'le': '0.21', 'lle': '2.58', 'sei': '4.63'};CHEMBL283309;;CHEMBL283309;4.28;0;http://www.openphacts.org/units/Nanomolar;31186;=;1;1;=;;Ki;nM;;52000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;52000.0
;;683566;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '12.42', 'le': '0.24', 'lle': '2.34', 'sei': '6.02'};CHEMBL278558;;CHEMBL278558;4.54;0;http://www.openphacts.org/units/Nanomolar;31203;=;1;1;=;;Ki;nM;;29000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;29000.0
;;685042;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NC(=O)c2ccccc2C(F)(F)F)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '10.61', 'le': '0.22', 'lle': '1.56', 'sei': '5.85'};CHEMBL283368;;CHEMBL283368;4.41;0;http://www.openphacts.org/units/Nanomolar;31199;=;1;1;=;;Ki;nM;;39000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;39000.0
;;685047;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.57', 'le': '0.22', 'lle': '2.00', 'sei': '5.16'};CHEMBL277693;;CHEMBL277693;4.37;0;http://www.openphacts.org/units/Nanomolar;31181;=;1;1;=;;Ki;nM;;43000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;43000.0
;;686324;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.25', 'le': '0.23', 'lle': '2.94', 'sei': '5.17'};CHEMBL281178;;CHEMBL281178;5.26;0;http://www.openphacts.org/units/Nanomolar;31193;=;1;1;=;;Ki;nM;;5500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5500.0
;;694015;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.95', 'le': '0.23', 'lle': '2.35', 'sei': '6.36'};CHEMBL23110;;CHEMBL23110;4.80;0;http://www.openphacts.org/units/Nanomolar;31200;=;1;1;=;;Ki;nM;;16000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;16000.0
;;695397;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.67', 'le': '0.24', 'lle': '2.87', 'sei': '5.15'};CHEMBL23979;;CHEMBL23979;5.24;1;http://www.openphacts.org/units/Nanomolar;31194;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5700.0
;;702337;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.07', 'le': '0.21', 'lle': '1.71', 'sei': '5.17'};CHEMBL279944;;CHEMBL279944;4.38;0;http://www.openphacts.org/units/Nanomolar;31180;=;1;1;=;;Ki;nM;;42000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;42000.0
;;703650;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '12.31', 'le': '0.24', 'lle': '2.57', 'sei': '6.26'};CHEMBL23660;;CHEMBL23660;4.72;0;http://www.openphacts.org/units/Nanomolar;31202;=;1;1;=;;Ki;nM;;19000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;19000.0
;;703653;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCCC1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '12.23', 'le': '0.23', 'lle': '1.98', 'sei': '5.19'};CHEMBL22679;;CHEMBL22679;4.40;1;http://www.openphacts.org/units/Nanomolar;31183;=;1;1;=;;Ki;nM;;40000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;40000.0
;;706254;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@@H](F)C1)[C@H]1CC[C@H](NC(=O)c2ccc(F)c(F)c2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '10.79', 'le': '0.21', 'lle': '1.99', 'sei': '5.48'};CHEMBL23924;;CHEMBL23924;4.14;0;http://www.openphacts.org/units/Nanomolar;31201;=;1;1;=;;Ki;nM;;73000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;73000.0
;;706257;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCC(F)(F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '10.87', 'le': '0.23', 'lle': '2.66', 'sei': '5.19'};CHEMBL423108;;CHEMBL423108;5.28;0;http://www.openphacts.org/units/Nanomolar;31191;=;1;1;=;;Ki;nM;;5300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5300.0
;;711474;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NC(=O)OCc2ccccc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.74', 'le': '0.22', 'lle': '2.06', 'sei': '5.23'};CHEMBL23891;;CHEMBL23891;4.43;0;http://www.openphacts.org/units/Nanomolar;31182;=;1;1;=;;Ki;nM;;37000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;37000.0
;;712813;[];CHEMBL682313;Binding affinity towards human ERG potassium ion channel was determined;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CCSC1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)CC1;;;CHEMBL1147603;Bioorg Med Chem Lett;2004.0;{'bei': '11.88', 'le': '0.25', 'lle': '3.27', 'sei': '5.46'};CHEMBL25211;;CHEMBL25211;5.55;1;http://www.openphacts.org/units/Nanomolar;31177;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2800.0
;;1028259;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.65', 'le': '0.16', 'lle': '-1.50', 'sei': '7.70'};CHEMBL177033;;CHEMBL177033;5.46;0;http://www.openphacts.org/units/Nanomolar;344525;=;1;1;=;;Ki;nM;;3500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.5
;;1030741;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.45', 'le': '0.16', 'lle': '-2.06', 'sei': '8.27'};CHEMBL366868;;CHEMBL366868;5.09;0;http://www.openphacts.org/units/Nanomolar;344540;=;1;1;=;;Ki;nM;;8100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.1
;;1034441;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.23', 'le': '0.16', 'lle': '-1.55', 'sei': '7.65'};CHEMBL176933;;CHEMBL176933;5.42;0;http://www.openphacts.org/units/Nanomolar;344572;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;1035802;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.66', 'le': '0.16', 'lle': '-1.18', 'sei': '7.88'};CHEMBL172854;;CHEMBL172854;4.85;0;http://www.openphacts.org/units/Nanomolar;344642;=;1;1;=;;Ki;nM;;14000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;14.0
;;1035836;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '7.50', 'le': '0.14', 'lle': '-1.38', 'sei': '5.82'};CHEMBL172090;;CHEMBL172090;4.66;0;http://www.openphacts.org/units/Nanomolar;344560;=;1;1;=;;Ki;nM;;22000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;22.0
;;1036949;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.07', 'le': '0.15', 'lle': '-1.51', 'sei': '7.34'};CHEMBL174457;;CHEMBL174457;4.52;0;http://www.openphacts.org/units/Nanomolar;344639;=;1;1;=;;Ki;nM;;30000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;30.0
;;1036967;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '7.99', 'le': '0.15', 'lle': '-1.08', 'sei': '6.19'};CHEMBL172806;;CHEMBL172806;4.96;0;http://www.openphacts.org/units/Nanomolar;344558;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;1036994;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '9.20', 'le': '0.17', 'lle': '-1.64', 'sei': '9.22'};CHEMBL174214;;CHEMBL174214;5.68;0;http://www.openphacts.org/units/Nanomolar;344536;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;1040437;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.11', 'le': '0.15', 'lle': '-1.79', 'sei': '7.08'};CHEMBL368204;;CHEMBL368204;5.02;0;http://www.openphacts.org/units/Nanomolar;344523;=;1;1;=;;Ki;nM;;9600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.6
;;1041652;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '10.24', 'le': '0.19', 'lle': '0.10', 'sei': '7.03'};CHEMBL367169;;CHEMBL367169;6.00;0;http://www.openphacts.org/units/Nanomolar;344621;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.0
;;1042729;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.67', 'le': '0.16', 'lle': '-1.49', 'sei': '7.72'};CHEMBL176459;;CHEMBL176459;5.47;0;http://www.openphacts.org/units/Nanomolar;344526;=;1;1;=;;Ki;nM;;3400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.4
;;1046663;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '7.14', 'le': '0.13', 'lle': '-1.61', 'sei': '5.54'};CHEMBL366871;;CHEMBL366871;4.43;0;http://www.openphacts.org/units/Nanomolar;344559;=;1;1;=;;Ki;nM;;37000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;37.0
;;1053828;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '7.93', 'le': '0.15', 'lle': '-1.63', 'sei': '6.77'};CHEMBL367700;;CHEMBL367700;4.80;0;http://www.openphacts.org/units/Nanomolar;344598;=;1;1;=;;Ki;nM;;16000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.0
;;1056393;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.30', 'le': '0.16', 'lle': '-1.95', 'sei': '7.41'};CHEMBL366328;;CHEMBL366328;5.25;0;http://www.openphacts.org/units/Nanomolar;344587;=;1;1;=;;Ki;nM;;5600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.6
;;1058898;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.85', 'le': '0.16', 'lle': '-2.05', 'sei': '9.15'};CHEMBL172296;;CHEMBL172296;5.64;0;http://www.openphacts.org/units/Nanomolar;344532;=;1;1;=;;Ki;nM;;2300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.3
;;1060100;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.10', 'le': '0.16', 'lle': '-1.71', 'sei': '7.37'};CHEMBL176426;;CHEMBL176426;5.22;0;http://www.openphacts.org/units/Nanomolar;344573;=;1;1;=;;Ki;nM;;6000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.0
;;1061392;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.31', 'le': '0.16', 'lle': '-1.72', 'sei': '7.40'};CHEMBL176571;;CHEMBL176571;5.24;0;http://www.openphacts.org/units/Nanomolar;344527;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.7
;;1061416;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '8.67', 'le': '0.16', 'lle': '-2.17', 'sei': '8.97'};CHEMBL174004;;CHEMBL174004;5.52;0;http://www.openphacts.org/units/Nanomolar;344534;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;1061425;[];CHEMBL819364;Binding affinity against hERG Voltage-gated potassium channel subunit Kv11.1;B;;;BAO_0000192;BAO_0000357;single protein format;CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1;;;CHEMBL1147446;Bioorg Med Chem Lett;2004.0;{'bei': '9.65', 'le': '0.18', 'lle': '-1.83', 'sei': '10.39'};CHEMBL368329;;CHEMBL368329;6.40;0;http://www.openphacts.org/units/Nanomolar;344531;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4
;;1403595;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCCn1nc(C2=C(c3cn(-c4cccnc4)c4ccccc34)C(=O)NC2=O)c2ccccc21;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '12.67', 'le': '0.23', 'lle': '2.32', 'sei': '7.31'};CHEMBL368416;;CHEMBL368416;6.21;0;http://www.openphacts.org/units/Nanomolar;360760;=;1;1;=;;Ki;nM;;610.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.61
;;1403620;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCCn1nc(C2=C(c3cn(-c4ccc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '14.09', 'le': '0.25', 'lle': '1.95', 'sei': '10.54'};CHEMBL368895;;CHEMBL368895;7.60;0;http://www.openphacts.org/units/Nanomolar;360789;=;1;1;=;;Ki;nM;;25.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.025
;;1403659;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCCn1nc(C2=C(c3cn(-c4cncc5ccccc45)c4ccccc34)C(=O)NC2=O)c2ccccc21;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '11.67', 'le': '0.21', 'lle': '1.26', 'sei': '7.42'};CHEMBL359808;;CHEMBL359808;6.31;0;http://www.openphacts.org/units/Nanomolar;360770;=;1;1;=;;Ki;nM;;490.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.49
;;1403672;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCCn1nc(C2=C(c3cn(-c4cnc5ccccc5c4)c4ccccc34)C(=O)NC2=O)c2ccccc21;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '13.81', 'le': '0.25', 'lle': '2.42', 'sei': '8.78'};CHEMBL359486;;CHEMBL359486;7.47;0;http://www.openphacts.org/units/Nanomolar;360771;=;1;1;=;;Ki;nM;;34.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.034
;;1403965;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '14.63', 'le': '0.29', 'lle': '1.87', 'sei': '15.01'};CHEMBL175586;;CHEMBL175586;5.61;0;http://www.openphacts.org/units/Nanomolar;360477;=;1;1;=;;Ki;nM;;2446.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2446.0
;;1404342;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '16.42', 'le': '0.33', 'lle': '2.55', 'sei': '16.05'};CHEMBL145939;;CHEMBL145939;6.00;1;http://www.openphacts.org/units/Nanomolar;360474;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1000.0
;;1404386;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '13.09', 'le': '0.27', 'lle': '1.37', 'sei': '14.06'};CHEMBL175832;;CHEMBL175832;5.25;0;http://www.openphacts.org/units/Nanomolar;360582;=;1;1;=;;Ki;nM;;5561.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5561.0
;;1404482;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(F)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '16.04', 'le': '0.32', 'lle': '2.57', 'sei': '16.45'};CHEMBL358075;;CHEMBL358075;6.15;1;http://www.openphacts.org/units/Nanomolar;360431;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;710.0
;;1404554;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NC(=O)C(c2nn(CCCN3CCOCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '10.44', 'le': '0.19', 'lle': '0.65', 'sei': '7.46'};CHEMBL367106;;CHEMBL367106;6.07;0;http://www.openphacts.org/units/Nanomolar;360776;=;1;1;=;;Ki;nM;;850.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.85
;;1404561;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NC(=O)C(c2nn(CCCN3CCCC3)c3ccccc23)=C1c1cn(-c2ccc3ccccc3c2)c2ccccc12;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '14.07', 'le': '0.25', 'lle': '1.77', 'sei': '11.03'};CHEMBL367107;;CHEMBL367107;7.96;0;http://www.openphacts.org/units/Nanomolar;360780;=;1;1;=;;Ki;nM;;11.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.011
;;1404648;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc(S(=O)(=O)C2(F)CCN(CCc3ccc(F)cc3F)CC2)cc1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '13.63', 'le': '0.27', 'lle': '1.96', 'sei': '9.10'};CHEMBL368816;;CHEMBL368816;5.57;0;http://www.openphacts.org/units/Nanomolar;360596;=;1;1;=;;Ki;nM;;2702.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2702.0
;;1404675;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCN(CCCn2nc(C3=C(c4cn(-c5ccc6ccccc6c5)c5ccccc45)C(=O)NC3=O)c3ccccc32)CC1;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '10.99', 'le': '0.20', 'lle': '1.20', 'sei': '8.67'};CHEMBL175845;;CHEMBL175845;6.54;0;http://www.openphacts.org/units/Nanomolar;360781;=;1;1;=;;Ki;nM;;290.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.29
;;1404695;[];CHEMBL839576;Inhibition of [3H]astemizole binding to Potassium channel HERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;;;CHEMBL1142718;J Med Chem;2005.0;{'bei': '13.77', 'le': '0.25', 'lle': '0.04', 'sei': '14.86'};CHEMBL17157;TERFENADINE;CHEMBL17157;6.50;0;http://www.openphacts.org/units/Nanomolar;360792;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;1404778;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(CN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccc(F)cc1F;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '13.62', 'le': '0.27', 'lle': '2.08', 'sei': '9.49'};CHEMBL177807;;CHEMBL177807;5.17;0;http://www.openphacts.org/units/Nanomolar;360432;=;1;1;=;;Ki;nM;;6800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6800.0
;;1405460;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(Cl)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '15.32', 'le': '0.32', 'lle': '2.00', 'sei': '17.12'};CHEMBL175544;;CHEMBL175544;6.40;0;http://www.openphacts.org/units/Nanomolar;360595;=;1;1;=;;Ki;nM;;397.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;397.0
;;1405496;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1F)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '15.94', 'le': '0.32', 'lle': '2.52', 'sei': '17.12'};CHEMBL177416;;CHEMBL177416;6.40;0;http://www.openphacts.org/units/Nanomolar;360534;=;1;1;=;;Ki;nM;;398.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;398.0
;;1405956;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(N2CCC2)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '11.40', 'le': '0.23', 'lle': '1.05', 'sei': '12.31'};CHEMBL176109;;CHEMBL176109;5.00;0;http://www.openphacts.org/units/Nanomolar;360549;=;1;1;=;;Ki;nM;;9971.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9971.0
;;1422906;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '15.95', 'le': '0.30', 'lle': '2.13', 'sei': '14.21'};CHEMBL74355;VOLINANSERIN;CHEMBL74355;5.96;1;http://www.openphacts.org/units/Nanomolar;366102;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1100.0
;;1496984;[];CHEMBL828081;Binding affinity against Potassium channel HERG was determined;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H](c1ccc(-c2ccc(F)cc2)cc1)[C@H](N)C(=O)N1CC[C@H](F)C1.O=C(O)C(F)(F)F;;;CHEMBL1139555;Bioorg Med Chem Lett;2005.0;{'bei': '17.30', 'le': '0.33', 'lle': '2.47', 'sei': '12.86'};CHEMBL189881;;CHEMBL237336;5.96;0;http://www.openphacts.org/units/Nanomolar;392265;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1100.0
;;1679998;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '15.10', 'le': '0.29', 'lle': '1.56', 'sei': '13.51'};CHEMBL319118;;CHEMBL319118;5.75;0;http://www.openphacts.org/units/Nanomolar;424893;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1800.0
;;1680013;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1nc(C2CC3(c4ccccc4)NC2CCC3NCc2cc(OC(F)(F)F)ccc2OC2CC2)[nH][nH]1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '10.16', 'le': '0.19', 'lle': '1.41', 'sei': '5.03'};CHEMBL379010;;CHEMBL379010;5.24;0;http://www.openphacts.org/units/Nanomolar;424903;=;1;1;=;;Ki;nM;;5800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5800.0
;;1680015;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(O)C1CC2(c3ccc(F)cc3)NC1CCC2NCc1cc(OC(F)(F)F)ccc1OC1CC1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '10.76', 'le': '0.21', 'lle': '0.84', 'sei': '6.66'};CHEMBL202568;;CHEMBL202568;5.32;0;http://www.openphacts.org/units/Nanomolar;424901;=;1;1;=;;Ki;nM;;4800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4800.0
;;1680016;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(NCC1CC2(c3ccc(F)cc3)NC1CCC2NCc1cc(OC(F)(F)F)ccc1OC1CC1)c1ccccc1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '10.85', 'le': '0.21', 'lle': '1.35', 'sei': '7.58'};CHEMBL202775;;CHEMBL202775;6.72;0;http://www.openphacts.org/units/Nanomolar;424900;=;1;1;=;;Ki;nM;;190.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;190.0
;;1680017;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)NCC1CC2(c3ccc(F)cc3)NC1CCC2NCc1cc(OC(F)(F)F)ccc1OC1CC1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '11.44', 'le': '0.23', 'lle': '2.44', 'sei': '7.19'};CHEMBL382848;;CHEMBL382848;6.38;0;http://www.openphacts.org/units/Nanomolar;424899;=;1;1;=;;Ki;nM;;420.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;420.0
;;1680018;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CC2(c3ccccc3)NC1CCC2NCc1cc(OC(F)(F)F)ccc1OC1CC1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '14.20', 'le': '0.27', 'lle': '2.33', 'sei': '10.47'};CHEMBL202417;;CHEMBL202417;6.57;0;http://www.openphacts.org/units/Nanomolar;424898;=;1;1;=;;Ki;nM;;270.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;270.0
;;1680019;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;FC(F)(F)Oc1ccc(Cl)c(CNC2CCC3CCC2(c2ccccc2)N3)c1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '14.25', 'le': '0.29', 'lle': '0.71', 'sei': '17.58'};CHEMBL202141;;CHEMBL202141;5.85;0;http://www.openphacts.org/units/Nanomolar;424897;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1400.0
;;1680020;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;FC(F)(F)Oc1ccc(OC2CC2)c(CNC2CCC3CCC2(c2ccccc2)N3)c1;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '14.90', 'le': '0.28', 'lle': '1.41', 'sei': '15.15'};CHEMBL382803;;CHEMBL382803;6.44;0;http://www.openphacts.org/units/Nanomolar;424896;=;1;1;=;;Ki;nM;;360.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;360.0
;;1680021;[];CHEMBL858932;Displacement of [35S]-labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(OC(F)(F)F)cc1CNC1CCC2CCC1(c1ccccc1)N2;;;CHEMBL1149413;Bioorg Med Chem Lett;2006.0;{'bei': '16.29', 'le': '0.31', 'lle': '2.13', 'sei': '15.57'};CHEMBL201362;;CHEMBL201362;6.62;0;http://www.openphacts.org/units/Nanomolar;424895;=;1;1;=;;Ki;nM;;240.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;240.0
;;1686242;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)[C@H]1CC[C@](c2ccccc2)(N2CCC(c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2=O)CC1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '12.05', 'le': '0.23', 'lle': '-0.43', 'sei': '25.51'};CHEMBL203700;;CHEMBL203700;6.01;0;http://www.openphacts.org/units/Nanomolar;432685;=;1;1;=;;Ki;nM;;984.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;984.0
;;1686243;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCN(c3ccccc3)C(=O)C2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '8.79', 'le': '0.17', 'lle': '-1.70', 'sei': '10.32'};CHEMBL380408;;CHEMBL380408;5.43;0;http://www.openphacts.org/units/Nanomolar;432696;=;1;1;=;;Ki;nM;;3706.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3706.0
;;1686244;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C(=O)N[C@]1(c2ccccc2)CC[C@@H](N2CCC3(CCOC3)CC2)CC1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '10.48', 'le': '0.20', 'lle': '-1.18', 'sei': '14.68'};CHEMBL381390;;CHEMBL381390;6.10;0;http://www.openphacts.org/units/Nanomolar;432695;=;1;1;=;;Ki;nM;;787.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;787.0
;;1686245;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC1(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCN([C@]2(c3ccccc3)CC[C@@H](N3CCC4(CCOC4)CC3)CC2)C1=O;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '9.64', 'le': '0.19', 'lle': '-1.12', 'sei': '14.34'};CHEMBL382331;;CHEMBL382331;6.02;0;http://www.openphacts.org/units/Nanomolar;432694;=;1;1;=;;Ki;nM;;947.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;947.0
;;1686246;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC1(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCN([C@]2(c3ccccc3)CC[C@@H](N3CCN(c4ccccc4Cl)C(=O)C3)CC2)C1=O;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '8.15', 'le': '0.16', 'lle': '-2.53', 'sei': '12.60'};CHEMBL381984;;CHEMBL381984;5.53;0;http://www.openphacts.org/units/Nanomolar;432693;=;1;1;=;;Ki;nM;;2987.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2987.0
;;1686247;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC1(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCN([C@]2(c3ccccc3)CC[C@@H](N3CCN(c4ccccc4)C(=O)C3)CC2)C1=O;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '8.87', 'le': '0.17', 'lle': '-1.69', 'sei': '13.02'};CHEMBL383048;;CHEMBL383048;5.71;0;http://www.openphacts.org/units/Nanomolar;432692;=;1;1;=;;Ki;nM;;1946.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1946.0
;;1686248;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC1(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCN([C@]2(c3ccccc3)CC[C@@H](N3CCC4(CCOC4)CC3)CC2)C1=O;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '10.58', 'le': '0.20', 'lle': '-1.11', 'sei': '19.64'};CHEMBL379224;;CHEMBL379224;6.44;0;http://www.openphacts.org/units/Nanomolar;432691;=;1;1;=;;Ki;nM;;364.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;364.0
;;1686249;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1N([C@]2(c3ccccc3)CC[C@@H](N3CCC4(CCOC4)CC3)CC2)CCC1(O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '9.93', 'le': '0.19', 'lle': '-0.42', 'sei': '11.44'};CHEMBL202884;;CHEMBL202884;6.06;0;http://www.openphacts.org/units/Nanomolar;432690;=;1;1;=;;Ki;nM;;862.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;862.0
;;1686250;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1CN([C@H]2CC[C@](c3ccccc3)(N3CCCC(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)C3=O)CC2)CCN1c1ccccc1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '8.06', 'le': '0.15', 'lle': '-2.43', 'sei': '11.82'};CHEMBL380651;;CHEMBL380651;5.18;0;http://www.openphacts.org/units/Nanomolar;432689;=;1;1;=;;Ki;nM;;6529.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6529.0
;;1686251;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1CN([C@H]2CC[C@](c3ccccc3)(N3CCC(c4cc(C(F)(F)F)cc(C(F)(F)F)c4)C3=O)CC2)CCN1c1ccccc1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '9.05', 'le': '0.17', 'lle': '-1.53', 'sei': '13.00'};CHEMBL203961;;CHEMBL203961;5.70;0;http://www.openphacts.org/units/Nanomolar;432688;=;1;1;=;;Ki;nM;;1996.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1996.0
;;1686252;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1C(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCCN1[C@]1(c2ccccc2)CC[C@@H](N2CCC3(CCOC3)CC2)CC1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '10.02', 'le': '0.19', 'lle': '-1.67', 'sei': '18.60'};CHEMBL381362;;CHEMBL381362;6.10;0;http://www.openphacts.org/units/Nanomolar;432687;=;1;1;=;;Ki;nM;;798.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;798.0
;;1686253;[];CHEMBL865929;Displacement of labelled MK-499 from cloned channel hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1C(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCN1[C@]1(c2ccccc2)CC[C@@H](N2CCC3(CCOC3)CC2)CC1;;;CHEMBL1138170;Bioorg Med Chem Lett;2006.0;{'bei': '10.91', 'le': '0.21', 'lle': '-0.89', 'sei': '19.78'};CHEMBL202439;;CHEMBL202439;6.49;0;http://www.openphacts.org/units/Nanomolar;432686;=;1;1;=;;Ki;nM;;327.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;327.0
;;1705124;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;FC(F)(F)c1cc(COC2CCC3CCC2(c2ccccc2)N3)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '15.19', 'le': '0.30', 'lle': '0.47', 'sei': '30.68'};CHEMBL380351;;CHEMBL380351;6.52;0;http://www.openphacts.org/units/Nanomolar;450449;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;300.0
;;1705127;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](OC1CCC2NC1(c1ccccc1)CC2c1nnnn1C)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '10.57', 'le': '0.20', 'lle': '0.02', 'sei': '8.56'};CHEMBL204573;;CHEMBL204573;5.55;0;http://www.openphacts.org/units/Nanomolar;450456;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2800.0
;;1705128;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](OC1CCC2NC1(c1ccccc1)CC2c1nnn(C)n1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '10.93', 'le': '0.21', 'lle': '0.21', 'sei': '8.86'};CHEMBL381965;;CHEMBL381965;5.75;0;http://www.openphacts.org/units/Nanomolar;450455;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1800.0
;;1705129;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nnnc1C1CC2(c3ccccc3)NC1CCC2OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '11.54', 'le': '0.22', 'lle': '0.93', 'sei': '9.10'};CHEMBL206983;;CHEMBL206983;5.90;0;http://www.openphacts.org/units/Nanomolar;450454;=;1;1;=;;Ki;nM;;1250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1250.0
;;1705130;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nnc(C2CC3(c4ccccc4)NC2CCC3OCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '13.69', 'le': '0.27', 'lle': '2.03', 'sei': '10.79'};CHEMBL380684;;CHEMBL380684;7.00;0;http://www.openphacts.org/units/Nanomolar;450453;=;1;1;=;;Ki;nM;;100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;100.0
;;1705131;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](OC1CCC2NC1(c1ccccc1)CC2S(=O)(=O)c1ccccc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '9.79', 'le': '0.20', 'lle': '-1.35', 'sei': '10.31'};CHEMBL381555;;CHEMBL381555;5.71;0;http://www.openphacts.org/units/Nanomolar;450452;=;1;1;=;;Ki;nM;;1930.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1930.0
;;1705132;[];CHEMBL868863;Displacement of [35S]-labeled MK499 from cloned hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)C1CC2(c3ccccc3)NC1CCC2OCc1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1146106;Bioorg Med Chem Lett;2006.0;{'bei': '10.33', 'le': '0.21', 'lle': '-0.61', 'sei': '10.62'};CHEMBL379152;;CHEMBL379152;5.89;0;http://www.openphacts.org/units/Nanomolar;450450;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1300.0
;;1708788;[];CHEMBL868467;Binding affinity to hERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(Br)cc1CCc1c(Cl)cccc1C(=O)N=C(N)N;;;CHEMBL1146974;Bioorg Med Chem Lett;2006.0;{'bei': '13.40', 'le': '0.31', 'lle': '2.19', 'sei': '6.07'};CHEMBL413931;;CHEMBL413931;5.50;0;http://www.openphacts.org/units/Nanomolar;459004;=;1;1;=;;Ki;nM;;3150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.15
;;1708789;[];CHEMBL868467;Binding affinity to hERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(Br)cc1CCc1c(Cl)cccc1C1=NCCN1;;;CHEMBL1146974;Bioorg Med Chem Lett;2006.0;{'bei': '15.43', 'le': '0.36', 'lle': '1.83', 'sei': '18.07'};CHEMBL205912;;CHEMBL205912;6.08;0;http://www.openphacts.org/units/Nanomolar;459031;=;1;1;=;;Ki;nM;;840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.84
;;1711655;[];CHEMBL870781;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccccc1Oc1cccc(CN2CCC(NC(=O)C3(c4ccccc4)CCNCC3)CC2)c1;;;CHEMBL1147650;J Med Chem;2006.0;{'bei': '12.20', 'le': '0.23', 'lle': '1.21', 'sei': '9.70'};CHEMBL205447;;CHEMBL205447;6.10;0;http://www.openphacts.org/units/Nanomolar;468543;=;1;1;=;;Ki;nM;;800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.8
;;1713826;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Oc1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '16.88', 'le': '0.33', 'lle': '2.55', 'sei': '10.40'};CHEMBL208028;;CHEMBL208028;6.95;0;http://www.openphacts.org/units/Nanomolar;472827;=;1;1;=;;Ki;nM;;112.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;112.0
;;1713873;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)nc(NC2CC3CCC(C2)N3Cc2ccc3c(c2)OCO3)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '14.37', 'le': '0.28', 'lle': '2.59', 'sei': '9.49'};CHEMBL448110;;CHEMBL448110;6.51;0;http://www.openphacts.org/units/Nanomolar;472850;=;1;1;=;;Ki;nM;;310.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;310.0
;;1713874;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1nc(NC2CC3CCC(C2)N3Cc2ccc3c(c2)OCO3)c2cc(Cl)ccc2n1CC(F)(F)F;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.29', 'le': '0.26', 'lle': '1.97', 'sei': '10.09'};CHEMBL205493;;CHEMBL205493;6.92;0;http://www.openphacts.org/units/Nanomolar;472849;=;1;1;=;;Ki;nM;;120.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;120.0
;;1713875;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)nc(NC2CC3CCC(C2)N3Cc2ccc3c(c2)OCO3)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.84', 'le': '0.27', 'lle': '2.35', 'sei': '9.13'};CHEMBL448110;;CHEMBL448110;6.27;0;http://www.openphacts.org/units/Nanomolar;472848;=;1;1;=;;Ki;nM;;540.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;540.0
;;1713876;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCn1c(=O)nc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '14.22', 'le': '0.28', 'lle': '1.82', 'sei': '10.01'};CHEMBL205760;;CHEMBL205760;6.87;0;http://www.openphacts.org/units/Nanomolar;472847;=;1;1;=;;Ki;nM;;135.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;135.0
;;1713877;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1nc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n1CC(F)(F)F;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '12.83', 'le': '0.26', 'lle': '1.93', 'sei': '9.26'};CHEMBL205492;;CHEMBL205492;6.35;0;http://www.openphacts.org/units/Nanomolar;472846;=;1;1;=;;Ki;nM;;445.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;445.0
;;1713878;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1nc(NC2CCN(Cc3ccc4ccccc4c3)CC2)c2cc(Cl)ccc2n1CC(F)(F)F;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.62', 'le': '0.27', 'lle': '0.98', 'sei': '13.60'};CHEMBL204508;;CHEMBL204508;6.82;0;http://www.openphacts.org/units/Nanomolar;472845;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;150.0
;;1713879;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)nc(NC2CCN(Cc3ccc4ncccc4c3)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.27', 'le': '0.25', 'lle': '1.55', 'sei': '9.13'};CHEMBL207308;;CHEMBL207308;5.76;0;http://www.openphacts.org/units/Nanomolar;472844;=;1;1;=;;Ki;nM;;1750.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1750.0
;;1713880;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)nc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '15.98', 'le': '0.31', 'lle': '3.43', 'sei': '9.94'};CHEMBL207668;;CHEMBL207668;6.82;0;http://www.openphacts.org/units/Nanomolar;472843;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;150.0
;;1713881;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)nc(NC2CCN(Cc3ccc4ccccc4c3)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '15.70', 'le': '0.30', 'lle': '1.98', 'sei': '13.55'};CHEMBL207296;;CHEMBL207296;6.80;0;http://www.openphacts.org/units/Nanomolar;472842;=;1;1;=;;Ki;nM;;160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;160.0
;;1713883;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)c1c(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n(C)c1=O;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '12.07', 'le': '0.23', 'lle': '2.06', 'sei': '7.12'};CHEMBL205741;;CHEMBL205741;5.84;0;http://www.openphacts.org/units/Nanomolar;472840;=;1;1;=;;Ki;nM;;1440.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1440.0
;;1713886;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1c(O)nc2ccc(Cl)cc2c1NC1CCN(Cc2ccc3c(c2)OCO3)CC1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '14.60', 'le': '0.28', 'lle': '2.11', 'sei': '7.04'};CHEMBL424865;;CHEMBL424865;6.38;0;http://www.openphacts.org/units/Nanomolar;472837;=;1;1;=;;Ki;nM;;420.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;420.0
;;1713887;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n1Cc1ccccn1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '12.44', 'le': '0.24', 'lle': '1.36', 'sei': '9.12'};CHEMBL206314;;CHEMBL206314;6.26;0;http://www.openphacts.org/units/Nanomolar;472836;=;1;1;=;;Ki;nM;;550.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;550.0
;;1713888;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1cc(NC2CCN(Cc3ccc4ccccc4c3)CC2)c2cc(Cl)ccc2n1Cc1ccccn1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.86', 'le': '0.26', 'lle': '0.73', 'sei': '14.07'};CHEMBL377084;;CHEMBL377084;7.06;0;http://www.openphacts.org/units/Nanomolar;472835;=;1;1;=;;Ki;nM;;88.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;88.0
;;1713889;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n1Cc1ccncc1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '12.82', 'le': '0.24', 'lle': '1.55', 'sei': '9.40'};CHEMBL208473;;CHEMBL208473;6.45;0;http://www.openphacts.org/units/Nanomolar;472834;=;1;1;=;;Ki;nM;;355.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;355.0
;;1713890;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(Cl)ccc2n1Cc1ccccc1;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '13.05', 'le': '0.25', 'lle': '1.04', 'sei': '11.76'};CHEMBL436953;;CHEMBL436953;6.55;0;http://www.openphacts.org/units/Nanomolar;472833;=;1;1;=;;Ki;nM;;280.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;280.0
;;1713891;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)cc(NC2CCN(Cc3ccc4c(c3)OCO4)CC2)c2cc(OC(F)(F)F)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '12.08', 'le': '0.23', 'lle': '1.50', 'sei': '8.84'};CHEMBL210273;;CHEMBL210273;5.75;0;http://www.openphacts.org/units/Nanomolar;472832;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1800.0
;;1713893;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc2c(c1)c(NC1CCN(Cc3ccc4c(c3)OCO4)CC1)cc(=O)n2C;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '14.49', 'le': '0.27', 'lle': '2.76', 'sei': '9.40'};CHEMBL207300;;CHEMBL207300;6.11;0;http://www.openphacts.org/units/Nanomolar;472830;=;1;1;=;;Ki;nM;;778.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;778.0
;;1713894;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)cc(NC2CCN(Cc3ccc4ccccc4c3)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '15.44', 'le': '0.29', 'lle': '1.25', 'sei': '17.89'};CHEMBL206953;;CHEMBL206953;6.67;0;http://www.openphacts.org/units/Nanomolar;472829;=;1;1;=;;Ki;nM;;215.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;215.0
;;1713895;[];CHEMBL865039;Binding affinity to hERG stably transfected in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(=O)cc(NC2CCN(C/C=C/c3ccccc3)CC2)c2cc(Cl)ccc21;;;CHEMBL1147687;Bioorg Med Chem Lett;2006.0;{'bei': '18.44', 'le': '0.35', 'lle': '2.74', 'sei': '20.18'};CHEMBL377884;;CHEMBL377884;7.52;0;http://www.openphacts.org/units/Nanomolar;472828;=;1;1;=;;Ki;nM;;30.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;30.0
;;1724708;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](O[C@H]1CCn2ccnc2C[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '12.03', 'le': '0.24', 'lle': '-1.09', 'sei': '21.64'};CHEMBL380388;;CHEMBL380388;5.85;0;http://www.openphacts.org/units/Nanomolar;480782;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;1724709;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](O[C@H]1CCc2nccn2C[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '11.81', 'le': '0.23', 'lle': '-1.20', 'sei': '21.24'};CHEMBL210630;;CHEMBL210630;5.75;0;http://www.openphacts.org/units/Nanomolar;480781;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;1724710;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](O[C@H]1CCC(=O)N(C)[C@@H](C)[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '10.53', 'le': '0.21', 'lle': '-1.56', 'sei': '17.51'};CHEMBL209240;;CHEMBL209240;5.17;0;http://www.openphacts.org/units/Nanomolar;480780;=;1;1;=;;Ki;nM;;6700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.7
;;1724711;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1C[C@H](O[C@H](C)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H](c2ccc(F)cc2)CN(C)C1=O;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '10.72', 'le': '0.21', 'lle': '-1.32', 'sei': '17.83'};CHEMBL378663;;CHEMBL378663;5.27;0;http://www.openphacts.org/units/Nanomolar;480779;=;1;1;=;;Ki;nM;;5400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.4
;;1724714;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1C[C@H](O[C@H](C)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H](c2ccc(F)cc2)CNC1=O;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '11.77', 'le': '0.23', 'lle': '-0.63', 'sei': '14.66'};CHEMBL209456;;CHEMBL209456;5.62;0;http://www.openphacts.org/units/Nanomolar;480776;=;1;1;=;;Ki;nM;;2400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.4
;;1724715;[];CHEMBL871230;Displacement of labeled MK-499 from cloned hERG channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1C[C@H](O[C@H](C)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[C@@H](c2ccc(F)cc2)CC(=O)N1;;;CHEMBL1147801;Bioorg Med Chem Lett;2006.0;{'bei': '10.62', 'le': '0.21', 'lle': '-1.32', 'sei': '13.23'};CHEMBL209407;;CHEMBL209407;5.07;0;http://www.openphacts.org/units/Nanomolar;480775;=;1;1;=;;Ki;nM;;8500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.5
;;1726698;[];CHEMBL861449;Binding affinity to human IKr;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(F)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1148517;Bioorg Med Chem Lett;2006.0;{'bei': '16.04', 'le': '0.32', 'lle': '2.57', 'sei': '16.45'};CHEMBL358075;;CHEMBL358075;6.15;1;http://www.openphacts.org/units/Nanomolar;489424;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;710.0
;;1726711;[];CHEMBL861449;Binding affinity to human IKr;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(F)cc1)N1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1148517;Bioorg Med Chem Lett;2006.0;{'bei': '13.82', 'le': '0.28', 'lle': '2.66', 'sei': '13.08'};CHEMBL207850;;CHEMBL207850;5.31;0;http://www.openphacts.org/units/Nanomolar;489426;=;1;1;=;;Ki;nM;;4869.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4869.0
;;1726712;[];CHEMBL861449;Binding affinity to human IKr;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4F)CC3)cccc12;;;CHEMBL1148517;Bioorg Med Chem Lett;2006.0;{'bei': '14.95', 'le': '0.28', 'lle': '2.58', 'sei': '9.34'};CHEMBL207566;;CHEMBL207566;5.90;0;http://www.openphacts.org/units/Nanomolar;489425;=;1;1;=;;Ki;nM;;1268.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1268.0
;;1746637;[];CHEMBL865554;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNC1CCN(c2ccc(NC(=O)c3ccc(-c4ccccc4)cc3)cn2)C1;;;CHEMBL1138061;J Med Chem;2006.0;{'bei': '17.99', 'le': '0.33', 'lle': '2.90', 'sei': '11.70'};CHEMBL425518;;CHEMBL425518;6.70;0;http://www.openphacts.org/units/Nanomolar;504472;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;1794636;[];CHEMBL863591;Displacement of [3H]Astemizole from hERG expressed in HEK293 cells at 10 uM;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1;;;CHEMBL1137244;Bioorg Med Chem Lett;2006.0;{'bei': '17.33', 'le': '0.32', 'lle': '1.52', 'sei': '40.44'};CHEMBL1008;BEPRIDIL;CHEMBL1008;6.35;0;http://www.openphacts.org/units/Nanomolar;618963;=;1;1;=;;Ki;nM;;444.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;444.0
;;1794637;[];CHEMBL863591;Displacement of [3H]Astemizole from hERG expressed in HEK293 cells at 10 uM;B;;;BAO_0000192;BAO_0000219;cell-based format;CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2;;;CHEMBL1137244;Bioorg Med Chem Lett;2006.0;{'bei': '16.35', 'le': '0.33', 'lle': '0.17', 'sei': '93.53'};CHEMBL479;THIORIDAZINE;CHEMBL479;6.06;0;http://www.openphacts.org/units/Nanomolar;618966;=;1;1;=;;Ki;nM;;869.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;869.0
;;1794638;[];CHEMBL863591;Displacement of [3H]Astemizole from hERG expressed in HEK293 cells at 10 uM;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1;;;CHEMBL1137244;Bioorg Med Chem Lett;2006.0;{'bei': '16.74', 'le': '0.33', 'lle': '1.86', 'sei': '15.52'};CHEMBL54;HALOPERIDOL;CHEMBL54;6.29;0;http://www.openphacts.org/units/Nanomolar;618965;=;1;1;=;;Ki;nM;;512.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;512.0
;;1794639;[];CHEMBL863591;Displacement of [3H]Astemizole from hERG expressed in HEK293 cells at 10 uM;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1;;;CHEMBL1137244;Bioorg Med Chem Lett;2006.0;{'bei': '15.98', 'le': '0.30', 'lle': '1.52', 'sei': '17.98'};CHEMBL1423;PIMOZIDE;CHEMBL1423;7.38;0;http://www.openphacts.org/units/Nanomolar;618964;=;1;1;=;;Ki;nM;;42.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;42.0
;;1806981;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Sc3ccccc3)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.30', 'le': '0.26', 'lle': '0.77', 'sei': '7.18'};CHEMBL221703;;CHEMBL221703;7.05;0;http://www.openphacts.org/units/Nanomolar;622316;=;1;1;=;;Ki;nM;;89.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.089
;;1806983;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(C(=O)Nc2ccc(-c3ccccc3CN3CCCCC3)cc2F)n(-c2cc3ccccc3cc2F)n1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '11.18', 'le': '0.20', 'lle': '-1.52', 'sei': '11.96'};CHEMBL384880;;CHEMBL384880;6.00;0;http://www.openphacts.org/units/Nanomolar;622354;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.0
;;1806985;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=N)N1CCC(Oc2ccc(N(Cc3ccc4ccc(C(=N)N)cc4c3)S(C)(=O)=O)cc2)CC1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '10.96', 'le': '0.21', 'lle': '1.48', 'sei': '4.38'};CHEMBL152069;;CHEMBL152069;5.41;0;http://www.openphacts.org/units/Nanomolar;622352;=;1;1;=;;Ki;nM;;3900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.9
;;1806987;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C/C(=C(\F)C(=O)Nc1ccc(-c2ccccc2S(N)(=O)=O)cc1)c1cccc(C(=N)N)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.87', 'le': '0.27', 'lle': '2.66', 'sei': '4.51'};CHEMBL286915;;CHEMBL286915;6.28;0;http://www.openphacts.org/units/Nanomolar;622350;=;1;1;=;;Ki;nM;;530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.53
;;1806989;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(C(=O)Nc2ccc(C(=N)N3CCCC3)cc2)n(-c2cc3ccccc3cc2C#N)n1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.50', 'le': '0.24', 'lle': '1.18', 'sei': '6.19'};CHEMBL220704;;CHEMBL220704;6.06;0;http://www.openphacts.org/units/Nanomolar;622348;=;1;1;=;;Ki;nM;;880.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.88
;;1806991;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)[C@H]1CN(S(=O)(=O)c2cc3cc(Cl)ccc3[nH]2)CC(=O)N1Cc1ccc(C(=N)N(C)C)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.09', 'le': '0.26', 'lle': '4.48', 'sei': '5.63'};CHEMBL386839;;CHEMBL386839;7.15;0;http://www.openphacts.org/units/Nanomolar;622346;=;1;1;=;;Ki;nM;;71.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.071
;;1806994;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN=C1c1ccc(C(=O)N2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2CC(=O)N2CCOCC2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '9.87', 'le': '0.20', 'lle': '3.21', 'sei': '6.05'};CHEMBL65219;;CHEMBL65219;6.22;0;http://www.openphacts.org/units/Nanomolar;622343;=;1;1;=;;Ki;nM;;600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.6
;;1806996;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)C1CCN(c2cc(C(=N)N(C)C)ccc2C(=O)Nc2ccc(OC)cc2C(=O)Nc2ccc(Cl)cn2)CC1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '10.25', 'le': '0.20', 'lle': '1.31', 'sei': '4.54'};CHEMBL376911;;CHEMBL376911;6.22;0;http://www.openphacts.org/units/Nanomolar;622341;=;1;1;=;;Ki;nM;;600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.6
;;1806997;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2N2CCCCC2)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '12.52', 'le': '0.24', 'lle': '1.57', 'sei': '6.05'};CHEMBL219106;;CHEMBL219106;6.70;0;http://www.openphacts.org/units/Nanomolar;622340;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;1807000;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(N2CCCC(C(=O)O)C2)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '9.93', 'le': '0.20', 'lle': '0.72', 'sei': '4.18'};CHEMBL218038;;CHEMBL218038;5.80;0;http://www.openphacts.org/units/Nanomolar;622337;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.6
;;1807002;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(N2CCCCC2)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '12.70', 'le': '0.25', 'lle': '1.08', 'sei': '6.76'};CHEMBL218609;;CHEMBL218609;6.85;0;http://www.openphacts.org/units/Nanomolar;622335;=;1;1;=;;Ki;nM;;140.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.14
;;1807003;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CCCC(=O)O)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '11.08', 'le': '0.22', 'lle': '0.84', 'sei': '4.32'};CHEMBL220807;;CHEMBL220807;5.85;0;http://www.openphacts.org/units/Nanomolar;622334;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;1807004;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CC(=O)O)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '11.70', 'le': '0.24', 'lle': '1.62', 'sei': '4.32'};CHEMBL220755;;CHEMBL220755;5.85;0;http://www.openphacts.org/units/Nanomolar;622333;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;1807005;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '15.34', 'le': '0.31', 'lle': '2.22', 'sei': '7.13'};CHEMBL221906;;CHEMBL221906;7.00;0;http://www.openphacts.org/units/Nanomolar;622332;=;1;1;=;;Ki;nM;;100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.1
;;1807007;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)C1CCN(C(=N)c2ccc(C(=O)Nc3c(OC)cc(Cl)cc3C(=O)Nc3ccc(Cl)cn3)c(F)c2)CC1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '11.83', 'le': '0.24', 'lle': '1.65', 'sei': '5.45'};CHEMBL221746;;CHEMBL221746;7.29;0;http://www.openphacts.org/units/Nanomolar;622330;=;1;1;=;;Ki;nM;;51.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.051
;;1807009;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)C1CCN(C(=N)c2ccc(C(=O)Nc3ccc(Cl)cc3C(=O)Nc3ccc(Cl)cn3)cc2)CC1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.67', 'le': '0.27', 'lle': '2.28', 'sei': '6.24'};CHEMBL218074;;CHEMBL218074;7.77;0;http://www.openphacts.org/units/Nanomolar;622328;=;1;1;=;;Ki;nM;;17.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.017
;;1807011;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)C1CCCN(C(=N)c2ccc(C(=O)Nc3ccc(Cl)cc3C(=O)Nc3ccc(Cl)cn3)cc2)C1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '13.71', 'le': '0.27', 'lle': '2.31', 'sei': '6.26'};CHEMBL218735;;CHEMBL218735;7.80;0;http://www.openphacts.org/units/Nanomolar;622326;=;1;1;=;;Ki;nM;;16.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.016
;;1807013;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '11.48', 'le': '0.22', 'lle': '1.94', 'sei': '4.50'};CHEMBL221178;;CHEMBL221178;6.01;0;http://www.openphacts.org/units/Nanomolar;622324;=;1;1;=;;Ki;nM;;970.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.97
;;1807015;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)CCc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '12.01', 'le': '0.23', 'lle': '1.87', 'sei': '4.90'};CHEMBL220757;;CHEMBL220757;6.10;0;http://www.openphacts.org/units/Nanomolar;622322;=;1;1;=;;Ki;nM;;790.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.79
;;1807017;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)c1ccc(Oc2ccc(NC(=O)c3ccc(C(=N)N(C)C)cc3)c(C(=O)Nc3ccc(Cl)cn3)c2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '10.92', 'le': '0.21', 'lle': '0.53', 'sei': '4.67'};CHEMBL218127;;CHEMBL218127;6.24;0;http://www.openphacts.org/units/Nanomolar;622320;=;1;1;=;;Ki;nM;;570.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.57
;;1807018;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Sc3ccc(C(=O)O)cc3)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '9.30', 'le': '0.18', 'lle': '-0.64', 'sei': '3.94'};CHEMBL218528;;CHEMBL218528;5.34;0;http://www.openphacts.org/units/Nanomolar;622319;=;1;1;=;;Ki;nM;;4600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.6
;;1807019;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Sc3ccc(C(=O)N(C)C)cc3)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '10.70', 'le': '0.21', 'lle': '0.45', 'sei': '5.43'};CHEMBL221756;;CHEMBL221756;6.43;0;http://www.openphacts.org/units/Nanomolar;622318;=;1;1;=;;Ki;nM;;370.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.37
;;1807020;[];CHEMBL907268;Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)c1ccc(Sc2ccc(NC(=O)c3ccc(C(=N)N(C)C)cc3)c(C(=O)Nc3ccc(Cl)cn3)c2)cc1;;;CHEMBL1139687;Bioorg Med Chem Lett;2006.0;{'bei': '12.16', 'le': '0.24', 'lle': '1.09', 'sei': '5.74'};CHEMBL221921;;CHEMBL221921;7.15;0;http://www.openphacts.org/units/Nanomolar;622317;=;1;1;=;;Ki;nM;;71.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.071
;;1808984;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(OCCN(C)C)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '14.55', 'le': '0.27', 'lle': '2.29', 'sei': '8.39'};CHEMBL385738;;CHEMBL385738;7.05;0;http://www.openphacts.org/units/Nanomolar;622949;=;1;1;=;;Ki;nM;;89.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.089
;;1809008;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C3(C)CCCCC3)CC2)c(-c2ccccc2)nc2c(F)cccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '9.35', 'le': '0.17', 'lle': '-1.10', 'sei': '7.31'};CHEMBL375419;;CHEMBL375419;5.70;0;http://www.openphacts.org/units/Nanomolar;622967;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;1809011;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCNCC2)c(-c2ccccc2)nc2c(F)cccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '9.90', 'le': '0.18', 'lle': '0.73', 'sei': '5.86'};CHEMBL375222;;CHEMBL375222;5.09;0;http://www.openphacts.org/units/Nanomolar;622964;=;1;1;=;;Ki;nM;;8200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.2
;;1809012;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CC2CCN(C3CCOCC3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '8.81', 'le': '0.16', 'lle': '-1.15', 'sei': '6.07'};CHEMBL221444;;CHEMBL221444;5.10;0;http://www.openphacts.org/units/Nanomolar;622963;=;1;1;=;;Ki;nM;;8000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.0
;;1809013;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CC2CCNCC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '12.71', 'le': '0.23', 'lle': '0.92', 'sei': '7.52'};CHEMBL222072;;CHEMBL222072;6.28;0;http://www.openphacts.org/units/Nanomolar;622962;=;1;1;=;;Ki;nM;;520.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.52
;;1809014;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(S(=O)(=O)c3ccccc3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '8.81', 'le': '0.17', 'lle': '0.27', 'sei': '5.00'};CHEMBL222078;;CHEMBL222078;5.60;0;http://www.openphacts.org/units/Nanomolar;622961;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.5
;;1809016;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(Cc3ccccc3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '10.71', 'le': '0.19', 'lle': '0.14', 'sei': '8.04'};CHEMBL374307;;CHEMBL374307;6.28;0;http://www.openphacts.org/units/Nanomolar;622959;=;1;1;=;;Ki;nM;;530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.53
;;1809017;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C3CCSCC3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '10.56', 'le': '0.20', 'lle': '0.46', 'sei': '8.07'};CHEMBL221238;;CHEMBL221238;6.29;0;http://www.openphacts.org/units/Nanomolar;622958;=;1;1;=;;Ki;nM;;510.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.51
;;1809018;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C3CCOCC3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '8.95', 'le': '0.16', 'lle': '0.07', 'sei': '5.95'};CHEMBL220963;;CHEMBL220963;5.19;0;http://www.openphacts.org/units/Nanomolar;622957;=;1;1;=;;Ki;nM;;6500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.5
;;1809019;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C3CCCCC3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '9.94', 'le': '0.18', 'lle': '-0.53', 'sei': '7.36'};CHEMBL221237;;CHEMBL221237;5.75;0;http://www.openphacts.org/units/Nanomolar;622956;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;1809020;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C(C)C)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '11.26', 'le': '0.21', 'lle': '0.71', 'sei': '7.76'};CHEMBL218639;;CHEMBL218639;6.06;0;http://www.openphacts.org/units/Nanomolar;622955;=;1;1;=;;Ki;nM;;880.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.88
;;1809021;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCN(C)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '12.74', 'le': '0.23', 'lle': '1.92', 'sei': '8.33'};CHEMBL374438;;CHEMBL374438;6.50;0;http://www.openphacts.org/units/Nanomolar;622954;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;1809022;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCNCC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '12.26', 'le': '0.22', 'lle': '1.86', 'sei': '7.00'};CHEMBL221299;;CHEMBL221299;6.08;0;http://www.openphacts.org/units/Nanomolar;622953;=;1;1;=;;Ki;nM;;840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.84
;;1809023;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(CN2CCCCC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '10.74', 'le': '0.20', 'lle': '-0.50', 'sei': '7.10'};CHEMBL221077;;CHEMBL221077;5.31;0;http://www.openphacts.org/units/Nanomolar;622952;=;1;1;=;;Ki;nM;;4900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.9
;;1809024;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(OC2CCN(C(C)(C)C)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '9.99', 'le': '0.18', 'lle': '-0.94', 'sei': '6.57'};CHEMBL426714;;CHEMBL426714;5.52;0;http://www.openphacts.org/units/Nanomolar;622951;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;1809025;[];CHEMBL910704;Displacement of labeled MK499 from cloned hERG potassium channel expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(=O)N(NC(=O)c1c(OC2CCN(C3CCOCC3)CC2)c(-c2ccccc2)nc2ccccc12)c1ccccc1;;;CHEMBL1139719;Bioorg Med Chem Lett;2006.0;{'bei': '8.70', 'le': '0.16', 'lle': '-0.79', 'sei': '5.42'};CHEMBL218321;;CHEMBL218321;5.05;0;http://www.openphacts.org/units/Nanomolar;622950;=;1;1;=;;Ki;nM;;8900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.9
;;1896905;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;CCC1(CN)CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2C)C1;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '11.64', 'le': '0.22', 'lle': '1.69', 'sei': '4.91'};CHEMBL388488;;CHEMBL388488;4.35;0;http://www.openphacts.org/units/Nanomolar;641801;=;1;1;=;;Ki;nM;;45000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;45.0
;;1896912;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1c(N2CC[C@@H]([C@H](C)NCCC#N)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '9.71', 'le': '0.18', 'lle': '0.94', 'sei': '4.21'};CHEMBL230813;;CHEMBL230813;4.14;0;http://www.openphacts.org/units/Nanomolar;641794;=;1;1;=;;Ki;nM;;72000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;72.0
;;1896913;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1c(N2CC[C@@H]([C@H](C)N)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '11.49', 'le': '0.22', 'lle': '1.63', 'sei': '4.85'};CHEMBL230812;;CHEMBL230812;4.29;0;http://www.openphacts.org/units/Nanomolar;641793;=;1;1;=;;Ki;nM;;51000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;51.0
;;1896916;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1c(N2CC[C@@H]([C@H](C)N)C2)ccc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '11.33', 'le': '0.21', 'lle': '1.99', 'sei': '4.30'};CHEMBL230704;;CHEMBL230704;4.21;0;http://www.openphacts.org/units/Nanomolar;641790;=;1;1;=;;Ki;nM;;62000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;62.0
;;1896918;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1c(N2CC[C@@H](CN)C2)ccc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '11.73', 'le': '0.22', 'lle': '2.36', 'sei': '4.29'};CHEMBL387838;;CHEMBL387838;4.19;0;http://www.openphacts.org/units/Nanomolar;641788;=;1;1;=;;Ki;nM;;64000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;64.0
;;1896923;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1c(N2CC[C@@H]([C@H](C)N)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '10.45', 'le': '0.20', 'lle': '1.71', 'sei': '4.16'};CHEMBL230598;;CHEMBL230598;4.07;0;http://www.openphacts.org/units/Nanomolar;641783;=;1;1;=;;Ki;nM;;85000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;85.0
;;1896925;[];CHEMBL886338;Displacement of [3H]dofetilide from human ERG by fliter binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1c(N2CC[C@@H](CN)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12;;;CHEMBL1144619;Bioorg Med Chem Lett;2007.0;{'bei': '12.31', 'le': '0.23', 'lle': '2.65', 'sei': '4.72'};CHEMBL231315;;CHEMBL231315;4.62;0;http://www.openphacts.org/units/Nanomolar;641781;=;1;1;=;;Ki;nM;;24000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;24.0
;;1901318;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '18.56', 'le': '0.39', 'lle': '6.21', 'sei': '7.82'};CHEMBL473;DOFETILIDE;CHEMBL473;8.19;0;http://www.openphacts.org/units/Nanomolar;643225;=;1;1;=;;Ki;nM;;6.4;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6.4
;;1901319;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '16.86', 'le': '0.33', 'lle': '1.79', 'sei': '17.85'};CHEMBL42;CLOZAPINE;CHEMBL42;5.51;0;http://www.openphacts.org/units/Nanomolar;643244;=;1;1;=;;Ki;nM;;3080.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3080.0
;;1901320;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '13.02', 'le': '0.24', 'lle': '1.18', 'sei': '9.57'};CHEMBL45816;MIBEFRADIL;CHEMBL45816;6.45;0;http://www.openphacts.org/units/Nanomolar;643243;=;1;1;=;;Ki;nM;;353.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;353.0
;;1901321;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '17.83', 'le': '0.33', 'lle': '1.71', 'sei': '41.60'};CHEMBL1008;BEPRIDIL;CHEMBL1008;6.54;0;http://www.openphacts.org/units/Nanomolar;643242;=;1;1;=;;Ki;nM;;291.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;291.0
;;1901322;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '19.21', 'le': '0.38', 'lle': '4.81', 'sei': '9.72'};CHEMBL536480;;CHEMBL327980;7.71;0;http://www.openphacts.org/units/Nanomolar;643241;=;1;1;=;;Ki;nM;;19.4;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;19.4
;;1901323;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '17.21', 'le': '0.32', 'lle': '2.54', 'sei': '18.65'};CHEMBL296419;ASTEMIZOLE;CHEMBL296419;7.89;0;http://www.openphacts.org/units/Nanomolar;643240;=;1;1;=;;Ki;nM;;12.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12.8
;;1901337;[];CHEMBL889315;Displacement of [3H]dofetilide from hERG expressed in HEK293 cells by SPA;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(CCN(CCOc2ccc(NS(C)(=O)=O)cc2)c2ccc([N+](=O)[O-])c3nonc23)cc1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '15.93', 'le': '0.32', 'lle': '6.41', 'sei': '5.04'};CHEMBL227134;;CHEMBL227134;9.41;0;http://www.openphacts.org/units/Nanomolar;643226;=;1;1;=;;Ki;nM;;0.39;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;0.39
;;1901338;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '18.62', 'le': '0.34', 'lle': '3.19', 'sei': '20.17'};CHEMBL296419;ASTEMIZOLE;CHEMBL296419;8.54;0;http://www.openphacts.org/units/Nanomolar;643240;=;1;1;=;;Ki;nM;;2.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.9
;;1901339;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '16.50', 'le': '0.32', 'lle': '1.67', 'sei': '17.47'};CHEMBL42;CLOZAPINE;CHEMBL42;5.39;0;http://www.openphacts.org/units/Nanomolar;643244;=;1;1;=;;Ki;nM;;4060.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4060.0
;;1901340;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '13.56', 'le': '0.25', 'lle': '1.45', 'sei': '9.96'};CHEMBL45816;MIBEFRADIL;CHEMBL45816;6.72;0;http://www.openphacts.org/units/Nanomolar;643243;=;1;1;=;;Ki;nM;;190.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;190.0
;;1901341;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '18.37', 'le': '0.34', 'lle': '1.91', 'sei': '42.87'};CHEMBL1008;BEPRIDIL;CHEMBL1008;6.74;0;http://www.openphacts.org/units/Nanomolar;643242;=;1;1;=;;Ki;nM;;184.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;184.0
;;1901342;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(CCN2CCC(C(=O)c3ccc(NS(C)(=O)=O)cc3)CC2)n1.Cl.Cl;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '19.25', 'le': '0.38', 'lle': '4.83', 'sei': '9.74'};CHEMBL536480;;CHEMBL327980;7.73;0;http://www.openphacts.org/units/Nanomolar;643241;=;1;1;=;;Ki;nM;;18.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18.7
;;1901343;[];CHEMBL889314;Binding affinity at hERG expressed in HEK293 cells by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CCOc1ccc(NS(C)(=O)=O)cc1)CCc1ccc(NS(C)(=O)=O)cc1;;;CHEMBL1145378;J Med Chem;2007.0;{'bei': '18.37', 'le': '0.38', 'lle': '6.13', 'sei': '7.74'};CHEMBL473;DOFETILIDE;CHEMBL473;8.11;0;http://www.openphacts.org/units/Nanomolar;643225;=;1;1;=;;Ki;nM;;7.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7.7
;;2020476;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(c2cccc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc23)CC1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.55', 'le': '0.26', 'lle': '1.02', 'sei': '10.79'};CHEMBL392586;;CHEMBL392586;5.89;0;http://www.openphacts.org/units/Nanomolar;671207;=;1;1;=;;Ki;nM;;1280.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1280.0
;;2020513;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.48', 'le': '0.26', 'lle': '0.82', 'sei': '9.34'};CHEMBL239603;;CHEMBL239603;6.69;0;http://www.openphacts.org/units/Nanomolar;671221;=;1;1;=;;Ki;nM;;206.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;206.0
;;2020514;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.43', 'le': '0.26', 'lle': '0.79', 'sei': '9.30'};CHEMBL239603;;CHEMBL239603;6.66;0;http://www.openphacts.org/units/Nanomolar;671220;=;1;1;=;;Ki;nM;;219.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;219.0
;;2020515;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.45', 'le': '0.26', 'lle': '0.80', 'sei': '9.31'};CHEMBL239603;;CHEMBL239603;6.67;0;http://www.openphacts.org/units/Nanomolar;671219;=;1;1;=;;Ki;nM;;214.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;214.0
;;2020516;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '12.94', 'le': '0.25', 'lle': '0.55', 'sei': '8.96'};CHEMBL239603;;CHEMBL239603;6.42;0;http://www.openphacts.org/units/Nanomolar;671218;=;1;1;=;;Ki;nM;;381.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;381.0
;;2020517;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(Cc1cccc(OCc2noc(-c3ccccc3F)n2)c1)C1CCN(C2CC(C)C(C)C2)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.51', 'le': '0.25', 'lle': '0.86', 'sei': '12.18'};CHEMBL392350;;CHEMBL392350;6.65;0;http://www.openphacts.org/units/Nanomolar;671217;=;1;1;=;;Ki;nM;;222.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;222.0
;;2020518;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4ccc(-c5ccccc5F)cn4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.07', 'le': '0.24', 'lle': '0.02', 'sei': '14.01'};CHEMBL239605;;CHEMBL239605;6.39;0;http://www.openphacts.org/units/Nanomolar;671216;=;1;1;=;;Ki;nM;;410.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;410.0
;;2020519;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccccc5F)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '12.27', 'le': '0.23', 'lle': '0.53', 'sei': '8.22'};CHEMBL394236;;CHEMBL394236;5.89;0;http://www.openphacts.org/units/Nanomolar;671215;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1300.0
;;2020520;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1CCCN(CCCC2CCCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)C1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.24', 'le': '0.26', 'lle': '0.70', 'sei': '9.17'};CHEMBL239603;;CHEMBL239603;6.57;0;http://www.openphacts.org/units/Nanomolar;671214;=;1;1;=;;Ki;nM;;271.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;271.0
;;2020521;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1(NCCCC2CCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)CCCC1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.03', 'le': '0.25', 'lle': '0.61', 'sei': '7.81'};CHEMBL393169;;CHEMBL393169;6.28;0;http://www.openphacts.org/units/Nanomolar;671213;=;1;1;=;;Ki;nM;;525.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;525.0
;;2020522;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1(N2CCN(C3CCc4ccc(OCc5noc(-c6ccccc6F)n5)cc43)CC2)CCCC1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '12.48', 'le': '0.23', 'lle': '1.79', 'sei': '8.21'};CHEMBL239601;;CHEMBL239601;6.15;0;http://www.openphacts.org/units/Nanomolar;671212;=;1;1;=;;Ki;nM;;709.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;709.0
;;2020523;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccccc1-c1nc(COc2ccc3c(c2)C(N2CCN(C4CCCC4)CC2)CC3)no1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.32', 'le': '0.25', 'lle': '1.16', 'sei': '11.27'};CHEMBL393168;;CHEMBL393168;6.16;0;http://www.openphacts.org/units/Nanomolar;671211;=;1;1;=;;Ki;nM;;693.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;693.0
;;2020524;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1(N2CCN(C3CCc4ccc(OCc5noc(-c6ccc(Cl)cc6)n5)cc43)CC2)CCCC1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '13.14', 'le': '0.25', 'lle': '1.81', 'sei': '8.93'};CHEMBL392770;;CHEMBL392770;6.69;0;http://www.openphacts.org/units/Nanomolar;671210;=;1;1;=;;Ki;nM;;205.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;205.0
;;2020525;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC1CC(N2CCN(C3CCc4ccc(OCc5noc(-c6ccc(Cl)cc6)n5)cc43)CC2)CC1C;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '12.98', 'le': '0.25', 'lle': '0.57', 'sei': '12.05'};CHEMBL239598;;CHEMBL239598;6.58;0;http://www.openphacts.org/units/Nanomolar;671209;=;1;1;=;;Ki;nM;;261.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;261.0
;;2020526;[];CHEMBL903410;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)N1CCN(C2CCc3ccc(OCc4noc(-c5ccc(Cl)cc5)n4)cc32)CC1;;;CHEMBL1139118;Bioorg Med Chem Lett;2007.0;{'bei': '15.47', 'le': '0.30', 'lle': '2.03', 'sei': '12.83'};CHEMBL239596;;CHEMBL239596;7.01;0;http://www.openphacts.org/units/Nanomolar;671208;=;1;1;=;;Ki;nM;;98.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;98.1
;;2023089;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][S+](c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2F)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.19', 'le': '0.30', 'lle': '0.49', 'sei': '14.43'};CHEMBL240887;;CHEMBL240887;5.19;0;http://www.openphacts.org/units/Nanomolar;672123;=;1;1;=;;Ki;nM;;6500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6500.0
;;2023186;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][S+](c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2F)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.75', 'le': '0.31', 'lle': '0.68', 'sei': '14.96'};CHEMBL240887;;CHEMBL240887;5.38;0;http://www.openphacts.org/units/Nanomolar;672122;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4200.0
;;2023187;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][S+](c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2F)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '16.27', 'le': '0.32', 'lle': '0.85', 'sei': '15.45'};CHEMBL240887;;CHEMBL240887;5.55;0;http://www.openphacts.org/units/Nanomolar;672121;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2800.0
;;2023188;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][S+](c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '16.73', 'le': '0.32', 'lle': '0.85', 'sei': '15.05'};CHEMBL240886;;CHEMBL240886;5.41;0;http://www.openphacts.org/units/Nanomolar;672120;=;1;1;=;;Ki;nM;;3900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3900.0
;;2023190;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;[O-][S+](c1ccc(/C=C/c2ccc(F)cc2)nc1)c1ccccc1F;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '16.22', 'le': '0.32', 'lle': '0.84', 'sei': '15.40'};CHEMBL395459;;CHEMBL395459;5.54;0;http://www.openphacts.org/units/Nanomolar;672118;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2900.0
;;2023191;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2F)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '14.12', 'le': '0.28', 'lle': '0.69', 'sei': '10.73'};CHEMBL1162962;;CHEMBL1162962;5.05;0;http://www.openphacts.org/units/Nanomolar;672117;=;1;1;=;;Ki;nM;;9000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9000.0
;;2023192;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(F)ccc1/C=C/c1ccc(S(=O)(=O)c2ccccc2F)cn1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.11', 'le': '0.30', 'lle': '1.48', 'sei': '10.41'};CHEMBL240878;;CHEMBL240878;5.85;0;http://www.openphacts.org/units/Nanomolar;672116;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1400.0
;;2023193;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(/C=C/c2ccccc2O)nc1)c1ccccc1F;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '16.47', 'le': '0.32', 'lle': '1.92', 'sei': '8.70'};CHEMBL240877;;CHEMBL240877;5.85;0;http://www.openphacts.org/units/Nanomolar;672115;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1400.0
;;2023194;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(/C=C/c2ccc(F)cc2O)nc1)c1ccccc1F;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.21', 'le': '0.30', 'lle': '1.61', 'sei': '8.44'};CHEMBL240876;;CHEMBL240876;5.68;0;http://www.openphacts.org/units/Nanomolar;672114;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2100.0
;;2023195;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1cc(F)ccc1/C=C/c1ccc(S(=O)(=O)c2ccccc2F)cn1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.23', 'le': '0.29', 'lle': '1.59', 'sei': '8.22'};CHEMBL395458;;CHEMBL395458;5.82;0;http://www.openphacts.org/units/Nanomolar;672113;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1500.0
;;2023196;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(F)ccc1/C=C/c1ccc(S(=O)(=O)c2ccccc2F)cn1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '14.27', 'le': '0.28', 'lle': '0.63', 'sei': '11.27'};CHEMBL240680;;CHEMBL240680;5.30;0;http://www.openphacts.org/units/Nanomolar;672112;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5000.0
;;2023197;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(/C=C/c2ccc(F)cc2Cl)nc1)c1ccccc1F;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '13.57', 'le': '0.28', 'lle': '0.30', 'sei': '11.31'};CHEMBL397112;;CHEMBL397112;5.32;0;http://www.openphacts.org/units/Nanomolar;672111;=;1;1;=;;Ki;nM;;4800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4800.0
;;2023199;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(/C=C/c2ccncc2)nc1)c1ccccc1F;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.80', 'le': '0.31', 'lle': '1.76', 'sei': '8.97'};CHEMBL240864;;CHEMBL240864;5.38;0;http://www.openphacts.org/units/Nanomolar;672109;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4200.0
;;2023205;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)c1ccc(/C=C/c2ccc(F)cc2)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '14.05', 'le': '0.27', 'lle': '0.66', 'sei': '10.68'};CHEMBL240841;;CHEMBL240841;5.02;0;http://www.openphacts.org/units/Nanomolar;672103;=;1;1;=;;Ki;nM;;9500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9500.0
;;2023206;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)c1ccc(/C=C/c2ccc(F)cc2)cn1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '15.34', 'le': '0.30', 'lle': '1.12', 'sei': '11.66'};CHEMBL240840;;CHEMBL240840;5.48;0;http://www.openphacts.org/units/Nanomolar;672102;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3300.0
;;2023207;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)c1ccc(CCc2ccc(F)cc2)nc1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '14.15', 'le': '0.28', 'lle': '1.11', 'sei': '10.81'};CHEMBL240839;;CHEMBL240839;5.09;0;http://www.openphacts.org/units/Nanomolar;672101;=;1;1;=;;Ki;nM;;8200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8200.0
;;2023208;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)c1ccc(CCc2ccc(F)cc2)cn1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '14.36', 'le': '0.28', 'lle': '1.18', 'sei': '10.97'};CHEMBL240246;;CHEMBL240246;5.16;0;http://www.openphacts.org/units/Nanomolar;672100;=;1;1;=;;Ki;nM;;6900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6900.0
;;2023209;[];CHEMBL886667;Displacement of [3H]dofetilide from hERG expressed in HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1139157;Bioorg Med Chem Lett;2007.0;{'bei': '13.08', 'le': '0.27', 'lle': '1.37', 'sei': '14.05'};CHEMBL175832;;CHEMBL175832;5.25;1;http://www.openphacts.org/units/Nanomolar;672099;=;1;1;=;;Ki;nM;;5600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5600.0
;;2075885;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.74', 'le': '0.29', 'lle': '2.67', 'sei': '14.43'};CHEMBL252816;;CHEMBL252816;7.00;0;http://www.openphacts.org/units/Nanomolar;688381;=;1;1;=;;Ki;nM;;101.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;101.0
;;2075887;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.84', 'le': '0.26', 'lle': '2.22', 'sei': '10.91'};CHEMBL252430;;CHEMBL252430;6.70;0;http://www.openphacts.org/units/Nanomolar;688404;=;1;1;=;;Ki;nM;;202.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;202.0
;;2075888;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.72', 'le': '0.26', 'lle': '1.65', 'sei': '14.17'};CHEMBL252429;;CHEMBL252429;6.87;0;http://www.openphacts.org/units/Nanomolar;688403;=;1;1;=;;Ki;nM;;135.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;135.0
;;2075889;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)C(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.84', 'le': '0.28', 'lle': '2.24', 'sei': '13.74'};CHEMBL398525;;CHEMBL398525;6.66;0;http://www.openphacts.org/units/Nanomolar;688402;=;1;1;=;;Ki;nM;;219.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;219.0
;;2075890;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C1CC1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '15.37', 'le': '0.29', 'lle': '2.69', 'sei': '14.16'};CHEMBL252230;;CHEMBL252230;6.86;0;http://www.openphacts.org/units/Nanomolar;688401;=;1;1;=;;Ki;nM;;137.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;137.0
;;2075891;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.64', 'le': '0.28', 'lle': '2.01', 'sei': '13.56'};CHEMBL252228;;CHEMBL252228;6.57;0;http://www.openphacts.org/units/Nanomolar;688400;=;1;1;=;;Ki;nM;;269.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;269.0
;;2075892;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '15.50', 'le': '0.30', 'lle': '2.57', 'sei': '13.90'};CHEMBL252031;;CHEMBL252031;6.74;0;http://www.openphacts.org/units/Nanomolar;688399;=;1;1;=;;Ki;nM;;184.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;184.0
;;2075893;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.45', 'le': '0.26', 'lle': '1.88', 'sei': '11.67'};CHEMBL252030;;CHEMBL252030;5.66;0;http://www.openphacts.org/units/Nanomolar;688398;=;1;1;=;;Ki;nM;;2202.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2202.0
;;2075894;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.42', 'le': '0.28', 'lle': '2.51', 'sei': '14.12'};CHEMBL398711;;CHEMBL398711;6.84;0;http://www.openphacts.org/units/Nanomolar;688397;=;1;1;=;;Ki;nM;;143.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;143.0
;;2075895;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.41', 'le': '0.27', 'lle': '2.75', 'sei': '9.16'};CHEMBL251834;;CHEMBL251834;6.82;0;http://www.openphacts.org/units/Nanomolar;688396;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;150.0
;;2075896;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '15.78', 'le': '0.30', 'lle': '2.79', 'sei': '12.10'};CHEMBL398744;;CHEMBL398744;7.46;0;http://www.openphacts.org/units/Nanomolar;688395;=;1;1;=;;Ki;nM;;35.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;35.0
;;2075897;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '12.32', 'le': '0.23', 'lle': '0.89', 'sei': '12.98'};CHEMBL252201;;CHEMBL252201;6.29;0;http://www.openphacts.org/units/Nanomolar;688394;=;1;1;=;;Ki;nM;;511.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;511.0
;;2075898;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.48', 'le': '0.25', 'lle': '1.69', 'sei': '13.82'};CHEMBL253878;;CHEMBL253878;6.70;0;http://www.openphacts.org/units/Nanomolar;688393;=;1;1;=;;Ki;nM;;201.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;201.0
;;2075899;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.33', 'le': '0.25', 'lle': '1.98', 'sei': '10.51'};CHEMBL398619;;CHEMBL398619;6.45;0;http://www.openphacts.org/units/Nanomolar;688392;=;1;1;=;;Ki;nM;;358.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;358.0
;;2075900;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.20', 'le': '0.27', 'lle': '1.89', 'sei': '14.66'};CHEMBL442290;;CHEMBL442290;7.11;0;http://www.openphacts.org/units/Nanomolar;688391;=;1;1;=;;Ki;nM;;78.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;78.0
;;2075901;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.11', 'le': '0.26', 'lle': '1.05', 'sei': '13.99'};CHEMBL253439;;CHEMBL253439;6.78;0;http://www.openphacts.org/units/Nanomolar;688390;=;1;1;=;;Ki;nM;;166.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;166.0
;;2075902;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.51', 'le': '0.25', 'lle': '1.32', 'sei': '13.85'};CHEMBL398618;;CHEMBL398618;6.71;0;http://www.openphacts.org/units/Nanomolar;688389;=;1;1;=;;Ki;nM;;194.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;194.0
;;2075903;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '13.60', 'le': '0.26', 'lle': '1.49', 'sei': '13.55'};CHEMBL253233;;CHEMBL253233;6.57;0;http://www.openphacts.org/units/Nanomolar;688388;=;1;1;=;;Ki;nM;;272.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;272.0
;;2075904;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.61', 'le': '0.28', 'lle': '2.14', 'sei': '13.53'};CHEMBL400236;;CHEMBL400236;6.56;0;http://www.openphacts.org/units/Nanomolar;688387;=;1;1;=;;Ki;nM;;278.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;278.0
;;2075905;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '16.69', 'le': '0.32', 'lle': '3.29', 'sei': '15.38'};CHEMBL253024;;CHEMBL253024;7.46;0;http://www.openphacts.org/units/Nanomolar;688386;=;1;1;=;;Ki;nM;;35.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;35.0
;;2075906;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.95', 'le': '0.29', 'lle': '2.15', 'sei': '13.84'};CHEMBL400235;;CHEMBL400235;6.71;0;http://www.openphacts.org/units/Nanomolar;688385;=;1;1;=;;Ki;nM;;196.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;196.0
;;2075907;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '15.61', 'le': '0.30', 'lle': '2.62', 'sei': '14.00'};CHEMBL253022;;CHEMBL253022;6.79;0;http://www.openphacts.org/units/Nanomolar;688384;=;1;1;=;;Ki;nM;;164.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;164.0
;;2075908;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '14.39', 'le': '0.28', 'lle': '2.27', 'sei': '12.49'};CHEMBL252818;;CHEMBL252818;6.05;0;http://www.openphacts.org/units/Nanomolar;688383;=;1;1;=;;Ki;nM;;885.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;885.0
;;2075909;[];CHEMBL944827;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21;;;CHEMBL1140829;Bioorg Med Chem Lett;2008.0;{'bei': '16.41', 'le': '0.31', 'lle': '2.60', 'sei': '13.68'};CHEMBL404000;;CHEMBL404000;6.21;0;http://www.openphacts.org/units/Nanomolar;688382;=;1;1;=;;Ki;nM;;616.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;616.0
;;2082419;[];CHEMBL928992;Binding affinity at human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cc(C)n(-c2cc(NC(=O)COc3ccccc3CCN3CCOCC3)nc(-c3ccc(C)o3)n2)n1;;;CHEMBL1141544;Bioorg Med Chem Lett;2008.0;{'bei': '13.06', 'le': '0.24', 'lle': '3.00', 'sei': '6.27'};CHEMBL256755;;CHEMBL256755;6.75;0;http://www.openphacts.org/units/Nanomolar;690287;=;1;1;=;;Ki;nM;;180.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;180.0
;;2103445;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(NS(C)(=O)=O)ccc1Oc1ccc(Cl)cc1C;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '14.48', 'le': '0.31', 'lle': '1.61', 'sei': '7.62'};CHEMBL258060;;CHEMBL258060;5.14;0;http://www.openphacts.org/units/Nanomolar;691298;=;1;1;=;;Ki;nM;;7250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7250.0
;;2103446;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(N2CCCS2(=O)=O)ccc1Oc1ccc(Cl)cc1C;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '15.22', 'le': '0.32', 'lle': '2.10', 'sei': '9.89'};CHEMBL403090;;CHEMBL403090;5.80;0;http://www.openphacts.org/units/Nanomolar;691297;=;1;1;=;;Ki;nM;;1590.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1590.0
;;2103447;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(C(=O)N(C)C)ccc1Oc1ccc(Cl)cc1C;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '16.30', 'le': '0.32', 'lle': '1.57', 'sei': '13.05'};CHEMBL272493;;CHEMBL272493;5.43;0;http://www.openphacts.org/units/Nanomolar;691296;=;1;1;=;;Ki;nM;;3751.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3751.0
;;2103449;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(C(N)=O)ccc1Oc1ccc(Cl)cc1C;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '17.76', 'le': '0.35', 'lle': '2.15', 'sei': '8.41'};CHEMBL401819;;CHEMBL401819;5.41;0;http://www.openphacts.org/units/Nanomolar;691294;=;1;1;=;;Ki;nM;;3866.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3866.0
;;2103450;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(N2CCCS2(=O)=O)ccc1Oc1ccc(Cl)cc1Cl;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '14.47', 'le': '0.32', 'lle': '1.76', 'sei': '9.90'};CHEMBL438889;;CHEMBL438889;5.81;0;http://www.openphacts.org/units/Nanomolar;691293;=;1;1;=;;Ki;nM;;1556.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1556.0
;;2103452;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(C(=O)NC)ccc1Oc1ccc(Cl)cc1Cl;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '16.97', 'le': '0.36', 'lle': '1.90', 'sei': '11.43'};CHEMBL404754;;CHEMBL404754;5.75;0;http://www.openphacts.org/units/Nanomolar;691291;=;1;1;=;;Ki;nM;;1757.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1757.0
;;2103454;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cc(C#N)ccc1Oc1ccc(Cl)cc1Cl;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '18.41', 'le': '0.39', 'lle': '1.28', 'sei': '12.55'};CHEMBL258063;;CHEMBL258063;5.66;0;http://www.openphacts.org/units/Nanomolar;691289;=;1;1;=;;Ki;nM;;2213.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2213.0
;;2103460;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1ccccc1Oc1ccc(Cl)cc1F;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '19.67', 'le': '0.40', 'lle': '1.24', 'sei': '24.59'};CHEMBL407815;;CHEMBL407815;5.23;0;http://www.openphacts.org/units/Nanomolar;691283;=;1;1;=;;Ki;nM;;5932.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5932.0
;;2103464;[];CHEMBL948900;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1ccccc1Oc1ccc(Cl)cc1OC;;;CHEMBL1141595;Bioorg Med Chem Lett;2008.0;{'bei': '19.29', 'le': '0.39', 'lle': '1.50', 'sei': '17.57'};CHEMBL256818;;CHEMBL256818;5.36;0;http://www.openphacts.org/units/Nanomolar;691279;=;1;1;=;;Ki;nM;;4380.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4380.0
;;2119270;[];CHEMBL950337;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNCc1cnc(C)cc1Oc1ccccc1Oc1ccccc1;;;CHEMBL1144031;Bioorg Med Chem Lett;2008.0;{'bei': '16.34', 'le': '0.30', 'lle': '0.55', 'sei': '12.07'};CHEMBL273208;;CHEMBL273208;5.24;0;http://www.openphacts.org/units/Nanomolar;705390;=;1;1;=;;Ki;nM;;5800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.8
;;2164039;[];CHEMBL932540;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cc(Cl)ccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1;;;CHEMBL1144811;Bioorg Med Chem Lett;2008.0;{'bei': '16.42', 'le': '0.33', 'lle': '2.02', 'sei': '13.80'};CHEMBL260259;;CHEMBL260259;5.48;0;http://www.openphacts.org/units/Nanomolar;708490;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.3
;;2248412;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.70', 'le': '0.27', 'lle': '2.45', 'sei': '9.41'};CHEMBL85;RISPERIDONE;CHEMBL85;6.04;0;http://www.openphacts.org/units/Nanomolar;776210;=;1;1;=;;Ki;nM;;920.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.92
;;2248413;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '13.36', 'le': '0.27', 'lle': '1.13', 'sei': '13.37'};CHEMBL1112;ARIPIPRAZOLE;CHEMBL1112;5.99;0;http://www.openphacts.org/units/Nanomolar;776209;=;1;1;=;;Ki;nM;;1020.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.02
;;2248414;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.22', 'le': '0.28', 'lle': '1.00', 'sei': '14.39'};CHEMBL715;OLANZAPINE;CHEMBL715;4.44;0;http://www.openphacts.org/units/Nanomolar;776208;=;1;1;=;;Ki;nM;;36000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;36.0
;;2248415;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.59', 'le': '0.28', 'lle': '1.05', 'sei': '15.45'};CHEMBL42;CLOZAPINE;CHEMBL42;4.77;0;http://www.openphacts.org/units/Nanomolar;776103;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;17.0
;;2248416;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '18.41', 'le': '0.36', 'lle': '2.49', 'sei': '17.07'};CHEMBL54;HALOPERIDOL;CHEMBL54;6.92;0;http://www.openphacts.org/units/Nanomolar;776102;=;1;1;=;;Ki;nM;;120.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.12
;;2248417;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc2cc3n(c12)CCN(CCCCN1CCn2c(cc4ccccc42)C1=O)C3;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.88', 'le': '0.27', 'lle': '2.23', 'sei': '15.44'};CHEMBL495573;;CHEMBL495573;6.58;0;http://www.openphacts.org/units/Nanomolar;776101;=;1;1;=;;Ki;nM;;260.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.26
;;2248418;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Clc1cccc(N2CCN(CCCCCOc3cc4ccccc4cn3)CC2)c1Cl;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '15.03', 'le': '0.30', 'lle': '0.77', 'sei': '23.35'};CHEMBL495572;;CHEMBL495572;6.68;0;http://www.openphacts.org/units/Nanomolar;776100;=;1;1;=;;Ki;nM;;210.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.21
;;2248419;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Clc1cccc(N2CCN(CCCCOc3cc4ccccc4cn3)CC2)c1Cl;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '15.79', 'le': '0.32', 'lle': '1.28', 'sei': '23.76'};CHEMBL522044;;CHEMBL522044;6.80;0;http://www.openphacts.org/units/Nanomolar;776099;=;1;1;=;;Ki;nM;;160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.16
;;2248421;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '15.41', 'le': '0.28', 'lle': '1.96', 'sei': '12.38'};CHEMBL496739;;CHEMBL496739;6.03;0;http://www.openphacts.org/units/Nanomolar;775853;=;1;1;=;;Ki;nM;;930.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.93
;;2248422;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1c2cc3ccccc3n2CCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.21', 'le': '0.29', 'lle': '1.69', 'sei': '21.12'};CHEMBL496531;;CHEMBL496531;6.70;0;http://www.openphacts.org/units/Nanomolar;775852;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;2248426;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '15.92', 'le': '0.29', 'lle': '2.77', 'sei': '8.84'};CHEMBL497604;;CHEMBL497604;6.41;0;http://www.openphacts.org/units/Nanomolar;777225;=;1;1;=;;Ki;nM;;390.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.39
;;2248427;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2cn1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '14.65', 'le': '0.30', 'lle': '1.83', 'sei': '13.82'};CHEMBL462508;;CHEMBL462508;6.70;0;http://www.openphacts.org/units/Nanomolar;777311;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;2248428;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1cc2ccccc2cn1;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '15.42', 'le': '0.30', 'lle': '2.30', 'sei': '13.46'};CHEMBL461236;;CHEMBL461236;6.52;0;http://www.openphacts.org/units/Nanomolar;777312;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3
;;2248429;[];CHEMBL954169;Binding affinity to human ERG expressed in HEK293 cells by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc2cc3n(c12)CCN(CCCCNC(=O)C1=Cc2ccccc2CN1)C3;;;CHEMBL1139353;J Med Chem;2009.0;{'bei': '13.32', 'le': '0.24', 'lle': '2.23', 'sei': '9.80'};CHEMBL461023;;CHEMBL461023;5.74;0;http://www.openphacts.org/units/Nanomolar;777313;=;1;1;=;;Ki;nM;;1840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.84
;;2257564;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c(c1)nc(-c1ccccn1)n2-c1ccc(OCCCN2CCCCC2)cc1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '16.62', 'le': '0.31', 'lle': '1.67', 'sei': '16.57'};CHEMBL495698;;CHEMBL495698;7.16;0;http://www.openphacts.org/units/Nanomolar;774872;=;1;1;=;;Ki;nM;;70.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;70.0
;;2257565;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c(c1)nc(-c1ccccn1)n2-c1ccc(OCCCN2CCOCC2)cc1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '16.66', 'le': '0.31', 'lle': '2.88', 'sei': '13.75'};CHEMBL522894;;CHEMBL522894;7.21;0;http://www.openphacts.org/units/Nanomolar;774874;=;1;1;=;;Ki;nM;;62.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;62.0
;;2257566;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H]1CCN(CCCOc2ccc(-n3c(-c4ccccn4)nc4cc(F)ccc43)cc2)C1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '16.54', 'le': '0.30', 'lle': '1.62', 'sei': '17.57'};CHEMBL521566;;CHEMBL521566;7.58;0;http://www.openphacts.org/units/Nanomolar;775032;=;1;1;=;;Ki;nM;;26.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;26.0
;;2257567;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c(c1)nc(-c1ccccn1)n2-c1ccc(OCCCN2CCSC2)cc1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '16.98', 'le': '0.32', 'lle': '2.38', 'sei': '17.08'};CHEMBL496523;;CHEMBL496523;7.38;0;http://www.openphacts.org/units/Nanomolar;775033;=;1;1;=;;Ki;nM;;42.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;42.0
;;2257568;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c(c1)nc(-c1ccccn1)n2-c1ccc(OCCCN2CCc3ccccc3C2)cc1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '14.68', 'le': '0.27', 'lle': '0.98', 'sei': '16.27'};CHEMBL524467;;CHEMBL524467;7.03;0;http://www.openphacts.org/units/Nanomolar;775115;=;1;1;=;;Ki;nM;;94.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;94.0
;;2257569;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;OC1CCN(CCCOc2ccc(-n3c(-c4ccccn4)nc4cc(F)ccc43)cc2)CC1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '17.46', 'le': '0.32', 'lle': '3.35', 'sei': '12.29'};CHEMBL526450;;CHEMBL526450;7.80;0;http://www.openphacts.org/units/Nanomolar;775117;=;1;1;=;;Ki;nM;;16.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;16.0
;;2257570;[];CHEMBL1004593;Binding affinity to human ERG assessed as rubidium efflux at 5 ug/mL pre-equilibrated for 30 mins by DiBAC4(3)-based flame atomic absorbance spectroscopy;B;;;BAO_0000192;BAO_0000357;single protein format;COC(=O)C1CCN(CCCOc2ccc(-n3c(-c4ccccn4)nc4cc(F)ccc43)cc2)CC1;;;CHEMBL1141692;Bioorg Med Chem Lett;2008.0;{'bei': '14.96', 'le': '0.28', 'lle': '2.43', 'sei': '10.52'};CHEMBL497575;;CHEMBL497575;7.31;0;http://www.openphacts.org/units/Nanomolar;775118;=;1;1;=;;Ki;nM;;49.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;49.0
;;2272150;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(C(=O)Nc3ccc4ccccc4n3)(c3ccccc3)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '18.35', 'le': '0.33', 'lle': '3.38', 'sei': '9.23'};CHEMBL521830;;CHEMBL521830;7.77;0;http://www.openphacts.org/units/Nanomolar;755360;=;1;1;=;;Ki;nM;;17.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;17.0
;;2272152;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC3(CC2)OC(c2ccccc2)c2ccccc23)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '21.67', 'le': '0.39', 'lle': '3.46', 'sei': '15.07'};CHEMBL492553;;CHEMBL492553;7.75;0;http://www.openphacts.org/units/Nanomolar;755526;=;1;1;=;;Ki;nM;;18.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18.0
;;2272161;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(C(=O)N3CCc4ccccc4C3)(c3ccccc3)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '18.07', 'le': '0.33', 'lle': '3.67', 'sei': '11.94'};CHEMBL493744;;CHEMBL493744;7.46;0;http://www.openphacts.org/units/Nanomolar;755362;=;1;1;=;;Ki;nM;;35.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;35.0
;;2272173;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(C(=O)NC2(c3ccccc3)CCN(c3cc(N)ccn3)CC2)c(OC)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '16.38', 'le': '0.30', 'lle': '3.48', 'sei': '7.90'};CHEMBL495346;;CHEMBL495346;7.09;0;http://www.openphacts.org/units/Nanomolar;755443;=;1;1;=;;Ki;nM;;82.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;82.0
;;2272176;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC(=O)N1CCN(C(=O)C2(c3ccccc3)CCN(c3cc(N)ccn3)CC2)CC1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '15.48', 'le': '0.29', 'lle': '4.27', 'sei': '7.36'};CHEMBL493743;;CHEMBL493743;6.77;0;http://www.openphacts.org/units/Nanomolar;755361;=;1;1;=;;Ki;nM;;169.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;169.0
;;2272178;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(CNC(=O)C2(c3ccccc3)CCN(c3cc(N)ccn3)CC2)cc1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '16.08', 'le': '0.30', 'lle': '3.17', 'sei': '8.32'};CHEMBL495345;;CHEMBL495345;6.70;0;http://www.openphacts.org/units/Nanomolar;755442;=;1;1;=;;Ki;nM;;201.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;201.0
;;2272181;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(C(=O)NC2(c3ccccc3)CCN(c3cc(N)ccn3)CC2)cc1Cl;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '14.80', 'le': '0.28', 'lle': '2.21', 'sei': '8.03'};CHEMBL492330;;CHEMBL492330;6.46;0;http://www.openphacts.org/units/Nanomolar;755444;=;1;1;=;;Ki;nM;;343.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;343.0
;;2272182;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(n3c(=O)n(Cc4ccccc4)c4cccnc43)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '15.69', 'le': '0.29', 'lle': '3.22', 'sei': '7.67'};CHEMBL493973;;CHEMBL493973;6.29;0;http://www.openphacts.org/units/Nanomolar;755720;=;1;1;=;;Ki;nM;;518.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;518.0
;;2272183;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(NC(=O)c3ccccn3)(c3ccccc3)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '16.77', 'le': '0.31', 'lle': '3.28', 'sei': '7.44'};CHEMBL522317;;CHEMBL522317;6.26;0;http://www.openphacts.org/units/Nanomolar;755445;=;1;1;=;;Ki;nM;;548.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;548.0
;;2272184;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(n3c(=O)n(CC4CC4)c4cccnc43)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '16.81', 'le': '0.31', 'lle': '3.70', 'sei': '7.48'};CHEMBL523504;;CHEMBL523504;6.13;0;http://www.openphacts.org/units/Nanomolar;755721;=;1;1;=;;Ki;nM;;746.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;746.0
;;2272186;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(-n2c(=O)n(C3CCN(c4cc(N)ccn4)CC3)c3ncccc32)cc1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '14.56', 'le': '0.27', 'lle': '3.05', 'sei': '6.65'};CHEMBL493972;;CHEMBL493972;6.06;0;http://www.openphacts.org/units/Nanomolar;755718;=;1;1;=;;Ki;nM;;865.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;865.0
;;2272187;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(N2CCC(n3c(=O)n(-c4ccccc4)c4cccnc43)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '15.64', 'le': '0.28', 'lle': '3.03', 'sei': '7.37'};CHEMBL522854;;CHEMBL522854;6.04;0;http://www.openphacts.org/units/Nanomolar;755719;=;1;1;=;;Ki;nM;;903.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;903.0
;;2272188;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cccc(C2(C)CN(c3cc(N)ccn3)C2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '21.29', 'le': '0.39', 'lle': '3.29', 'sei': '11.16'};CHEMBL492909;;CHEMBL492909;5.74;0;http://www.openphacts.org/units/Nanomolar;755641;=;1;1;=;;Ki;nM;;1840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1840.0
;;2272189;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)C(=O)[C@H]1CC2(CCN(c3cc(N)ccn3)CC2)c2ccccc21;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '15.20', 'le': '0.28', 'lle': '2.55', 'sei': '8.53'};CHEMBL492908;;CHEMBL492908;5.33;0;http://www.openphacts.org/units/Nanomolar;755640;=;1;1;=;;Ki;nM;;4710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4710.0
;;2272190;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(C(=O)N(c2cc(C)ccn2)C2CCN(c3cc(N)ccn3)CC2)cc1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '12.69', 'le': '0.23', 'lle': '1.61', 'sei': '6.26'};CHEMBL493515;;CHEMBL493515;5.30;0;http://www.openphacts.org/units/Nanomolar;755642;=;1;1;=;;Ki;nM;;5030.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5030.0
;;2272191;[];CHEMBL963244;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cccc(C(=O)N(c2ccccn2)C2CCN(c3cc(N)ccn3)CC2)c1;;;CHEMBL1153304;Bioorg Med Chem Lett;2009.0;{'bei': '12.43', 'le': '0.23', 'lle': '1.63', 'sei': '5.93'};CHEMBL493517;;CHEMBL493517;5.01;0;http://www.openphacts.org/units/Nanomolar;755644;=;1;1;=;;Ki;nM;;9690.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9690.0
;;2273999;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CC(Oc2ccc(Cl)cc2)C1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '14.46', 'le': '0.30', 'lle': '3.20', 'sei': '9.69'};CHEMBL523521;;CHEMBL523521;5.68;0;http://www.openphacts.org/units/Nanomolar;755245;=;1;1;=;;Ki;nM;;2090.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2090.0
;;2274000;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CCC(Oc2ccccc2Cl)CC1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '13.15', 'le': '0.27', 'lle': '2.28', 'sei': '9.44'};CHEMBL492301;;CHEMBL492301;5.54;0;http://www.openphacts.org/units/Nanomolar;755325;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2900.0
;;2274001;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(CC1COc2ccccc21)S(=O)(=O)c1ccc2c(c1)CCNCC2;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '14.83', 'le': '0.29', 'lle': '3.35', 'sei': '9.42'};CHEMBL492556;;CHEMBL492556;5.52;0;http://www.openphacts.org/units/Nanomolar;755321;=;1;1;=;;Ki;nM;;2990.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2990.0
;;2274002;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CC(Oc2ccccc2Cl)C1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '13.91', 'le': '0.29', 'lle': '2.99', 'sei': '9.32'};CHEMBL524171;;CHEMBL524171;5.47;0;http://www.openphacts.org/units/Nanomolar;755243;=;1;1;=;;Ki;nM;;3410.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3410.0
;;2274003;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CC[C@@H](Oc2ccccc2Cl)C1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '13.43', 'le': '0.28', 'lle': '2.59', 'sei': '9.32'};CHEMBL448971;;CHEMBL448971;5.46;0;http://www.openphacts.org/units/Nanomolar;755246;=;1;1;=;;Ki;nM;;3430.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3430.0
;;2274004;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CC(Oc2cccc(Cl)c2)C1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '13.83', 'le': '0.29', 'lle': '2.95', 'sei': '9.26'};CHEMBL493757;;CHEMBL493757;5.43;0;http://www.openphacts.org/units/Nanomolar;755244;=;1;1;=;;Ki;nM;;3690.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3690.0
;;2274005;[];CHEMBL1030736;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc2c(c1)CCNCC2)N1CC[C@H](Oc2ccccc2Cl)C1;;;CHEMBL1153351;Bioorg Med Chem Lett;2009.0;{'bei': '12.98', 'le': '0.27', 'lle': '2.41', 'sei': '9.01'};CHEMBL492557;;CHEMBL492557;5.28;0;http://www.openphacts.org/units/Nanomolar;755322;=;1;1;=;;Ki;nM;;5240.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5240.0
;;2295088;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '15.74', 'le': '0.30', 'lle': '3.00', 'sei': '15.27'};CHEMBL83894;FANANSERIN;CHEMBL83894;6.70;1;http://www.openphacts.org/units/Nanomolar;811128;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.69897
;;2295089;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '15.95', 'le': '0.30', 'lle': '2.13', 'sei': '14.21'};CHEMBL74355;VOLINANSERIN;CHEMBL74355;5.96;1;http://www.openphacts.org/units/Nanomolar;811129;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.958607
;;2295090;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc2c(c1)CCC1(CCN(CCc3ccc(F)cc3F)CC1)O2;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '20.62', 'le': '0.39', 'lle': '3.32', 'sei': '35.48'};CHEMBL146233;;CHEMBL146233;7.70;1;http://www.openphacts.org/units/Nanomolar;811130;=;1;1;=;;Ki;nM;;20.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.69897
;;2295091;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;OC1c2ccccc2CCC12CCN(CCc1ccccc1)CC2;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '18.42', 'le': '0.34', 'lle': '1.93', 'sei': '25.23'};CHEMBL146144;;CHEMBL146144;5.92;1;http://www.openphacts.org/units/Nanomolar;811131;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.920819
;;2295092;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)c(F)c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '20.26', 'le': '0.38', 'lle': '2.59', 'sei': '55.80'};CHEMBL147431;;CHEMBL147431;6.96;1;http://www.openphacts.org/units/Nanomolar;811209;=;1;1;=;;Ki;nM;;110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.958607
;;2295093;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)c(F)c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '20.97', 'le': '0.39', 'lle': '2.38', 'sei': '221.02'};CHEMBL150210;;CHEMBL150210;7.16;1;http://www.openphacts.org/units/Nanomolar;811210;=;1;1;=;;Ki;nM;;69.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.161151
;;2295094;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S1(=O)c2ccccc2CCC12CCN(CCc1ccc(F)cc1F)CC2;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '15.95', 'le': '0.32', 'lle': '2.48', 'sei': '16.70'};CHEMBL146595;;CHEMBL146595;6.24;1;http://www.openphacts.org/units/Nanomolar;811211;=;1;1;=;;Ki;nM;;570.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.244125
;;2295095;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.42', 'le': '0.33', 'lle': '2.55', 'sei': '16.05'};CHEMBL145939;;CHEMBL145939;6.00;1;http://www.openphacts.org/units/Nanomolar;811212;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;2295096;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.44', 'le': '0.34', 'lle': '2.57', 'sei': '15.37'};CHEMBL148280;;CHEMBL148280;5.75;1;http://www.openphacts.org/units/Nanomolar;811213;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.744727
;;2295097;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccccc1)C1CCN(CCCc2ccccc2)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.31', 'le': '0.32', 'lle': '2.04', 'sei': '14.99'};CHEMBL148565;;CHEMBL148565;5.60;1;http://www.openphacts.org/units/Nanomolar;811305;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.60206
;;2295098;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.01', 'le': '0.32', 'lle': '2.93', 'sei': '10.22'};CHEMBL150220;;CHEMBL150220;6.25;1;http://www.openphacts.org/units/Nanomolar;811306;=;1;1;=;;Ki;nM;;560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.251812
;;2295099;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '14.65', 'le': '0.29', 'lle': '2.40', 'sei': '9.35'};CHEMBL147048;;CHEMBL147048;5.72;1;http://www.openphacts.org/units/Nanomolar;811307;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.721246
;;2295100;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccccc1S(=O)(=O)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '13.82', 'le': '0.27', 'lle': '2.08', 'sei': '8.82'};CHEMBL146998;;CHEMBL146998;5.40;1;http://www.openphacts.org/units/Nanomolar;811308;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.39794
;;2295101;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(F)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.04', 'le': '0.32', 'lle': '2.57', 'sei': '16.45'};CHEMBL358075;;CHEMBL358075;6.15;1;http://www.openphacts.org/units/Nanomolar;811309;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.148742
;;2295102;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1ccc(Cl)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.06', 'le': '0.36', 'lle': '2.72', 'sei': '18.26'};CHEMBL149429;;CHEMBL149429;6.82;1;http://www.openphacts.org/units/Nanomolar;811386;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.823909
;;2295103;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;NC(=O)c1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '14.41', 'le': '0.29', 'lle': '3.35', 'sei': '7.31'};CHEMBL148058;;CHEMBL148058;5.89;1;http://www.openphacts.org/units/Nanomolar;811387;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.886057
;;2295104;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;NC(=O)c1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '12.60', 'le': '0.25', 'lle': '2.61', 'sei': '6.40'};CHEMBL146485;;CHEMBL146485;5.15;1;http://www.openphacts.org/units/Nanomolar;811388;=;1;1;=;;Ki;nM;;7143.01;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.146119
;;2295105;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(CN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccc(F)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '14.30', 'le': '0.28', 'lle': '2.22', 'sei': '9.49'};CHEMBL146620;;CHEMBL146620;5.17;1;http://www.openphacts.org/units/Nanomolar;811389;=;1;1;=;;Ki;nM;;6800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.167491
;;2295106;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(CCN2CCC(c3c(-c4ccccc4)[nH]c4ccccc34)CC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '18.65', 'le': '0.33', 'lle': '0.84', 'sei': '37.29'};CHEMBL40584;;CHEMBL40584;7.10;1;http://www.openphacts.org/units/Nanomolar;811390;=;1;1;=;;Ki;nM;;80.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.09691
;;2295107;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(-c2[nH]c3ccccc3c2C2CC3CCC(C2)N3)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '25.61', 'le': '0.46', 'lle': '2.91', 'sei': '27.84'};CHEMBL501295;;CHEMBL501295;7.75;0;http://www.openphacts.org/units/Nanomolar;811479;=;1;1;=;;Ki;nM;;18.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.744727
;;2295108;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(-c2[nH]c3ccccc3c2C2CCNCC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '18.97', 'le': '0.34', 'lle': '0.94', 'sei': '18.85'};CHEMBL295559;;CHEMBL295559;5.24;1;http://www.openphacts.org/units/Nanomolar;811480;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.244125
;;2295109;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '19.21', 'le': '0.35', 'lle': '1.01', 'sei': '19.09'};CHEMBL42557;;CHEMBL42557;5.31;1;http://www.openphacts.org/units/Nanomolar;811481;=;1;1;=;;Ki;nM;;4900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.309804
;;2295110;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCCC(c2c(-c3ccccc3)[nH]c3ccccc23)C1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.28', 'le': '0.31', 'lle': '0.38', 'sei': '26.37'};CHEMBL43819;;CHEMBL43819;5.02;1;http://www.openphacts.org/units/Nanomolar;811482;=;1;1;=;;Ki;nM;;9599.99;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.017729
;;2295111;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCCCC1c1c(-c2ccccc2)[nH]c2ccccc12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.75', 'le': '0.32', 'lle': '0.16', 'sei': '27.09'};CHEMBL43697;;CHEMBL43697;5.16;1;http://www.openphacts.org/units/Nanomolar;811483;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.154902
;;2295112;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.84', 'le': '0.32', 'lle': '0.33', 'sei': '34.35'};CHEMBL46523;;CHEMBL46523;6.54;1;http://www.openphacts.org/units/Nanomolar;811484;=;1;1;=;;Ki;nM;;290.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.537602
;;2295113;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(CCN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.49', 'le': '0.30', 'lle': '0.02', 'sei': '32.98'};CHEMBL44310;;CHEMBL44310;6.28;1;http://www.openphacts.org/units/Nanomolar;811555;=;1;1;=;;Ki;nM;;530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.275724
;;2295114;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2ccccc12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '20.24', 'le': '0.37', 'lle': '1.71', 'sei': '21.42'};CHEMBL497877;;CHEMBL497877;5.96;0;http://www.openphacts.org/units/Nanomolar;811556;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.958607
;;2295115;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2[nH]c(-c3ccccc3)c([C@@H]3CNCC[C@H]3F)c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.50', 'le': '0.31', 'lle': '0.76', 'sei': '18.53'};CHEMBL497878;;CHEMBL497878;5.16;0;http://www.openphacts.org/units/Nanomolar;811557;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.154902
;;2295116;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2ccc(Cl)cc12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '15.68', 'le': '0.31', 'lle': '0.25', 'sei': '18.53'};CHEMBL496852;;CHEMBL496852;5.16;0;http://www.openphacts.org/units/Nanomolar;811558;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.154902
;;2295117;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccccc3)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.28', 'le': '0.32', 'lle': '1.01', 'sei': '19.40'};CHEMBL504699;;CHEMBL504699;5.40;1;http://www.openphacts.org/units/Nanomolar;811559;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.39794
;;2295118;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2cc(Cl)ccc12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.80', 'le': '0.35', 'lle': '0.95', 'sei': '21.04'};CHEMBL498048;;CHEMBL498048;5.85;1;http://www.openphacts.org/units/Nanomolar;811560;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.853872
;;2295119;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccccc3)[nH]c12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.68', 'le': '0.33', 'lle': '1.13', 'sei': '19.85'};CHEMBL498729;;CHEMBL498729;5.52;1;http://www.openphacts.org/units/Nanomolar;811625;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.522879
;;2295120;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;F[C@@H]1CCNC[C@H]1c1c(-c2ccccc2)[nH]c2c(Cl)cccc12;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.27', 'le': '0.34', 'lle': '0.78', 'sei': '20.41'};CHEMBL523585;;CHEMBL523585;5.68;1;http://www.openphacts.org/units/Nanomolar;811626;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.677781
;;2295121;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccc4ccccc34)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '19.20', 'le': '0.35', 'lle': '1.42', 'sei': '25.01'};CHEMBL496687;;CHEMBL496687;6.96;1;http://www.openphacts.org/units/Nanomolar;811627;=;1;1;=;;Ki;nM;;110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.958607
;;2295122;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccc4ccccc4c3)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.39', 'le': '0.32', 'lle': '0.76', 'sei': '22.65'};CHEMBL496860;;CHEMBL496860;6.30;1;http://www.openphacts.org/units/Nanomolar;811628;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.30103
;;2295123;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccnc3)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.88', 'le': '0.33', 'lle': '1.82', 'sei': '13.76'};CHEMBL523760;;CHEMBL523760;5.60;1;http://www.openphacts.org/units/Nanomolar;811629;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.60206
;;2295124;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccsc3)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '18.29', 'le': '0.36', 'lle': '1.37', 'sei': '20.93'};CHEMBL497054;;CHEMBL497054;5.82;1;http://www.openphacts.org/units/Nanomolar;811710;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.823909
;;2295125;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(C3CCCCC3)[nH]c2c1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '16.54', 'le': '0.31', 'lle': '0.50', 'sei': '18.93'};CHEMBL507898;;CHEMBL507898;5.27;1;http://www.openphacts.org/units/Nanomolar;811711;=;1;1;=;;Ki;nM;;5400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.267606
;;2295128;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(-c2[nH]c3cc(F)ccc3c2[C@@H]2CNCC[C@H]2F)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '17.54', 'le': '0.33', 'lle': '1.27', 'sei': '20.83'};CHEMBL523245;;CHEMBL523245;5.80;1;http://www.openphacts.org/units/Nanomolar;811714;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.79588
;;2295129;[];CHEMBL1027667;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(-c2[nH]c3cc(F)ccc3c2C2CCCNC2)cc1;;;CHEMBL1137783;J Med Chem;2009.0;{'bei': '18.84', 'le': '0.35', 'lle': '1.31', 'sei': '21.16'};CHEMBL296512;;CHEMBL296512;5.89;1;http://www.openphacts.org/units/Nanomolar;811715;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.886057
;;2401119;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccccc1NC(=O)c1ccc(N2CCC3(CC2)C(=O)NCN3c2ccccc2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.22', 'le': '0.19', 'lle': '1.67', 'sei': '4.37'};CHEMBL487346;;CHEMBL487346;4.52;0;http://www.openphacts.org/units/Nanomolar;804369;=;1;1;=;;Ki;nM;;30000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;30000.0
;;2401120;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccccc1NC(=O)c1ccc(N2CCC3(CCN(S(=O)(=O)c4ccccc4)C3)C2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '9.52', 'le': '0.18', 'lle': '1.34', 'sei': '4.18'};CHEMBL486737;;CHEMBL486737;4.54;0;http://www.openphacts.org/units/Nanomolar;804448;=;1;1;=;;Ki;nM;;28500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;28500.0
;;2401121;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccccc1NC(=O)c1ccc(N2CCC3(CC2)CNc2ccccc23)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.84', 'le': '0.22', 'lle': '0.85', 'sei': '5.68'};CHEMBL520050;;CHEMBL520050;4.73;0;http://www.openphacts.org/units/Nanomolar;804449;=;1;1;=;;Ki;nM;;18540.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18540.0
;;2401122;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccccc1NC(=O)c1ccc(N2CCC3(CC2)CNCc2ccccc23)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '13.92', 'le': '0.25', 'lle': '2.19', 'sei': '6.91'};CHEMBL486738;;CHEMBL486738;5.75;0;http://www.openphacts.org/units/Nanomolar;804450;=;1;1;=;;Ki;nM;;1760.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1760.0
;;2401123;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccccc1NC(=O)c1ccc(N2CCC3(CCNC3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '13.28', 'le': '0.25', 'lle': '2.17', 'sei': '5.61'};CHEMBL499776;;CHEMBL499776;4.67;0;http://www.openphacts.org/units/Nanomolar;804549;=;1;1;=;;Ki;nM;;21450.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;21450.0
;;2401124;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCNC3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '14.07', 'le': '0.27', 'lle': '1.88', 'sei': '7.33'};CHEMBL513568;;CHEMBL513568;6.10;0;http://www.openphacts.org/units/Nanomolar;804551;=;1;1;=;;Ki;nM;;790.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;790.0
;;2401125;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2ccsc2)cc1NC(=O)c1ccc(N2CCC3(CCNC3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '13.65', 'le': '0.26', 'lle': '1.70', 'sei': '7.11'};CHEMBL511797;;CHEMBL511797;5.92;0;http://www.openphacts.org/units/Nanomolar;804632;=;1;1;=;;Ki;nM;;1210.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1210.0
;;2401126;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cc(-c2ccc(N)c(NC(=O)c3ccc(N4CCC5(CCNC5)CC4)nc3)c2)cn1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.93', 'le': '0.20', 'lle': '1.82', 'sei': '4.66'};CHEMBL470156;;CHEMBL470156;4.72;0;http://www.openphacts.org/units/Nanomolar;804633;=;1;1;=;;Ki;nM;;19250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;19250.0
;;2401128;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(-c2ccc(N)c(NC(=O)c3ccc(N4CCC5(CCNC5)CC4)nc3)c2)c1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.61', 'le': '0.21', 'lle': '2.11', 'sei': '4.95'};CHEMBL472252;;CHEMBL472252;5.01;0;http://www.openphacts.org/units/Nanomolar;804635;=;1;1;=;;Ki;nM;;9800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9800.0
;;2401129;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N1CCC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)CC2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.53', 'le': '0.20', 'lle': '0.53', 'sei': '5.47'};CHEMBL471414;;CHEMBL471414;5.01;0;http://www.openphacts.org/units/Nanomolar;804720;=;1;1;=;;Ki;nM;;9790.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9790.0
;;2401130;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCNC(=O)N1CCC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)CC2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '12.56', 'le': '0.24', 'lle': '1.67', 'sei': '6.12'};CHEMBL470581;;CHEMBL470581;6.34;0;http://www.openphacts.org/units/Nanomolar;804721;=;1;1;=;;Ki;nM;;460.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;460.0
;;2401131;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)N1CCC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)CC2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.33', 'le': '0.21', 'lle': '1.38', 'sei': '4.86'};CHEMBL470582;;CHEMBL470582;5.28;0;http://www.openphacts.org/units/Nanomolar;804722;=;1;1;=;;Ki;nM;;5210.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5210.0
;;2401132;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CCN(c2ncccn2)C3)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.96', 'le': '0.23', 'lle': '1.19', 'sei': '6.10'};CHEMBL470798;;CHEMBL470798;6.12;0;http://www.openphacts.org/units/Nanomolar;804723;=;1;1;=;;Ki;nM;;760.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;760.0
;;2401133;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCN(CC(F)(F)F)C3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.10', 'le': '0.22', 'lle': '0.22', 'sei': '7.68'};CHEMBL472261;;CHEMBL472261;5.72;0;http://www.openphacts.org/units/Nanomolar;804806;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1900.0
;;2401134;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCN(CCO)C3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '14.17', 'le': '0.27', 'lle': '2.84', 'sei': '7.15'};CHEMBL513250;;CHEMBL513250;6.77;0;http://www.openphacts.org/units/Nanomolar;804807;=;1;1;=;;Ki;nM;;170.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;170.0
;;2401135;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCN(CC(=O)O)C3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.18', 'le': '0.21', 'lle': '1.47', 'sei': '4.92'};CHEMBL471219;;CHEMBL471219;5.50;0;http://www.openphacts.org/units/Nanomolar;804808;=;1;1;=;;Ki;nM;;3200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3200.0
;;2401136;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)CN1CCC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)CC2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '14.29', 'le': '0.27', 'lle': '3.59', 'sei': '5.96'};CHEMBL471220;;CHEMBL471220;7.01;0;http://www.openphacts.org/units/Nanomolar;804809;=;1;1;=;;Ki;nM;;97.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;97.0
;;2401137;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N1CCC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)C2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '12.03', 'le': '0.23', 'lle': '1.46', 'sei': '6.07'};CHEMBL472442;;CHEMBL472442;5.55;0;http://www.openphacts.org/units/Nanomolar;804937;=;1;1;=;;Ki;nM;;2790.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2790.0
;;2401138;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N1CC2(CCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)CC2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.27', 'le': '0.22', 'lle': '1.11', 'sei': '5.68'};CHEMBL472443;;CHEMBL472443;5.20;0;http://www.openphacts.org/units/Nanomolar;804938;=;1;1;=;;Ki;nM;;6300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6300.0
;;2401139;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N1CCC2(CCCN(c3ccc(C(=O)Nc4cc(-c5cccs5)ccc4N)cn3)C2)C1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.39', 'le': '0.22', 'lle': '0.94', 'sei': '5.92'};CHEMBL471399;;CHEMBL471399;5.42;0;http://www.openphacts.org/units/Nanomolar;804939;=;1;1;=;;Ki;nM;;3810.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3810.0
;;2401140;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N1CCCC12CCN(c1ccc(C(=O)Nc3cc(-c4cccs4)ccc3N)cn1)CC2;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.04', 'le': '0.19', 'lle': '0.15', 'sei': '5.22'};CHEMBL471400;;CHEMBL471400;4.78;0;http://www.openphacts.org/units/Nanomolar;804940;=;1;1;=;;Ki;nM;;16740.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;16740.0
;;2401141;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNc2ccccc23)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.36', 'le': '0.19', 'lle': '-0.62', 'sei': '5.99'};CHEMBL511625;;CHEMBL511625;4.99;0;http://www.openphacts.org/units/Nanomolar;805021;=;1;1;=;;Ki;nM;;10250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10250.0
;;2401143;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCCC3O)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.20', 'le': '0.21', 'lle': '0.25', 'sei': '5.49'};CHEMBL470148;;CHEMBL470148;5.03;0;http://www.openphacts.org/units/Nanomolar;805023;=;1;1;=;;Ki;nM;;9420.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9420.0
;;2401144;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CCNC3=O)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.32', 'le': '0.22', 'lle': '1.31', 'sei': '5.05'};CHEMBL469514;;CHEMBL469514;5.06;0;http://www.openphacts.org/units/Nanomolar;805024;=;1;1;=;;Ki;nM;;8620.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8620.0
;;2401145;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC3=O)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.44', 'le': '0.22', 'lle': '1.60', 'sei': '4.94'};CHEMBL470791;;CHEMBL470791;4.96;0;http://www.openphacts.org/units/Nanomolar;805118;=;1;1;=;;Ki;nM;;10980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10980.0
;;2401146;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC(=O)C3)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.31', 'le': '0.22', 'lle': '1.31', 'sei': '5.04'};CHEMBL511984;;CHEMBL511984;5.06;0;http://www.openphacts.org/units/Nanomolar;805119;=;1;1;=;;Ki;nM;;8699.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8699.0
;;2401147;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)NC(=O)NC3=O)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.90', 'le': '0.21', 'lle': '2.22', 'sei': '3.90'};CHEMBL513027;;CHEMBL513027;5.04;0;http://www.openphacts.org/units/Nanomolar;805120;=;1;1;=;;Ki;nM;;9070.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9070.0
;;2401148;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)NCNC3=O)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '11.42', 'le': '0.22', 'lle': '2.46', 'sei': '4.56'};CHEMBL469950;;CHEMBL469950;5.12;0;http://www.openphacts.org/units/Nanomolar;805121;=;1;1;=;;Ki;nM;;7540.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7540.0
;;2401149;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)C(=O)NCN3c2ccccc2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '9.91', 'le': '0.19', 'lle': '0.62', 'sei': '5.02'};CHEMBL521193;;CHEMBL521193;5.20;0;http://www.openphacts.org/units/Nanomolar;803747;=;1;1;=;;Ki;nM;;6330.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6330.0
;;2401150;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2cccs2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC(=O)N3)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '10.78', 'le': '0.21', 'lle': '1.54', 'sei': '4.30'};CHEMBL486152;;CHEMBL486152;4.84;0;http://www.openphacts.org/units/Nanomolar;803748;=;1;1;=;;Ki;nM;;14560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;14560.0
;;2401152;[];CHEMBL940379;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccc(N2CCC3(CCNC3)CC2)nc1;;;CHEMBL1152282;Bioorg Med Chem Lett;2008.0;{'bei': '14.57', 'le': '0.27', 'lle': '2.07', 'sei': '7.48'};CHEMBL471824;;CHEMBL471824;6.23;0;http://www.openphacts.org/units/Nanomolar;804550;=;1;1;=;;Ki;nM;;590.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;590.0
;;2411531;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '17.89', 'le': '0.33', 'lle': '3.96', 'sei': '12.48'};CHEMBL490417;;CHEMBL490417;7.20;0;http://www.openphacts.org/units/Nanomolar;810253;=;1;1;=;;Ki;nM;;63.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.2
;;2411532;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)N(C)C(=O)CO5)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '14.64', 'le': '0.27', 'lle': '2.84', 'sei': '12.47'};CHEMBL522257;;CHEMBL522257;6.10;0;http://www.openphacts.org/units/Nanomolar;810254;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;2411533;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '13.91', 'le': '0.25', 'lle': '2.36', 'sei': '9.71'};CHEMBL513715;;CHEMBL513715;5.60;0;http://www.openphacts.org/units/Nanomolar;810255;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;2411534;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '12.96', 'le': '0.24', 'lle': '2.14', 'sei': '11.04'};CHEMBL469345;;CHEMBL469345;5.40;0;http://www.openphacts.org/units/Nanomolar;810339;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;2411535;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)OCC(=O)N5)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '17.39', 'le': '0.32', 'lle': '3.76', 'sei': '12.13'};CHEMBL512724;;CHEMBL512724;7.00;0;http://www.openphacts.org/units/Nanomolar;810340;=;1;1;=;;Ki;nM;;100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.0
;;2411536;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)OCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '13.20', 'le': '0.24', 'lle': '2.24', 'sei': '11.25'};CHEMBL472289;;CHEMBL472289;5.50;0;http://www.openphacts.org/units/Nanomolar;810341;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;2411537;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN1C(=O)COc2c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc21;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.85', 'le': '0.22', 'lle': '1.45', 'sei': '10.43'};CHEMBL472290;;CHEMBL472290;5.10;0;http://www.openphacts.org/units/Nanomolar;810342;=;1;1;=;;Ki;nM;;7943.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.1
;;2411538;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C(C)C)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.92', 'le': '0.22', 'lle': '1.26', 'sei': '10.84'};CHEMBL469567;;CHEMBL469567;5.30;0;http://www.openphacts.org/units/Nanomolar;810422;=;1;1;=;;Ki;nM;;5011.87;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.3
;;2411539;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C4CC4)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '13.11', 'le': '0.24', 'lle': '2.00', 'sei': '11.86'};CHEMBL469568;;CHEMBL469568;5.80;0;http://www.openphacts.org/units/Nanomolar;810423;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;2411540;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5CC4CC4)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '12.70', 'le': '0.23', 'lle': '1.76', 'sei': '11.86'};CHEMBL469995;;CHEMBL469995;5.80;0;http://www.openphacts.org/units/Nanomolar;810424;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;2411541;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5CC(F)F)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '13.72', 'le': '0.26', 'lle': '2.50', 'sei': '13.09'};CHEMBL511279;;CHEMBL511279;6.40;0;http://www.openphacts.org/units/Nanomolar;810425;=;1;1;=;;Ki;nM;;398.11;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.4
;;2411542;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)[C@H](C)C3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.61', 'le': '0.21', 'lle': '1.35', 'sei': '10.22'};CHEMBL511815;;CHEMBL511815;5.00;0;http://www.openphacts.org/units/Nanomolar;810500;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.0
;;2411543;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)[C@@H](C)C3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.38', 'le': '0.21', 'lle': '1.25', 'sei': '10.02'};CHEMBL471047;;CHEMBL471047;4.90;0;http://www.openphacts.org/units/Nanomolar;810501;=;1;1;=;;Ki;nM;;12589.25;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.9
;;2411544;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)CC3)cc(F)cc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '12.43', 'le': '0.23', 'lle': '2.00', 'sei': '11.04'};CHEMBL469374;;CHEMBL469374;5.40;0;http://www.openphacts.org/units/Nanomolar;810502;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;2411545;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)[C@H](C)C3)cc(F)cc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '12.26', 'le': '0.23', 'lle': '1.71', 'sei': '11.25'};CHEMBL513875;;CHEMBL513875;5.50;0;http://www.openphacts.org/units/Nanomolar;810503;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;2411546;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCCc4cccc5c4OCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '12.31', 'le': '0.23', 'lle': '1.65', 'sei': '10.84'};CHEMBL469375;;CHEMBL469375;5.30;0;http://www.openphacts.org/units/Nanomolar;810580;=;1;1;=;;Ki;nM;;5011.87;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.3
;;2411547;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCCc4cccc5c4OCC(=O)N5C)[C@H](C)C3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.70', 'le': '0.22', 'lle': '1.16', 'sei': '10.63'};CHEMBL469376;;CHEMBL469376;5.20;0;http://www.openphacts.org/units/Nanomolar;810581;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;2411548;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCCc4cccc5c4OCC(=O)N5C)CC3)cc(F)cc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.59', 'le': '0.22', 'lle': '1.41', 'sei': '10.63'};CHEMBL469589;;CHEMBL469589;5.20;0;http://www.openphacts.org/units/Nanomolar;810582;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;2411549;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCCc4cccc5c4OCC(=O)N5C)[C@H](C)C3)cc(F)cc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '11.89', 'le': '0.22', 'lle': '1.32', 'sei': '11.25'};CHEMBL470217;;CHEMBL470217;5.50;0;http://www.openphacts.org/units/Nanomolar;810583;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;2411550;[];CHEMBL976148;Displacement of [3H]dofetilide human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCCc4cccc5c4OCC(=O)N5)CC3)cccc2n1;;;CHEMBL1153978;Bioorg Med Chem Lett;2009.0;{'bei': '14.88', 'le': '0.27', 'lle': '2.57', 'sei': '10.75'};CHEMBL470849;;CHEMBL470849;6.20;0;http://www.openphacts.org/units/Nanomolar;810664;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;2417481;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc2cc(CO[C@H]3CCNC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '21.13', 'le': '0.39', 'lle': '2.08', 'sei': '22.60'};CHEMBL445794;;CHEMBL445794;4.80;0;http://www.openphacts.org/units/Nanomolar;810141;=;1;1;=;;Ki;nM;;15700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;15.7
;;2417485;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc2cc(CO[C@@H]3CCNC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '21.05', 'le': '0.38', 'lle': '2.07', 'sei': '22.51'};CHEMBL469809;;CHEMBL469809;4.79;0;http://www.openphacts.org/units/Nanomolar;810142;=;1;1;=;;Ki;nM;;16400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.4
;;2417489;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccc2cc(CO[C@H]3CCNC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '21.19', 'le': '0.38', 'lle': '2.76', 'sei': '11.87'};CHEMBL469810;;CHEMBL469810;5.35;0;http://www.openphacts.org/units/Nanomolar;810143;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.5
;;2417493;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2cc(CO[C@@H]3CCNC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '20.33', 'le': '0.38', 'lle': '2.13', 'sei': '23.46'};CHEMBL469811;;CHEMBL469811;4.99;0;http://www.openphacts.org/units/Nanomolar;810144;=;1;1;=;;Ki;nM;;10300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.3
;;2417501;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCN(C1CCNCC1)S(=O)(=O)c1ccc2ccccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '17.73', 'le': '0.35', 'lle': '2.77', 'sei': '12.44'};CHEMBL512665;;CHEMBL512665;6.14;0;http://www.openphacts.org/units/Nanomolar;810146;=;1;1;=;;Ki;nM;;716.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;716.0
;;2417517;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCN([C@H]1CCNC1)S(=O)(=O)c1ccc2ccccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '19.21', 'le': '0.38', 'lle': '3.40', 'sei': '12.92'};CHEMBL513367;;CHEMBL513367;6.38;0;http://www.openphacts.org/units/Nanomolar;810227;=;1;1;=;;Ki;nM;;412.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;412.0
;;2417553;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc2cc(OCC3CCNCC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '22.46', 'le': '0.41', 'lle': '2.20', 'sei': '25.49'};CHEMBL453996;;CHEMBL453996;5.42;0;http://www.openphacts.org/units/Nanomolar;810321;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;2417561;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccc2ccc(OCC3CCNCC3)cc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '20.48', 'le': '0.37', 'lle': '2.37', 'sei': '12.11'};CHEMBL444985;;CHEMBL444985;5.46;0;http://www.openphacts.org/units/Nanomolar;810401;=;1;1;=;;Ki;nM;;3500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.5
;;2417573;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc2cc(CCN3CCNCC3)ccc2c1;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '19.63', 'le': '0.36', 'lle': '2.64', 'sei': '33.21'};CHEMBL465515;;CHEMBL465515;5.07;0;http://www.openphacts.org/units/Nanomolar;810404;=;1;1;=;;Ki;nM;;8500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.5
;;2417577;[];CHEMBL954296;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(CCN2CCNCC2)ccc2cc(F)ccc12;;;CHEMBL1153958;Bioorg Med Chem Lett;2009.0;{'bei': '18.34', 'le': '0.34', 'lle': '2.26', 'sei': '32.72'};CHEMBL443090;;CHEMBL443090;5.00;0;http://www.openphacts.org/units/Nanomolar;810405;=;1;1;=;;Ki;nM;;10100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.1
;;2492238;[];CHEMBL993079;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cc(C(=O)N2CCN(C(=O)C3CCCO3)CC2)ccc1OCc1cccc(Cl)c1;;;CHEMBL1143329;Bioorg Med Chem Lett;2009.0;{'bei': '17.21', 'le': '0.34', 'lle': '3.93', 'sei': '12.90'};CHEMBL480226;;CHEMBL480226;7.62;0;http://www.openphacts.org/units/Nanomolar;751523;=;1;1;=;;Ki;nM;;23.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;23.9
;;2492239;[];CHEMBL993079;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCN(C(=O)c2ccc(OCc3cccc(Cl)c3)c(Cl)c2)CC1=O;;;CHEMBL1143329;Bioorg Med Chem Lett;2009.0;{'bei': '18.89', 'le': '0.39', 'lle': '3.94', 'sei': '14.90'};CHEMBL480844;;CHEMBL480844;7.43;0;http://www.openphacts.org/units/Nanomolar;751437;=;1;1;=;;Ki;nM;;37.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;37.2
;;2516657;[];CHEMBL968700;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1;;;CHEMBL1138586;Bioorg Med Chem Lett;2009.0;{'bei': '15.25', 'le': '0.31', 'lle': '2.18', 'sei': '7.09'};CHEMBL221906;;CHEMBL221906;6.96;0;http://www.openphacts.org/units/Nanomolar;732952;=;1;1;=;;Ki;nM;;110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.11
;;2516658;[];CHEMBL968700;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1138586;Bioorg Med Chem Lett;2009.0;{'bei': '12.71', 'le': '0.25', 'lle': '1.60', 'sei': '5.35'};CHEMBL512351;BETRIXABAN;CHEMBL512351;5.75;0;http://www.openphacts.org/units/Nanomolar;733482;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;2516659;[];CHEMBL968700;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)C(=N)c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)c(F)c1;;;CHEMBL1138586;Bioorg Med Chem Lett;2009.0;{'bei': '13.44', 'le': '0.27', 'lle': '1.46', 'sei': '6.49'};CHEMBL472967;;CHEMBL472967;6.38;0;http://www.openphacts.org/units/Nanomolar;732959;=;1;1;=;;Ki;nM;;420.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.42
;;2516663;[];CHEMBL968700;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2F)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1138586;Bioorg Med Chem Lett;2009.0;{'bei': '12.08', 'le': '0.23', 'lle': '1.41', 'sei': '5.29'};CHEMBL515919;;CHEMBL515919;5.68;0;http://www.openphacts.org/units/Nanomolar;733796;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;2516664;[];CHEMBL968700;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(NC(=O)c2ccc(C(=N)N(C)C)cc2N2CCCCC2)c(C(=O)Nc2ccc(Cl)cn2)c1;;;CHEMBL1138586;Bioorg Med Chem Lett;2009.0;{'bei': '12.52', 'le': '0.24', 'lle': '1.57', 'sei': '6.05'};CHEMBL219106;;CHEMBL219106;6.70;1;http://www.openphacts.org/units/Nanomolar;733797;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;2527942;[];CHEMBL985007;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCC(Nc2nccc(-c3c[nH]nc3-c3ccc(Cl)cc3)n2)CC1;;;CHEMBL1154397;Bioorg Med Chem Lett;2009.0;{'bei': '16.24', 'le': '0.31', 'lle': '2.30', 'sei': '8.59'};CHEMBL450660;;CHEMBL450660;5.99;0;http://www.openphacts.org/units/Nanomolar;809121;=;1;1;=;;Ki;nM;;1020.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1020.0
;;2563286;[];CHEMBL993590;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)C(=O)N(Cc1ccccc1-c1ccccc1)[C@H]1CCNC1;;;CHEMBL1155858;Bioorg Med Chem Lett;2008.0;{'bei': '17.20', 'le': '0.32', 'lle': '1.85', 'sei': '17.15'};CHEMBL476116;;CHEMBL476116;5.55;0;http://www.openphacts.org/units/Nanomolar;770389;=;1;1;=;;Ki;nM;;2840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2840.0
;;2563297;[];CHEMBL993590;Displacement of [3H]dofetilide from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC(=O)N(Cc1ccccc1-c1ccccc1)[C@H]1CCNC1;;;CHEMBL1155858;Bioorg Med Chem Lett;2008.0;{'bei': '17.10', 'le': '0.32', 'lle': '1.88', 'sei': '13.35'};CHEMBL478834;;CHEMBL478834;5.55;0;http://www.openphacts.org/units/Nanomolar;770476;=;1;1;=;;Ki;nM;;2830.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2830.0
;;2606579;[];CHEMBL1023104;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;N[C@H](C(=O)N1CC[C@H](F)C1)[C@H]1CC[C@H](NS(=O)(=O)c2ccc(F)cc2F)CC1;;;CHEMBL1152762;Bioorg Med Chem;2009.0;{'bei': '10.27', 'le': '0.21', 'lle': '2.61', 'sei': '4.66'};CHEMBL22310;;CHEMBL22310;4.31;1;http://www.openphacts.org/units/Nanomolar;806290;=;1;1;=;;Ki;nM;;49000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;49000.0
;;2655247;[];CHEMBL1036186;Binding affinity to human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C[C@H]2CCN(c3ccc(-c4ccc(C#N)cc4)cc3)[C@H]2C1;;;CHEMBL1158476;J Med Chem;2009.0;{'bei': '21.59', 'le': '0.39', 'lle': '3.18', 'sei': '21.64'};CHEMBL563998;;CHEMBL563998;6.55;0;http://www.openphacts.org/units/Nanomolar;816456;=;1;1;=;;Ki;nM;;282.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;282.0
;;2705779;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '14.80', 'le': '0.28', 'lle': '1.47', 'sei': '11.59'};CHEMBL538137;;CHEMBL538137;4.70;0;http://www.openphacts.org/units/Nanomolar;827622;=;1;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;;2705780;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;COC[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '12.69', 'le': '0.24', 'lle': '1.55', 'sei': '8.86'};CHEMBL538877;;CHEMBL538877;4.41;0;http://www.openphacts.org/units/Nanomolar;827623;=;1;1;=;;Ki;nM;;39000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;39000.0
;;2705781;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)[C@H](Cc5cccc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '16.08', 'le': '0.30', 'lle': '2.03', 'sei': '16.33'};CHEMBL556229;;CHEMBL556229;6.62;0;http://www.openphacts.org/units/Nanomolar;827692;=;1;1;=;;Ki;nM;;240.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;240.0
;;2705782;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cccc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '18.40', 'le': '0.34', 'lle': '2.72', 'sei': '18.59'};CHEMBL562471;;CHEMBL562471;7.54;0;http://www.openphacts.org/units/Nanomolar;827693;=;1;1;=;;Ki;nM;;29.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;29.0
;;2705783;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cc(F)cc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '17.16', 'le': '0.32', 'lle': '2.38', 'sei': '18.10'};CHEMBL556431;;CHEMBL556431;7.34;0;http://www.openphacts.org/units/Nanomolar;827694;=;1;1;=;;Ki;nM;;46.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;46.0
;;2705784;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5ccccc5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '16.98', 'le': '0.31', 'lle': '1.97', 'sei': '16.40'};CHEMBL560935;;CHEMBL560935;6.65;0;http://www.openphacts.org/units/Nanomolar;827695;=;1;1;=;;Ki;nM;;225.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;225.0
;;2705785;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;C/C=C1\C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '15.46', 'le': '0.29', 'lle': '1.55', 'sei': '12.57'};CHEMBL557116;;CHEMBL557116;5.09;0;http://www.openphacts.org/units/Nanomolar;827765;=;1;1;=;;Ki;nM;;8050.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8050.0
;;2705787;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5ccncc5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '16.55', 'le': '0.31', 'lle': '2.41', 'sei': '12.16'};CHEMBL556848;;CHEMBL556848;6.50;0;http://www.openphacts.org/units/Nanomolar;827767;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;320.0
;;2705788;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cccnc5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '13.87', 'le': '0.26', 'lle': '1.36', 'sei': '10.19'};CHEMBL562780;;CHEMBL562780;5.44;0;http://www.openphacts.org/units/Nanomolar;827768;=;1;1;=;;Ki;nM;;3600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3600.0
;;2705789;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cncnc5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '12.77', 'le': '0.24', 'lle': '1.56', 'sei': '7.58'};CHEMBL551269;;CHEMBL551269;5.03;0;http://www.openphacts.org/units/Nanomolar;827844;=;1;1;=;;Ki;nM;;9400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9400.0
;;2705790;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)/C(=C/c5cnc(C6CC6)nc5)C[C@H]4[C@@H]3CC[C@@H]12;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '12.30', 'le': '0.23', 'lle': '0.98', 'sei': '8.04'};CHEMBL551270;;CHEMBL551270;5.33;0;http://www.openphacts.org/units/Nanomolar;827845;=;1;1;=;;Ki;nM;;4650.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4650.0
;;2705791;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '12.05', 'le': '0.22', 'lle': '1.62', 'sei': '6.75'};CHEMBL559878;;CHEMBL559878;5.10;0;http://www.openphacts.org/units/Nanomolar;827846;=;1;1;=;;Ki;nM;;7900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7900.0
;;2705792;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '11.84', 'le': '0.22', 'lle': '1.04', 'sei': '7.27'};CHEMBL549375;;CHEMBL549375;4.82;0;http://www.openphacts.org/units/Nanomolar;827847;=;1;1;=;;Ki;nM;;15000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;15000.0
;;2705793;[];CHEMBL1064182;Binding affinity to human ERG potassium channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1;;;CHEMBL1153470;J Med Chem;2009.0;{'bei': '11.00', 'le': '0.20', 'lle': '1.14', 'sei': '5.93'};CHEMBL563597;;CHEMBL563597;4.65;0;http://www.openphacts.org/units/Nanomolar;827926;=;1;1;=;;Ki;nM;;22500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;22500.0
;;2719636;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cnn(C2CCN(c3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '13.90', 'le': '0.25', 'lle': '0.84', 'sei': '13.93'};CHEMBL556450;;CHEMBL556450;5.42;0;http://www.openphacts.org/units/Nanomolar;831514;=;1;1;=;;Ki;nM;;3849.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3849.0
;;2719639;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(Cn2c(N3CCC(n4cccn4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '14.52', 'le': '0.27', 'lle': '1.19', 'sei': '14.02'};CHEMBL551347;;CHEMBL551347;5.45;0;http://www.openphacts.org/units/Nanomolar;831513;=;1;1;=;;Ki;nM;;3536.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3536.0
;;2719642;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(Cn2c(N3CCC(n4ccnc4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '18.28', 'le': '0.33', 'lle': '2.60', 'sei': '17.65'};CHEMBL556449;;CHEMBL556449;6.86;0;http://www.openphacts.org/units/Nanomolar;831512;=;1;1;=;;Ki;nM;;137.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;137.0
;;2719645;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(Cn2c(N3CCC(n4cccc4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '18.17', 'le': '0.33', 'lle': '1.93', 'sei': '26.18'};CHEMBL558339;;CHEMBL558339;6.80;0;http://www.openphacts.org/units/Nanomolar;831511;=;1;1;=;;Ki;nM;;157.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;157.0
;;2719651;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)CCN(C)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '14.92', 'le': '0.28', 'lle': '2.42', 'sei': '22.19'};CHEMBL559061;;CHEMBL559061;6.11;0;http://www.openphacts.org/units/Nanomolar;831434;=;1;1;=;;Ki;nM;;776.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;776.0
;;2719654;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(Cn2c(N3CCC(NCC4CCOCC4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '13.43', 'le': '0.25', 'lle': '1.76', 'sei': '11.32'};CHEMBL563055;;CHEMBL563055;5.83;0;http://www.openphacts.org/units/Nanomolar;831433;=;1;1;=;;Ki;nM;;1461.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1461.0
;;2719657;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(Cn2c(N3CCC(NCC4CCOCC4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '15.08', 'le': '0.28', 'lle': '2.16', 'sei': '15.05'};CHEMBL559060;;CHEMBL559060;6.37;0;http://www.openphacts.org/units/Nanomolar;831432;=;1;1;=;;Ki;nM;;426.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;426.0
;;2719660;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CCO)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '18.13', 'le': '0.34', 'lle': '3.82', 'sei': '15.57'};CHEMBL557210;;CHEMBL557210;6.94;0;http://www.openphacts.org/units/Nanomolar;831431;=;1;1;=;;Ki;nM;;116.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;116.0
;;2719663;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COCCN(C)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '18.66', 'le': '0.35', 'lle': '3.63', 'sei': '22.06'};CHEMBL550337;;CHEMBL550337;7.40;0;http://www.openphacts.org/units/Nanomolar;831245;=;1;1;=;;Ki;nM;;40.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;40.0
;;2719666;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(Cn2c(N3CCC(N(C)CC4CCOCC4)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '15.58', 'le': '0.29', 'lle': '2.57', 'sei': '16.35'};CHEMBL558663;;CHEMBL558663;6.99;0;http://www.openphacts.org/units/Nanomolar;831327;=;1;1;=;;Ki;nM;;102.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;102.0
;;2719669;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CC1CCOCC1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '17.74', 'le': '0.33', 'lle': '3.19', 'sei': '23.10'};CHEMBL550818;;CHEMBL550818;7.75;0;http://www.openphacts.org/units/Nanomolar;831326;=;1;1;=;;Ki;nM;;18.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18.0
;;2719672;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(Cn2c(N3CCC(N(C)C)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '18.66', 'le': '0.34', 'lle': '3.18', 'sei': '20.28'};CHEMBL558468;;CHEMBL558468;6.80;0;http://www.openphacts.org/units/Nanomolar;831325;=;1;1;=;;Ki;nM;;158.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;158.0
;;2719675;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(Cn2c(N3CCC(N(C)C)CC3)nc3ccccc32)cc1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '20.48', 'le': '0.37', 'lle': '3.22', 'sei': '29.37'};CHEMBL563451;;CHEMBL563451;7.14;0;http://www.openphacts.org/units/Nanomolar;831324;=;1;1;=;;Ki;nM;;73.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;73.0
;;2719678;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(C)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '20.55', 'le': '0.38', 'lle': '3.49', 'sei': '29.81'};CHEMBL558467;;CHEMBL558467;7.24;0;http://www.openphacts.org/units/Nanomolar;831323;=;1;1;=;;Ki;nM;;57.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;57.0
;;2719681;[];CHEMBL1060931;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1;;;CHEMBL1154013;Bioorg Med Chem Lett;2009.0;{'bei': '11.88', 'le': '0.22', 'lle': '1.73', 'sei': '7.34'};CHEMBL94454;MIZOLASTINE;CHEMBL94454;5.14;0;http://www.openphacts.org/units/Nanomolar;831246;=;1;1;=;;Ki;nM;;7258.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7258.0
;;3012136;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCN(C(=O)c1ccc2ccccc2c1)C1CCNCC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '16.52', 'le': '0.30', 'lle': '1.46', 'sei': '15.14'};CHEMBL565638;;CHEMBL565638;4.90;0;http://www.openphacts.org/units/Nanomolar;862612;=;1;1;=;;Ki;nM;;12700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.7
;;3012141;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)CN(C(=O)c1ccc2ccccc2c1)[C@@H]1CCNC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '17.39', 'le': '0.32', 'lle': '1.85', 'sei': '15.94'};CHEMBL577283;;CHEMBL577283;5.16;0;http://www.openphacts.org/units/Nanomolar;862452;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.0
;;3013201;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)N(Cc1ccc2ccccc2c1)[C@@H]1CCNC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '17.66', 'le': '0.35', 'lle': '3.42', 'sei': '10.88'};CHEMBL566576;;CHEMBL566576;5.38;0;http://www.openphacts.org/units/Nanomolar;862593;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;3013202;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(CN([C@@H]2CCNC2)S(C)(=O)=O)ccc2cc(F)ccc12;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '17.23', 'le': '0.34', 'lle': '3.39', 'sei': '11.73'};CHEMBL576821;;CHEMBL576821;5.80;0;http://www.openphacts.org/units/Nanomolar;862594;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.6
;;3013203;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)N(Cc1ccc2ccccc2c1)C1CCNCC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '17.26', 'le': '0.34', 'lle': '3.14', 'sei': '11.12'};CHEMBL568350;;CHEMBL568350;5.50;0;http://www.openphacts.org/units/Nanomolar;862615;=;1;1;=;;Ki;nM;;3200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.2
;;3013204;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)N(Cc1ccc2ccccc2c1)[C@H]1CCNC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '16.29', 'le': '0.32', 'lle': '3.00', 'sei': '10.04'};CHEMBL567943;;CHEMBL567943;4.96;0;http://www.openphacts.org/units/Nanomolar;862415;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;3013206;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCC(=O)N(Cc1ccc2ccccc2c1)C1CCNCC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '16.60', 'le': '0.31', 'lle': '1.59', 'sei': '15.22'};CHEMBL567288;;CHEMBL567288;4.92;0;http://www.openphacts.org/units/Nanomolar;862430;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.0
;;3013208;[];CHEMBL1048874;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)N(Cc1ccc2ccccc2c1)[C@@H]1CCNC1;;;CHEMBL1156048;Bioorg Med Chem Lett;2009.0;{'bei': '18.99', 'le': '0.35', 'lle': '2.55', 'sei': '15.76'};CHEMBL577497;;CHEMBL577497;5.10;0;http://www.openphacts.org/units/Nanomolar;862432;=;1;1;=;;Ki;nM;;8000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.0
;;3015180;[];CHEMBL1038976;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cnc2c(NCc3nnc4ccc(-c5cc(F)cc(F)c5)nn34)ccnc2c1;;;CHEMBL1156101;Bioorg Med Chem Lett;2009.0;{'bei': '15.97', 'le': '0.30', 'lle': '3.07', 'sei': '7.43'};CHEMBL568138;;CHEMBL568138;6.70;0;http://www.openphacts.org/units/Nanomolar;862923;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.2
;;3015181;[];CHEMBL1038976;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1cnc2c(NCc3nnc4ccc(-c5cc(C)ns5)nn34)ccnc2c1;;;CHEMBL1156101;Bioorg Med Chem Lett;2009.0;{'bei': '14.33', 'le': '0.27', 'lle': '2.68', 'sei': '5.63'};CHEMBL566685;;CHEMBL566685;5.80;0;http://www.openphacts.org/units/Nanomolar;862945;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.6
;;3021324;[];CHEMBL1047320;Displacement of [35S]MK499 from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1cccc2c1C(=O)Nc1ncc(-c3ccccc3)cc1C2;;;CHEMBL1155351;Bioorg Med Chem Lett;2009.0;{'bei': '20.45', 'le': '0.36', 'lle': '2.59', 'sei': '9.68'};CHEMBL585530;;CHEMBL585530;6.37;0;http://www.openphacts.org/units/Nanomolar;857444;=;1;1;=;;Ki;nM;;431.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;431.0
;;3053790;[];CHEMBL1045136;Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(OCCNCCNc2ccc(Cl)c(Cl)c2)cc1;;;CHEMBL1152519;Bioorg Med Chem;2009.0;{'bei': '15.59', 'le': '0.34', 'lle': '3.07', 'sei': '8.21'};CHEMBL596046;;CHEMBL596046;6.52;0;http://www.openphacts.org/units/Nanomolar;876069;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;300.0
;;3053799;[];CHEMBL1045136;Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(CCC(=O)NCCNc2ccc(Cl)c(Cl)c2)cc1;;;CHEMBL1152519;Bioorg Med Chem;2009.0;{'bei': '12.40', 'le': '0.27', 'lle': '1.81', 'sei': '6.11'};CHEMBL595318;;CHEMBL595318;5.33;0;http://www.openphacts.org/units/Nanomolar;876068;=;1;1;=;;Ki;nM;;4620.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4620.0
;;3053800;[];CHEMBL1045136;Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(CCCNCCNc2ccc(Cl)c(Cl)c2)cc1;;;CHEMBL1152519;Bioorg Med Chem;2009.0;{'bei': '18.86', 'le': '0.41', 'lle': '3.85', 'sei': '11.18'};CHEMBL594615;;CHEMBL594615;7.85;0;http://www.openphacts.org/units/Nanomolar;875920;=;1;1;=;;Ki;nM;;14.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;14.0
;;3053801;[];CHEMBL1045136;Displacement of [3H]astemizole from human recombinant ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(CCC(=O)NC/C=C/c2ccc(Cl)c(Cl)c2)cc1;;;CHEMBL1152519;Bioorg Med Chem;2009.0;{'bei': '12.92', 'le': '0.28', 'lle': '1.39', 'sei': '7.34'};CHEMBL609857;;CHEMBL609857;5.52;0;http://www.openphacts.org/units/Nanomolar;876080;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3000.0
;;3095206;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CC(C)(C)O)C[C@@H]3C2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '11.28', 'le': '0.22', 'lle': '1.98', 'sei': '7.65'};CHEMBL605744;;CHEMBL605744;5.42;0;http://www.openphacts.org/units/Nanomolar;883948;=;1;1;=;;Ki;nM;;3810.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3810.0
;;3095207;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CC(O)c4ccccc4)C[C@@H]3C2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '12.77', 'le': '0.24', 'lle': '2.34', 'sei': '9.53'};CHEMBL597033;;CHEMBL597033;6.75;0;http://www.openphacts.org/units/Nanomolar;883947;=;1;1;=;;Ki;nM;;177.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;177.0
;;3095208;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@@H]2C[C@@H]3CN(CCC(F)(F)F)C[C@@H]3C2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '10.59', 'le': '0.21', 'lle': '0.72', 'sei': '10.56'};CHEMBL597032;;CHEMBL597032;5.34;0;http://www.openphacts.org/units/Nanomolar;883946;=;1;1;=;;Ki;nM;;4530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4530.0
;;3095210;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN1C[C@H]2C[C@@H](N(Cc3cccc(OC(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '13.00', 'le': '0.25', 'lle': '1.99', 'sei': '11.22'};CHEMBL604805;;CHEMBL604805;5.68;0;http://www.openphacts.org/units/Nanomolar;883853;=;1;1;=;;Ki;nM;;2110.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2110.0
;;3095211;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(OC4CCCC4)c3)C(=O)c3cn(C)cn3)C[C@H]2C1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '12.05', 'le': '0.23', 'lle': '1.45', 'sei': '10.49'};CHEMBL599482;;CHEMBL599482;5.31;0;http://www.openphacts.org/units/Nanomolar;883852;=;1;1;=;;Ki;nM;;4910.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4910.0
;;3095212;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(C(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '13.38', 'le': '0.26', 'lle': '2.12', 'sei': '13.72'};CHEMBL603695;;CHEMBL603695;5.68;0;http://www.openphacts.org/units/Nanomolar;883851;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2100.0
;;3095213;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN1C[C@H]2C[C@@H](N(Cc3ccc(F)c(C(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '12.19', 'le': '0.24', 'lle': '1.40', 'sei': '12.92'};CHEMBL599480;;CHEMBL599480;5.35;0;http://www.openphacts.org/units/Nanomolar;883850;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4500.0
;;3095214;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1C[C@H]2C[C@@H](N(Cc3cccc(OC(F)(F)F)c3)C(=O)c3cn(C)cn3)C[C@H]2C1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '13.24', 'le': '0.25', 'lle': '2.29', 'sei': '11.05'};CHEMBL598659;;CHEMBL598659;5.59;0;http://www.openphacts.org/units/Nanomolar;883765;=;1;1;=;;Ki;nM;;2560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2560.0
;;3095219;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(C(=O)N(Cc2cccc(OC(F)(F)F)c2)[C@H]2C[C@H]3CNC[C@H]3C2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '14.16', 'le': '0.27', 'lle': '2.82', 'sei': '9.74'};CHEMBL596700;;CHEMBL596700;5.78;0;http://www.openphacts.org/units/Nanomolar;883679;=;1;1;=;;Ki;nM;;1650.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1650.0
;;3095220;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc(C(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)[C@H]2C[C@H]3CNC[C@H]3C2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '13.35', 'le': '0.26', 'lle': '2.26', 'sei': '10.93'};CHEMBL596699;;CHEMBL596699;5.48;0;http://www.openphacts.org/units/Nanomolar;883678;=;1;1;=;;Ki;nM;;3310.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3310.0
;;3095221;[];CHEMBL1074123;Displacement of radiolabeled dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.Cl.Cl.Cn1cnc(C(=O)N(Cc2cccc(Cl)c2)[C@H]2CC[C@@H](N)CC2)c1;;;CHEMBL1159083;Bioorg Med Chem Lett;2010.0;{'bei': '15.64', 'le': '0.31', 'lle': '2.43', 'sei': '8.46'};CHEMBL3217125;;CHEMBL563761;5.42;0;http://www.openphacts.org/units/Nanomolar;883677;=;1;1;=;;Ki;nM;;3760.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3760.0
;;3124680;[];CHEMBL1068920;Displacement of [3H]dofetilidine from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1;;;CHEMBL1157620;J Med Chem;2010.0;{'bei': '17.12', 'le': '0.37', 'lle': '1.78', 'sei': '23.05'};CHEMBL608151;;CHEMBL608151;4.90;0;http://www.openphacts.org/units/Nanomolar;878968;=;1;1;=;;Ki;nM;;12589.25;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.9
;;3225317;[];CHEMBL1112218;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CNC(=O)Cn1c(=O)n(C2CCN([C@H]3CC[C@@H](C(C)C)CC3)CC2)c2ccccc21;;;CHEMBL1154346;Bioorg Med Chem Lett;2009.0;{'bei': '13.03', 'le': '0.24', 'lle': '1.98', 'sei': '9.07'};CHEMBL1080485;;CHEMBL1080485;5.38;0;http://www.openphacts.org/units/Nanomolar;890731;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;3225319;[];CHEMBL1112218;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CNC(=O)Cn1c(=O)n(C2CCN(CCC(Oc3cc(OC)ccc3C)C(C)C)CC2)c2ccccc21;;;CHEMBL1154346;Bioorg Med Chem Lett;2009.0;{'bei': '14.26', 'le': '0.27', 'lle': '3.25', 'sei': '9.33'};CHEMBL391487;;CHEMBL391487;7.25;0;http://www.openphacts.org/units/Nanomolar;890732;=;1;1;=;;Ki;nM;;56.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;56.0
;;3246168;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(c1)CC(CCN(C)C)=C2Cc1cnccn1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '20.62', 'le': '0.38', 'lle': '2.76', 'sei': '20.85'};CHEMBL1092600;;CHEMBL1092600;6.05;0;http://www.openphacts.org/units/Nanomolar;901885;=;1;1;=;;Ki;nM;;890.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.89
;;3246170;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCC1=C(Cc2cnccn2)c2ccc(Cl)cc2C1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '18.65', 'le': '0.36', 'lle': '2.22', 'sei': '20.17'};CHEMBL1092259;;CHEMBL1092259;5.85;0;http://www.openphacts.org/units/Nanomolar;901887;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;3246171;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCC1=C(Cc2cnccn2)c2ccc(F)cc2C1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '20.25', 'le': '0.37', 'lle': '2.90', 'sei': '20.75'};CHEMBL1092649;;CHEMBL1092649;6.02;0;http://www.openphacts.org/units/Nanomolar;901966;=;1;1;=;;Ki;nM;;950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.95
;;3246172;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1nccnc1CC1=C(CCN(C)C)Cc2cc(Cl)ccc21;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '17.12', 'le': '0.33', 'lle': '2.25', 'sei': '15.39'};CHEMBL1092650;;CHEMBL1092650;5.89;0;http://www.openphacts.org/units/Nanomolar;901967;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.3
;;3246174;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)CCC1=C(Cc2cccnn2)c2ccc(Cl)cc2C1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '20.46', 'le': '0.40', 'lle': '2.79', 'sei': '22.12'};CHEMBL1092652;;CHEMBL1092652;6.42;0;http://www.openphacts.org/units/Nanomolar;901969;=;1;1;=;;Ki;nM;;380.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.38
;;3246216;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(c1)CC(CCN(C)C)=C2[C@@H](C)c1cnccn1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '17.21', 'le': '0.31', 'lle': '1.44', 'sei': '18.24'};CHEMBL1092663;;CHEMBL1092663;5.29;0;http://www.openphacts.org/units/Nanomolar;901971;=;1;1;=;;Ki;nM;;5100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1
;;3246221;[];CHEMBL1115187;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](C1=C(CCN(C)C)Cc2cc(F)ccc21)c1nccs1;;;CHEMBL1156971;Bioorg Med Chem Lett;2010.0;{'bei': '18.71', 'le': '0.37', 'lle': '1.57', 'sei': '36.71'};CHEMBL1090527;;CHEMBL1090527;5.92;0;http://www.openphacts.org/units/Nanomolar;902050;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;3247876;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@H]2CN(c3cccnc3)C[C@@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccccc1;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '16.87', 'le': '0.31', 'lle': '3.71', 'sei': '14.64'};CHEMBL1089104;;CHEMBL1089104;8.29;0;http://www.openphacts.org/units/Nanomolar;903280;=;1;1;=;;Ki;nM;;5.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.07
;;3247877;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@H]2CN(c3ccccn3)C[C@@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccccc1;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '16.95', 'le': '0.32', 'lle': '3.75', 'sei': '14.70'};CHEMBL1089103;;CHEMBL1089103;8.33;0;http://www.openphacts.org/units/Nanomolar;903279;=;1;1;=;;Ki;nM;;4.65;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4.65
;;3247879;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@H]2CN(C3CCC3)C[C@@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccccc1;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '17.57', 'le': '0.33', 'lle': '3.70', 'sei': '18.80'};CHEMBL1092571;;CHEMBL1092571;8.23;0;http://www.openphacts.org/units/Nanomolar;903165;=;1;1;=;;Ki;nM;;5.87;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.87
;;3247882;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@@H]2CNC[C@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccccc1;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '19.73', 'le': '0.37', 'lle': '4.91', 'sei': '15.55'};CHEMBL1092209;;CHEMBL1092209;8.18;0;http://www.openphacts.org/units/Nanomolar;903002;=;1;1;=;;Ki;nM;;6.65;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6.65
;;3247888;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccccn1;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '17.46', 'le': '0.33', 'lle': '4.05', 'sei': '14.53'};CHEMBL1089830;;CHEMBL1089830;8.23;0;http://www.openphacts.org/units/Nanomolar;903940;=;1;1;=;;Ki;nM;;5.84;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.84
;;3247890;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1c(F)cccc1F;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '16.39', 'le': '0.31', 'lle': '3.24', 'sei': '18.96'};CHEMBL1092550;;CHEMBL1092550;8.30;0;http://www.openphacts.org/units/Nanomolar;903867;=;1;1;=;;Ki;nM;;5.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.0
;;3247892;[];CHEMBL1116908;Displacement of [3H]dofetilide from human ERG expressed in CHO cells by patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CN(C(=O)[C@@H]2CN(C(C)(C)C)C[C@H]2c2ccc(F)cc2F)C[C@H](C)[C@@]1(O)c1ccc(F)cc1.Cl;;;CHEMBL1156187;J Med Chem;2010.0;{'bei': '16.58', 'le': '0.32', 'lle': '3.18', 'sei': '18.51'};CHEMBL1204061;;CHEMBL1091151;8.10;0;http://www.openphacts.org/units/Nanomolar;903787;=;1;1;=;;Ki;nM;;7.91;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7.91
;;3248553;[];CHEMBL1106981;Displacement of [3H]Dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H](c1ccccn1)c1c(CCN2CCCC2)sc2ccccc12;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '17.71', 'le': '0.34', 'lle': '0.87', 'sei': '36.94'};CHEMBL1091774;;CHEMBL1091774;5.96;0;http://www.openphacts.org/units/Nanomolar;900610;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;3248558;[];CHEMBL1106981;Displacement of [3H]Dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(c1ccncc1)c1c(CCN(C)C)sc2ccccc12;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '18.50', 'le': '0.36', 'lle': '1.19', 'sei': '35.62'};CHEMBL1091790;;CHEMBL1091790;5.75;0;http://www.openphacts.org/units/Nanomolar;900707;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;3249589;[];CHEMBL1106982;Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](c1ccccn1)c1c(CCN(C)C)sc2ccccc12;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '18.85', 'le': '0.36', 'lle': '1.30', 'sei': '36.29'};CHEMBL564144;;CHEMBL564144;5.85;0;http://www.openphacts.org/units/Nanomolar;900531;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;3249591;[];CHEMBL1106982;Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CNCCc1sc2ccccc2c1[C@@H](C)c1ccccn1;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '17.50', 'le': '0.34', 'lle': '0.98', 'sei': '20.81'};CHEMBL1093044;;CHEMBL1093044;5.19;0;http://www.openphacts.org/units/Nanomolar;900609;=;1;1;=;;Ki;nM;;6500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.5
;;3249593;[];CHEMBL1106982;Inhibition of human ERG expressed in HEK cells assessed as blockade of potassium tail current by standard patch clamp analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H](c1ccccn1)c1c(CCN2CCC2)sc2ccccc12;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '28.33', 'le': '0.54', 'lle': '4.44', 'sei': '56.64'};CHEMBL1091775;;CHEMBL1091775;9.14;0;http://www.openphacts.org/units/Nanomolar;900611;=;1;1;=;;Ki;nM;;0.73;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;0.73
;;3249661;[];CHEMBL1106981;Displacement of [3H]Dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H](c1ccc(F)cn1)c1c(CCN(C)C)sc2ccccc12;;;CHEMBL1156278;Bioorg Med Chem Lett;2010.0;{'bei': '17.06', 'le': '0.33', 'lle': '0.91', 'sei': '34.73'};CHEMBL1092495;;CHEMBL1092495;5.60;0;http://www.openphacts.org/units/Nanomolar;900790;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.5
;;3279568;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccccn2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '16.27', 'le': '0.30', 'lle': '1.70', 'sei': '14.69'};CHEMBL1095200;;CHEMBL1095200;4.99;0;http://www.openphacts.org/units/Nanomolar;911747;=;1;1;=;;Ki;nM;;10336.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10336.0
;;3279571;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCC[C@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '16.04', 'le': '0.30', 'lle': '1.16', 'sei': '24.63'};CHEMBL1094549;;CHEMBL1094549;5.19;0;http://www.openphacts.org/units/Nanomolar;911744;=;1;1;=;;Ki;nM;;6515.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6515.0
;;3279572;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '16.74', 'le': '0.31', 'lle': '1.38', 'sei': '25.70'};CHEMBL1095819;;CHEMBL1095819;5.41;0;http://www.openphacts.org/units/Nanomolar;911664;=;1;1;=;;Ki;nM;;3860.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3860.0
;;3279574;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1csc(Cn2c(C3CCCN(C4CCCCC4)C3)nc3ccccc32)n1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '15.02', 'le': '0.29', 'lle': '0.57', 'sei': '17.46'};CHEMBL1095511;;CHEMBL1095511;5.93;0;http://www.openphacts.org/units/Nanomolar;911662;=;1;1;=;;Ki;nM;;1183.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1183.0
;;3279578;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(Cn2c(C3CCCN(C4CCCCC4)C3)nc3ccccc32)cc1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '14.21', 'le': '0.26', 'lle': '0.13', 'sei': '18.93'};CHEMBL1094851;;CHEMBL1094851;5.74;0;http://www.openphacts.org/units/Nanomolar;911583;=;1;1;=;;Ki;nM;;1840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1840.0
;;3279579;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(Cn2c(C3CCCN(C(C)C)C3)nc3ccccc32)cc1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '15.34', 'le': '0.28', 'lle': '0.90', 'sei': '18.41'};CHEMBL1095364;;CHEMBL1095364;5.58;0;http://www.openphacts.org/units/Nanomolar;911582;=;1;1;=;;Ki;nM;;2649.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2649.0
;;3279580;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1ccc(Cn2c(C3CCCN(C4CCCCC4)C3)nc3ccccc32)cc1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '15.41', 'le': '0.28', 'lle': '0.29', 'sei': '28.65'};CHEMBL1094525;;CHEMBL1094525;6.03;0;http://www.openphacts.org/units/Nanomolar;911581;=;1;1;=;;Ki;nM;;926.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;926.0
;;3279581;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)N1CCCC(c2nc3ccccc3n2Cc2ccc(F)cc2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '16.68', 'le': '0.31', 'lle': '1.05', 'sei': '27.84'};CHEMBL1098766;;CHEMBL1098766;5.86;0;http://www.openphacts.org/units/Nanomolar;911580;=;1;1;=;;Ki;nM;;1373.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1373.0
;;3279582;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCCC(c2nc3ccccc3n2CC2CCCO2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '20.69', 'le': '0.38', 'lle': '3.18', 'sei': '20.45'};CHEMBL1098125;;CHEMBL1098125;6.20;0;http://www.openphacts.org/units/Nanomolar;911498;=;1;1;=;;Ki;nM;;638.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;638.0
;;3279585;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOCCn1c(C2CCCN(C)C2)nc2ccccc21;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '20.52', 'le': '0.38', 'lle': '3.02', 'sei': '19.47'};CHEMBL1095031;;CHEMBL1095031;5.90;0;http://www.openphacts.org/units/Nanomolar;911495;=;1;1;=;;Ki;nM;;1262.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1262.0
;;3279586;[];CHEMBL1110020;Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCCC(c2nc3ccccc3n2CCOc2ccccc2)C1;;;CHEMBL1157885;Bioorg Med Chem Lett;2010.0;{'bei': '15.73', 'le': '0.29', 'lle': '1.36', 'sei': '17.42'};CHEMBL1094510;;CHEMBL1094510;5.28;0;http://www.openphacts.org/units/Nanomolar;911494;=;1;1;=;;Ki;nM;;5291.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5291.0
;;3285039;[];CHEMBL1112964;Displacement of labeled MK-499 from human ERG in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1NCc2c(-c3ccc(F)cc3F)cc(N3CCNCC3)cc2N1c1c(Cl)cccc1Cl;;;CHEMBL1158539;Bioorg Med Chem Lett;2010.0;{'bei': '12.38', 'le': '0.25', 'lle': '0.35', 'sei': '12.73'};CHEMBL94417;;CHEMBL94417;6.06;0;http://www.openphacts.org/units/Nanomolar;909327;=;1;1;=;;Ki;nM;;870.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.87
;;3285040;[];CHEMBL1112964;Displacement of labeled MK-499 from human ERG in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1cc2c(ccc(=O)n2-c2c(F)cccc2F)c(-c2ccc(F)cc2F)n1;;;CHEMBL1158539;Bioorg Med Chem Lett;2010.0;{'bei': '13.74', 'le': '0.26', 'lle': '1.10', 'sei': '8.69'};CHEMBL219804;;CHEMBL219804;5.29;0;http://www.openphacts.org/units/Nanomolar;909403;=;1;1;=;;Ki;nM;;5100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1
;;3302543;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)c1cc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)on1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.17', 'le': '0.26', 'lle': '1.29', 'sei': '7.85'};CHEMBL1084583;;CHEMBL1084583;5.38;0;http://www.openphacts.org/units/Nanomolar;916244;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;3302544;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccn[nH]3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.32', 'le': '0.30', 'lle': '1.35', 'sei': '11.16'};CHEMBL1084581;;CHEMBL1084581;5.00;0;http://www.openphacts.org/units/Nanomolar;916242;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302545;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cn[nH]c3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.32', 'le': '0.30', 'lle': '1.35', 'sei': '11.16'};CHEMBL1084582;;CHEMBL1084582;5.00;0;http://www.openphacts.org/units/Nanomolar;916243;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302546;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1n[nH]cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.72', 'le': '0.30', 'lle': '1.40', 'sei': '11.95'};CHEMBL1084314;;CHEMBL1084314;5.36;0;http://www.openphacts.org/units/Nanomolar;916241;=;1;1;=;;Ki;nM;;4400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.4
;;3302547;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1C;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.95', 'le': '0.27', 'lle': '1.03', 'sei': '14.73'};CHEMBL1084827;;CHEMBL1084827;5.00;0;http://www.openphacts.org/units/Nanomolar;916165;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302548;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nn(C)cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.57', 'le': '0.28', 'lle': '1.24', 'sei': '15.34'};CHEMBL442242;;CHEMBL442242;5.21;0;http://www.openphacts.org/units/Nanomolar;916164;=;1;1;=;;Ki;nM;;6200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.2
;;3302549;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1n[nH]c(C)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.95', 'le': '0.27', 'lle': '0.73', 'sei': '11.16'};CHEMBL1084826;;CHEMBL1084826;5.00;0;http://www.openphacts.org/units/Nanomolar;916163;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302550;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccoc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '18.53', 'le': '0.34', 'lle': '1.16', 'sei': '19.40'};CHEMBL1085326;;CHEMBL1085326;5.68;0;http://www.openphacts.org/units/Nanomolar;916161;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;3302551;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccsc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '18.36', 'le': '0.35', 'lle': '0.93', 'sei': '36.71'};CHEMBL1085572;;CHEMBL1085572;5.92;0;http://www.openphacts.org/units/Nanomolar;916162;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;3302552;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cccs3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '19.25', 'le': '0.37', 'lle': '1.22', 'sei': '38.48'};CHEMBL1085829;;CHEMBL1085829;6.21;0;http://www.openphacts.org/units/Nanomolar;915828;=;1;1;=;;Ki;nM;;620.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.62
;;3302553;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cncnc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.70', 'le': '0.28', 'lle': '1.28', 'sei': '11.93'};CHEMBL1085828;;CHEMBL1085828;5.00;0;http://www.openphacts.org/units/Nanomolar;915827;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302554;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ncc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cn1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.07', 'le': '0.28', 'lle': '1.52', 'sei': '10.27'};CHEMBL1082489;;CHEMBL1082489;5.25;0;http://www.openphacts.org/units/Nanomolar;915825;=;1;1;=;;Ki;nM;;5600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.6
;;3302555;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(N2CCCC2)ncc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.91', 'le': '0.25', 'lle': '0.96', 'sei': '12.37'};CHEMBL237191;;CHEMBL237191;5.58;0;http://www.openphacts.org/units/Nanomolar;915826;=;1;1;=;;Ki;nM;;2600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.6
;;3302556;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)nc(-c2ccccc2)n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '18.41', 'le': '0.33', 'lle': '1.83', 'sei': '17.95'};CHEMBL1082488;;CHEMBL1082488;7.52;0;http://www.openphacts.org/units/Nanomolar;915824;=;1;1;=;;Ki;nM;;30.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.03
;;3302557;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC1CCN(c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)CC1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.56', 'le': '0.29', 'lle': '0.75', 'sei': '27.11'};CHEMBL1085337;;CHEMBL1085337;5.25;0;http://www.openphacts.org/units/Nanomolar;915700;=;1;1;=;;Ki;nM;;5600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.6
;;3302558;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(N4CCCCC4)cc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.42', 'le': '0.28', 'lle': '0.24', 'sei': '31.81'};CHEMBL1085336;;CHEMBL1085336;6.16;0;http://www.openphacts.org/units/Nanomolar;915699;=;1;1;=;;Ki;nM;;690.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.69
;;3302559;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(-n4ccc(=O)cc4)cc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.94', 'le': '0.23', 'lle': '0.22', 'sei': '13.90'};CHEMBL1086514;;CHEMBL1086514;5.30;0;http://www.openphacts.org/units/Nanomolar;915698;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.0
;;3302560;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cnc(-c4ccccc4)s3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.19', 'le': '0.30', 'lle': '0.42', 'sei': '22.29'};CHEMBL1086513;;CHEMBL1086513;6.47;0;http://www.openphacts.org/units/Nanomolar;915697;=;1;1;=;;Ki;nM;;340.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.34
;;3302561;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2cccs2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.37', 'le': '0.28', 'lle': '-0.39', 'sei': '20.78'};CHEMBL1086292;;CHEMBL1086292;6.03;0;http://www.openphacts.org/units/Nanomolar;915696;=;1;1;=;;Ki;nM;;930.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.93
;;3302562;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2cnccn2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.28', 'le': '0.23', 'lle': '-0.05', 'sei': '9.31'};CHEMBL1085592;;CHEMBL1085592;5.10;0;http://www.openphacts.org/units/Nanomolar;916348;=;1;1;=;;Ki;nM;;7900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.9
;;3302563;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(N2CCOCC2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.52', 'le': '0.24', 'lle': '0.76', 'sei': '12.76'};CHEMBL1086561;;CHEMBL1086561;5.29;0;http://www.openphacts.org/units/Nanomolar;915017;=;1;1;=;;Ki;nM;;5100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1
;;3302564;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2ccccn2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.39', 'le': '0.25', 'lle': '-0.21', 'sei': '13.25'};CHEMBL1085866;;CHEMBL1085866;5.55;0;http://www.openphacts.org/units/Nanomolar;915018;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.8
;;3302565;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2cccnc2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.05', 'le': '0.27', 'lle': '0.06', 'sei': '13.90'};CHEMBL1082606;;CHEMBL1082606;5.82;0;http://www.openphacts.org/units/Nanomolar;915019;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5
;;3302566;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)nnn1-c1ccc(F)cc1F;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.17', 'le': '0.26', 'lle': '1.04', 'sei': '13.11'};CHEMBL1086098;;CHEMBL1086098;6.14;0;http://www.openphacts.org/units/Nanomolar;915020;=;1;1;=;;Ki;nM;;720.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.72
;;3302567;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc(Cl)cc2)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.72', 'le': '0.28', 'lle': '-0.19', 'sei': '15.08'};CHEMBL1085641;;CHEMBL1085641;6.36;0;http://www.openphacts.org/units/Nanomolar;915094;=;1;1;=;;Ki;nM;;440.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.44
;;3302568;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1onc(-c2ccc(Cl)cc2)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.81', 'le': '0.28', 'lle': '-0.15', 'sei': '15.18'};CHEMBL1085396;;CHEMBL1085396;6.40;0;http://www.openphacts.org/units/Nanomolar;915095;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4
;;3302569;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3c(-c4ccccc4)nn(C)c3Cl)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.51', 'le': '0.26', 'lle': '-0.16', 'sei': '17.15'};CHEMBL1085397;;CHEMBL1085397;5.82;0;http://www.openphacts.org/units/Nanomolar;915096;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5
;;3302570;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1onc(-c2ccccc2)c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.58', 'le': '0.26', 'lle': '-0.09', 'sei': '13.75'};CHEMBL1085398;;CHEMBL1085398;5.80;0;http://www.openphacts.org/units/Nanomolar;915097;=;1;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.6
;;3302571;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3nc4ccccc4s3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.92', 'le': '0.32', 'lle': '0.78', 'sei': '21.77'};CHEMBL1083562;;CHEMBL1083562;6.32;0;http://www.openphacts.org/units/Nanomolar;915178;=;1;1;=;;Ki;nM;;480.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.48
;;3302572;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)sc2nc3ccccc3n12;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.92', 'le': '0.28', 'lle': '0.27', 'sei': '19.04'};CHEMBL1085142;;CHEMBL1085142;6.37;0;http://www.openphacts.org/units/Nanomolar;915179;=;1;1;=;;Ki;nM;;430.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.43
;;3302573;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)sc2ncnn12;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.29', 'le': '0.31', 'lle': '1.81', 'sei': '13.27'};CHEMBL1084383;;CHEMBL1084383;6.15;0;http://www.openphacts.org/units/Nanomolar;915180;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.71
;;3302574;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cn4c(n3)SCC4)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.72', 'le': '0.26', 'lle': '0.77', 'sei': '14.73'};CHEMBL1084384;;CHEMBL1084384;5.00;0;http://www.openphacts.org/units/Nanomolar;915181;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302575;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc2ccccn2c1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.38', 'le': '0.28', 'lle': '0.82', 'sei': '17.05'};CHEMBL1084385;;CHEMBL1084385;5.70;0;http://www.openphacts.org/units/Nanomolar;915182;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;3302576;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc4nccnc4c3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.41', 'le': '0.28', 'lle': '0.81', 'sei': '13.55'};CHEMBL1083447;;CHEMBL1083447;5.68;0;http://www.openphacts.org/units/Nanomolar;915268;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;3302577;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc2ncccc2cc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.07', 'le': '0.24', 'lle': '-0.18', 'sei': '11.93'};CHEMBL263101;;CHEMBL263101;5.00;0;http://www.openphacts.org/units/Nanomolar;915269;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302578;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc4c(c3)COCO4)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.13', 'le': '0.29', 'lle': '1.24', 'sei': '17.46'};CHEMBL1083448;;CHEMBL1083448;6.04;0;http://www.openphacts.org/units/Nanomolar;915270;=;1;1;=;;Ki;nM;;910.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.91
;;3302579;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(C#N)s3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '18.18', 'le': '0.35', 'lle': '1.46', 'sei': '15.83'};CHEMBL1086315;;CHEMBL1086315;6.32;0;http://www.openphacts.org/units/Nanomolar;915271;=;1;1;=;;Ki;nM;;480.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.48
;;3302580;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=N)c1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)s1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.04', 'le': '0.29', 'lle': '0.57', 'sei': '12.03'};CHEMBL1086534;;CHEMBL1086534;5.92;0;http://www.openphacts.org/units/Nanomolar;915272;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;3302581;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccccn3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.84', 'le': '0.30', 'lle': '1.03', 'sei': '18.42'};CHEMBL1082496;;CHEMBL1082496;5.35;0;http://www.openphacts.org/units/Nanomolar;915348;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.5
;;3302582;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2ccncc2)sc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.28', 'le': '0.27', 'lle': '0.16', 'sei': '14.13'};CHEMBL1085841;;CHEMBL1085841;5.92;0;http://www.openphacts.org/units/Nanomolar;915349;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;3302583;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(-c2nc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)cs2)cs1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.10', 'le': '0.26', 'lle': '-0.31', 'sei': '13.14'};CHEMBL1086072;;CHEMBL1086072;5.51;0;http://www.openphacts.org/units/Nanomolar;915350;=;1;1;=;;Ki;nM;;3100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.1
;;3302584;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2nc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)cs2)no1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.20', 'le': '0.29', 'lle': '0.80', 'sei': '11.17'};CHEMBL1086073;;CHEMBL1086073;6.15;0;http://www.openphacts.org/units/Nanomolar;915351;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.71
;;3302585;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cnc4c(c3)OCO4)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.83', 'le': '0.25', 'lle': '0.95', 'sei': '10.53'};CHEMBL1086074;;CHEMBL1086074;5.00;0;http://www.openphacts.org/units/Nanomolar;915352;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3302586;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c(C)n2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.68', 'le': '0.27', 'lle': '1.07', 'sei': '12.21'};CHEMBL392573;;CHEMBL392573;5.66;0;http://www.openphacts.org/units/Nanomolar;915446;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;3302587;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccn4ncnc4n3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.74', 'le': '0.27', 'lle': '1.91', 'sei': '8.92'};CHEMBL1084616;;CHEMBL1084616;5.28;0;http://www.openphacts.org/units/Nanomolar;915447;=;1;1;=;;Ki;nM;;5200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.2
;;3304374;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)C1CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '16.04', 'le': '0.32', 'lle': '2.57', 'sei': '16.45'};CHEMBL358075;;CHEMBL358075;6.15;1;http://www.openphacts.org/units/Nanomolar;916539;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;710.0
;;3304375;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '13.09', 'le': '0.27', 'lle': '1.37', 'sei': '14.06'};CHEMBL175832;;CHEMBL175832;5.25;1;http://www.openphacts.org/units/Nanomolar;916540;=;1;1;=;;Ki;nM;;5561.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5561.0
;;3305076;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(c1ccccc1)c1ccc(/C=C/c2ccc(F)cc2F)cc1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '15.05', 'le': '0.29', 'lle': '0.39', 'sei': '15.71'};CHEMBL1082773;;CHEMBL1082773;5.36;0;http://www.openphacts.org/units/Nanomolar;916543;=;1;1;=;;Ki;nM;;4342.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4342.0
;;3305080;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)c1ccc(S(=O)(=O)c2ccc(/C=C/c3ccc(F)cc3F)cc2)cc1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '12.77', 'le': '0.25', 'lle': '1.03', 'sei': '6.61'};CHEMBL1082467;;CHEMBL1082467;5.10;0;http://www.openphacts.org/units/Nanomolar;916653;=;1;1;=;;Ki;nM;;7919.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7919.0
;;3305081;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)c1ccccc1S(=O)(=O)c1ccc(/C=C/c2ccc(F)cc2)cc1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '14.11', 'le': '0.27', 'lle': '0.52', 'sei': '9.93'};CHEMBL1084721;;CHEMBL1084721;5.40;0;http://www.openphacts.org/units/Nanomolar;916654;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4000.0
;;3305082;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@H](O)c1ccccc1S(=O)(=O)c1ccc(/C=C/c2ccc(F)cc2)cc1;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '13.29', 'le': '0.26', 'lle': '0.20', 'sei': '9.35'};CHEMBL1084976;;CHEMBL1084976;5.08;0;http://www.openphacts.org/units/Nanomolar;916735;=;1;1;=;;Ki;nM;;8252.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8252.0
;;3305083;[];CHEMBL1120468;Displacement of [3H]-dofetilide from human ERG receptor expressed HEK cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC;;;CHEMBL1158627;Bioorg Med Chem Lett;2010.0;{'bei': '15.95', 'le': '0.30', 'lle': '2.13', 'sei': '14.21'};CHEMBL74355;VOLINANSERIN;CHEMBL74355;5.96;1;http://www.openphacts.org/units/Nanomolar;916736;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1100.0
;;3310342;[];CHEMBL1117803;Displacement of [3H]dofetolide from human ERG channel in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(S(=O)(=O)N2C[C@H](C(=O)N3CCCNCC3)c3ccccc32)c2ccccc12;;;CHEMBL1155540;Bioorg Med Chem Lett;2010.0;{'bei': '12.67', 'le': '0.24', 'lle': '2.94', 'sei': '7.47'};CHEMBL1084215;;CHEMBL1084215;5.90;0;http://www.openphacts.org/units/Nanomolar;917077;=;1;1;=;;Ki;nM;;1258.93;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.9
;;3311036;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3occc3c2)nn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '26.29', 'le': '0.48', 'lle': '5.28', 'sei': '17.74'};CHEMBL1083301;;CHEMBL1083301;8.06;0;http://www.openphacts.org/units/Nanomolar;917637;=;1;1;=;;Ki;nM;;8.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8.8
;;3311037;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3sccc3c2)nn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '27.12', 'le': '0.52', 'lle': '5.49', 'sei': '27.11'};CHEMBL1083302;;CHEMBL1083302;8.74;0;http://www.openphacts.org/units/Nanomolar;917638;=;1;1;=;;Ki;nM;;1.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.8
;;3311039;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3[nH]ccc3c2)nn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '25.14', 'le': '0.46', 'lle': '5.16', 'sei': '15.98'};CHEMBL1083304;;CHEMBL1083304;7.68;0;http://www.openphacts.org/units/Nanomolar;917640;=;1;1;=;;Ki;nM;;21.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;21.0
;;3311040;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3[nH]c(C(F)(F)F)cc3c2)nn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '23.19', 'le': '0.44', 'lle': '5.12', 'sei': '18.02'};CHEMBL1083614;;CHEMBL1083614;8.66;0;http://www.openphacts.org/units/Nanomolar;917718;=;1;1;=;;Ki;nM;;2.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.2
;;3311042;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3cc[nH]c3c2)nn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '25.94', 'le': '0.47', 'lle': '5.40', 'sei': '16.48'};CHEMBL1083615;;CHEMBL1083615;7.92;0;http://www.openphacts.org/units/Nanomolar;917720;=;1;1;=;;Ki;nM;;12.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12.0
;;3311043;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cc2cc(-c3ccc(N4C[C@@H]5C[C@H]4CN5C)nn3)ccc2[nH]1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '24.80', 'le': '0.45', 'lle': '5.09', 'sei': '16.48'};CHEMBL1083616;;CHEMBL1083616;7.92;0;http://www.openphacts.org/units/Nanomolar;917721;=;1;1;=;;Ki;nM;;12.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12.0
;;3311044;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccccc2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.48', 'le': '0.52', 'lle': '5.55', 'sei': '23.51'};CHEMBL1083617;;CHEMBL1083617;7.58;0;http://www.openphacts.org/units/Nanomolar;917722;=;1;1;=;;Ki;nM;;26.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;26.0
;;3311045;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccc3occc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '27.01', 'le': '0.49', 'lle': '5.50', 'sei': '18.23'};CHEMBL1084021;;CHEMBL1084021;8.28;0;http://www.openphacts.org/units/Nanomolar;916466;=;1;1;=;;Ki;nM;;5.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.3
;;3311046;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccc3sccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '27.67', 'le': '0.53', 'lle': '5.67', 'sei': '27.65'};CHEMBL1084022;;CHEMBL1084022;8.92;0;http://www.openphacts.org/units/Nanomolar;916467;=;1;1;=;;Ki;nM;;1.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.2
;;3311048;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccc3[nH]ccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '25.72', 'le': '0.47', 'lle': '5.33', 'sei': '16.35'};CHEMBL1082466;;CHEMBL1082466;7.85;0;http://www.openphacts.org/units/Nanomolar;916469;=;1;1;=;;Ki;nM;;14.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;14.0
;;3311049;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccc3[nH]c(C(F)(F)F)cc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '23.36', 'le': '0.44', 'lle': '5.18', 'sei': '18.15'};CHEMBL1082786;;CHEMBL1082786;8.72;0;http://www.openphacts.org/units/Nanomolar;916470;=;1;1;=;;Ki;nM;;1.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.9
;;3311051;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1cnc(-c2ccc3cc[nH]c3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '26.35', 'le': '0.48', 'lle': '5.53', 'sei': '16.74'};CHEMBL1086506;;CHEMBL1086506;8.05;0;http://www.openphacts.org/units/Nanomolar;916564;=;1;1;=;;Ki;nM;;9.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9.0
;;3311052;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2ccccc2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.75', 'le': '0.52', 'lle': '5.62', 'sei': '23.74'};CHEMBL1085581;;CHEMBL1085581;7.66;0;http://www.openphacts.org/units/Nanomolar;916565;=;1;1;=;;Ki;nM;;22.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;22.0
;;3311053;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2ccc3occc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '29.00', 'le': '0.53', 'lle': '6.11', 'sei': '19.57'};CHEMBL1085805;;CHEMBL1085805;8.89;0;http://www.openphacts.org/units/Nanomolar;916566;=;1;1;=;;Ki;nM;;1.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.3
;;3311054;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2ccc3sccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.69', 'le': '0.55', 'lle': '6.00', 'sei': '28.68'};CHEMBL1085806;;CHEMBL1085806;9.25;0;http://www.openphacts.org/units/Nanomolar;916567;=;1;1;=;;Ki;nM;;0.56;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;0.56
;;3311056;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2ccc3[nH]ccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '27.40', 'le': '0.50', 'lle': '5.85', 'sei': '17.41'};CHEMBL1086524;;CHEMBL1086524;8.37;0;http://www.openphacts.org/units/Nanomolar;916674;=;1;1;=;;Ki;nM;;4.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4.3
;;3311057;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2ccc3[nH]c(C(F)(F)F)cc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '23.39', 'le': '0.44', 'lle': '5.19', 'sei': '18.17'};CHEMBL1086525;;CHEMBL1086525;8.73;0;http://www.openphacts.org/units/Nanomolar;916675;=;1;1;=;;Ki;nM;;1.85;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.85
;;3311058;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ncc(-c2cccc3[nH]ccc23)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '25.82', 'le': '0.47', 'lle': '5.37', 'sei': '16.41'};CHEMBL1085599;;CHEMBL1085599;7.89;0;http://www.openphacts.org/units/Nanomolar;916676;=;1;1;=;;Ki;nM;;13.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;13.0
;;3311059;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccccc2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '30.15', 'le': '0.55', 'lle': '5.36', 'sei': '41.30'};CHEMBL1085824;;CHEMBL1085824;8.00;0;http://www.openphacts.org/units/Nanomolar;916677;=;1;1;=;;Ki;nM;;10.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10.0
;;3311060;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3occc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.06', 'le': '0.51', 'lle': '5.18', 'sei': '26.36'};CHEMBL1085089;;CHEMBL1085089;8.57;0;http://www.openphacts.org/units/Nanomolar;916758;=;1;1;=;;Ki;nM;;2.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.7
;;3311061;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3sccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.81', 'le': '0.55', 'lle': '5.40', 'sei': '47.80'};CHEMBL1085090;;CHEMBL1085090;9.26;0;http://www.openphacts.org/units/Nanomolar;916759;=;1;1;=;;Ki;nM;;0.55;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;0.55
;;3311062;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3[nH]ncc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '24.03', 'le': '0.44', 'lle': '4.82', 'sei': '15.27'};CHEMBL1085091;;CHEMBL1085091;7.34;0;http://www.openphacts.org/units/Nanomolar;916760;=;1;1;=;;Ki;nM;;46.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;46.0
;;3311063;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3[nH]ccc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '26.15', 'le': '0.47', 'lle': '4.84', 'sei': '22.64'};CHEMBL1086480;;CHEMBL1086480;7.96;0;http://www.openphacts.org/units/Nanomolar;916761;=;1;1;=;;Ki;nM;;11.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;11.0
;;3311064;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3[nH]c(C(F)(F)F)cc3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '23.36', 'le': '0.44', 'lle': '4.56', 'sei': '24.74'};CHEMBL1086481;;CHEMBL1086481;8.70;0;http://www.openphacts.org/units/Nanomolar;916762;=;1;1;=;;Ki;nM;;2.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.0
;;3311065;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2cccc3[nH]ccc23)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '24.62', 'le': '0.45', 'lle': '4.37', 'sei': '21.32'};CHEMBL1085778;;CHEMBL1085778;7.50;0;http://www.openphacts.org/units/Nanomolar;916836;=;1;1;=;;Ki;nM;;32.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;32.0
;;3311066;[];CHEMBL1118597;Displacement of [3H]dofetidile from human ERG by whole-cell patch clamp;B;;;BAO_0000192;BAO_0000019;assay format;CN1C[C@@H]2C[C@H]1CN2c1ccc(-c2ccc3cc[nH]c3c2)cn1;;;CHEMBL1155544;Bioorg Med Chem Lett;2010.0;{'bei': '28.05', 'le': '0.51', 'lle': '5.42', 'sei': '24.28'};CHEMBL1085779;;CHEMBL1085779;8.54;0;http://www.openphacts.org/units/Nanomolar;916837;=;1;1;=;;Ki;nM;;2.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.9
;;3316976;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1cc2cc(-c3ccc(C#N)cc3)ccc2o1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '19.36', 'le': '0.35', 'lle': '1.40', 'sei': '15.93'};CHEMBL351231;;CHEMBL351231;6.40;0;http://www.openphacts.org/units/Nanomolar;916072;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4
;;3316977;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(C#N)cc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.89', 'le': '0.32', 'lle': '1.31', 'sei': '15.30'};CHEMBL1085800;;CHEMBL1085800;6.11;0;http://www.openphacts.org/units/Nanomolar;916073;=;1;1;=;;Ki;nM;;780.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.78
;;3316978;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2ncccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '20.80', 'le': '0.38', 'lle': '1.74', 'sei': '31.00'};CHEMBL1086032;;CHEMBL1086032;5.00;0;http://www.openphacts.org/units/Nanomolar;916074;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3316979;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.78', 'le': '0.31', 'lle': '0.70', 'sei': '26.46'};CHEMBL1086033;;CHEMBL1086033;4.27;0;http://www.openphacts.org/units/Nanomolar;916075;=;1;1;=;;Ki;nM;;54000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;54.0
;;3316980;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(C3CC3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.68', 'le': '0.32', 'lle': '0.82', 'sei': '30.74'};CHEMBL1086034;;CHEMBL1086034;4.96;0;http://www.openphacts.org/units/Nanomolar;916076;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;3316981;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(C(C)(C)C)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '19.46', 'le': '0.36', 'lle': '1.21', 'sei': '35.77'};CHEMBL1085325;;CHEMBL1085325;5.77;0;http://www.openphacts.org/units/Nanomolar;916160;=;1;1;=;;Ki;nM;;1700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.7
;;3316982;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3nccs3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.12', 'le': '0.33', 'lle': '1.15', 'sei': '19.08'};CHEMBL1086521;;CHEMBL1086521;5.54;0;http://www.openphacts.org/units/Nanomolar;916346;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;3316983;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(C3=NCCS3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.98', 'le': '0.31', 'lle': '1.44', 'sei': '18.25'};CHEMBL1085591;;CHEMBL1085591;5.20;0;http://www.openphacts.org/units/Nanomolar;916347;=;1;1;=;;Ki;nM;;6300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.3
;;3316984;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)s1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.06', 'le': '0.29', 'lle': '0.29', 'sei': '18.24'};CHEMBL1084559;;CHEMBL1084559;5.29;0;http://www.openphacts.org/units/Nanomolar;915992;=;1;1;=;;Ki;nM;;5100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1
;;3316985;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cccnc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.40', 'le': '0.31', 'lle': '1.20', 'sei': '19.03'};CHEMBL1084560;;CHEMBL1084560;5.52;0;http://www.openphacts.org/units/Nanomolar;915993;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;3316986;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccncc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.26', 'le': '0.29', 'lle': '0.84', 'sei': '17.78'};CHEMBL1083406;;CHEMBL1083406;5.16;0;http://www.openphacts.org/units/Nanomolar;915994;=;1;1;=;;Ki;nM;;6900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.9
;;3316987;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3ccc(Cl)nc3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.22', 'le': '0.33', 'lle': '1.08', 'sei': '20.88'};CHEMBL1083407;;CHEMBL1083407;6.06;0;http://www.openphacts.org/units/Nanomolar;915995;=;1;1;=;;Ki;nM;;870.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.87
;;3316988;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cn1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.63', 'le': '0.28', 'lle': '0.55', 'sei': '17.85'};CHEMBL1082781;;CHEMBL1082781;5.18;0;http://www.openphacts.org/units/Nanomolar;916071;=;1;1;=;;Ki;nM;;6600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.6
;;3316989;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)c(C)n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.34', 'le': '0.28', 'lle': '0.36', 'sei': '18.27'};CHEMBL1082447;;CHEMBL1082447;5.30;0;http://www.openphacts.org/units/Nanomolar;915908;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.0
;;3316990;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cc1C#N;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.32', 'le': '0.28', 'lle': '0.87', 'sei': '10.75'};CHEMBL1085560;;CHEMBL1085560;5.68;0;http://www.openphacts.org/units/Nanomolar;915909;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;3316991;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cc1C(N)=O;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.87', 'le': '0.24', 'lle': '0.96', 'sei': '6.93'};CHEMBL1085782;;CHEMBL1085782;5.00;0;http://www.openphacts.org/units/Nanomolar;915910;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3316992;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3c(O)ccnc3C(F)(F)F)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.46', 'le': '0.24', 'lle': '-0.05', 'sei': '10.15'};CHEMBL1085783;;CHEMBL1085783;5.00;0;http://www.openphacts.org/units/Nanomolar;915911;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3316993;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cnccn3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.35', 'le': '0.30', 'lle': '1.49', 'sei': '12.43'};CHEMBL1085964;;CHEMBL1085964;5.21;0;http://www.openphacts.org/units/Nanomolar;915912;=;1;1;=;;Ki;nM;;6200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.2
;;3316994;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4cc(Cl)nc(Cl)c4)n3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '11.27', 'le': '0.23', 'lle': '-1.46', 'sei': '12.63'};CHEMBL1084294;;CHEMBL1084294;5.29;0;http://www.openphacts.org/units/Nanomolar;915991;=;1;1;=;;Ki;nM;;5100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1
;;3316995;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4ccccc4)n3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '16.01', 'le': '0.30', 'lle': '0.35', 'sei': '22.05'};CHEMBL1084878;;CHEMBL1084878;6.40;0;http://www.openphacts.org/units/Nanomolar;915605;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4
;;3316996;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3csc(-c4ccc(OCC(F)(F)F)nc4)n3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.88', 'le': '0.25', 'lle': '0.03', 'sei': '12.55'};CHEMBL1084879;;CHEMBL1084879;6.42;0;http://www.openphacts.org/units/Nanomolar;915606;=;1;1;=;;Ki;nM;;380.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.38
;;3316997;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(-c2ccc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)s2)s1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '15.05', 'le': '0.30', 'lle': '-0.73', 'sei': '39.06'};CHEMBL1085124;;CHEMBL1085124;6.30;0;http://www.openphacts.org/units/Nanomolar;915607;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.5
;;3316998;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccc(Cl)c(Cl)c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.66', 'le': '0.29', 'lle': '0.09', 'sei': '20.10'};CHEMBL1083463;;CHEMBL1083463;6.82;0;http://www.openphacts.org/units/Nanomolar;915526;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.15
;;3316999;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccccn1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '13.33', 'le': '0.24', 'lle': '0.48', 'sei': '11.32'};CHEMBL393581;;CHEMBL393581;5.30;0;http://www.openphacts.org/units/Nanomolar;915527;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.0
;;3317000;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(C(F)(F)F)cc(-n2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c2C)n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '11.21', 'le': '0.21', 'lle': '-0.76', 'sei': '11.48'};CHEMBL1084877;;CHEMBL1084877;5.38;0;http://www.openphacts.org/units/Nanomolar;915604;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;3317001;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOc1ccc(-n2ncc(-c3ccc4cc(CCN5CCC[C@H]5C)ccc4n3)c2C)nn1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.62', 'le': '0.23', 'lle': '0.98', 'sei': '8.10'};CHEMBL237394;;CHEMBL237394;5.58;0;http://www.openphacts.org/units/Nanomolar;915524;=;1;1;=;;Ki;nM;;2600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.6
;;3317002;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cnn1-c1ccc(N(C)C)nn1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '12.11', 'le': '0.22', 'lle': '1.07', 'sei': '8.49'};CHEMBL1083462;;CHEMBL1083462;5.35;0;http://www.openphacts.org/units/Nanomolar;915525;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.5
;;3317003;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)o1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.91', 'le': '0.27', 'lle': '0.47', 'sei': '11.86'};CHEMBL1083274;;CHEMBL1083274;5.00;0;http://www.openphacts.org/units/Nanomolar;916344;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;3317004;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;C[C@@H]1CCCN1CCc1ccc2nc(-c3cc(Br)no3)ccc2c1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '17.23', 'le': '0.38', 'lle': '1.98', 'sei': '15.79'};CHEMBL1086520;;CHEMBL1086520;6.66;0;http://www.openphacts.org/units/Nanomolar;916345;=;1;1;=;;Ki;nM;;220.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.22
;;3317005;[];CHEMBL1120719;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOC(=O)c1c(C)noc1-c1ccc2cc(CCN3CCC[C@H]3C)ccc2n1;;;CHEMBL1155513;Bioorg Med Chem Lett;2010.0;{'bei': '14.80', 'le': '0.27', 'lle': '1.42', 'sei': '8.51'};CHEMBL1084584;;CHEMBL1084584;5.82;0;http://www.openphacts.org/units/Nanomolar;916245;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5
;;3367708;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(N2CCN(CCCCCCN3CCN(c4ccccc4)CC3)CC2)cc1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.53', 'le': '0.23', 'lle': '0.91', 'sei': '39.33'};CHEMBL1172205;;CHEMBL1172205;5.10;0;http://www.openphacts.org/units/Nanomolar;924191;=;1;1;=;;Ki;nM;;8000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.0
;;3367709;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4cccc(C)c4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '13.02', 'le': '0.24', 'lle': '0.85', 'sei': '43.65'};CHEMBL1172204;;CHEMBL1172204;5.66;0;http://www.openphacts.org/units/Nanomolar;924190;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;3367710;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc(N2CCN(CCCCCCN3CCN(c4cccc(OC)c4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.04', 'le': '0.23', 'lle': '1.41', 'sei': '17.89'};CHEMBL1172206;;CHEMBL1172206;5.62;0;http://www.openphacts.org/units/Nanomolar;924192;=;1;1;=;;Ki;nM;;2400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.4
;;3367711;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Clc1cccc(N2CCN(CCCCCCN3CCN(c4cccc(Cl)c4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '13.72', 'le': '0.28', 'lle': '1.02', 'sei': '50.33'};CHEMBL1171823;;CHEMBL1171823;6.52;0;http://www.openphacts.org/units/Nanomolar;924275;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3
;;3367713;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(N2CCN(CCCCCCN3CCN(c4ccccn4)CC3)CC2)cc1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '11.99', 'le': '0.22', 'lle': '1.30', 'sei': '18.90'};CHEMBL1171646;;CHEMBL1171646;4.89;0;http://www.openphacts.org/units/Nanomolar;924277;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;3367714;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4ccccc4)CC3)CC2)n1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.32', 'le': '0.23', 'lle': '1.30', 'sei': '20.09'};CHEMBL1171824;;CHEMBL1171824;5.19;0;http://www.openphacts.org/units/Nanomolar;924278;=;1;1;=;;Ki;nM;;6400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.4
;;3367715;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4ccccc4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.89', 'le': '0.24', 'lle': '0.92', 'sei': '41.82'};CHEMBL1172734;;CHEMBL1172734;5.42;0;http://www.openphacts.org/units/Nanomolar;924379;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;3367716;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;c1ccc(N2CCN(CCCCCCN3CCN(c4ccnc5ccccc45)CC3)CC2)cc1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '11.84', 'le': '0.22', 'lle': '0.68', 'sei': '20.97'};CHEMBL1173017;;CHEMBL1173017;5.42;0;http://www.openphacts.org/units/Nanomolar;924380;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;3367717;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4ccccn4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.00', 'le': '0.22', 'lle': '1.17', 'sei': '19.58'};CHEMBL1173018;;CHEMBL1173018;5.06;0;http://www.openphacts.org/units/Nanomolar;924381;=;1;1;=;;Ki;nM;;8700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.7
;;3367718;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4cccc(C)n4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.37', 'le': '0.23', 'lle': '1.19', 'sei': '20.84'};CHEMBL1173077;;CHEMBL1173077;5.39;0;http://www.openphacts.org/units/Nanomolar;924382;=;1;1;=;;Ki;nM;;4100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.1
;;3367719;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCCCN3CCN(c4ccnc5ccccc45)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.82', 'le': '0.24', 'lle': '1.00', 'sei': '23.39'};CHEMBL1173142;;CHEMBL1173142;6.05;0;http://www.openphacts.org/units/Nanomolar;924462;=;1;1;=;;Ki;nM;;900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.9
;;3367720;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cccc(N2CCN(CCCCCCN3CCN(c4cccc(Cl)c4)CC3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '12.57', 'le': '0.25', 'lle': '1.07', 'sei': '26.68'};CHEMBL1173143;;CHEMBL1173143;5.92;0;http://www.openphacts.org/units/Nanomolar;924463;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;3367721;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '14.59', 'le': '0.28', 'lle': '1.05', 'sei': '15.45'};CHEMBL42;CLOZAPINE;CHEMBL42;4.77;1;http://www.openphacts.org/units/Nanomolar;924464;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;17.0
;;3367722;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '14.22', 'le': '0.28', 'lle': '1.00', 'sei': '14.39'};CHEMBL715;OLANZAPINE;CHEMBL715;4.44;1;http://www.openphacts.org/units/Nanomolar;924465;=;1;1;=;;Ki;nM;;36000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;36.0
;;3367723;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '13.36', 'le': '0.27', 'lle': '1.13', 'sei': '13.37'};CHEMBL1112;ARIPIPRAZOLE;CHEMBL1112;5.99;1;http://www.openphacts.org/units/Nanomolar;924466;=;1;1;=;;Ki;nM;;1020.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.02
;;3367724;[];CHEMBL1176236;Binding affinity to human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1;;;CHEMBL1177700;J Med Chem;2010.0;{'bei': '15.41', 'le': '0.28', 'lle': '1.96', 'sei': '12.38'};CHEMBL496739;;CHEMBL496739;6.03;1;http://www.openphacts.org/units/Nanomolar;924549;=;1;1;=;;Ki;nM;;930.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.93
;;3376256;[];CHEMBL1211587;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.c1cncc(-c2ccccc2O[C@H]2C[C@@H]3CNC[C@H]2C3)c1;;;CHEMBL1208792;Bioorg Med Chem Lett;2010.0;{'bei': '20.21', 'le': '0.37', 'lle': '2.54', 'sei': '16.59'};CHEMBL1209070;;CHEMBL1229177;5.67;0;http://www.openphacts.org/units/Nanomolar;926697;=;1;1;=;;Ki;nM;;2160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2160.0
;;3376259;[];CHEMBL1211587;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.Oc1cncc(-c2ccccc2O[C@H]2C[C@@H]3CNC[C@H]2C3)c1;;;CHEMBL1208792;Bioorg Med Chem Lett;2010.0;{'bei': '19.57', 'le': '0.36', 'lle': '2.97', 'sei': '10.67'};CHEMBL1209124;;CHEMBL1229182;5.80;0;http://www.openphacts.org/units/Nanomolar;926775;=;1;1;=;;Ki;nM;;1580.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1580.0
;;3376262;[];CHEMBL1211587;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.Fc1ccncc1-c1ccccc1O[C@H]1C[C@@H]2CNC[C@H]1C2;;;CHEMBL1208792;Bioorg Med Chem Lett;2010.0;{'bei': '19.27', 'le': '0.36', 'lle': '2.49', 'sei': '16.84'};CHEMBL1209126;;CHEMBL1229184;5.75;0;http://www.openphacts.org/units/Nanomolar;926778;=;1;1;=;;Ki;nM;;1780.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1780.0
;;3423903;[];CHEMBL1227789;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C(=O)CC[C@@H](C1CCCCC1)N1Cc2cc(Oc3ccccc3)ccc2N=C1N)C1CCCCC1;;;CHEMBL1221253;Bioorg Med Chem Lett;2010.0;{'bei': '14.08', 'le': '0.26', 'lle': '0.32', 'sei': '9.94'};CHEMBL244347;;CHEMBL244347;7.08;0;http://www.openphacts.org/units/Nanomolar;935339;=;1;1;=;;Ki;nM;;84.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;84.0
;;3430612;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '17.89', 'le': '0.33', 'lle': '3.96', 'sei': '12.48'};CHEMBL490417;;CHEMBL490417;7.20;1;http://www.openphacts.org/units/Nanomolar;954041;=;1;1;=;;Ki;nM;;63.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.2
;;3430620;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4ccc5c(c4)N(C)C(=O)CO5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '14.64', 'le': '0.27', 'lle': '2.84', 'sei': '12.47'};CHEMBL522257;;CHEMBL522257;6.10;1;http://www.openphacts.org/units/Nanomolar;954172;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;3430628;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '13.91', 'le': '0.25', 'lle': '2.36', 'sei': '9.71'};CHEMBL513715;;CHEMBL513715;5.60;1;http://www.openphacts.org/units/Nanomolar;954173;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;3430636;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.96', 'le': '0.24', 'lle': '2.14', 'sei': '11.04'};CHEMBL469345;;CHEMBL469345;5.40;1;http://www.openphacts.org/units/Nanomolar;954303;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;3430644;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4nccn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '13.63', 'le': '0.25', 'lle': '1.81', 'sei': '12.49'};CHEMBL1242904;;CHEMBL1242904;5.80;0;http://www.openphacts.org/units/Nanomolar;954304;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;3430652;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cn2c(n1)COc1c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc1-2;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '14.56', 'le': '0.26', 'lle': '2.11', 'sei': '13.79'};CHEMBL1241547;;CHEMBL1241547;6.40;0;http://www.openphacts.org/units/Nanomolar;952330;=;1;1;=;;Ki;nM;;398.11;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.4
;;3430660;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4nc(C)c(C)n4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '14.11', 'le': '0.26', 'lle': '1.80', 'sei': '13.79'};CHEMBL1241548;;CHEMBL1241548;6.40;0;http://www.openphacts.org/units/Nanomolar;952331;=;1;1;=;;Ki;nM;;398.11;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.4
;;3430668;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4nc(C(F)(F)F)cn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '15.40', 'le': '0.29', 'lle': '2.60', 'sei': '16.37'};CHEMBL1241641;;CHEMBL1241641;7.60;0;http://www.openphacts.org/units/Nanomolar;952468;=;1;1;=;;Ki;nM;;25.12;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.6
;;3430676;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4cncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '14.10', 'le': '0.26', 'lle': '2.01', 'sei': '12.93'};CHEMBL1241642;;CHEMBL1241642;6.00;0;http://www.openphacts.org/units/Nanomolar;952469;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;3430684;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4nnc(C)n4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '11.12', 'le': '0.20', 'lle': '1.21', 'sei': '8.26'};CHEMBL1241738;;CHEMBL1241738;4.90;0;http://www.openphacts.org/units/Nanomolar;952609;=;1;1;=;;Ki;nM;;12589.25;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.9
;;3430692;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C)nnn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.71', 'le': '0.23', 'lle': '1.91', 'sei': '9.44'};CHEMBL1241546;;CHEMBL1241546;5.60;0;http://www.openphacts.org/units/Nanomolar;952329;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;3430700;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4nnnn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '14.74', 'le': '0.27', 'lle': '3.52', 'sei': '8.73'};CHEMBL1241639;;CHEMBL1241639;6.30;0;http://www.openphacts.org/units/Nanomolar;952466;=;1;1;=;;Ki;nM;;501.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.3
;;3430708;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC(=O)c1ncn2c1COc1c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc1-2;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '10.25', 'le': '0.19', 'lle': '0.94', 'sei': '7.01'};CHEMBL1241640;;CHEMBL1241640;5.10;0;http://www.openphacts.org/units/Nanomolar;952467;=;1;1;=;;Ki;nM;;7943.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.1
;;3430716;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)c1ncn2c1COc1c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc1-2;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '11.12', 'le': '0.20', 'lle': '1.01', 'sei': '8.19'};CHEMBL1241736;;CHEMBL1241736;5.20;0;http://www.openphacts.org/units/Nanomolar;952607;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;3430724;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;CO/N=C(\C)c1ncn2c1COc1c(CCN3CCN(c4cccc5nc(C)ccc45)CC3)cccc1-2;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '11.28', 'le': '0.21', 'lle': '1.24', 'sei': '8.23'};CHEMBL1241737;;CHEMBL1241737;5.60;0;http://www.openphacts.org/units/Nanomolar;952608;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;3430732;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N(C)C)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '10.87', 'le': '0.20', 'lle': '1.71', 'sei': '8.09'};CHEMBL1241824;;CHEMBL1241824;5.40;0;http://www.openphacts.org/units/Nanomolar;952740;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;3430740;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C#N)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '13.32', 'le': '0.24', 'lle': '2.14', 'sei': '8.55'};CHEMBL1241825;;CHEMBL1241825;6.00;0;http://www.openphacts.org/units/Nanomolar;952741;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;3430756;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(N)=O)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.42', 'sei': '5.03'};CHEMBL1241913;;CHEMBL1241913;4.50;0;http://www.openphacts.org/units/Nanomolar;952871;=;1;1;=;;Ki;nM;;31622.78;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.5
;;3430764;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)NC(C)C)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '10.97', 'le': '0.20', 'lle': '1.48', 'sei': '7.42'};CHEMBL1241998;;CHEMBL1241998;5.60;0;http://www.openphacts.org/units/Nanomolar;953001;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;3430772;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)NC6CC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.19', 'le': '0.22', 'lle': '2.32', 'sei': '8.21'};CHEMBL1242081;;CHEMBL1242081;6.20;0;http://www.openphacts.org/units/Nanomolar;953132;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;3430780;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)NC6CCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.05', 'le': '0.22', 'lle': '2.03', 'sei': '8.34'};CHEMBL1242167;;CHEMBL1242167;6.30;0;http://www.openphacts.org/units/Nanomolar;953263;=;1;1;=;;Ki;nM;;501.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.3
;;3430788;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)NC6CCCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.48', 'le': '0.23', 'lle': '2.04', 'sei': '8.87'};CHEMBL1242257;;CHEMBL1242257;6.70;0;http://www.openphacts.org/units/Nanomolar;953395;=;1;1;=;;Ki;nM;;199.53;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.7
;;3430796;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)NCC6CC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.82', 'le': '0.23', 'lle': '2.57', 'sei': '8.87'};CHEMBL1242345;;CHEMBL1242345;6.70;0;http://www.openphacts.org/units/Nanomolar;953527;=;1;1;=;;Ki;nM;;199.53;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.7
;;3430804;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N6CCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '12.39', 'le': '0.23', 'lle': '2.47', 'sei': '9.44'};CHEMBL1242436;;CHEMBL1242436;6.30;0;http://www.openphacts.org/units/Nanomolar;953653;=;1;1;=;;Ki;nM;;501.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.3
;;3430812;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N6CCCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '11.29', 'le': '0.21', 'lle': '1.68', 'sei': '8.84'};CHEMBL1242533;;CHEMBL1242533;5.90;0;http://www.openphacts.org/units/Nanomolar;953782;=;1;1;=;;Ki;nM;;1258.93;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.9
;;3430820;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N6CCCCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '11.18', 'le': '0.20', 'lle': '1.39', 'sei': '8.99'};CHEMBL1242623;;CHEMBL1242623;6.00;0;http://www.openphacts.org/units/Nanomolar;953910;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;3430828;[];CHEMBL1248651;Displacement of [3H]-dofetilide from human ERG by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCc4c(C(=O)N6CCOCC6)ncn4-5)CC3)cccc2n1;;;CHEMBL1240442;J Med Chem;2010.0;{'bei': '8.35', 'le': '0.15', 'lle': '1.04', 'sei': '5.92'};CHEMBL1242717;;CHEMBL1242717;4.50;0;http://www.openphacts.org/units/Nanomolar;954040;=;1;1;=;;Ki;nM;;31622.78;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.5
;;3500916;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '15.16', 'le': '0.28', 'lle': '2.55', 'sei': '14.19'};CHEMBL1258880;;CHEMBL1258880;6.36;0;http://www.openphacts.org/units/Nanomolar;963909;=;1;1;=;;Ki;nM;;439.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;439.0
;;3500920;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.88', 'le': '0.28', 'lle': '1.36', 'sei': '13.89'};CHEMBL1112;ARIPIPRAZOLE;CHEMBL1112;6.22;0;http://www.openphacts.org/units/Nanomolar;963278;=;1;1;=;;Ki;nM;;598.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;598.0
;;3500921;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc2c(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)cccc2c1;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '15.76', 'le': '0.29', 'lle': '2.08', 'sei': '22.02'};CHEMBL1258312;;CHEMBL1258312;6.11;0;http://www.openphacts.org/units/Nanomolar;963279;=;1;1;=;;Ki;nM;;779.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;779.0
;;3500922;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.81', 'le': '0.26', 'lle': '2.09', 'sei': '13.48'};CHEMBL1257145;;CHEMBL1257145;6.04;0;http://www.openphacts.org/units/Nanomolar;961999;=;1;1;=;;Ki;nM;;907.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;907.0
;;3500923;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2cccc(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)c2c1;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '14.87', 'le': '0.27', 'lle': '1.86', 'sei': '21.74'};CHEMBL1258426;;CHEMBL1258426;6.03;0;http://www.openphacts.org/units/Nanomolar;963402;=;1;1;=;;Ki;nM;;931.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;931.0
;;3500924;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.87', 'le': '0.26', 'lle': '1.81', 'sei': '13.42'};CHEMBL1257144;;CHEMBL1257144;6.01;0;http://www.openphacts.org/units/Nanomolar;961998;=;1;1;=;;Ki;nM;;969.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;969.0
;;3500926;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '14.04', 'le': '0.26', 'lle': '2.08', 'sei': '13.14'};CHEMBL1258761;;CHEMBL1258761;5.89;0;http://www.openphacts.org/units/Nanomolar;963784;=;1;1;=;;Ki;nM;;1290.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1290.0
;;3500927;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc2c(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)cccc2c1;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '14.46', 'le': '0.26', 'lle': '1.39', 'sei': '20.93'};CHEMBL1258425;;CHEMBL1258425;5.81;0;http://www.openphacts.org/units/Nanomolar;963401;=;1;1;=;;Ki;nM;;1560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1560.0
;;3500928;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc2cccc(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)c2c1;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.76', 'le': '0.25', 'lle': '1.21', 'sei': '20.82'};CHEMBL1258532;;CHEMBL1258532;5.78;0;http://www.openphacts.org/units/Nanomolar;963528;=;1;1;=;;Ki;nM;;1680.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1680.0
;;3500930;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.80', 'le': '0.25', 'lle': '1.67', 'sei': '12.79'};CHEMBL1258647;;CHEMBL1258647;5.73;0;http://www.openphacts.org/units/Nanomolar;963655;=;1;1;=;;Ki;nM;;1850.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1850.0
;;3500931;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '12.69', 'le': '0.24', 'lle': '1.39', 'sei': '12.79'};CHEMBL1257261;;CHEMBL1257261;5.73;0;http://www.openphacts.org/units/Nanomolar;962126;=;1;1;=;;Ki;nM;;1860.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1860.0
;;3500932;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.12', 'le': '0.24', 'lle': '1.49', 'sei': '12.69'};CHEMBL1258879;;CHEMBL1258879;5.69;0;http://www.openphacts.org/units/Nanomolar;963908;=;1;1;=;;Ki;nM;;2060.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2060.0
;;3500935;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '13.83', 'le': '0.25', 'lle': '1.88', 'sei': '12.39'};CHEMBL1258533;;CHEMBL1258533;5.55;0;http://www.openphacts.org/units/Nanomolar;963529;=;1;1;=;;Ki;nM;;2810.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2810.0
;;3500936;[];CHEMBL1260557;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21;;;CHEMBL1255556;Bioorg Med Chem Lett;2010.0;{'bei': '12.97', 'le': '0.24', 'lle': '1.63', 'sei': '12.15'};CHEMBL1258648;;CHEMBL1258648;5.44;0;http://www.openphacts.org/units/Nanomolar;963656;=;1;1;=;;Ki;nM;;3610.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3610.0
;;3516347;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCN2CCCCC2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '18.15', 'le': '0.34', 'lle': '2.35', 'sei': '12.87'};CHEMBL1084400;;CHEMBL1084400;6.80;0;http://www.openphacts.org/units/Nanomolar;966563;=;1;1;=;;Ki;nM;;160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.16
;;3516348;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCN2CCCCC2)cc(C2CCCCCC2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '18.85', 'le': '0.35', 'lle': '1.95', 'sei': '11.65'};CHEMBL1084403;;CHEMBL1084403;6.16;0;http://www.openphacts.org/units/Nanomolar;966684;=;1;1;=;;Ki;nM;;700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.7
;;3516351;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCc1cc(-c2cc(C(=O)N(C)CCN(C)C)cc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.66', 'le': '0.28', 'lle': '2.53', 'sei': '8.41'};CHEMBL1271070;;CHEMBL1271070;6.15;0;http://www.openphacts.org/units/Nanomolar;966806;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.71
;;3516352;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCc1cc(-c2cc(C(=O)N(CCN(C)C)Cc3ccccc3)cc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '13.97', 'le': '0.26', 'lle': '1.73', 'sei': '9.47'};CHEMBL1234898;;CHEMBL1234898;6.92;0;http://www.openphacts.org/units/Nanomolar;966920;=;1;1;=;;Ki;nM;;120.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.12
;;3516353;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCc1cc(-c2cc(C(=O)N(C)Cc3ccccc3)cc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.67', 'le': '0.27', 'lle': '1.17', 'sei': '9.20'};CHEMBL1271174;;CHEMBL1271174;6.43;0;http://www.openphacts.org/units/Nanomolar;966921;=;1;1;=;;Ki;nM;;370.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.37
;;3516354;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCO)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.67', 'le': '0.28', 'lle': '1.55', 'sei': '6.46'};CHEMBL1271273;;CHEMBL1271273;4.51;0;http://www.openphacts.org/units/Nanomolar;967037;=;1;1;=;;Ki;nM;;31000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;31.0
;;3516356;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCC(CC)NC(=O)CCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.09', 'le': '0.27', 'lle': '1.23', 'sei': '6.99'};CHEMBL1271275;;CHEMBL1271275;5.50;0;http://www.openphacts.org/units/Nanomolar;967039;=;1;1;=;;Ki;nM;;3160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.16
;;3516357;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCC(CC)NCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '17.25', 'le': '0.33', 'lle': '1.75', 'sei': '10.54'};CHEMBL1084401;;CHEMBL1084401;6.50;0;http://www.openphacts.org/units/Nanomolar;967157;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;3516358;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CNCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '19.36', 'le': '0.37', 'lle': '3.01', 'sei': '10.07'};CHEMBL1271380;;CHEMBL1271380;6.20;0;http://www.openphacts.org/units/Nanomolar;967158;=;1;1;=;;Ki;nM;;630.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.63
;;3516359;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCNCC(F)(F)F)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '16.23', 'le': '0.32', 'lle': '2.18', 'sei': '10.23'};CHEMBL1269847;;CHEMBL1269847;6.30;0;http://www.openphacts.org/units/Nanomolar;965332;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.5
;;3516360;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CCN(CCCc2cc(-c3cccc(C(F)(F)F)c3)nc(C#N)n2)CC1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '15.41', 'le': '0.29', 'lle': '2.79', 'sei': '10.70'};CHEMBL1269848;;CHEMBL1269848;6.00;0;http://www.openphacts.org/units/Nanomolar;965333;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.0
;;3516361;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCN2CCOCC2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '17.26', 'le': '0.33', 'lle': '3.19', 'sei': '10.47'};CHEMBL1269955;;CHEMBL1269955;6.50;0;http://www.openphacts.org/units/Nanomolar;965459;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;3516362;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COCCNCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '17.16', 'le': '0.33', 'lle': '3.05', 'sei': '8.83'};CHEMBL1269956;;CHEMBL1269956;6.25;0;http://www.openphacts.org/units/Nanomolar;965460;=;1;1;=;;Ki;nM;;560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.56
;;3516363;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCN2CCC(O)CC2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '15.24', 'le': '0.29', 'lle': '2.53', 'sei': '8.15'};CHEMBL1270062;;CHEMBL1270062;5.95;0;http://www.openphacts.org/units/Nanomolar;965586;=;1;1;=;;Ki;nM;;1120.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.12
;;3516364;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCNc2ccccn2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '16.69', 'le': '0.31', 'lle': '1.93', 'sei': '8.59'};CHEMBL1270063;;CHEMBL1270063;6.40;0;http://www.openphacts.org/units/Nanomolar;965587;=;1;1;=;;Ki;nM;;400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4
;;3516367;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCNCC(N)=O)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.86', 'le': '0.28', 'lle': '3.36', 'sei': '5.16'};CHEMBL1270268;;CHEMBL1270268;5.40;0;http://www.openphacts.org/units/Nanomolar;965834;=;1;1;=;;Ki;nM;;3980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.98
;;3516368;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(NCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1)C(N)=O;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.05', 'le': '0.27', 'lle': '2.68', 'sei': '5.25'};CHEMBL1270269;;CHEMBL1270269;5.50;0;http://www.openphacts.org/units/Nanomolar;965835;=;1;1;=;;Ki;nM;;3160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.16
;;3516369;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCNC2(C(N)=O)CC2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.90', 'le': '0.28', 'lle': '3.23', 'sei': '5.54'};CHEMBL1270366;;CHEMBL1270366;5.80;0;http://www.openphacts.org/units/Nanomolar;965958;=;1;1;=;;Ki;nM;;1580.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.58
;;3516370;[];CHEMBL1275133;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1nc(CCCNC2(C(N)=O)CCC2)cc(-c2cccc(C(F)(F)F)c2)n1;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '13.88', 'le': '0.26', 'lle': '2.64', 'sei': '5.35'};CHEMBL1270367;;CHEMBL1270367;5.60;0;http://www.openphacts.org/units/Nanomolar;965959;=;1;1;=;;Ki;nM;;2510.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.51
;;3516432;[];CHEMBL1275154;Inhibition of human ERG channel expressed in HEK293 cells by patch clamp assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(NCCCc1cc(-c2cccc(C(F)(F)F)c2)nc(C#N)n1)C(N)=O;;;CHEMBL1268809;Bioorg Med Chem Lett;2010.0;{'bei': '14.11', 'le': '0.27', 'lle': '2.70', 'sei': '5.28'};CHEMBL1270269;;CHEMBL1270269;5.52;0;http://www.openphacts.org/units/Nanomolar;965835;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;3519168;[];CHEMBL1273286;Inhibition of human ERG by patch clamp assay;B;;;BAO_0000192;BAO_0000019;assay format;N=C(c1ccc(C(=O)Nc2ccc(Cl)cc2C(=O)Nc2ccc(Cl)cn2)cc1)N1CCCCC1;;;CHEMBL1268866;J Med Chem;2010.0;{'bei': '13.50', 'le': '0.27', 'lle': '1.00', 'sei': '6.82'};CHEMBL473772;;CHEMBL473772;6.70;0;http://www.openphacts.org/units/Nanomolar;966789;=;1;1;=;;Ki;nM;;200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;200.0
;;3598430;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '13.91', 'le': '0.25', 'lle': '2.36', 'sei': '9.71'};CHEMBL513715;;CHEMBL513715;5.60;1;http://www.openphacts.org/units/Nanomolar;975890;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;3598431;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4OCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '12.96', 'le': '0.24', 'lle': '2.14', 'sei': '11.04'};CHEMBL469345;;CHEMBL469345;5.40;1;http://www.openphacts.org/units/Nanomolar;975891;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;3598432;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4CCC(=O)N5)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '13.73', 'le': '0.25', 'lle': '1.71', 'sei': '11.35'};CHEMBL1290486;;CHEMBL1290486;5.50;0;http://www.openphacts.org/units/Nanomolar;976017;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;3598433;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4cccc5c4CCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '13.03', 'le': '0.24', 'lle': '1.58', 'sei': '13.61'};CHEMBL1290487;;CHEMBL1290487;5.40;0;http://www.openphacts.org/units/Nanomolar;976018;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;3598434;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4c(C)ccc5c4CCC(=O)N5)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '13.03', 'le': '0.24', 'lle': '1.30', 'sei': '11.14'};CHEMBL1290596;;CHEMBL1290596;5.40;0;http://www.openphacts.org/units/Nanomolar;976154;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;3598435;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4c(C)ccc5c4CCC(=O)N5C)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '14.23', 'le': '0.26', 'lle': '1.97', 'sei': '15.37'};CHEMBL1290597;;CHEMBL1290597;6.10;0;http://www.openphacts.org/units/Nanomolar;976155;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;3598438;[];CHEMBL1293148;Displacement of [3H]-dofetilide in human hERG expressed in CHO cells by proximity assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc2c(N3CCN(CCc4c(C)ccc5[nH]c(=O)ccc45)CC3)cccc2n1;;;CHEMBL1287678;Bioorg Med Chem Lett;2010.0;{'bei': '11.15', 'le': '0.20', 'lle': '0.54', 'sei': '8.81'};CHEMBL1289047;;CHEMBL1289047;4.60;0;http://www.openphacts.org/units/Nanomolar;974313;=;1;1;=;;Ki;nM;;25118.86;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.6
;;3599841;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(=O)OC)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.94', 'le': '0.22', 'lle': '0.05', 'sei': '6.73'};CHEMBL1290649;;CHEMBL1290649;5.20;0;http://www.openphacts.org/units/Nanomolar;976210;=;1;1;=;;Ki;nM;;6300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.3
;;3599844;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(CO)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.92', 'le': '0.22', 'lle': '0.03', 'sei': '6.87'};CHEMBL1289093;;CHEMBL1289093;4.89;0;http://www.openphacts.org/units/Nanomolar;974364;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;3599845;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(C)(C)O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '11.74', 'le': '0.23', 'lle': '-0.01', 'sei': '7.85'};CHEMBL1289094;;CHEMBL1289094;5.58;0;http://www.openphacts.org/units/Nanomolar;974365;=;1;1;=;;Ki;nM;;2600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.6
;;3599846;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(C)O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '11.74', 'le': '0.23', 'lle': '0.00', 'sei': '7.62'};CHEMBL1289214;;CHEMBL1289214;5.42;0;http://www.openphacts.org/units/Nanomolar;974499;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;3599847;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(C)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '11.66', 'le': '0.23', 'lle': '-0.21', 'sei': '7.88'};CHEMBL1289215;;CHEMBL1289215;5.36;0;http://www.openphacts.org/units/Nanomolar;974500;=;1;1;=;;Ki;nM;;4400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.4
;;3599850;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(N)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.36', 'le': '0.20', 'lle': '0.30', 'sei': '5.07'};CHEMBL1289446;;CHEMBL1289446;4.77;0;http://www.openphacts.org/units/Nanomolar;974765;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;17.0
;;3599851;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@](O)(c1cn(Cc2ccc3c(-c4ccccc4)c(C(N)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.41', 'le': '0.20', 'lle': '0.33', 'sei': '5.10'};CHEMBL1289447;;CHEMBL1289447;4.80;0;http://www.openphacts.org/units/Nanomolar;974766;=;1;1;=;;Ki;nM;;16000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.0
;;3599852;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@](O)(c1cn(Cc2ccc3c(-c4cccc(F)c4)c(C(N)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.14', 'le': '0.20', 'lle': '0.24', 'sei': '5.16'};CHEMBL1289557;;CHEMBL1289557;4.85;0;http://www.openphacts.org/units/Nanomolar;974898;=;1;1;=;;Ki;nM;;14000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;14.0
;;3599853;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@](O)(c1cn(Cc2ccc3c(-c4ccc(F)cc4)c(C(N)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.21', 'le': '0.20', 'lle': '0.28', 'sei': '5.20'};CHEMBL1289558;;CHEMBL1289558;4.89;0;http://www.openphacts.org/units/Nanomolar;974899;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;3599854;[];CHEMBL1291160;Displacement of labeled MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC[C@@](O)(c1cn(Cc2ccc3c(-c4ccc(F)cc4)c(C(N)=O)sc3c2)nn1)C(F)(F)F;;;CHEMBL1287744;Bioorg Med Chem Lett;2010.0;{'bei': '10.36', 'le': '0.21', 'lle': '0.35', 'sei': '5.27'};CHEMBL1289664;;CHEMBL1289664;4.96;0;http://www.openphacts.org/units/Nanomolar;975028;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;5087625;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5ccccc5)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '16.20', 'le': '0.29', 'lle': '2.14', 'sei': '15.06'};CHEMBL1632210;;CHEMBL1632210;7.30;0;http://www.openphacts.org/units/Nanomolar;1316154;=;1;1;=;;Ki;nM;;50.12;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;7.3
;;5087656;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)Nc5ccccc5)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '13.96', 'le': '0.25', 'lle': '0.95', 'sei': '10.74'};CHEMBL1632223;;CHEMBL1632223;6.50;0;http://www.openphacts.org/units/Nanomolar;1316167;=;1;1;=;;Ki;nM;;316.23;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.5
;;5087657;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5csc(C)n5)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '13.78', 'le': '0.26', 'lle': '1.57', 'sei': '10.59'};CHEMBL1632218;;CHEMBL1632218;6.50;0;http://www.openphacts.org/units/Nanomolar;1316162;=;1;1;=;;Ki;nM;;316.23;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.5
;;5087670;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '14.84', 'le': '0.29', 'lle': '3.02', 'sei': '9.61'};CHEMBL1631535;;CHEMBL1631535;6.30;0;http://www.openphacts.org/units/Nanomolar;1315045;=;1;1;=;;Ki;nM;;501.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.3
;;5087676;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;CCNC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '14.85', 'le': '0.27', 'lle': '2.15', 'sei': '10.25'};CHEMBL1632220;;CHEMBL1632220;6.20;0;http://www.openphacts.org/units/Nanomolar;1316164;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;5087707;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(N5CCOC5=O)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '13.68', 'le': '0.25', 'lle': '1.84', 'sei': '11.65'};CHEMBL1631542;;CHEMBL1631542;5.70;0;http://www.openphacts.org/units/Nanomolar;1315054;=;1;1;=;;Ki;nM;;1995.26;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.7
;;5087715;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '13.90', 'le': '0.25', 'lle': '1.53', 'sei': '11.14'};CHEMBL1632206;;CHEMBL1632206;5.40;0;http://www.openphacts.org/units/Nanomolar;1316150;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;5087719;[];CHEMBL1635449;Displacement of [3H]dofetilide from human ERG by SPA;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1;;;CHEMBL1629528;J Med Chem;2010.0;{'bei': '11.79', 'le': '0.22', 'lle': '1.46', 'sei': '9.48'};CHEMBL1631540;GSK163090;CHEMBL1631540;4.90;0;http://www.openphacts.org/units/Nanomolar;1315052;=;1;1;=;;Ki;nM;;12589.25;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.9
;;5122892;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nccc2cc(CNCCc3ccccc3)ccc12;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '19.83', 'le': '0.36', 'lle': '2.35', 'sei': '10.80'};CHEMBL1643361;;CHEMBL1643361;5.50;0;http://www.openphacts.org/units/Nanomolar;1318840;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;5123974;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nccc2cc(O[C@H]3CCCN(Cc4ccccc4)C3)ccc12;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '18.29', 'le': '0.33', 'lle': '2.24', 'sei': '11.87'};CHEMBL1643574;;CHEMBL1643574;6.10;0;http://www.openphacts.org/units/Nanomolar;1319076;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;5123975;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nccc2cc(O[C@H]3CCCNC3)ccc12;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '19.32', 'le': '0.36', 'lle': '2.75', 'sei': '7.81'};CHEMBL1643368;;CHEMBL1643368;4.70;0;http://www.openphacts.org/units/Nanomolar;1318847;=;1;1;=;;Ki;nM;;19952.62;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.7
;;5123980;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1cccc2cnccc12)N1CCCNCC1;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '15.79', 'le': '0.31', 'lle': '3.38', 'sei': '7.38'};CHEMBL38380;FASUDIL;CHEMBL38380;4.60;0;http://www.openphacts.org/units/Nanomolar;1319079;=;1;1;=;;Ki;nM;;25118.86;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.6
;;5123989;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '16.58', 'le': '0.31', 'lle': '1.93', 'sei': '6.03'};CHEMBL559147;Y-27632;CHEMBL559147;4.10;0;http://www.openphacts.org/units/Nanomolar;1319080;=;1;1;=;;Ki;nM;;79432.82;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.1
;;5123998;[];CHEMBL1647669;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1;;;CHEMBL1641363;Bioorg Med Chem Lett;2011.0;{'bei': '16.59', 'le': '0.33', 'lle': '4.18', 'sei': '6.18'};CHEMBL1233300;HYDROXYFASUDIL;CHEMBL1233300;5.10;0;http://www.openphacts.org/units/Nanomolar;1319081;=;1;1;=;;Ki;nM;;7943.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.1
;;5139618;[];CHEMBL1647515;Inhibition of human ERG by dofetilide binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(-c2cccc(O[C@@H]3C[C@H]4CC[C@@H](C3)N4)n2)cc1;;;CHEMBL1641536;Bioorg Med Chem Lett;2011.0;{'bei': '31.69', 'le': '0.58', 'lle': '5.48', 'sei': '26.02'};CHEMBL1644470;;CHEMBL1644470;8.89;0;http://www.openphacts.org/units/Nanomolar;1320192;=;1;1;=;;Ki;nM;;1.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1.3
;;5139619;[];CHEMBL1647515;Inhibition of human ERG by dofetilide binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1cc(O[C@@H]2C[C@H]3CC[C@@H](C2)N3)nc(-c2ccccc2)c1;;;CHEMBL1641536;Bioorg Med Chem Lett;2011.0;{'bei': '22.67', 'le': '0.41', 'lle': '3.64', 'sei': '11.95'};CHEMBL1644605;;CHEMBL1644605;6.92;0;http://www.openphacts.org/units/Nanomolar;1320399;=;1;1;=;;Ki;nM;;119.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;119.0
;;5139620;[];CHEMBL1647515;Inhibition of human ERG by dofetilide binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccccc1-c1cccc(O[C@@H]2C[C@H]3CC[C@@H](C2)N3)n1;;;CHEMBL1641536;Bioorg Med Chem Lett;2011.0;{'bei': '16.86', 'le': '0.31', 'lle': '1.87', 'sei': '8.89'};CHEMBL1644609;;CHEMBL1644609;5.15;0;http://www.openphacts.org/units/Nanomolar;1320403;=;1;1;=;;Ki;nM;;7080.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7080.0
;;5139648;[];CHEMBL1647515;Inhibition of human ERG by dofetilide binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1cc(O[C@@H]2C[C@H]3CC[C@@H](C2)N3)cc(-c2ncccc2C#N)c1;;;CHEMBL1641536;Bioorg Med Chem Lett;2011.0;{'bei': '16.40', 'le': '0.30', 'lle': '2.27', 'sei': '6.63'};CHEMBL1644612;;CHEMBL1644612;5.42;0;http://www.openphacts.org/units/Nanomolar;1320406;=;1;1;=;;Ki;nM;;3802.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3802.0
;;5139649;[];CHEMBL1647515;Inhibition of human ERG by dofetilide binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1cc(O[C@@H]2C[C@H]3CC[C@@H](C2)N3)cc(-c2ccccn2)c1;;;CHEMBL1641536;Bioorg Med Chem Lett;2011.0;{'bei': '18.96', 'le': '0.34', 'lle': '2.51', 'sei': '9.99'};CHEMBL1644611;;CHEMBL1644611;5.79;0;http://www.openphacts.org/units/Nanomolar;1320405;=;1;1;=;;Ki;nM;;1621.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1621.0
;;5165879;[];CHEMBL1663293;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells after 60 mins by liquid scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;OCC1(N2CCC(n3c(N4CC5CNCC5C4)nc4ccccc43)CC2)CCCCCCC1;;;CHEMBL1649335;Bioorg Med Chem;2010.0;{'bei': '12.03', 'le': '0.22', 'lle': '1.63', 'sei': '9.60'};CHEMBL1650844;;CHEMBL1650844;5.43;0;http://www.openphacts.org/units/Nanomolar;1323877;=;1;1;=;;Ki;nM;;3700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3700.0
;;5207991;[];CHEMBL1680289;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C)Cc1c[nH]c(C(C)(O)Cc2ccc(-c3ccc(F)cn3)cc2)n1;;;CHEMBL1671827;ACS Med Chem Lett;2011.0;{'bei': '14.23', 'le': '0.26', 'lle': '0.58', 'sei': '8.46'};CHEMBL1672351;;CHEMBL1672351;5.23;0;http://www.openphacts.org/units/Nanomolar;1330702;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.9
;;5207992;[];CHEMBL1680289;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C)Cc1c[nH]c(CC(C)(O)c2ccc(-c3ccc(F)cn3)cc2)n1;;;CHEMBL1671827;ACS Med Chem Lett;2011.0;{'bei': '14.63', 'le': '0.27', 'lle': '0.73', 'sei': '8.70'};CHEMBL1672352;;CHEMBL1672352;5.38;0;http://www.openphacts.org/units/Nanomolar;1330703;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;5250503;[];CHEMBL1686924;Displacement of [35S]MK499 from human ERG channel in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CC(N)=O)Cc1nc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)no1;;;CHEMBL1681724;Bioorg Med Chem Lett;2011.0;{'bei': '10.77', 'le': '0.21', 'lle': '1.81', 'sei': '4.53'};CHEMBL1682272;;CHEMBL1682272;4.50;0;http://www.openphacts.org/units/Nanomolar;1333350;=;1;1;=;;Ki;nM;;31622.78;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.5
;;6157213;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1cccc2c(-c3nc(CN4CCCC4)cs3)cn(CC3CCOCC3)c12.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.65', 'le': '0.28', 'lle': '0.65', 'sei': '19.81'};CHEMBL1762799;;CHEMBL1789326;6.00;0;http://www.openphacts.org/units/Nanomolar;1415366;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;6157230;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1cccc2c(-c3nc(CN(CC)CC)cs3)cn(CC3CCOCC3)c12.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.33', 'le': '0.28', 'lle': '0.30', 'sei': '19.48'};CHEMBL1762800;;CHEMBL1789266;5.90;0;http://www.openphacts.org/units/Nanomolar;1415367;=;1;1;=;;Ki;nM;;1258.93;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.9
;;6157231;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Fc1cccc2c(-c3nc(CN4CCCC4)cs3)cn(CC3CCOCC3)c12;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.52', 'le': '0.28', 'lle': '0.87', 'sei': '19.15'};CHEMBL1762801;;CHEMBL1762801;5.80;0;http://www.openphacts.org/units/Nanomolar;1415368;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;6157232;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(CC)Cc1csc(-c2cn(CC3CCOCC3)c3c(F)cccc23)n1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '15.19', 'le': '0.30', 'lle': '0.93', 'sei': '20.14'};CHEMBL1762802;;CHEMBL1762802;6.10;0;http://www.openphacts.org/units/Nanomolar;1415369;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;6157233;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.Clc1cccc2c(-c3nc(CN4CCCC4)cs3)cn(CC3CCOCC3)c12;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.66', 'le': '0.30', 'lle': '0.66', 'sei': '20.14'};CHEMBL1762803;;CHEMBL1789268;6.10;0;http://www.openphacts.org/units/Nanomolar;1415370;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;6157234;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(CC)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.83', 'le': '0.30', 'lle': '0.51', 'sei': '20.47'};CHEMBL1760028;;CHEMBL1789241;6.20;0;http://www.openphacts.org/units/Nanomolar;1415371;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;6157261;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COCCN(C)Cc1csc(-c2cn(CC3CCCCC3)c3c(Cl)cccc23)n1.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '15.28', 'le': '0.31', 'lle': '0.52', 'sei': '21.79'};CHEMBL1762804;;CHEMBL1789185;6.60;0;http://www.openphacts.org/units/Nanomolar;1415372;=;1;1;=;;Ki;nM;;251.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.6
;;6157262;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COCCN(C)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '13.82', 'le': '0.28', 'lle': '1.08', 'sei': '15.18'};CHEMBL1762805;;CHEMBL1789222;6.00;0;http://www.openphacts.org/units/Nanomolar;1415373;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;6157263;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN(CCO)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '13.57', 'le': '0.28', 'lle': '1.43', 'sei': '11.28'};CHEMBL1762806;;CHEMBL1762806;5.70;0;http://www.openphacts.org/units/Nanomolar;1415374;=;1;1;=;;Ki;nM;;1995.26;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.7
;;6157264;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(CCO)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.05', 'le': '0.29', 'lle': '1.44', 'sei': '12.07'};CHEMBL1762807;;CHEMBL1762807;6.10;0;http://www.openphacts.org/units/Nanomolar;1415375;=;1;1;=;;Ki;nM;;794.33;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.1
;;6157265;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)N(CCO)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '13.39', 'le': '0.27', 'lle': '0.95', 'sei': '11.88'};CHEMBL1762808;;CHEMBL1762808;6.00;0;http://www.openphacts.org/units/Nanomolar;1415376;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;6157266;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;OC1CCN(Cc2csc(-c3cn(CC4CCOCC4)c4c(Cl)cccc34)n2)CC1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '12.56', 'le': '0.25', 'lle': '0.80', 'sei': '11.08'};CHEMBL1762809;;CHEMBL1762809;5.60;0;http://www.openphacts.org/units/Nanomolar;1415377;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;6157267;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;COC1CCN(Cc2csc(-c3cn(CC4CCOCC4)c4c(Cl)cccc34)n2)CC1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '12.61', 'le': '0.26', 'lle': '0.34', 'sei': '14.68'};CHEMBL1762810;;CHEMBL1762810;5.80;0;http://www.openphacts.org/units/Nanomolar;1415378;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;6157268;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Clc1cccc2c(-c3nc(CN4CCOCC4)cs3)cn(CC3CCOCC3)c12;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '12.50', 'le': '0.25', 'lle': '0.72', 'sei': '13.66'};CHEMBL1762811;;CHEMBL1762811;5.40;0;http://www.openphacts.org/units/Nanomolar;1415379;=;1;1;=;;Ki;nM;;3981.07;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.4
;;6157269;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.OCCN(CCO)Cc1csc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)n1;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '12.44', 'le': '0.25', 'lle': '1.97', 'sei': '7.92'};CHEMBL1762812;;CHEMBL1789163;5.60;0;http://www.openphacts.org/units/Nanomolar;1415380;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;6157270;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1sc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)nc1CN(C)CCO.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '13.84', 'le': '0.28', 'lle': '1.37', 'sei': '12.27'};CHEMBL1762813;;CHEMBL1789189;6.20;0;http://www.openphacts.org/units/Nanomolar;1415381;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;6157271;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1sc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)nc1CN(CC)CCO.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '14.07', 'le': '0.29', 'lle': '1.28', 'sei': '12.87'};CHEMBL1762814;;CHEMBL1789190;6.50;0;http://www.openphacts.org/units/Nanomolar;1415382;=;1;1;=;;Ki;nM;;316.23;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.5
;;6157272;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1sc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)nc1CN(CCO)C(C)C.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '13.86', 'le': '0.28', 'lle': '0.99', 'sei': '13.06'};CHEMBL1762815;;CHEMBL1789175;6.60;0;http://www.openphacts.org/units/Nanomolar;1415383;=;1;1;=;;Ki;nM;;251.19;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.6
;;6157273;[];CHEMBL1762952;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)N(CCO)Cc1nc(-c2cn(CC3CCOCC3)c3c(Cl)cccc23)sc1Cl.Cl;;;CHEMBL1759932;Bioorg Med Chem Lett;2011.0;{'bei': '12.85', 'le': '0.27', 'lle': '0.50', 'sei': '12.27'};CHEMBL1762816;;CHEMBL1789209;6.20;0;http://www.openphacts.org/units/Nanomolar;1415384;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;6161957;[];CHEMBL1764269;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccc(OCCOc3c(Cl)cc(C)cc3Cl)cc2)C2CC2)cc(OCCOC)c1;;;CHEMBL1759994;Bioorg Med Chem Lett;2011.0;{'bei': '10.14', 'le': '0.20', 'lle': '-0.15', 'sei': '9.04'};CHEMBL1761519;;CHEMBL1761519;7.10;0;http://www.openphacts.org/units/Nanomolar;1413733;=;1;1;=;;Ki;nM;;80.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.08
;;6161958;[];CHEMBL1764269;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccc(OCCOc3c(Cl)cc(C)cc3Cl)cc2)C2CC2)cc(OCCN(C)C)c1;;;CHEMBL1759994;Bioorg Med Chem Lett;2011.0;{'bei': '9.46', 'le': '0.19', 'lle': '-0.42', 'sei': '9.30'};CHEMBL1761520;;CHEMBL1761520;6.75;0;http://www.openphacts.org/units/Nanomolar;1413734;=;1;1;=;;Ki;nM;;180.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.18
;;6161961;[];CHEMBL1764269;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccc(OCCOc3c(Cl)cc(C)cc3Cl)cc2)C2CC2)cc(OCC(C)(C)O)c1;;;CHEMBL1759994;Bioorg Med Chem Lett;2011.0;{'bei': '9.65', 'le': '0.19', 'lle': '-0.48', 'sei': '7.69'};CHEMBL1761523;;CHEMBL1761523;6.89;0;http://www.openphacts.org/units/Nanomolar;1413737;=;1;1;=;;Ki;nM;;130.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.13
;;6162878;[];CHEMBL1764302;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)NCc1c(C(=O)N[C@@H]2CCC[C@H](O)C2)noc1-c1ccc(C(F)(F)F)cc1;;;CHEMBL1759846;Bioorg Med Chem Lett;2011.0;{'bei': '12.22', 'le': '0.24', 'lle': '1.31', 'sei': '5.95'};CHEMBL1761688;;CHEMBL1761688;5.20;1;http://www.openphacts.org/units/Nanomolar;1413912;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;6162879;[];CHEMBL1764302;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N[C@@H]1CCC[C@H](O)C1)c1noc(-c2ccc(C(F)(F)F)cc2)c1CNCC1CC1;;;CHEMBL1759846;Bioorg Med Chem Lett;2011.0;{'bei': '12.12', 'le': '0.23', 'lle': '1.41', 'sei': '6.06'};CHEMBL1761694;;CHEMBL1761694;5.30;0;http://www.openphacts.org/units/Nanomolar;1413918;=;1;1;=;;Ki;nM;;5011.87;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.3
;;6162880;[];CHEMBL1764302;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N[C@@H]1CCC[C@H](O)C1)c1noc(-c2ccc(C(F)(F)F)cc2)c1CNCC1CCC1;;;CHEMBL1759846;Bioorg Med Chem Lett;2011.0;{'bei': '13.07', 'le': '0.25', 'lle': '1.62', 'sei': '6.75'};CHEMBL1761695;;CHEMBL1761695;5.90;0;http://www.openphacts.org/units/Nanomolar;1413919;=;1;1;=;;Ki;nM;;1258.93;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.9
;;6181376;[];CHEMBL1772133;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccc(Nc2ccc(-c3ccc(N4CCNCC4)nc3)cc2)n1;;;CHEMBL1770137;Bioorg Med Chem Lett;2011.0;{'bei': '17.82', 'le': '0.32', 'lle': '2.54', 'sei': '11.60'};CHEMBL1770752;;CHEMBL1770752;6.16;0;http://www.openphacts.org/units/Nanomolar;1419318;=;1;1;=;;Ki;nM;;700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.7
;;6187263;[];CHEMBL1777309;Displacement of [3H]dofetilide from human ERG channel expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2c(Cl)cc(Cl)cc2OCCCC(F)(F)F)nc(N)n1;;;CHEMBL1772974;J Med Chem;2011.0;{'bei': '12.98', 'le': '0.28', 'lle': '-0.12', 'sei': '8.09'};CHEMBL1774835;;CHEMBL1774835;4.94;0;http://www.openphacts.org/units/Nanomolar;1422925;=;1;1;=;;Ki;nM;;11600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.6
;;6196186;[];CHEMBL1776942;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(Cc1ccc(Cl)cc1)N[C@H](Cc1ccc(Cl)cc1)C(=O)N[C@H]1C[C@H]2CC[C@@H](C1)N2;;;CHEMBL1773049;Bioorg Med Chem Lett;2011.0;{'bei': '11.69', 'le': '0.24', 'lle': '1.72', 'sei': '7.66'};CHEMBL1774023;;CHEMBL1774023;5.38;0;http://www.openphacts.org/units/Nanomolar;1421815;=;1;1;=;;Ki;nM;;4168.69;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.38
;;6196187;[];CHEMBL1776942;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(N[C@H]1C[C@H]2CC[C@@H](C1)N2)[C@@H](Cc1ccc(Cl)cc1)NC(=O)C1(c2ccc(Cl)cc2)CC1;;;CHEMBL1773049;Bioorg Med Chem Lett;2011.0;{'bei': '11.92', 'le': '0.24', 'lle': '1.65', 'sei': '8.26'};CHEMBL1774024;;CHEMBL1774024;5.80;0;http://www.openphacts.org/units/Nanomolar;1421816;=;1;1;=;;Ki;nM;;1584.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.8
;;6263794;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccc(OCCOc3c(Cl)cc(C)cc3Cl)cc2)C2CC2)cc(OCCOC)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '8.71', 'le': '0.17', 'lle': '-1.15', 'sei': '7.77'};CHEMBL1761519;;CHEMBL1761519;6.10;0;http://www.openphacts.org/units/Nanomolar;1435801;=;1;1;=;;Ki;nM;;800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;800.0
;;6263800;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccccc2)C2CC2)cc(OCCOC)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.70', 'le': '0.20', 'lle': '0.96', 'sei': '8.57'};CHEMBL1795901;;CHEMBL1795901;5.14;0;http://www.openphacts.org/units/Nanomolar;1435802;=;1;1;=;;Ki;nM;;7200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7200.0
;;6263830;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2cc(=O)n(C)c3ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '8.11', 'le': '0.15', 'lle': '0.52', 'sei': '5.55'};CHEMBL1795906;;CHEMBL1795906;4.55;0;http://www.openphacts.org/units/Nanomolar;1435807;=;1;1;=;;Ki;nM;;28000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;28000.0
;;6263836;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2cc(=O)n(C)c3cc(Cl)ccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '8.67', 'le': '0.17', 'lle': '0.49', 'sei': '6.30'};CHEMBL1795907;;CHEMBL1795907;5.17;0;http://www.openphacts.org/units/Nanomolar;1435808;=;1;1;=;;Ki;nM;;6800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;6800.0
;;6263842;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cccc(Cl)c2Cl)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '11.25', 'le': '0.23', 'lle': '1.31', 'sei': '8.99'};CHEMBL1795908;;CHEMBL1795908;4.89;0;http://www.openphacts.org/units/Nanomolar;1435809;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;13000.0
;;6263848;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(Cl)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.50', 'le': '0.21', 'lle': '1.16', 'sei': '8.37'};CHEMBL1795909;;CHEMBL1795909;5.32;0;http://www.openphacts.org/units/Nanomolar;1435810;=;1;1;=;;Ki;nM;;4800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4800.0
;;6263861;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1ccc(Cl)c(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.65', 'le': '0.19', 'lle': '1.05', 'sei': '7.16'};CHEMBL1795910;;CHEMBL1795910;4.55;0;http://www.openphacts.org/units/Nanomolar;1435811;=;1;1;=;;Ki;nM;;28000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;28000.0
;;6263867;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(Cl)cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.85', 'le': '0.21', 'lle': '1.62', 'sei': '8.05'};CHEMBL1795911;;CHEMBL1795911;5.12;0;http://www.openphacts.org/units/Nanomolar;1435812;=;1;1;=;;Ki;nM;;7600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7600.0
;;6263872;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCc1cc(Cl)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.07', 'le': '0.21', 'lle': '1.19', 'sei': '7.80'};CHEMBL1795912;;CHEMBL1795912;4.96;0;http://www.openphacts.org/units/Nanomolar;1435813;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;11000.0
;;6263878;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cc(CCCC#N)cc(Cl)c2Cl)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.12', 'le': '0.20', 'lle': '0.66', 'sei': '6.50'};CHEMBL1795913;;CHEMBL1795913;5.08;0;http://www.openphacts.org/units/Nanomolar;1435814;=;1;1;=;;Ki;nM;;8400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8400.0
;;6263884;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cc(CCC#N)cc(Cl)c2Cl)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.79', 'le': '0.20', 'lle': '0.74', 'sei': '6.10'};CHEMBL1795914;;CHEMBL1795914;4.77;0;http://www.openphacts.org/units/Nanomolar;1435815;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;17000.0
;;6263896;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COC(=O)NCCc1cc(Cl)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.01', 'le': '0.18', 'lle': '1.35', 'sei': '5.21'};CHEMBL1795916;;CHEMBL1795916;4.82;0;http://www.openphacts.org/units/Nanomolar;1435817;=;1;1;=;;Ki;nM;;15000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;15000.0
;;6263902;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCNc1cc(Cl)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.35', 'le': '0.19', 'lle': '1.11', 'sei': '6.28'};CHEMBL1796060;;CHEMBL1796060;4.75;0;http://www.openphacts.org/units/Nanomolar;1435990;=;1;1;=;;Ki;nM;;18000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18000.0
;;6263914;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(Br)cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '10.26', 'le': '0.22', 'lle': '1.69', 'sei': '8.34'};CHEMBL1796062;;CHEMBL1796062;5.30;0;http://www.openphacts.org/units/Nanomolar;1435992;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5000.0
;;6263920;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)cc(Br)c1C;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '8.94', 'le': '0.19', 'lle': '0.82', 'sei': '7.46'};CHEMBL1796063;;CHEMBL1796063;4.75;0;http://www.openphacts.org/units/Nanomolar;1435993;=;1;1;=;;Ki;nM;;18000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;18000.0
;;6263954;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)cc(-c2ccccc2)c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '11.23', 'le': '0.21', 'lle': '1.25', 'sei': '9.08'};CHEMBL1796064;;CHEMBL1796064;5.77;0;http://www.openphacts.org/units/Nanomolar;1435994;=;1;1;=;;Ki;nM;;1700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1700.0
;;6263960;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c2ccccc2c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.78', 'le': '0.18', 'lle': '0.77', 'sei': '7.50'};CHEMBL1796065;;CHEMBL1796065;4.77;0;http://www.openphacts.org/units/Nanomolar;1435995;=;1;1;=;;Ki;nM;;17000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;17000.0
;;6263972;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c2ncccc2c1;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.35', 'le': '0.17', 'lle': '1.17', 'sei': '5.98'};CHEMBL1796067;;CHEMBL1796067;4.57;0;http://www.openphacts.org/units/Nanomolar;1435997;=;1;1;=;;Ki;nM;;27000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;27000.0
;;6264002;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c2c(Cl)cccc21;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.08', 'le': '0.18', 'lle': '0.73', 'sei': '6.77'};CHEMBL1796070;;CHEMBL1796070;4.64;0;http://www.openphacts.org/units/Nanomolar;1436000;=;1;1;=;;Ki;nM;;23000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;23000.0
;;6264623;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@@H]2c2ccn(C)c(=O)c2)C2CC2)c2c(Br)cccc21;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '8.93', 'le': '0.19', 'lle': '0.94', 'sei': '7.24'};CHEMBL1796071;;CHEMBL1796071;4.96;0;http://www.openphacts.org/units/Nanomolar;1436001;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;11000.0
;;6264635;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cn(Cc3ccccc3)c3cccc(F)c23)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '11.75', 'le': '0.22', 'lle': '1.61', 'sei': '10.16'};CHEMBL1796073;;CHEMBL1796073;6.02;0;http://www.openphacts.org/units/Nanomolar;1436003;=;1;1;=;;Ki;nM;;950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;950.0
;;6264641;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cn(Cc3cccc(F)c3)c3cccc(F)c23)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '11.16', 'le': '0.21', 'lle': '1.37', 'sei': '9.99'};CHEMBL1796074;;CHEMBL1796074;5.92;0;http://www.openphacts.org/units/Nanomolar;1436004;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1200.0
;;6264649;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cn(Cc3ccc(F)cc3)c3cccc(F)c23)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '11.54', 'le': '0.21', 'lle': '1.57', 'sei': '10.33'};CHEMBL1796075;;CHEMBL1796075;6.12;0;http://www.openphacts.org/units/Nanomolar;1436005;=;1;1;=;;Ki;nM;;750.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;750.0
;;6264657;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cn(Cc3cccnc3)c3cccc(F)c23)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.58', 'le': '0.18', 'lle': '1.11', 'sei': '6.82'};CHEMBL1796077;;CHEMBL1796077;4.92;0;http://www.openphacts.org/units/Nanomolar;1436007;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12000.0
;;6264658;[];CHEMBL1799739;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc([C@H]2CCNC[C@@H]2C(=O)N(Cc2cn(Cc3ccncc3)c3cccc(F)c23)C2CC2)cc1=O;;;CHEMBL1795332;Bioorg Med Chem Lett;2011.0;{'bei': '9.39', 'le': '0.17', 'lle': '1.01', 'sei': '6.69'};CHEMBL1796078;;CHEMBL1796078;4.82;0;http://www.openphacts.org/units/Nanomolar;1436008;=;1;1;=;;Ki;nM;;15000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;15000.0
;;6292149;[];CHEMBL1810638;Displacement of labeled-dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)NCc1c(C(=O)N[C@@H]2CCC[C@H](O)C2)noc1-c1ccc(C(F)(F)F)cc1;;;CHEMBL1806385;Bioorg Med Chem Lett;2011.0;{'bei': '12.22', 'le': '0.24', 'lle': '1.31', 'sei': '5.95'};CHEMBL1761688;;CHEMBL1761688;5.20;0;http://www.openphacts.org/units/Nanomolar;1444402;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;6345450;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)C1CCC(c2ccc(OCCCN3CCCCC3)cc2)CC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '14.51', 'le': '0.27', 'lle': '0.47', 'sei': '31.83'};CHEMBL1822862;;CHEMBL1822862;5.00;0;http://www.openphacts.org/units/Nanomolar;1453682;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10000.0
;;6345451;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC(=O)c1ccc(-c2ccc(OCCCN3CCCCC3)cc2)cc1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '22.03', 'le': '0.41', 'lle': '3.31', 'sei': '20.88'};CHEMBL1822861;;CHEMBL1822861;8.10;0;http://www.openphacts.org/units/Nanomolar;1453681;=;1;1;=;;Ki;nM;;8.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8.0
;;6345452;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccccc1-c1ccc(OCCCN2CCCCC2)cc1)N1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '14.97', 'le': '0.28', 'lle': '0.86', 'sei': '18.57'};CHEMBL1822860;;CHEMBL1822860;6.09;0;http://www.openphacts.org/units/Nanomolar;1453680;=;1;1;=;;Ki;nM;;818.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;818.0
;;6345453;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccccc1-c1ccc(OCCCN2CCCCC2)cc1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '21.87', 'le': '0.41', 'lle': '2.50', 'sei': '32.81'};CHEMBL1822859;;CHEMBL1822859;7.12;0;http://www.openphacts.org/units/Nanomolar;1453679;=;1;1;=;;Ki;nM;;76.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;76.0
;;6345454;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(-c2ccc3c(c2)OCO3)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '24.46', 'le': '0.45', 'lle': '3.96', 'sei': '26.84'};CHEMBL1822858;;CHEMBL1822858;8.30;0;http://www.openphacts.org/units/Nanomolar;1453678;=;1;1;=;;Ki;nM;;5.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5.0
;;6345455;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(C2CCOCC2)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '18.63', 'le': '0.35', 'lle': '1.81', 'sei': '26.05'};CHEMBL1822857;;CHEMBL1822857;5.65;0;http://www.openphacts.org/units/Nanomolar;1453677;=;1;1;=;;Ki;nM;;2220.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2220.0
;;6345456;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(C2CCCCO2)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '19.60', 'le': '0.37', 'lle': '1.77', 'sei': '27.41'};CHEMBL1822856;;CHEMBL1822856;5.95;0;http://www.openphacts.org/units/Nanomolar;1453676;=;1;1;=;;Ki;nM;;1125.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1125.0
;;6345458;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(C2CCCCC2)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '26.16', 'le': '0.49', 'lle': '2.90', 'sei': '63.24'};CHEMBL1822854;;CHEMBL1822854;7.89;0;http://www.openphacts.org/units/Nanomolar;1453674;=;1;1;=;;Ki;nM;;13.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;13.0
;;6345459;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C1=C(c2ccc(OCCCN3CCCCC3)cc2)CCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '23.26', 'le': '0.43', 'lle': '2.13', 'sei': '53.23'};CHEMBL1822853;;CHEMBL1822853;6.64;0;http://www.openphacts.org/units/Nanomolar;1453673;=;1;1;=;;Ki;nM;;230.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;230.0
;;6345460;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(C2=NCCO2)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '17.34', 'le': '0.33', 'lle': '2.28', 'sei': '14.68'};CHEMBL1822852;;CHEMBL1822852;5.00;0;http://www.openphacts.org/units/Nanomolar;1453672;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10000.0
;;6345461;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1ncc(-c2ccc(OCCCN3CCCCC3)cc2)o1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '20.68', 'le': '0.39', 'lle': '2.32', 'sei': '15.38'};CHEMBL1822851;;CHEMBL1822851;5.92;0;http://www.openphacts.org/units/Nanomolar;1453671;=;1;1;=;;Ki;nM;;1194.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1194.0
;;6345462;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1nccc1-c1ccc(OCCCN2CCCCC2)cc1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '22.45', 'le': '0.42', 'lle': '3.38', 'sei': '22.19'};CHEMBL1822850;;CHEMBL1822850;6.72;0;http://www.openphacts.org/units/Nanomolar;1453670;=;1;1;=;;Ki;nM;;190.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;190.0
;;6345463;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1c[nH]c(-c2ccc(OCCCN3CCCCC3)cc2)n1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '17.52', 'le': '0.33', 'lle': '1.67', 'sei': '12.15'};CHEMBL1822849;;CHEMBL1822849;5.00;0;http://www.openphacts.org/units/Nanomolar;1453669;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10000.0
;;6345464;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1cc(C2CCCO2)ccc1OCCCN1CCCCC1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '19.21', 'le': '0.36', 'lle': '1.77', 'sei': '25.63'};CHEMBL1822690;;CHEMBL1822690;5.56;0;http://www.openphacts.org/units/Nanomolar;1453443;=;1;1;=;;Ki;nM;;2747.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2747.0
;;6345465;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1coc(-c2ccc(OCCCN3CCCCC3)cc2)c1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '24.69', 'le': '0.46', 'lle': '2.85', 'sei': '27.51'};CHEMBL1822689;;CHEMBL1822689;7.05;0;http://www.openphacts.org/units/Nanomolar;1453442;=;1;1;=;;Ki;nM;;90.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;90.0
;;6345466;[];CHEMBL1827362;Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;c1csc(-c2ccc(OCCCN3CCCCC3)cc2)c1;;;CHEMBL1821550;Bioorg Med Chem Lett;2011.0;{'bei': '26.05', 'le': '0.51', 'lle': '3.18', 'sei': '62.98'};CHEMBL1822688;;CHEMBL1822688;7.85;0;http://www.openphacts.org/units/Nanomolar;1453441;=;1;1;=;;Ki;nM;;14.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;14.0
;;6383737;[];CHEMBL1838314;Displacement of [3H]-dofetilide from human ERG channel expressed in HEK293 by scintillation counting;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)CN1C(=O)CN(Cc2ccc(-c3cccc(CN4CCCCC4)n3)cc2)C1=O;;;CHEMBL1833934;J Med Chem;2011.0;{'bei': '13.08', 'le': '0.24', 'lle': '1.35', 'sei': '9.69'};CHEMBL1835119;;CHEMBL1835119;5.50;0;http://www.openphacts.org/units/Nanomolar;1461289;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;7602162;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-];;;CHEMBL1909046;;;{'bei': '17.09', 'le': '0.32', 'lle': '0.98', 'sei': '38.20'};CHEMBL221753;BENZETHONIUM CHLORIDE;CHEMBL1182210;7.05;0;http://www.openphacts.org/units/Nanomolar;1539535;=;15;1;=;;Ki;nM;;88.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.0889
;;7649803;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1;;;CHEMBL1909046;;;{'bei': '15.05', 'le': '0.28', 'lle': '-0.15', 'sei': '23.92'};CHEMBL305660;EBASTINE;CHEMBL305660;7.07;0;http://www.openphacts.org/units/Nanomolar;1539723;=;15;1;=;;Ki;nM;;85.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.0858
;;7665523;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O;;;CHEMBL1909046;;;{'bei': '12.02', 'le': '0.22', 'lle': '0.29', 'sei': '7.87'};CHEMBL1493;FLAVOXATE;CHEMBL1493;4.70;0;http://www.openphacts.org/units/Nanomolar;1539767;=;15;1;=;;Ki;nM;;19750.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.7503
;;7665651;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1;;;CHEMBL1909046;;;{'bei': '15.59', 'le': '0.29', 'lle': '0.91', 'sei': '97.29'};CHEMBL30008;FLUNARIZINE;CHEMBL30008;6.30;0;http://www.openphacts.org/units/Nanomolar;1539775;=;15;1;=;;Ki;nM;;496.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.4963
;;7665768;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1;;;CHEMBL1909046;;;{'bei': '16.15', 'le': '0.31', 'lle': '0.56', 'sei': '23.50'};CHEMBL41;FLUOXETINE;CHEMBL41;5.00;0;http://www.openphacts.org/units/Nanomolar;1539783;=;15;1;=;;Ki;nM;;10066.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.066
;;7670033;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1;;;CHEMBL1909046;;;{'bei': '12.18', 'le': '0.24', 'lle': '1.02', 'sei': '17.80'};CHEMBL726;FLUPHENAZINE;CHEMBL726;5.33;0;http://www.openphacts.org/units/Nanomolar;1539784;=;15;1;=;;Ki;nM;;4674.6;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.6746
;;7675411;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1;;;CHEMBL1909046;;;{'bei': '16.13', 'le': '0.30', 'lle': '2.44', 'sei': '10.53'};CHEMBL1108;DROPERIDOL;CHEMBL1108;6.12;0;http://www.openphacts.org/units/Nanomolar;1539721;=;15;1;=;;Ki;nM;;759.6;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.7596
;;7679556;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12;;;CHEMBL1909046;;;{'bei': '13.46', 'le': '0.25', 'lle': '1.73', 'sei': '7.22'};CHEMBL723;CARVEDILOL;CHEMBL723;5.47;0;http://www.openphacts.org/units/Nanomolar;1539591;=;15;1;=;;Ki;nM;;3374.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.3749
;;7681482;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN(C)CCOC(c1ccccc1)c1ccccc1;;;CHEMBL1909046;;;{'bei': '17.95', 'le': '0.33', 'lle': '1.23', 'sei': '36.75'};CHEMBL657;DIPHENHYDRAMINE;CHEMBL657;4.58;0;http://www.openphacts.org/units/Nanomolar;1539706;=;15;1;=;;Ki;nM;;26101.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;26.1013
;;7682348;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1;;;CHEMBL1909046;;;{'bei': '18.87', 'le': '0.37', 'lle': '1.39', 'sei': '52.04'};CHEMBL1626;CLEMASTINE;CHEMBL1626;6.49;0;http://www.openphacts.org/units/Nanomolar;1539632;=;15;1;=;;Ki;nM;;323.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3237
;;7685945;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC;;;CHEMBL1909046;;;{'bei': '12.72', 'le': '0.24', 'lle': '4.02', 'sei': '5.11'};CHEMBL707;DOXAZOSIN;CHEMBL707;5.74;0;http://www.openphacts.org/units/Nanomolar;1539715;=;15;1;=;;Ki;nM;;1815.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8151
;;7686554;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC;;;CHEMBL1909046;;;{'bei': '14.71', 'le': '0.29', 'lle': '3.50', 'sei': '7.97'};CHEMBL1729;CISAPRIDE;CHEMBL1729;6.86;0;http://www.openphacts.org/units/Nanomolar;1539625;=;15;1;=;;Ki;nM;;139.4;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.1394
;;7691914;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1;;;CHEMBL1909046;;;{'bei': '15.42', 'le': '0.30', 'lle': '0.37', 'sei': '16.16'};CHEMBL1123;DICYCLOMINE;CHEMBL1123;4.77;0;http://www.openphacts.org/units/Nanomolar;1539692;=;15;1;=;;Ki;nM;;16869.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.8697
;;7695096;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21;;;CHEMBL1909046;;;{'bei': '15.00', 'le': '0.28', 'lle': '1.05', 'sei': '13.42'};CHEMBL549;CITALOPRAM;CHEMBL549;4.86;0;http://www.openphacts.org/units/Nanomolar;1539627;=;15;1;=;;Ki;nM;;13661.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.6618
;;7698065;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CNCCCN1c2ccccc2CCc2ccccc21;;;CHEMBL1909046;;;{'bei': '17.42', 'le': '0.32', 'lle': '1.11', 'sei': '30.40'};CHEMBL72;DESIPRAMINE;CHEMBL72;4.64;0;http://www.openphacts.org/units/Nanomolar;1539677;=;15;1;=;;Ki;nM;;22816.6;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;22.8166
;;7706248;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1;;;CHEMBL1909046;;;{'bei': '15.49', 'le': '0.30', 'lle': '1.34', 'sei': '16.40'};CHEMBL42;CLOZAPINE;CHEMBL42;5.06;0;http://www.openphacts.org/units/Nanomolar;1539647;=;15;1;=;;Ki;nM;;8660.6;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.6606
;;7707788;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21;;;CHEMBL1909046;;;{'bei': '16.69', 'le': '0.35', 'lle': '0.43', 'sei': '82.12'};CHEMBL71;CHLORPROMAZINE;CHEMBL71;5.32;0;http://www.openphacts.org/units/Nanomolar;1539606;=;15;1;=;;Ki;nM;;4774.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.7743
;;7710876;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1;;;CHEMBL1909046;;;{'bei': '16.89', 'le': '0.30', 'lle': '0.15', 'sei': '149.84'};CHEMBL516;CYPROHEPTADINE;CHEMBL516;4.86;0;http://www.openphacts.org/units/Nanomolar;1539664;=;15;1;=;;Ki;nM;;13967.9;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.9679
;;7721287;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1;;;CHEMBL1909046;;;{'bei': '15.39', 'le': '0.29', 'lle': '1.74', 'sei': '12.76'};CHEMBL490;PAROXETINE;CHEMBL490;5.07;0;http://www.openphacts.org/units/Nanomolar;1540030;=;15;1;=;;Ki;nM;;8544.5;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.5445
;;7721414;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1;;;CHEMBL1909046;;;{'bei': '14.36', 'le': '0.27', 'lle': '2.01', 'sei': '4.14'};CHEMBL55;PENTAMIDINE;CHEMBL55;4.89;0;http://www.openphacts.org/units/Nanomolar;1540038;=;15;1;=;;Ki;nM;;12880.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.8802
;;7728391;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC;;;CHEMBL1909046;;;{'bei': '12.26', 'le': '0.23', 'lle': '2.92', 'sei': '4.40'};CHEMBL2;PRAZOSIN;CHEMBL2;4.70;0;http://www.openphacts.org/units/Nanomolar;1540072;=;15;1;=;;Ki;nM;;19890.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.8902
;;7735207;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;COc1ccc(CN(CCN(C)C)c2ccccn2)cc1;;;CHEMBL1909046;;;{'bei': '17.47', 'le': '0.32', 'lle': '2.33', 'sei': '17.43'};CHEMBL511;PYRILAMINE;CHEMBL511;4.99;0;http://www.openphacts.org/units/Nanomolar;1540098;=;15;1;=;;Ki;nM;;10337.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.3378
;;7736473;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1;;;CHEMBL1909046;;;{'bei': '13.52', 'le': '0.28', 'lle': '1.52', 'sei': '18.24'};CHEMBL567;PERPHENAZINE;CHEMBL567;5.46;0;http://www.openphacts.org/units/Nanomolar;1540042;=;15;1;=;;Ki;nM;;3454.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.4541
;;7736595;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1;;;CHEMBL1909046;;;{'bei': '17.00', 'le': '0.31', 'lle': '1.94', 'sei': '10.00'};CHEMBL597;PHENTOLAMINE;CHEMBL597;4.78;0;http://www.openphacts.org/units/Nanomolar;1540050;=;15;1;=;;Ki;nM;;16448.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.448
;;7745734;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1;;;CHEMBL1909046;;;{'bei': '15.56', 'le': '0.32', 'lle': '1.24', 'sei': '59.87'};CHEMBL728;PROCHLORPERAZINE;CHEMBL728;5.82;0;http://www.openphacts.org/units/Nanomolar;1540084;=;15;1;=;;Ki;nM;;1514.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5141
;;7750108;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CCN(CC)CCOCCC1=CCC2CC1C2(C)C;;;CHEMBL1909046;;;{'bei': '20.03', 'le': '0.38', 'lle': '1.59', 'sei': '42.63'};CHEMBL1630579;MYRTECAINE;CHEMBL1630579;5.32;0;http://www.openphacts.org/units/Nanomolar;1539965;=;15;1;=;;Ki;nM;;4835.7;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.8357
;;7778776;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1;;;CHEMBL1909046;;;{'bei': '11.74', 'le': '0.23', 'lle': '-0.40', 'sei': '10.59'};CHEMBL998;LORATADINE;CHEMBL998;4.50;0;http://www.openphacts.org/units/Nanomolar;1539898;=;15;1;=;;Ki;nM;;32022.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;32.0228
;;7781271;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1;;;CHEMBL1909046;;;{'bei': '12.99', 'le': '0.26', 'lle': '0.34', 'sei': '54.45'};CHEMBL422;TRIFLUOPERAZINE;CHEMBL422;5.29;0;http://www.openphacts.org/units/Nanomolar;1540247;=;15;1;=;;Ki;nM;;5100.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.1008
;;7802084;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2;;;CHEMBL1909046;;;{'bei': '15.88', 'le': '0.32', 'lle': '0.00', 'sei': '90.83'};CHEMBL479;THIORIDAZINE;CHEMBL479;5.89;0;http://www.openphacts.org/units/Nanomolar;1540216;=;15;1;=;;Ki;nM;;1301.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.301
;;7803847;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1;;;CHEMBL1909046;;;{'bei': '16.42', 'le': '0.30', 'lle': '0.10', 'sei': '48.93'};CHEMBL83;TAMOXIFEN;CHEMBL83;6.10;0;http://www.openphacts.org/units/Nanomolar;1540192;=;15;1;=;;Ki;nM;;792.2;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.7922
;;7806980;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2;;;CHEMBL1909046;;;{'bei': '13.31', 'le': '0.25', 'lle': '1.87', 'sei': '8.52'};CHEMBL85;RISPERIDONE;CHEMBL85;5.46;0;http://www.openphacts.org/units/Nanomolar;1540120;=;15;1;=;;Ki;nM;;3432.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.4328
;;7811599;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21;;;CHEMBL1909046;;;{'bei': '16.87', 'le': '0.35', 'lle': '-0.01', 'sei': '42.95'};CHEMBL809;SERTRALINE;CHEMBL809;5.17;0;http://www.openphacts.org/units/Nanomolar;1540145;=;15;1;=;;Ki;nM;;6814.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.8141
;;7816024;[];CHEMBL1909190;DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole);B;;;BAO_0000192;BAO_0000249;cell membrane format;C[C@@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@H](C)N1;;;CHEMBL1909046;;;{'bei': '11.25', 'le': '0.22', 'lle': '2.33', 'sei': '4.39'};CHEMBL850;SPARFLOXACIN;CHEMBL850;4.41;0;http://www.openphacts.org/units/Nanomolar;1540154;=;15;1;=;;Ki;nM;;38619.4;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;38.6194
;;7854173;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)C2CNCCC2(O)c2ccc(F)c(F)c2)C2CC2)cc(OCCOC)c1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.04', 'le': '0.19', 'lle': '1.79', 'sei': '6.66'};CHEMBL1910294;;CHEMBL1910294;5.35;0;http://www.openphacts.org/units/Nanomolar;1542529;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.5
;;7854202;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cccc(Cl)c1Cl)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '13.55', 'le': '0.28', 'lle': '1.91', 'sei': '11.73'};CHEMBL1910295;;CHEMBL1910295;6.17;0;http://www.openphacts.org/units/Nanomolar;1542530;=;1;1;=;;Ki;nM;;680.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.68
;;7854206;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1ccc(Cl)c(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '12.17', 'le': '0.24', 'lle': '1.81', 'sei': '9.71'};CHEMBL1910296;;CHEMBL1910296;6.00;0;http://www.openphacts.org/units/Nanomolar;1542531;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.0
;;7854210;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCc1ccc(Cl)c(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.81', 'le': '0.23', 'lle': '1.86', 'sei': '9.15'};CHEMBL1824499;;CHEMBL1824499;5.66;0;http://www.openphacts.org/units/Nanomolar;1542532;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;7854214;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1c[nH]c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '13.20', 'le': '0.25', 'lle': '2.28', 'sei': '8.56'};CHEMBL1910297;;CHEMBL1910297;5.85;0;http://www.openphacts.org/units/Nanomolar;1542533;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;7854218;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1c[nH]c2cccc(Cl)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '13.13', 'le': '0.26', 'lle': '1.95', 'sei': '8.84'};CHEMBL1910298;;CHEMBL1910298;6.04;0;http://www.openphacts.org/units/Nanomolar;1542534;=;1;1;=;;Ki;nM;;910.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.91
;;7854222;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1c[nH]c2cccc(Br)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '12.56', 'le': '0.27', 'lle': '2.14', 'sei': '9.27'};CHEMBL1910299;;CHEMBL1910299;6.34;0;http://www.openphacts.org/units/Nanomolar;1542535;=;1;1;=;;Ki;nM;;460.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.46
;;7854226;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)cccc21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.42', 'le': '0.22', 'lle': '1.81', 'sei': '8.82'};CHEMBL1910300;;CHEMBL1910300;5.89;0;http://www.openphacts.org/units/Nanomolar;1542536;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.3
;;7854230;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1ccc(F)c2c(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)c[nH]c12;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.56', 'le': '0.22', 'lle': '1.81', 'sei': '7.68'};CHEMBL1910301;;CHEMBL1910301;5.96;0;http://www.openphacts.org/units/Nanomolar;1542537;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;7854234;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1ccc(F)c2c(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)cn(CCCOC)c12;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.33', 'le': '0.20', 'lle': '1.41', 'sei': '7.99'};CHEMBL1910302;;CHEMBL1910302;6.07;0;http://www.openphacts.org/units/Nanomolar;1542538;=;1;1;=;;Ki;nM;;850.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.85
;;7854238;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)ccc(CCC#N)c21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.94', 'le': '0.21', 'lle': '1.68', 'sei': '6.87'};CHEMBL1910303;;CHEMBL1910303;6.22;0;http://www.openphacts.org/units/Nanomolar;1542539;=;1;1;=;;Ki;nM;;600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.6
;;7854242;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)ccc(CS(C)(=O)=O)c21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.45', 'le': '0.19', 'lle': '2.11', 'sei': '5.70'};CHEMBL1910304;;CHEMBL1910304;5.75;0;http://www.openphacts.org/units/Nanomolar;1542540;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;7854246;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)ccc(CN3CCOCC3)c21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.84', 'le': '0.19', 'lle': '2.13', 'sei': '7.63'};CHEMBL1910305;;CHEMBL1910305;6.05;0;http://www.openphacts.org/units/Nanomolar;1542541;=;1;1;=;;Ki;nM;;900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.9
;;7854250;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)ccc(Cn3ccnc3)c21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.83', 'le': '0.19', 'lle': '1.52', 'sei': '6.92'};CHEMBL1910306;;CHEMBL1910306;5.85;0;http://www.openphacts.org/units/Nanomolar;1542542;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;7854254;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CONC(=O)Cn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)cccc21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.57', 'le': '0.18', 'lle': '2.36', 'sei': '5.30'};CHEMBL1910307;;CHEMBL1910307;5.08;0;http://www.openphacts.org/units/Nanomolar;1542543;=;1;1;=;;Ki;nM;;8400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.4
;;7854258;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CON(C)C(=O)Cn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)cccc21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.43', 'le': '0.20', 'lle': '2.61', 'sei': '6.52'};CHEMBL1909649;;CHEMBL1909649;5.68;0;http://www.openphacts.org/units/Nanomolar;1542544;=;1;1;=;;Ki;nM;;2100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.1
;;7854262;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ncco2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.36', 'le': '0.21', 'lle': '1.88', 'sei': '7.13'};CHEMBL1910308;;CHEMBL1910308;5.96;0;http://www.openphacts.org/units/Nanomolar;1542545;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;7854266;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccon2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.53', 'le': '0.22', 'lle': '1.97', 'sei': '7.24'};CHEMBL1910309;;CHEMBL1910309;6.05;0;http://www.openphacts.org/units/Nanomolar;1542546;=;1;1;=;;Ki;nM;;900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.9
;;7854270;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cc(Cn2cc(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)c3c(F)cccc32)no1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.24', 'le': '0.21', 'lle': '1.67', 'sei': '7.25'};CHEMBL1910310;;CHEMBL1910310;6.06;0;http://www.openphacts.org/units/Nanomolar;1542547;=;1;1;=;;Ki;nM;;880.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.88
;;7854274;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1noc(Cn2cc(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)c3c(F)cccc32)n1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.60', 'le': '0.20', 'lle': '1.93', 'sei': '5.93'};CHEMBL1910311;;CHEMBL1910311;5.72;0;http://www.openphacts.org/units/Nanomolar;1542548;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.9
;;7854278;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2cnoc2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.83', 'le': '0.22', 'lle': '2.13', 'sei': '7.43'};CHEMBL1910312;;CHEMBL1910312;6.21;0;http://www.openphacts.org/units/Nanomolar;1542549;=;1;1;=;;Ki;nM;;620.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.62
;;7854282;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1noc(C)c1Cn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)cccc21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.13', 'le': '0.21', 'lle': '1.45', 'sei': '7.36'};CHEMBL1910313;;CHEMBL1910313;6.15;0;http://www.openphacts.org/units/Nanomolar;1542550;=;1;1;=;;Ki;nM;;710.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.71
;;7854286;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ncnc1Cn1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)C2CC2)c2c(F)cccc21;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.95', 'le': '0.19', 'lle': '2.14', 'sei': '6.07'};CHEMBL1910314;;CHEMBL1910314;5.36;0;http://www.openphacts.org/units/Nanomolar;1542551;=;1;1;=;;Ki;nM;;4400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.4
;;7854290;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccccc2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '12.37', 'le': '0.23', 'lle': '1.50', 'sei': '11.48'};CHEMBL1910315;;CHEMBL1910315;6.60;0;http://www.openphacts.org/units/Nanomolar;1542552;=;1;1;=;;Ki;nM;;250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.25
;;7854294;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccccc2OC(F)F)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.04', 'le': '0.21', 'lle': '0.92', 'sei': '9.92'};CHEMBL1910316;;CHEMBL1910316;6.62;0;http://www.openphacts.org/units/Nanomolar;1542553;=;1;1;=;;Ki;nM;;240.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.24
;;7854298;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2cccc(OC(F)F)c2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.88', 'le': '0.21', 'lle': '0.82', 'sei': '9.78'};CHEMBL1910317;;CHEMBL1910317;6.52;0;http://www.openphacts.org/units/Nanomolar;1542554;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3
;;7854302;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccc(OC(F)F)cc2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.33', 'le': '0.22', 'lle': '1.10', 'sei': '10.18'};CHEMBL1910318;;CHEMBL1910318;6.80;0;http://www.openphacts.org/units/Nanomolar;1542555;=;1;1;=;;Ki;nM;;160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.16
;;7854306;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2cccc(F)c2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.97', 'le': '0.23', 'lle': '1.37', 'sei': '11.48'};CHEMBL1910319;;CHEMBL1910319;6.60;0;http://www.openphacts.org/units/Nanomolar;1542556;=;1;1;=;;Ki;nM;;250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.25
;;7854310;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccc(F)c(F)c2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.45', 'le': '0.22', 'lle': '1.15', 'sei': '11.34'};CHEMBL1910320;;CHEMBL1910320;6.52;0;http://www.openphacts.org/units/Nanomolar;1542557;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3
;;7854314;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2cccnc2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '12.10', 'le': '0.23', 'lle': '1.98', 'sei': '9.19'};CHEMBL1910321;;CHEMBL1910321;6.47;0;http://www.openphacts.org/units/Nanomolar;1542558;=;1;1;=;;Ki;nM;;340.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.34
;;7854318;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(O)c1ccc(F)c(F)c1)N(Cc1cn(Cc2ccncc2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.15', 'le': '0.21', 'lle': '1.47', 'sei': '8.47'};CHEMBL1910322;;CHEMBL1910322;5.96;0;http://www.openphacts.org/units/Nanomolar;1542559;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;7854322;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(Cn2cc(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)c3c(F)cccc32)cn1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '11.75', 'le': '0.22', 'lle': '1.64', 'sei': '9.15'};CHEMBL1910545;;CHEMBL1910545;6.44;0;http://www.openphacts.org/units/Nanomolar;1542815;=;1;1;=;;Ki;nM;;360.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.36
;;7854326;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cc(Cn2cc(CN(C(=O)[C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)C3CC3)c3c(F)cccc32)ccn1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '10.96', 'le': '0.21', 'lle': '1.21', 'sei': '8.54'};CHEMBL1910546;;CHEMBL1910546;6.01;0;http://www.openphacts.org/units/Nanomolar;1542816;=;1;1;=;;Ki;nM;;970.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.97
;;7854347;[];CHEMBL1913542;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@]1(OCC(O)CO)c1ccc(F)c(F)c1)N(Cc1cn(Cc2cccc(F)c2)c2cccc(F)c12)C1CC1;;;CHEMBL1909544;Bioorg Med Chem Lett;2011.0;{'bei': '9.74', 'le': '0.19', 'lle': '1.49', 'sei': '7.01'};CHEMBL1910547;;CHEMBL1910547;6.10;0;http://www.openphacts.org/units/Nanomolar;1542817;=;1;1;=;;Ki;nM;;800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.8
;;7951279;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@]2(O)c2ccccc2)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.67', 'le': '0.20', 'lle': '2.02', 'sei': '6.60'};CHEMBL1910286;;CHEMBL1910286;5.30;0;http://www.openphacts.org/units/Nanomolar;1562193;=;1;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.0
;;7951280;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OCc2ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.24', 'le': '0.17', 'lle': '0.88', 'sei': '6.78'};CHEMBL1923106;;CHEMBL1923106;4.70;0;http://www.openphacts.org/units/Nanomolar;1562194;=;1;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;20.0
;;7951281;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OC(=O)c2ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.03', 'le': '0.17', 'lle': '1.26', 'sei': '5.47'};CHEMBL1923107;;CHEMBL1923107;4.72;0;http://www.openphacts.org/units/Nanomolar;1562195;=;1;1;=;;Ki;nM;;19000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.0
;;7951892;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OCCc2ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '8.84', 'le': '0.17', 'lle': '0.76', 'sei': '6.67'};CHEMBL1923108;;CHEMBL1923108;4.62;0;http://www.openphacts.org/units/Nanomolar;1562196;=;1;1;=;;Ki;nM;;24000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;24.0
;;7951893;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OC=Cc2ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.90', 'le': '0.19', 'lle': '0.86', 'sei': '7.44'};CHEMBL1923109;;CHEMBL1923109;5.16;0;http://www.openphacts.org/units/Nanomolar;1562197;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.0
;;7951894;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OC(=O)Cc2ccccc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '8.14', 'le': '0.15', 'lle': '0.98', 'sei': '5.06'};CHEMBL1923110;;CHEMBL1923110;4.37;0;http://www.openphacts.org/units/Nanomolar;1562198;=;1;1;=;;Ki;nM;;43000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;43.0
;;7951895;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)cc(OCCOC)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '8.48', 'le': '0.16', 'lle': '0.52', 'sei': '6.67'};CHEMBL1923111;;CHEMBL1923111;4.62;0;http://www.openphacts.org/units/Nanomolar;1562199;=;1;1;=;;Ki;nM;;24000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;24.0
;;7951896;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1ccccc1Cl)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.85', 'le': '0.21', 'lle': '0.56', 'sei': '11.30'};CHEMBL1923112;;CHEMBL1923112;4.70;0;http://www.openphacts.org/units/Nanomolar;1562200;=;1;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;20.0
;;7951897;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1cccc(Cl)c1Cl)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.61', 'le': '0.22', 'lle': '0.16', 'sei': '11.93'};CHEMBL1923113;;CHEMBL1923113;4.96;0;http://www.openphacts.org/units/Nanomolar;1562201;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;7951898;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1ccc(Cl)cc1Cl)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.77', 'le': '0.22', 'lle': '0.23', 'sei': '12.10'};CHEMBL1923114;;CHEMBL1923114;5.03;0;http://www.openphacts.org/units/Nanomolar;1562202;=;1;1;=;;Ki;nM;;9300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.3
;;7951899;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1cc(Cl)ccc1Cl)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '12.29', 'le': '0.25', 'lle': '0.94', 'sei': '13.82'};CHEMBL1923115;;CHEMBL1923115;5.75;0;http://www.openphacts.org/units/Nanomolar;1562203;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;7951900;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccc(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1C;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.71', 'le': '0.20', 'lle': '0.46', 'sei': '10.99'};CHEMBL1923116;;CHEMBL1923116;4.57;0;http://www.openphacts.org/units/Nanomolar;1562204;=;1;1;=;;Ki;nM;;27000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;27.0
;;7951901;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)cccc1C(F)(F)F;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.81', 'le': '0.21', 'lle': '0.37', 'sei': '12.49'};CHEMBL1923117;;CHEMBL1923117;5.19;0;http://www.openphacts.org/units/Nanomolar;1562205;=;1;1;=;;Ki;nM;;6400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.4
;;7951902;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1cccc(C(F)(F)F)c1Cl)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.82', 'le': '0.20', 'lle': '-0.24', 'sei': '11.84'};CHEMBL1923118;;CHEMBL1923118;4.92;0;http://www.openphacts.org/units/Nanomolar;1562206;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.0
;;7951903;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(C)c(C)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.03', 'le': '0.19', 'lle': '0.31', 'sei': '9.84'};CHEMBL1923119;;CHEMBL1923119;5.00;0;http://www.openphacts.org/units/Nanomolar;1562207;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;7951904;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1cccc2ccccc12)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '11.69', 'le': '0.22', 'lle': '0.60', 'sei': '12.62'};CHEMBL1923120;;CHEMBL1923120;5.24;0;http://www.openphacts.org/units/Nanomolar;1562208;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.7
;;7951905;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c2ccccc2c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.45', 'le': '0.18', 'lle': '-0.30', 'sei': '9.69'};CHEMBL1923121;;CHEMBL1923121;4.92;0;http://www.openphacts.org/units/Nanomolar;1562209;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.0
;;7951906;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cccc2cccc(CN(C(=O)[C@H]3CNCC[C@@]34OCc3cc(F)c(F)cc34)C3CC3)c12;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.83', 'le': '0.18', 'lle': '-0.10', 'sei': '10.08'};CHEMBL1923122;;CHEMBL1923122;5.12;0;http://www.openphacts.org/units/Nanomolar;1562210;=;1;1;=;;Ki;nM;;7600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.6
;;7951908;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1ccnc2ccccc12)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.48', 'le': '0.18', 'lle': '0.22', 'sei': '7.82'};CHEMBL1923124;;CHEMBL1923124;4.26;0;http://www.openphacts.org/units/Nanomolar;1562212;=;1;1;=;;Ki;nM;;55000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;55.0
;;7951909;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C([C@H]1CNCC[C@@]12OCc1cc(F)c(F)cc12)N(Cc1cccc2cccnc12)C1CC1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '10.09', 'le': '0.19', 'lle': '0.50', 'sei': '8.33'};CHEMBL1923125;;CHEMBL1923125;4.54;0;http://www.openphacts.org/units/Nanomolar;1562213;=;1;1;=;;Ki;nM;;29000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;29.0
;;7951910;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C1O[C@@]2(CCNC[C@@H]2C(=O)N(Cc2cccc(C(F)(F)F)c2Cl)C2CC2)c2cc(F)c(F)cc21;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '9.49', 'le': '0.19', 'lle': '0.09', 'sei': '8.33'};CHEMBL1923126;;CHEMBL1923126;4.89;0;http://www.openphacts.org/units/Nanomolar;1562214;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;7951911;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CCCN2CCOCC2)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '7.34', 'le': '0.14', 'lle': '-0.35', 'sei': '7.33'};CHEMBL1923127;;CHEMBL1923127;4.64;0;http://www.openphacts.org/units/Nanomolar;1562215;=;1;1;=;;Ki;nM;;23000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;23.0
;;7951912;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCN(CC)CCCc1cc(CCCOC)cc(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1Cl;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '7.96', 'le': '0.16', 'lle': '-1.08', 'sei': '9.11'};CHEMBL1923128;;CHEMBL1923128;4.92;0;http://www.openphacts.org/units/Nanomolar;1562216;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.0
;;7951913;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CCCCNS(C)(=O)=O)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '7.77', 'le': '0.16', 'lle': '0.49', 'sei': '5.25'};CHEMBL1923129;;CHEMBL1923129;5.09;0;http://www.openphacts.org/units/Nanomolar;1562217;=;1;1;=;;Ki;nM;;8200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.2
;;7951914;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CCCNS(C)(=O)=O)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '7.28', 'le': '0.15', 'lle': '0.45', 'sei': '4.80'};CHEMBL1923130;;CHEMBL1923130;4.66;0;http://www.openphacts.org/units/Nanomolar;1562218;=;1;1;=;;Ki;nM;;22000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;22.0
;;7951915;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CCCN2CCS(=O)(=O)CC2)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '7.52', 'le': '0.15', 'lle': '0.72', 'sei': '5.80'};CHEMBL1923131;;CHEMBL1923131;5.11;0;http://www.openphacts.org/units/Nanomolar;1562219;=;1;1;=;;Ki;nM;;7700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.7
;;7951916;[];CHEMBL1924167;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COCCCc1cc(CCC(=O)N2CCOCC2)c(Cl)c(CN(C(=O)[C@H]2CNCC[C@@]23OCc2cc(F)c(F)cc23)C2CC2)c1;;;CHEMBL1921748;Bioorg Med Chem Lett;2011.0;{'bei': '6.70', 'le': '0.13', 'lle': '-0.18', 'sei': '5.39'};CHEMBL1923132;;CHEMBL1923132;4.33;0;http://www.openphacts.org/units/Nanomolar;1562220;=;1;1;=;;Ki;nM;;47000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;47.0
;;7982074;[];CHEMBL1938198;Displacement of [3H]dofetolide from human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCC[C@@H](c2nc3ccccc3n2Cc2ccc(F)cc2)C1;;;CHEMBL1932929;Bioorg Med Chem Lett;2012.0;{'bei': '16.72', 'le': '0.31', 'lle': '1.38', 'sei': '25.68'};CHEMBL1095819;;CHEMBL1095819;5.41;1;http://www.openphacts.org/units/Nanomolar;1569637;=;1;1;=;;Ki;nM;;3900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.9
;;7982075;[];CHEMBL1938198;Displacement of [3H]dofetolide from human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)C(=O)CN1CCCC(c2nc3ccccc3n2Cc2ccc(F)cc2)C1;;;CHEMBL1932929;Bioorg Med Chem Lett;2012.0;{'bei': '14.16', 'le': '0.26', 'lle': '2.10', 'sei': '13.50'};CHEMBL1935431;;CHEMBL1935431;5.58;0;http://www.openphacts.org/units/Nanomolar;1569638;=;1;1;=;;Ki;nM;;2600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.6
;;7982078;[];CHEMBL1938198;Displacement of [3H]dofetolide from human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCCC(c2nc3ccccc3n2CCOc2ccccc2)C1;;;CHEMBL1932929;Bioorg Med Chem Lett;2012.0;{'bei': '15.59', 'le': '0.29', 'lle': '1.31', 'sei': '17.26'};CHEMBL1094510;;CHEMBL1094510;5.23;0;http://www.openphacts.org/units/Nanomolar;1569641;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.9
;;8042589;[];CHEMBL1952450;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S1(=O)c2ccccc2-c2ccc(N3CCN4CCC3CC4)cc21;;;CHEMBL1949494;Bioorg Med Chem Lett;2012.0;{'bei': '18.59', 'le': '0.36', 'lle': '3.55', 'sei': '15.58'};CHEMBL1950167;;CHEMBL1950167;6.33;0;http://www.openphacts.org/units/Nanomolar;1577372;=;1;1;=;;Ki;nM;;470.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.47
;;8042590;[];CHEMBL1952450;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1CC2CN(c3ccc4oc5ccccc5c(=O)c4c3)CC2C1;;;CHEMBL1949494;Bioorg Med Chem Lett;2012.0;{'bei': '18.60', 'le': '0.34', 'lle': '3.02', 'sei': '16.24'};CHEMBL1950171;;CHEMBL1950171;5.96;0;http://www.openphacts.org/units/Nanomolar;1577376;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10834840;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ncnc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '17.97', 'le': '0.35', 'lle': '2.00', 'sei': '6.56'};CHEMBL2011947;;CHEMBL2011947;5.64;0;http://www.openphacts.org/units/Nanomolar;1632444;=;1;1;=;;Ki;nM;;2300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.3
;;10834841;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '20.36', 'le': '0.40', 'lle': '2.12', 'sei': '8.71'};CHEMBL2011950;;CHEMBL2011950;6.37;0;http://www.openphacts.org/units/Nanomolar;1632447;=;1;1;=;;Ki;nM;;430.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.43
;;10834842;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nccc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '20.77', 'le': '0.40', 'lle': '2.24', 'sei': '8.89'};CHEMBL2011952;;CHEMBL2011952;6.50;0;http://www.openphacts.org/units/Nanomolar;1632449;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;10834843;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1cncc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)c1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '21.80', 'le': '0.42', 'lle': '1.95', 'sei': '11.29'};CHEMBL2011946;;CHEMBL2011946;6.80;0;http://www.openphacts.org/units/Nanomolar;1632443;=;1;1;=;;Ki;nM;;160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.16
;;10834844;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)c1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '23.42', 'le': '0.45', 'lle': '2.45', 'sei': '12.13'};CHEMBL2012014;;CHEMBL2012014;7.30;0;http://www.openphacts.org/units/Nanomolar;1632524;=;1;1;=;;Ki;nM;;50.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.05
;;10834845;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1cncc(Nc2ccc(Oc3ccc(Cl)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '17.71', 'le': '0.34', 'lle': '1.29', 'sei': '7.58'};CHEMBL2012017;;CHEMBL2012017;5.54;0;http://www.openphacts.org/units/Nanomolar;1632527;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;10834846;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN(c1ccc(Cl)cc1)c1ccc(Nc2nccc(N)n2)cc1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '18.71', 'le': '0.36', 'lle': '1.88', 'sei': '9.09'};CHEMBL2012023;;CHEMBL2012023;6.10;0;http://www.openphacts.org/units/Nanomolar;1632533;=;1;1;=;;Ki;nM;;800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.8
;;10834847;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccccc3Cl)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '18.72', 'le': '0.36', 'lle': '1.60', 'sei': '8.01'};CHEMBL2012027;;CHEMBL2012027;5.85;0;http://www.openphacts.org/units/Nanomolar;1632537;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;10834848;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(F)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '19.31', 'le': '0.36', 'lle': '1.99', 'sei': '7.83'};CHEMBL2012028;;CHEMBL2012028;5.72;0;http://www.openphacts.org/units/Nanomolar;1632538;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.9
;;10834849;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(Oc2ccc(Nc3nccc(N)n3)cc2)cc1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '20.38', 'le': '0.37', 'lle': '2.06', 'sei': '8.16'};CHEMBL2012029;;CHEMBL2012029;5.96;0;http://www.openphacts.org/units/Nanomolar;1632539;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10834850;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(C4CC4)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '19.79', 'le': '0.36', 'lle': '1.83', 'sei': '8.62'};CHEMBL2012030;;CHEMBL2012030;6.30;0;http://www.openphacts.org/units/Nanomolar;1632540;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.5
;;10834851;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc(Oc2ccc(Nc3nccc(N)n3)cc2)cc1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '19.52', 'le': '0.35', 'lle': '2.45', 'sei': '6.11'};CHEMBL2012032;;CHEMBL2012032;5.92;0;http://www.openphacts.org/units/Nanomolar;1632542;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;10834852;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '17.46', 'le': '0.33', 'lle': '1.44', 'sei': '8.28'};CHEMBL2012037;;CHEMBL2012037;6.05;0;http://www.openphacts.org/units/Nanomolar;1632547;=;1;1;=;;Ki;nM;;900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.9
;;10834853;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccnc(Nc2ccc(Oc3ccc(OC(F)(F)F)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '19.32', 'le': '0.37', 'lle': '2.51', 'sei': '8.51'};CHEMBL2012038;;CHEMBL2012038;7.00;0;http://www.openphacts.org/units/Nanomolar;1632548;=;1;1;=;;Ki;nM;;100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.1
;;10834854;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1cncc(Nc2ccc(Oc3ccc(F)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '20.11', 'le': '0.37', 'lle': '2.23', 'sei': '8.16'};CHEMBL2012040;;CHEMBL2012040;5.96;0;http://www.openphacts.org/units/Nanomolar;1632550;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10834855;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(Oc2ccc(Nc3cncc(N)n3)cc2)cc1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '19.49', 'le': '0.35', 'lle': '1.80', 'sei': '7.80'};CHEMBL2012041;;CHEMBL2012041;5.70;0;http://www.openphacts.org/units/Nanomolar;1632551;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;10834856;[];CHEMBL2013363;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1cncc(Nc2ccc(Oc3ccc(C(F)(F)F)cc3)cc2)n1;;;CHEMBL2010700;Bioorg Med Chem Lett;2012.0;{'bei': '16.03', 'le': '0.30', 'lle': '0.94', 'sei': '7.60'};CHEMBL2012044;;CHEMBL2012044;5.55;0;http://www.openphacts.org/units/Nanomolar;1632554;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.8
;;10836707;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1c(C)n(Cc2ccccc2)c2ncnc(OC3CCN(Cc4cscn4)CC3)c12;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '12.92', 'le': '0.25', 'lle': '1.00', 'sei': '9.99'};CHEMBL2012178;;CHEMBL2012178;5.60;0;http://www.openphacts.org/units/Nanomolar;1632754;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.5
;;10836708;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cn(Cc2ccccc2)c2ncnc(OC3CCN(Cc4cscn4)CC3)c12;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.95', 'le': '0.27', 'lle': '1.56', 'sei': '10.44'};CHEMBL2012179;;CHEMBL2012179;5.85;0;http://www.openphacts.org/units/Nanomolar;1632755;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;10836709;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cn(Cc2ccccc2)c2ncnc(OC3CCN(Cc4cscn4)CC3)c12;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.23', 'le': '0.26', 'lle': '1.48', 'sei': '9.99'};CHEMBL2012180;;CHEMBL2012180;5.60;0;http://www.openphacts.org/units/Nanomolar;1632756;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.5
;;10836710;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1cn(Cc2ccccc2)c2ncnc(OC3CCN(Cc4cscn4)CC3)c12;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.24', 'le': '0.27', 'lle': '1.19', 'sei': '10.39'};CHEMBL2012181;;CHEMBL2012181;5.82;0;http://www.openphacts.org/units/Nanomolar;1632757;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5
;;10836711;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1nc(OC2CCN(Cc3cscn3)CC2)c2ccn(Cc3ccccc3)c2n1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '12.68', 'le': '0.25', 'lle': '1.00', 'sei': '10.71'};CHEMBL2012246;;CHEMBL2012246;6.00;0;http://www.openphacts.org/units/Nanomolar;1632829;=;1;1;=;;Ki;nM;;990.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.99
;;10836712;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccccc1Cn1ccc2c(OC3CCN(Cc4cscn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.75', 'le': '0.27', 'lle': '1.70', 'sei': '10.39'};CHEMBL2012259;;CHEMBL2012259;5.82;0;http://www.openphacts.org/units/Nanomolar;1632842;=;1;1;=;;Ki;nM;;1500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.5
;;10836713;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)c1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.07', 'le': '0.27', 'lle': '1.84', 'sei': '10.63'};CHEMBL2012260;;CHEMBL2012260;5.96;0;http://www.openphacts.org/units/Nanomolar;1632843;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10836714;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1cccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)c1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.46', 'le': '0.27', 'lle': '1.29', 'sei': '10.56'};CHEMBL2012263;;CHEMBL2012263;5.92;0;http://www.openphacts.org/units/Nanomolar;1632846;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;10836715;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccccc1Cn1ccc2c(OC3CCN(Cc4cscn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.10', 'le': '0.25', 'lle': '1.20', 'sei': '9.80'};CHEMBL2012265;;CHEMBL2012265;5.50;0;http://www.openphacts.org/units/Nanomolar;1632848;=;1;1;=;;Ki;nM;;3200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.2
;;10836716;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)c1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.38', 'le': '0.27', 'lle': '1.74', 'sei': '10.76'};CHEMBL2012266;;CHEMBL2012266;6.03;0;http://www.openphacts.org/units/Nanomolar;1632849;=;1;1;=;;Ki;nM;;930.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.93
;;10836717;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)cc1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.25', 'le': '0.25', 'lle': '1.27', 'sei': '9.92'};CHEMBL2012267;;CHEMBL2012267;5.56;0;http://www.openphacts.org/units/Nanomolar;1632850;=;1;1;=;;Ki;nM;;2750.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.75
;;10836718;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1ccccc1Cn1ccc2c(OC3CCN(Cc4cscn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '11.85', 'le': '0.23', 'lle': '0.61', 'sei': '10.00'};CHEMBL2012268;;CHEMBL2012268;5.61;0;http://www.openphacts.org/units/Nanomolar;1632851;=;1;1;=;;Ki;nM;;2460.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.46
;;10836719;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1cccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)c1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.14', 'le': '0.26', 'lle': '1.22', 'sei': '11.10'};CHEMBL2012269;;CHEMBL2012269;6.22;0;http://www.openphacts.org/units/Nanomolar;1632852;=;1;1;=;;Ki;nM;;600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.6
;;10836720;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)c1F;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '12.77', 'le': '0.25', 'lle': '1.38', 'sei': '10.06'};CHEMBL2012271;;CHEMBL2012271;5.64;0;http://www.openphacts.org/units/Nanomolar;1632854;=;1;1;=;;Ki;nM;;2300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.3
;;10836721;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1c(Cl)cccc1Cn1ccc2c(OC3CCN(Cc4cscn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.15', 'le': '0.27', 'lle': '1.25', 'sei': '10.74'};CHEMBL2012272;;CHEMBL2012272;6.02;0;http://www.openphacts.org/units/Nanomolar;1632855;=;1;1;=;;Ki;nM;;950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.95
;;10836722;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1c(Cn2ccc3c(OC4CCN(Cc5cscn5)CC4)ncnc32)cccc1C(F)(F)F;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.27', 'le': '0.26', 'lle': '1.38', 'sei': '11.63'};CHEMBL2012273;;CHEMBL2012273;6.52;0;http://www.openphacts.org/units/Nanomolar;1632856;=;1;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.3
;;10836723;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc(F)c1Cn1ccc2c(OC3CCN(Cc4cscn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '12.77', 'le': '0.25', 'lle': '1.38', 'sei': '10.06'};CHEMBL2012274;;CHEMBL2012274;5.64;0;http://www.openphacts.org/units/Nanomolar;1632857;=;1;1;=;;Ki;nM;;2300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.3
;;10836724;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)cc1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.86', 'le': '0.27', 'lle': '1.40', 'sei': '13.71'};CHEMBL2012277;;CHEMBL2012277;5.92;0;http://www.openphacts.org/units/Nanomolar;1632860;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;10836725;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)n1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.59', 'le': '0.25', 'lle': '1.39', 'sei': '10.02'};CHEMBL2012290;;CHEMBL2012290;5.62;0;http://www.openphacts.org/units/Nanomolar;1632873;=;1;1;=;;Ki;nM;;2400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.4
;;10836726;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)nc1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.53', 'le': '0.26', 'lle': '1.78', 'sei': '10.72'};CHEMBL2012291;;CHEMBL2012291;6.01;0;http://www.openphacts.org/units/Nanomolar;1632874;=;1;1;=;;Ki;nM;;980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.98
;;10836727;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccnc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)c1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.68', 'le': '0.25', 'lle': '1.43', 'sei': '10.09'};CHEMBL2012292;;CHEMBL2012292;5.66;0;http://www.openphacts.org/units/Nanomolar;1632875;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;10836728;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccnc1CN1CCC(Oc2ncnc3c2ccn3Cc2ccccc2)CC1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.84', 'le': '0.27', 'lle': '1.91', 'sei': '10.94'};CHEMBL2012293;;CHEMBL2012293;6.14;0;http://www.openphacts.org/units/Nanomolar;1632876;=;1;1;=;;Ki;nM;;730.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.73
;;10836729;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)n1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.26', 'le': '0.24', 'lle': '1.48', 'sei': '9.88'};CHEMBL2012294;;CHEMBL2012294;5.54;0;http://www.openphacts.org/units/Nanomolar;1632877;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;10836730;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(CN2CCC(Oc3ncnc4c3ccn4Cc3ccccc3)CC2)nc1;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '14.27', 'le': '0.26', 'lle': '1.90', 'sei': '10.63'};CHEMBL2012295;;CHEMBL2012295;5.96;0;http://www.openphacts.org/units/Nanomolar;1632878;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10836731;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccccc1Cn1ccc2c(OC3CCN(Cc4ccccn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.76', 'le': '0.25', 'lle': '1.68', 'sei': '10.25'};CHEMBL2012298;;CHEMBL2012298;5.75;0;http://www.openphacts.org/units/Nanomolar;1632881;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.8
;;10836732;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1cccc(Cn2ccc3c(OC4CCN(Cc5ccccn5)CC4)ncnc32)c1F;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.78', 'le': '0.26', 'lle': '1.80', 'sei': '10.70'};CHEMBL2012299;;CHEMBL2012299;6.00;0;http://www.openphacts.org/units/Nanomolar;1632882;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.0
;;10836733;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1c(Cl)cccc1Cn1ccc2c(OC3CCN(Cc4ccccn4)CC3)ncnc21;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.65', 'le': '0.26', 'lle': '1.46', 'sei': '11.00'};CHEMBL2012300;;CHEMBL2012300;6.17;0;http://www.openphacts.org/units/Nanomolar;1632883;=;1;1;=;;Ki;nM;;680.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.68
;;10836734;[];CHEMBL2013639;Displacement of dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1c(Cn2ccc3c(OC4CCN(Cc5ccccn5)CC4)ncnc32)cccc1C(F)(F)F;;;CHEMBL2010651;Bioorg Med Chem Lett;2012.0;{'bei': '13.38', 'le': '0.25', 'lle': '1.41', 'sei': '11.58'};CHEMBL2012301;;CHEMBL2012301;6.50;0;http://www.openphacts.org/units/Nanomolar;1632884;=;1;1;=;;Ki;nM;;320.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.32
;;10848360;[];CHEMBL2019592;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;NC(=O)CN1CCN(Cc2nc(-c3cn(CC4CCOCC4)c4c(Cl)cccc34)no2)CC1;;;CHEMBL2016544;Bioorg Med Chem Lett;2012.0;{'bei': '9.94', 'le': '0.19', 'lle': '2.33', 'sei': '4.58'};CHEMBL2017684;;CHEMBL2017684;4.70;0;http://www.openphacts.org/units/Nanomolar;1635288;=;1;1;=;;Ki;nM;;19952.62;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.7
;;10859013;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1ccc([C@H]2CNCC[C@@H]2c2ccc(F)c(F)c2)c(Cl)c1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '12.71', 'le': '0.25', 'lle': '0.14', 'sei': '14.49'};CHEMBL1957676;;CHEMBL1957676;5.96;0;http://www.openphacts.org/units/Nanomolar;1634445;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;10859014;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1cc(-c2ccc(F)cc2Br)no1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '12.73', 'le': '0.28', 'lle': '1.28', 'sei': '9.90'};CHEMBL2016935;;CHEMBL2016935;5.77;0;http://www.openphacts.org/units/Nanomolar;1634446;=;1;1;=;;Ki;nM;;1700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.7
;;10859015;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1cc(-c2c(Cl)cccc2Cl)no1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '13.06', 'le': '0.27', 'lle': '0.66', 'sei': '9.53'};CHEMBL2016936;;CHEMBL2016936;5.55;0;http://www.openphacts.org/units/Nanomolar;1634447;=;1;1;=;;Ki;nM;;2800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.8
;;10859016;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1cc(-c2ccc(F)cc2Cl)no1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '13.38', 'le': '0.27', 'lle': '1.09', 'sei': '9.38'};CHEMBL2016937;;CHEMBL2016937;5.47;0;http://www.openphacts.org/units/Nanomolar;1634448;=;1;1;=;;Ki;nM;;3400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.4
;;10859017;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1onc(-c2ccccc2Cl)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '11.09', 'le': '0.25', 'lle': '0.21', 'sei': '8.93'};CHEMBL2016938;;CHEMBL2016938;5.21;0;http://www.openphacts.org/units/Nanomolar;1634449;=;1;1;=;;Ki;nM;;6200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.2
;;10859018;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccc(-c2noc([C@H]3CNCC[C@]3(O)c3ccc(F)c(F)c3)c2Br)c1C;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '11.27', 'le': '0.25', 'lle': '0.26', 'sei': '8.96'};CHEMBL2017098;;CHEMBL2017098;5.22;0;http://www.openphacts.org/units/Nanomolar;1634625;=;1;1;=;;Ki;nM;;6000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.0
;;10859019;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1onc(-c2c(Cl)cccc2Cl)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '10.73', 'le': '0.25', 'lle': '-0.24', 'sei': '9.28'};CHEMBL2017099;;CHEMBL2017099;5.41;0;http://www.openphacts.org/units/Nanomolar;1634626;=;1;1;=;;Ki;nM;;3900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.9
;;10859020;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1onc(-c2cccc3ccccc23)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '11.08', 'le': '0.24', 'lle': '-0.12', 'sei': '9.22'};CHEMBL2017100;;CHEMBL2017100;5.38;0;http://www.openphacts.org/units/Nanomolar;1634627;=;1;1;=;;Ki;nM;;4200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.2
;;10859021;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1noc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '9.57', 'le': '0.21', 'lle': '0.95', 'sei': '5.70'};CHEMBL2017101;;CHEMBL2017101;4.98;0;http://www.openphacts.org/units/Nanomolar;1634628;=;1;1;=;;Ki;nM;;10500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.5
;;10859022;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '9.55', 'le': '0.21', 'lle': '0.94', 'sei': '5.69'};CHEMBL2017102;;CHEMBL2017102;4.97;0;http://www.openphacts.org/units/Nanomolar;1634629;=;1;1;=;;Ki;nM;;10700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.7
;;10859023;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1cc(-c2c(Cl)cccc2Cl)on1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '11.78', 'le': '0.24', 'lle': '0.12', 'sei': '8.59'};CHEMBL2017103;;CHEMBL2017103;5.01;0;http://www.openphacts.org/units/Nanomolar;1634630;=;1;1;=;;Ki;nM;;9800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.8
;;10859024;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1cc(F)ccc1-c1onc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '8.62', 'le': '0.19', 'lle': '0.48', 'sei': '5.31'};CHEMBL2017104;;CHEMBL2017104;4.64;0;http://www.openphacts.org/units/Nanomolar;1634631;=;1;1;=;;Ki;nM;;23000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;23.0
;;10859025;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1cc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)no1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '12.42', 'le': '0.23', 'lle': '2.22', 'sei': '6.27'};CHEMBL2017105;;CHEMBL2017105;5.48;0;http://www.openphacts.org/units/Nanomolar;1634632;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.3
;;10859026;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1Cl;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '10.12', 'le': '0.20', 'lle': '0.90', 'sei': '5.51'};CHEMBL2017106;;CHEMBL2017106;4.82;0;http://www.openphacts.org/units/Nanomolar;1634633;=;1;1;=;;Ki;nM;;15300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;15.3
;;10859027;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1C(C)=O;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '10.06', 'le': '0.19', 'lle': '1.39', 'sei': '4.66'};CHEMBL2017107;;CHEMBL2017107;4.86;0;http://www.openphacts.org/units/Nanomolar;1634634;=;1;1;=;;Ki;nM;;13700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.7
;;10859028;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@]2(O)c2ccc(F)c(F)c2)c1C(C)O;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '9.21', 'le': '0.17', 'lle': '1.15', 'sei': '4.16'};CHEMBL2017108;;CHEMBL2017108;4.47;0;http://www.openphacts.org/units/Nanomolar;1634635;=;1;1;=;;Ki;nM;;33600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;33.6
;;10859029;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@@H]2c2ccc(F)c(F)c2)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '9.34', 'le': '0.20', 'lle': '-0.21', 'sei': '7.01'};CHEMBL2017109;;CHEMBL2017109;4.71;0;http://www.openphacts.org/units/Nanomolar;1634636;=;1;1;=;;Ki;nM;;19500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.5
;;10859030;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CO[C@]1(c2ccc(F)c(F)c2)CCNC[C@@H]1c1noc(-c2ccccc2CCNC(C)=O)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '8.75', 'le': '0.19', 'lle': '-0.01', 'sei': '6.12'};CHEMBL2017110;;CHEMBL2017110;4.67;0;http://www.openphacts.org/units/Nanomolar;1634637;=;1;1;=;;Ki;nM;;21200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;21.2
;;10859031;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CC(=O)NCCc1ccccc1-c1onc([C@H]2CNCC[C@]2(C(N)=O)c2ccc(F)c(F)c2)c1Br;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '8.26', 'le': '0.18', 'lle': '0.96', 'sei': '4.10'};CHEMBL2017111;;CHEMBL2017111;4.52;0;http://www.openphacts.org/units/Nanomolar;1634638;=;1;1;=;;Ki;nM;;30000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;30.0
;;10859725;[];CHEMBL2020695;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;COC[C@H](C)COCc1ccc([C@@]2(O)CCNC[C@@H]2c2noc(-c3ccccc3CCNC(C)=O)c2Br)cc1;;;CHEMBL2016495;Bioorg Med Chem Lett;2012.0;{'bei': '7.50', 'le': '0.16', 'lle': '-0.04', 'sei': '4.26'};CHEMBL2017113;;CHEMBL2017113;4.51;0;http://www.openphacts.org/units/Nanomolar;1634640;=;1;1;=;;Ki;nM;;31200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;31.2
;;10883913;[];CHEMBL2032908;Binding affinity to human Erg;B;;;BAO_0000192;BAO_0000357;single protein format;CCOC(=O)C1CCCN(C(=N)c2ccc(C(=O)Nc3ccc(Cl)cc3C(=O)Nc3ccc(Cl)cn3)cc2)C1;;;CHEMBL2029200;Bioorg Med Chem Lett;2012.0;{'bei': '13.71', 'le': '0.27', 'lle': '2.31', 'sei': '6.26'};CHEMBL218735;;CHEMBL218735;7.80;1;http://www.openphacts.org/units/Nanomolar;1644233;=;1;1;=;;Ki;nM;;16.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.016
;;10915078;[];CHEMBL2037899;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN1C[C@@H]2CN(c3ccc(-c4ccc5[nH]ccc5c4)nc3)C[C@@H]21;;;CHEMBL2034921;Bioorg Med Chem;2012.0;{'bei': '18.80', 'le': '0.34', 'lle': '2.74', 'sei': '16.27'};CHEMBL2036415;;CHEMBL2036415;5.72;0;http://www.openphacts.org/units/Nanomolar;1646394;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.9
;;12033517;[];CHEMBL875187;Binding affinity against human IKr channel;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1cccc(F)c1)C1(F)CCN(CCc2ccc(F)cc2F)CC1;;;CHEMBL1142766;Bioorg Med Chem Lett;2005.0;{'bei': '14.49', 'le': '0.29', 'lle': '1.94', 'sei': '15.56'};CHEMBL177401;;CHEMBL177401;5.82;0;http://www.openphacts.org/units/Nanomolar;360533;=;1;1;=;;Ki;nM;;1525.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1525.0
;;12141919;[];CHEMBL2185328;Displacement of [3H]astemizole from human ERG by microbeta scintillation counting;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1;;;CHEMBL2176989;J Med Chem;2012.0;{'bei': '13.61', 'le': '0.28', 'lle': '1.75', 'sei': '9.59'};CHEMBL2179217;;CHEMBL2179217;6.10;0;http://www.openphacts.org/units/Nanomolar;1752246;=;1;1;=;;Ki;nM;;800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;800.0
;;12141920;[];CHEMBL2185328;Displacement of [3H]astemizole from human ERG by microbeta scintillation counting;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(S(=O)(=O)n2cc(C)c3cc(F)ccc32)cc1NC1CCN(C)CC1;;;CHEMBL2176989;J Med Chem;2012.0;{'bei': '13.96', 'le': '0.27', 'lle': '2.18', 'sei': '9.47'};CHEMBL2179216;;CHEMBL2179216;6.02;0;http://www.openphacts.org/units/Nanomolar;1752245;=;1;1;=;;Ki;nM;;950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;950.0
;;12172894;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc(C2(c3noc(C)n3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '11.79', 'le': '0.22', 'lle': '1.59', 'sei': '4.36'};CHEMBL2204940;;CHEMBL2204940;5.85;0;http://www.openphacts.org/units/Nanomolar;1757820;=;1;1;=;;Ki;nM;;1403.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1403.0
;;12172895;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1cc(C2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)cn1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '11.33', 'le': '0.21', 'lle': '1.24', 'sei': '6.06'};CHEMBL2204939;;CHEMBL2204939;5.58;0;http://www.openphacts.org/units/Nanomolar;1757819;=;1;1;=;;Ki;nM;;2616.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2616.0
;;12172896;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc([C@]2(c3cnn(C)c3)N[C@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '12.67', 'le': '0.23', 'lle': '1.97', 'sei': '5.53'};CHEMBL2204938;;CHEMBL2204938;6.26;0;http://www.openphacts.org/units/Nanomolar;1757818;=;1;1;=;;Ki;nM;;543.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;543.0
;;12172897;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc([C@@]2(c3cnn(C)c3)N[C@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '12.81', 'le': '0.23', 'lle': '2.04', 'sei': '5.59'};CHEMBL2204937;;CHEMBL2204937;6.33;0;http://www.openphacts.org/units/Nanomolar;1757817;=;1;1;=;;Ki;nM;;462.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;462.0
;;12172898;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc([C@@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '11.70', 'le': '0.21', 'lle': '1.49', 'sei': '5.11'};CHEMBL2204936;;CHEMBL2204936;5.79;0;http://www.openphacts.org/units/Nanomolar;1757816;=;1;1;=;;Ki;nM;;1638.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1638.0
;;12172899;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc([C@]2(c3cnn(C)c3)N[C@@H](c3nc(-c4ccc(F)cc4)c[nH]3)Cc3c2[nH]c2ccccc32)no1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '11.67', 'le': '0.21', 'lle': '1.47', 'sei': '5.09'};CHEMBL2204935;;CHEMBL2204935;5.77;0;http://www.openphacts.org/units/Nanomolar;1757815;=;1;1;=;;Ki;nM;;1701.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1701.0
;;12172900;[];CHEMBL2210522;Displacement of radiolabeled MK-499 from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(c4ccccc4)(c4ccccc4)N3)n2)cc1;;;CHEMBL2203114;ACS Med Chem Lett;2012.0;{'bei': '15.18', 'le': '0.27', 'lle': '0.48', 'sei': '13.02'};CHEMBL2204934;;CHEMBL2204934;7.36;0;http://www.openphacts.org/units/Nanomolar;1757814;=;1;1;=;;Ki;nM;;44.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;44.0
;;12187729;[];CHEMBL2208509;Displacement of [3H]dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1;;;CHEMBL2203010;Chem Biol Drug Des;2006.0;{'bei': '15.61', 'le': '0.29', 'lle': '2.58', 'sei': '12.42'};CHEMBL2203612;;CHEMBL2203612;7.38;0;http://www.openphacts.org/units/Nanomolar;1756097;=;1;1;=;;Ki;nM;;42.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;42.0
;;13287670;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNC1CN(c2nc(N)nc3cc(C(C)C)cnc23)C1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '17.95', 'le': '0.33', 'lle': '3.75', 'sei': '6.12'};CHEMBL2376805;;CHEMBL2376805;4.89;0;http://www.openphacts.org/units/Nanomolar;1891393;=;1;1;=;;Ki;nM;;12882.5;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.89
;;13287674;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1cnc2c(N3CC[C@@H](NC)C3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '16.01', 'le': '0.30', 'lle': '3.39', 'sei': '5.45'};CHEMBL2376801;;CHEMBL2376801;4.36;0;http://www.openphacts.org/units/Nanomolar;1891389;=;1;1;=;;Ki;nM;;43651.58;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.36
;;13287675;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1cnc2c(N3CC(NC)C3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '17.26', 'le': '0.32', 'lle': '3.88', 'sei': '5.58'};CHEMBL2376800;;CHEMBL2376800;4.46;0;http://www.openphacts.org/units/Nanomolar;1891388;=;1;1;=;;Ki;nM;;34673.69;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.46
;;13287676;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1cnc2c(N3CCN(C)CC3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '16.78', 'le': '0.31', 'lle': '3.65', 'sei': '6.42'};CHEMBL2376799;;CHEMBL2376799;4.57;0;http://www.openphacts.org/units/Nanomolar;1891387;=;1;1;=;;Ki;nM;;26915.35;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;4.57
;;13287677;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CN[C@@H]1CCN(c2cc(NCC3CC3)nc(N)n2)C1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '20.81', 'le': '0.39', 'lle': '4.78', 'sei': '6.90'};CHEMBL1915540;ADRIFORANT;CHEMBL1915540;5.46;0;http://www.openphacts.org/units/Nanomolar;1891386;=;1;1;=;;Ki;nM;;3467.37;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.46
;;13287679;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1ccc2c(N3CC[C@@H](NC)C3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '20.49', 'le': '0.38', 'lle': '3.99', 'sei': '8.29'};CHEMBL2376797;;CHEMBL2376797;5.56;0;http://www.openphacts.org/units/Nanomolar;1891384;=;1;1;=;;Ki;nM;;2754.23;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.56
;;13287680;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1ccc2c(N3CC(NC)C3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '21.80', 'le': '0.40', 'lle': '4.43', 'sei': '8.36'};CHEMBL2376796;;CHEMBL2376796;5.61;0;http://www.openphacts.org/units/Nanomolar;1891383;=;1;1;=;;Ki;nM;;2454.71;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.61
;;13287681;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CCc1ccc2c(N3CCNCC3)nc(N)nc2c1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '22.62', 'le': '0.42', 'lle': '4.64', 'sei': '8.68'};CHEMBL2376795;;CHEMBL2376795;5.82;0;http://www.openphacts.org/units/Nanomolar;1891382;=;1;1;=;;Ki;nM;;1513.56;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.82
;;13287682;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNC1CN(c2nc(N)nc3cc(C4CC4)ccc23)C1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '20.20', 'le': '0.37', 'lle': '3.94', 'sei': '8.11'};CHEMBL2376794;;CHEMBL2376794;5.44;0;http://www.openphacts.org/units/Nanomolar;1891381;=;1;1;=;;Ki;nM;;3630.78;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.44
;;13287683;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nc(N2CCNCC2)c2ccc(C3CC3)cc2n1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '19.79', 'le': '0.36', 'lle': '3.83', 'sei': '7.95'};CHEMBL2376793;;CHEMBL2376793;5.33;0;http://www.openphacts.org/units/Nanomolar;1891380;=;1;1;=;;Ki;nM;;4677.35;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.33
;;13287686;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CNC1CN(c2nc(N)nc3cc(C4CCCC4)ccc23)C1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '20.44', 'le': '0.38', 'lle': '3.80', 'sei': '9.07'};CHEMBL2376790;;CHEMBL2376790;6.08;0;http://www.openphacts.org/units/Nanomolar;1891377;=;1;1;=;;Ki;nM;;831.76;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.08
;;13287687;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nc(N2CCNCC2)c2ccc(C3CCCC3)cc2n1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '18.39', 'le': '0.34', 'lle': '3.19', 'sei': '8.16'};CHEMBL2376789;;CHEMBL2376789;5.47;0;http://www.openphacts.org/units/Nanomolar;1891376;=;1;1;=;;Ki;nM;;3388.44;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.47
;;13287688;[];CHEMBL2379703;Displacement of [3H]astemizole from human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1nc(N2CCNCC2)c2ccc(-c3ccco3)cc2n1;;;CHEMBL2375287;Bioorg Med Chem Lett;2013.0;{'bei': '18.59', 'le': '0.34', 'lle': '3.61', 'sei': '6.84'};CHEMBL1935574;;CHEMBL1935574;5.49;0;http://www.openphacts.org/units/Nanomolar;1891375;=;1;1;=;;Ki;nM;;3235.94;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.49
;;13294560;[];CHEMBL2378543;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O[C@H]1CC[C@H](c2ccc(OCCCN3CCCCC3)cc2)CC1;;;CHEMBL2375312;Bioorg Med Chem Lett;2013.0;{'bei': '16.49', 'le': '0.31', 'lle': '1.28', 'sei': '16.01'};CHEMBL2375587;;CHEMBL2375587;5.24;0;http://www.openphacts.org/units/Nanomolar;1889698;=;1;1;=;;Ki;nM;;5800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.8
;;13340293;[];CHEMBL2395084;Displacement of [3H]Astemizole from human recombinant ERG expressed in HEK293 cells at after 60 mins;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1;;;CHEMBL2390918;Bioorg Med Chem Lett;2013.0;{'bei': '18.92', 'le': '0.35', 'lle': '3.33', 'sei': '20.51'};CHEMBL296419;ASTEMIZOLE;CHEMBL296419;8.68;0;http://www.openphacts.org/units/Nanomolar;1899922;=;1;1;=;;Ki;nM;;2.1;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2.1
;;13410296;[];CHEMBL2415345;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N[C@@H]1CC[C@H]2CN(Cc3cccc(C(F)(F)F)c3)C[C@H]21)C(C1CCCCC1)C1CCCCC1;;;CHEMBL2412957;Bioorg Med Chem Lett;2013.0;{'bei': '10.23', 'le': '0.20', 'lle': '-1.79', 'sei': '15.53'};CHEMBL2414773;;CHEMBL2414773;5.02;0;http://www.openphacts.org/units/Nanomolar;1912750;=;1;1;=;;Ki;nM;;9520.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.52
;;13410362;[];CHEMBL2415345;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N[C@H]1CC[C@H]2CN(Cc3cccc(C(F)(F)F)c3)C[C@H]21)C(C1CCCCC1)C1CCCCC1;;;CHEMBL2412957;Bioorg Med Chem Lett;2013.0;{'bei': '12.56', 'le': '0.24', 'lle': '-0.65', 'sei': '19.05'};CHEMBL2047726;;CHEMBL2047726;6.16;0;http://www.openphacts.org/units/Nanomolar;1912749;=;1;1;=;;Ki;nM;;690.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.69
;;13850939;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCCN(CC)C/C=C/Cc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '26.05', 'le': '0.52', 'lle': '2.29', 'sei': '247.60'};CHEMBL3093986;;CHEMBL3093986;8.02;0;http://www.openphacts.org/units/Nanomolar;1954177;=;1;1;=;;Ki;nM;;9.5;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;9.5
;;13850941;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCCN(CC)CCCCc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '26.07', 'le': '0.53', 'lle': '2.12', 'sei': '249.41'};CHEMBL3093959;;CHEMBL3093959;8.08;0;http://www.openphacts.org/units/Nanomolar;1954149;=;1;1;=;;Ki;nM;;8.3;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8.3
;;13850942;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1.Cc1ccc(S(=O)(=O)[O-])cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '27.72', 'le': '0.56', 'lle': '2.91', 'sei': None};CHEMBL598270;;CHEMBL9484;9.40;0;http://www.openphacts.org/units/Nanomolar;1954154;=;1;1;=;;Ki;nM;;0.4;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;0.4
;;13850943;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCCN(CC)CC#CCc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '22.16', 'le': '0.44', 'lle': '1.60', 'sei': '209.18'};CHEMBL3093969;;CHEMBL3093969;6.78;0;http://www.openphacts.org/units/Nanomolar;1954160;=;1;1;=;;Ki;nM;;167.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;167.0
;;13850944;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCCN(CC)CC#CCCc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '21.35', 'le': '0.42', 'lle': '1.26', 'sei': '210.79'};CHEMBL3093976;;CHEMBL3093976;6.83;0;http://www.openphacts.org/units/Nanomolar;1954167;=;1;1;=;;Ki;nM;;148.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;148.0
;;13850945;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCN(CC)CC#CC#Cc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '20.88', 'le': '0.41', 'lle': '1.90', 'sei': '176.43'};CHEMBL3093979;;CHEMBL3093979;5.72;0;http://www.openphacts.org/units/Nanomolar;1954170;=;1;1;=;;Ki;nM;;1921.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1921.0
;;13850946;[];CHEMBL3096732;Displacement of [3H]astemizole from human ERG channel expressed in HEK293 cell membrane after 1 hr by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCCCCN(CC)CC#CCOc1ccc(Cl)cc1;;;CHEMBL3091311;J Med Chem;2013.0;{'bei': '19.64', 'le': '0.39', 'lle': '1.31', 'sei': '50.69'};CHEMBL3093982;;CHEMBL3093982;6.32;0;http://www.openphacts.org/units/Nanomolar;1954173;=;1;1;=;;Ki;nM;;478.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;478.0
;;13860054;[];CHEMBL3100173;Inhibition of human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;O[C@@H](c1cc(C(F)(F)F)nc2c(C(F)(F)F)cccc12)[C@H]1CCCCN1;;;CHEMBL3098117;ACS Med Chem Lett;2013.0;{'bei': '15.12', 'le': '0.30', 'lle': '1.27', 'sei': '12.67'};CHEMBL172;(S,R)-MEFLOQUINE;CHEMBL172;5.72;0;http://www.openphacts.org/units/Nanomolar;1956499;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.9
;;13860055;[];CHEMBL3100173;Inhibition of human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c2cc(C(F)(F)F)ccc12;;;CHEMBL3098117;ACS Med Chem Lett;2013.0;{'bei': '10.24', 'le': '0.21', 'lle': '-3.52', 'sei': '21.84'};CHEMBL1107;HALOFANTRINE;CHEMBL1107;5.12;0;http://www.openphacts.org/units/Nanomolar;1956498;=;1;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.5
;;13860058;[];CHEMBL3100173;Inhibition of human ERG expressed in CHO cells;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12;;;CHEMBL3098117;ACS Med Chem Lett;2013.0;{'bei': '16.02', 'le': '0.32', 'lle': '0.31', 'sei': '18.20'};CHEMBL76;CHLOROQUINE;CHEMBL76;5.12;0;http://www.openphacts.org/units/Nanomolar;1956037;=;1;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.5
;;14721757;[];CHEMBL3293609;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1csc(-c2ccc(N)c(NC(=O)c3ccc(N4CCC5(CC4)CNC(=O)O5)nc3)c2)c1;;;CHEMBL3286368;ACS Med Chem Lett;2014.0;{'bei': '12.29', 'le': '0.24', 'lle': '1.67', 'sei': '5.20'};CHEMBL3286734;;CHEMBL3286734;5.70;0;http://www.openphacts.org/units/Nanomolar;2113862;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;14721758;[];CHEMBL3293609;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccc(-c2ccccc2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC(=O)O3)nc1;;;CHEMBL3286368;ACS Med Chem Lett;2014.0;{'bei': '12.33', 'le': '0.23', 'lle': '1.81', 'sei': '4.99'};CHEMBL3286735;;CHEMBL3286735;5.47;0;http://www.openphacts.org/units/Nanomolar;2113863;=;1;1;=;;Ki;nM;;3400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.4
;;14721759;[];CHEMBL3293609;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Nc1ccc(-c2ccc(F)cc2)cc1NC(=O)c1ccc(N2CCC3(CC2)CNC(=O)O3)nc1;;;CHEMBL3286368;ACS Med Chem Lett;2014.0;{'bei': '13.45', 'le': '0.25', 'lle': '2.41', 'sei': '5.66'};CHEMBL3286736;;CHEMBL3286736;6.21;0;http://www.openphacts.org/units/Nanomolar;2113864;=;1;1;=;;Ki;nM;;620.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.62
;;14740142;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CS(=O)(=O)c1ccc(-c2nn(-c3ccc(F)cc3)cc2Sc2ccc(Cl)cc2)cc1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '13.50', 'le': '0.28', 'lle': '0.31', 'sei': '11.92'};CHEMBL3287928;;CHEMBL3287928;6.20;0;http://www.openphacts.org/units/Nanomolar;2115365;=;1;1;=;;Ki;nM;;637.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;637.0
;;14740143;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(O)c1cnc(-c2nn(-c3ccc(F)cc3)cc2Sc2ccc(Cl)cc2)cn1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '13.90', 'le': '0.28', 'lle': '0.63', 'sei': '9.60'};CHEMBL3287930;;CHEMBL3287930;6.13;0;http://www.openphacts.org/units/Nanomolar;2115367;=;1;1;=;;Ki;nM;;740.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;740.0
;;14740145;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(O)c1ccc(-c2nc(-c3ccc(F)cc3)oc2Sc2ccc(Cl)cn2)cn1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '13.35', 'le': '0.27', 'lle': '-0.07', 'sei': '8.19'};CHEMBL1812717;;CHEMBL1812717;5.90;0;http://www.openphacts.org/units/Nanomolar;2115370;=;1;1;=;;Ki;nM;;1254.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1254.0
;;14740146;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1ccc(Sc2c[nH]nc2-c2ccc3c(c2)OCCO3)cc1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '16.86', 'le': '0.35', 'lle': '1.16', 'sei': '12.33'};CHEMBL3287926;;CHEMBL3287926;5.81;0;http://www.openphacts.org/units/Nanomolar;2115363;=;1;1;=;;Ki;nM;;1538.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1538.0
;;14740147;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CS(=O)(=O)c1ccc(-c2nc(-c3ccc(F)cc3)oc2Sc2ccc(Cl)cn2)cc1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '12.15', 'le': '0.26', 'lle': '-0.15', 'sei': '7.67'};CHEMBL3287932;;CHEMBL3287932;5.60;0;http://www.openphacts.org/units/Nanomolar;2115369;=;1;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2500.0
;;14740148;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1ccc(Sc2cn(-c3cccnc3)nc2-c2ccc(-c3ncon3)cc2)cc1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '12.23', 'le': '0.24', 'lle': '-0.51', 'sei': '7.59'};CHEMBL3287929;;CHEMBL3287929;5.28;0;http://www.openphacts.org/units/Nanomolar;2115366;=;1;1;=;;Ki;nM;;5214.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5214.0
;;14740152;[];CHEMBL3295963;Displacement of [35S]MK-499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CS(=O)(=O)c1ccc(-c2nc(-c3ccccc3)oc2Sc2ccc(Cl)cc2)cc1;;;CHEMBL3286267;ACS Med Chem Lett;2014.0;{'bei': '10.28', 'le': '0.21', 'lle': '-1.68', 'sei': '7.55'};CHEMBL3287931;;CHEMBL3287931;4.54;0;http://www.openphacts.org/units/Nanomolar;2115368;=;1;1;=;;Ki;nM;;28540.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;28540.0
;;15069479;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '14.25', 'le': '0.26', 'lle': '1.87', 'sei': '6.24'};CHEMBL2177343;;CHEMBL2177343;5.74;0;http://www.openphacts.org/units/Nanomolar;2247712;=;1;1;=;;Ki;nM;;1840.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.84
;;15069480;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '14.84', 'le': '0.27', 'lle': '1.92', 'sei': '6.73'};CHEMBL3354688;;CHEMBL3354688;6.18;0;http://www.openphacts.org/units/Nanomolar;2247713;=;1;1;=;;Ki;nM;;660.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.66
;;15069481;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)C#Cc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '16.62', 'le': '0.30', 'lle': '2.58', 'sei': '8.26'};CHEMBL3354689;;CHEMBL3354689;6.82;0;http://www.openphacts.org/units/Nanomolar;2247714;=;1;1;=;;Ki;nM;;150.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.15
;;15069482;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)CCc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '15.41', 'le': '0.28', 'lle': '1.57', 'sei': '7.73'};CHEMBL3354690;;CHEMBL3354690;6.39;0;http://www.openphacts.org/units/Nanomolar;2247715;=;1;1;=;;Ki;nM;;410.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.41
;;15069483;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(O)C#Cc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '11.77', 'le': '0.21', 'lle': '1.89', 'sei': '4.72'};CHEMBL3354691;;CHEMBL3354691;4.85;0;http://www.openphacts.org/units/Nanomolar;2247716;=;1;1;=;;Ki;nM;;14000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;14.0
;;15069484;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(C)(C)C#Cc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '13.71', 'le': '0.25', 'lle': '2.24', 'sei': '6.37'};CHEMBL3354692;;CHEMBL3354692;5.85;0;http://www.openphacts.org/units/Nanomolar;2247717;=;1;1;=;;Ki;nM;;1420.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.42
;;15069485;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@]2(CO1)c1cc(C3=CCOCC3)ccc1Oc1ccc(-c3cncnc3)cc12;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '12.05', 'le': '0.22', 'lle': '1.33', 'sei': '5.41'};CHEMBL3354693;;CHEMBL3354693;4.97;0;http://www.openphacts.org/units/Nanomolar;2247718;=;1;1;=;;Ki;nM;;10700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.7
;;15069488;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@]2(CO1)c1cc(OCC3CCCCC3)ccc1Oc1ccc(-c3cncnc3)cc12;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '15.92', 'le': '0.29', 'lle': '2.25', 'sei': '7.67'};CHEMBL3354696;;CHEMBL3354696;7.05;0;http://www.openphacts.org/units/Nanomolar;2247721;=;1;1;=;;Ki;nM;;90.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.09
;;15069491;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(F)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '12.61', 'le': '0.23', 'lle': '1.34', 'sei': '5.77'};CHEMBL3354699;;CHEMBL3354699;5.30;0;http://www.openphacts.org/units/Nanomolar;2247724;=;1;1;=;;Ki;nM;;4980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.98
;;15069492;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C#N)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '11.54', 'le': '0.21', 'lle': '1.16', 'sei': '4.26'};CHEMBL3354700;;CHEMBL3354700;4.93;0;http://www.openphacts.org/units/Nanomolar;2247725;=;1;1;=;;Ki;nM;;11700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.7
;;15069494;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3ccccn3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '15.17', 'le': '0.28', 'lle': '1.43', 'sei': '7.98'};CHEMBL3354702;;CHEMBL3354702;6.30;0;http://www.openphacts.org/units/Nanomolar;2247727;=;1;1;=;;Ki;nM;;496.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.496
;;15069495;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3ccncc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '14.93', 'le': '0.27', 'lle': '1.33', 'sei': '7.86'};CHEMBL3354703;;CHEMBL3354703;6.21;0;http://www.openphacts.org/units/Nanomolar;2247728;=;1;1;=;;Ki;nM;;624.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.624
;;15069496;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cccnc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '14.68', 'le': '0.27', 'lle': '1.23', 'sei': '7.72'};CHEMBL3354704;;CHEMBL3354704;6.10;0;http://www.openphacts.org/units/Nanomolar;2247729;=;1;1;=;;Ki;nM;;797.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.797
;;15069497;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3ccc(F)nc3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '15.19', 'le': '0.28', 'lle': '1.58', 'sei': '8.34'};CHEMBL3354705;;CHEMBL3354705;6.59;0;http://www.openphacts.org/units/Nanomolar;2247730;=;1;1;=;;Ki;nM;;259.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.259
;;15069498;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncc(C#N)c3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '15.52', 'le': '0.28', 'lle': '2.10', 'sei': '6.66'};CHEMBL3354706;;CHEMBL3354706;6.84;0;http://www.openphacts.org/units/Nanomolar;2247731;=;1;1;=;;Ki;nM;;145.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.145
;;15069499;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncc(F)c3)ccc1O2;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '14.82', 'le': '0.27', 'lle': '1.41', 'sei': '8.14'};CHEMBL3354707;;CHEMBL3354707;6.42;0;http://www.openphacts.org/units/Nanomolar;2247732;=;1;1;=;;Ki;nM;;377.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.377
;;15069505;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c(F)cc(C3=CCOCC3)cc12;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '12.26', 'le': '0.23', 'lle': '0.96', 'sei': '6.95'};CHEMBL3354718;;CHEMBL3354718;5.48;0;http://www.openphacts.org/units/Nanomolar;2247743;=;1;1;=;;Ki;nM;;3280.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.28
;;15069509;[];CHEMBL3372246;Inhibition of human ERG expressing HEK293 cells by [3H]dofetilide binding assay;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c(F)cc(-c3ccccn3)cc12;;;CHEMBL3351923;J Med Chem;2014.0;{'bei': '12.56', 'le': '0.23', 'lle': '0.78', 'sei': '6.73'};CHEMBL3355143;;CHEMBL3355143;5.56;0;http://www.openphacts.org/units/Nanomolar;2249704;=;1;1;=;;Ki;nM;;2770.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.77
;;15088192;[];CHEMBL3386699;Displacement of radiolabeled MK499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL3351398;ACS Med Chem Lett;2014.0;{'bei': '11.31', 'le': '0.21', 'lle': '0.57', 'sei': '5.43'};CHEMBL3342770;;CHEMBL3342770;4.96;0;http://www.openphacts.org/units/Nanomolar;2264587;=;1;1;=;;Ki;nM;;11000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.0
;;15088194;[];CHEMBL3386699;Displacement of radiolabeled MK499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL3351398;ACS Med Chem Lett;2014.0;{'bei': '10.60', 'le': '0.21', 'lle': '-0.09', 'sei': '5.28'};CHEMBL3342772;;CHEMBL3342772;4.82;0;http://www.openphacts.org/units/Nanomolar;2264589;=;1;1;=;;Ki;nM;;15000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;15.0
;;15088195;[];CHEMBL3386699;Displacement of radiolabeled MK499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL3351398;ACS Med Chem Lett;2014.0;{'bei': '11.86', 'le': '0.23', 'lle': '0.49', 'sei': '5.91'};CHEMBL3342773;;CHEMBL3342773;5.40;0;http://www.openphacts.org/units/Nanomolar;2264590;=;1;1;=;;Ki;nM;;4000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.0
;;15088196;[];CHEMBL3386699;Displacement of radiolabeled MK499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL3351398;ACS Med Chem Lett;2014.0;{'bei': '10.55', 'le': '0.20', 'lle': '-0.12', 'sei': '5.64'};CHEMBL3342774;;CHEMBL3342774;5.16;0;http://www.openphacts.org/units/Nanomolar;2264591;=;1;1;=;;Ki;nM;;7000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.0
;;15088197;[];CHEMBL3386699;Displacement of radiolabeled MK499 from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL3351398;ACS Med Chem Lett;2014.0;{'bei': '10.24', 'le': '0.20', 'lle': '-0.27', 'sei': '5.47'};CHEMBL3342775;;CHEMBL3342775;5.00;0;http://www.openphacts.org/units/Nanomolar;2264592;=;1;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.0
;;15102641;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)C#Cc1cnc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cccnc3F)ccc1O2;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '13.85', 'le': '0.25', 'lle': '1.57', 'sei': '7.18'};CHEMBL3359760;;CHEMBL3359760;5.94;0;http://www.openphacts.org/units/Nanomolar;2268863;=;1;1;=;;Ki;nM;;1160.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.16
;;15102643;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccc(-c2cnc3c(c2)[C@]2(COC(N)=N2)c2cc(-c4cccnc4F)ccc2O3)cc1;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '14.86', 'le': '0.27', 'lle': '2.16', 'sei': '6.28'};CHEMBL3359758;;CHEMBL3359758;6.68;0;http://www.openphacts.org/units/Nanomolar;2268861;=;1;1;=;;Ki;nM;;210.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.21
;;15102644;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ccc(-c2cnc3c(c2)[C@]2(COC(N)=N2)c2cc(-c4cccnc4F)ccc2O3)cc1;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '13.47', 'le': '0.24', 'lle': '0.96', 'sei': '7.15'};CHEMBL3359757;;CHEMBL3359757;5.91;0;http://www.openphacts.org/units/Nanomolar;2268860;=;1;1;=;;Ki;nM;;1240.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.24
;;15102650;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;COC(C)(C)COc1cnc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cccnc3F)ccc1O2;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '12.28', 'le': '0.23', 'lle': '1.75', 'sei': '5.47'};CHEMBL3359751;;CHEMBL3359751;5.53;0;http://www.openphacts.org/units/Nanomolar;2268854;=;1;1;=;;Ki;nM;;2950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.95
;;15102651;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)cnc1O2;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '12.98', 'le': '0.24', 'lle': '1.76', 'sei': '5.17'};CHEMBL3359750;;CHEMBL3359750;5.42;0;http://www.openphacts.org/units/Nanomolar;2268853;=;1;1;=;;Ki;nM;;3810.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.81
;;15102652;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1cnc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cccnc3F)ccc1O2;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '12.73', 'le': '0.24', 'lle': '1.13', 'sei': '6.02'};CHEMBL3359749;;CHEMBL3359749;5.53;0;http://www.openphacts.org/units/Nanomolar;2268852;=;1;1;=;;Ki;nM;;2950.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.95
;;15102655;[];CHEMBL3377656;Inhibition of human ERG channel expressed in HEK293 cells assessed as [3H]-dofetilide binding after 90 mins by liquid scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)COc1ccc2c(c1)[C@]1(COC(N)=N1)c1cc(-c3cncnc3)ccc1O2;;;CHEMBL3352228;J Med Chem;2014.0;{'bei': '14.84', 'le': '0.27', 'lle': '1.92', 'sei': '6.73'};CHEMBL3354688;;CHEMBL3354688;6.18;1;http://www.openphacts.org/units/Nanomolar;2268849;=;1;1;=;;Ki;nM;;660.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.66
;;15127095;[];CHEMBL3369365;Displacement of [3H]astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@H](CC(=O)[C@H]1Cc2ccc(O)cc2CN1)CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1;;;CHEMBL3352410;J Med Chem;2014.0;{'bei': '10.88', 'le': '0.20', 'lle': '0.41', 'sei': '6.94'};CHEMBL3326630;;CHEMBL3326630;5.05;0;http://www.openphacts.org/units/Nanomolar;2249118;=;1;1;=;;Ki;nM;;8820.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.82
;;15127096;[];CHEMBL3369365;Displacement of [3H]astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@H](CC(=O)[C@H]1Cc2ccc(O)cc2CN1)CN1CC[C@@](C)(c2ccccc2)[C@@H](C)C1;;;CHEMBL3352410;J Med Chem;2014.0;{'bei': '11.48', 'le': '0.21', 'lle': '0.21', 'sei': '9.80'};CHEMBL3326631;;CHEMBL3326631;5.15;0;http://www.openphacts.org/units/Nanomolar;2249119;=;1;1;=;;Ki;nM;;7050.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.05
;;15127097;[];CHEMBL3369365;Displacement of [3H]astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@H](CC(=O)[C@H]1Cc2ccc(O)cc2CN1)CN1CC[C@@](C)(c2cccc(F)c2)[C@@H](C)C1;;;CHEMBL3352410;J Med Chem;2014.0;{'bei': '11.15', 'le': '0.21', 'lle': '0.12', 'sei': '9.90'};CHEMBL3326784;;CHEMBL3326784;5.20;0;http://www.openphacts.org/units/Nanomolar;2249120;=;1;1;=;;Ki;nM;;6250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.25
;;15127143;[];CHEMBL3369373;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1;;;CHEMBL3352410;J Med Chem;2014.0;{'bei': '16.79', 'le': '0.31', 'lle': '2.35', 'sei': '18.19'};CHEMBL296419;ASTEMIZOLE;CHEMBL296419;7.70;0;http://www.openphacts.org/units/Nanomolar;2249132;=;1;1;=;;Ki;nM;;20.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20.0
;;15146106;[];CHEMBL3395117;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1cnc(N3CC[C@@H](F)C3)cc12;;;CHEMBL3393054;Bioorg Med Chem Lett;2015.0;{'bei': '11.73', 'le': '0.22', 'lle': '1.58', 'sei': '5.95'};CHEMBL3394051;;CHEMBL3394051;5.11;0;http://www.openphacts.org/units/Nanomolar;2277658;=;1;1;=;;Ki;nM;;7800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.8
;;15146114;[];CHEMBL3395117;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c(F)cc(C3=CCOCC3)cc12;;;CHEMBL3393054;Bioorg Med Chem Lett;2015.0;{'bei': '12.25', 'le': '0.23', 'lle': '0.96', 'sei': '6.94'};CHEMBL3354718;;CHEMBL3354718;5.48;1;http://www.openphacts.org/units/Nanomolar;2277666;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.3
;;15148591;[];CHEMBL3396464;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c2cc(N2CCC(F)(F)CC2)nc1F;;;CHEMBL3393040;ACS Med Chem Lett;2015.0;{'bei': '10.63', 'le': '0.20', 'lle': '0.81', 'sei': '6.01'};CHEMBL3394225;;CHEMBL3394225;5.16;0;http://www.openphacts.org/units/Nanomolar;2277856;=;1;1;=;;Ki;nM;;6900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.9
;;15148592;[];CHEMBL3396464;Displacement of [3H]-dofetilide from human ERG expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting method;B;;;BAO_0000192;BAO_0000219;cell-based format;NC1=N[C@@]2(CO1)c1cc(-c3cccnc3F)ccc1Oc1c2cc(N2CCC(F)(F)C2)nc1F;;;CHEMBL3393040;ACS Med Chem Lett;2015.0;{'bei': '11.14', 'le': '0.21', 'lle': '1.29', 'sei': '6.12'};CHEMBL3394226;;CHEMBL3394226;5.25;0;http://www.openphacts.org/units/Nanomolar;2277857;=;1;1;=;;Ki;nM;;5600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.6
;;15240064;[];CHEMBL3424160;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;;;CHEMBL3421561;J Med Chem;2015.0;{'bei': '15.37', 'le': '0.28', 'lle': '0.80', 'sei': '16.59'};CHEMBL17157;TERFENADINE;CHEMBL17157;7.25;0;http://www.openphacts.org/units/Nanomolar;2294462;=;1;1;=;;Ki;nM;;56.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;56.0
;;15240065;[];CHEMBL3424160;Inhibition of human ERG channel;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;;;CHEMBL3421561;J Med Chem;2015.0;{'bei': '9.25', 'le': '0.17', 'lle': '-0.87', 'sei': '5.73'};CHEMBL914;FEXOFENADINE;CHEMBL914;4.64;0;http://www.openphacts.org/units/Nanomolar;2294463;=;1;1;=;;Ki;nM;;23000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;23000.0
;;15615023;[];CHEMBL3583383;Inhibition of MK499 binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(C4CCCCC4)O3)n2)cc1;;;CHEMBL3580651;ACS Med Chem Lett;2015.0;{'bei': '15.99', 'le': '0.29', 'lle': '-0.13', 'sei': '11.84'};CHEMBL3582309;;CHEMBL3582309;6.36;0;http://www.openphacts.org/units/Nanomolar;2483242;=;1;1;=;;Ki;nM;;440.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.44
;;15615024;[];CHEMBL3583383;Inhibition of MK499 binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC1(c2ccccc2)N[C@@H](c2nc(-c3ccc(F)cc3)c[nH]2)Cc2c1[nH]c1ccccc21;;;CHEMBL3580651;ACS Med Chem Lett;2015.0;{'bei': '13.12', 'le': '0.24', 'lle': '-0.31', 'sei': '9.81'};CHEMBL3582310;;CHEMBL3582310;5.54;0;http://www.openphacts.org/units/Nanomolar;2483243;=;1;1;=;;Ki;nM;;2870.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.87
;;15615025;[];CHEMBL3583383;Inhibition of MK499 binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Fc1ccc(-c2c[nH]c([C@H]3Cc4c([nH]c5ccccc45)C(c4ccccc4)(C(F)(F)F)N3)n2)cc1;;;CHEMBL3580651;ACS Med Chem Lett;2015.0;{'bei': '12.89', 'le': '0.24', 'lle': '-0.25', 'sei': '10.87'};CHEMBL3582311;;CHEMBL3582311;6.14;0;http://www.openphacts.org/units/Nanomolar;2483244;=;1;1;=;;Ki;nM;;720.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.72
;;15697434;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '10.76', 'le': '0.20', 'lle': '0.87', 'sei': '7.09'};CHEMBL3609749;;CHEMBL3609749;5.54;0;http://www.openphacts.org/units/Nanomolar;2498082;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;15697435;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cn(-c2ccc(-c3cn([C@H]4CCc5c(F)cccc5N(CC(F)(F)F)C4=O)nn3)cc2)cn1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '11.24', 'le': '0.21', 'lle': '0.78', 'sei': '7.91'};CHEMBL3608384;;CHEMBL3608384;5.44;0;http://www.openphacts.org/units/Nanomolar;2496368;=;1;1;=;;Ki;nM;;3600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.6
;;15697436;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(-n2cnc(C)c2)ccc1-c1cn([C@H]2CCc3c(F)cccc3N(CC(F)(F)F)C2=O)nn1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '11.12', 'le': '0.21', 'lle': '1.05', 'sei': '7.33'};CHEMBL3609752;;CHEMBL3609752;5.72;0;http://www.openphacts.org/units/Nanomolar;2498085;=;1;1;=;;Ki;nM;;1900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.9
;;15697437;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cn(-c2ccc(-c3cn([C@H]4CCc5c(F)cccc5N(CC(F)(F)F)C4=O)nn3)cc2OCC(F)(F)F)cn1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '9.78', 'le': '0.19', 'lle': '0.10', 'sei': '7.30'};CHEMBL3608385;;CHEMBL3608385;5.70;0;http://www.openphacts.org/units/Nanomolar;2496369;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;15697438;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cn(-c2ccc(-c3cn([C@H]4CCc5c(F)cccc5N(CC(F)(F)F)C4=O)nn3)c(F)c2)cn1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '10.11', 'le': '0.19', 'lle': '0.28', 'sei': '7.38'};CHEMBL3609754;;CHEMBL3609754;5.08;0;http://www.openphacts.org/units/Nanomolar;2498087;=;1;1;=;;Ki;nM;;8300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.3
;;15697439;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1c(-n2cnc(C)c2)ccc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)c1F;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '10.29', 'le': '0.20', 'lle': '0.67', 'sei': '7.02'};CHEMBL3608387;;CHEMBL3608387;5.48;0;http://www.openphacts.org/units/Nanomolar;2496371;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3300.0
;;15697440;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1c(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc(-n2cnc(C)c2)c1F;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '9.74', 'le': '0.19', 'lle': '0.38', 'sei': '6.64'};CHEMBL3609755;;CHEMBL3609755;5.19;0;http://www.openphacts.org/units/Nanomolar;2498088;=;1;1;=;;Ki;nM;;6500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.5
;;15697441;[];CHEMBL3611882;Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)n1;;;CHEMBL3608233;Bioorg Med Chem Lett;2015.0;{'bei': '9.16', 'le': '0.17', 'lle': '0.66', 'sei': '5.19'};CHEMBL3609759;;CHEMBL3609759;4.72;0;http://www.openphacts.org/units/Nanomolar;2498092;=;1;1;=;;Ki;nM;;19000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.0
;;15707366;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(O)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '10.86', 'le': '0.20', 'lle': '1.50', 'sei': '5.96'};CHEMBL415247;JDTIC;CHEMBL415247;5.05;0;http://www.openphacts.org/units/Nanomolar;2499962;=;1;1;=;;Ki;nM;;8820.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.82
;;15707367;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CC[C@@](C)(c2ccccc2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '11.46', 'le': '0.21', 'lle': '1.30', 'sei': '7.98'};CHEMBL3613445;;CHEMBL3613445;5.15;0;http://www.openphacts.org/units/Nanomolar;2499963;=;1;1;=;;Ki;nM;;7048.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.048
;;15707368;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CC[C@@](C)(c2cccc(F)c2)[C@@H](C)C1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '11.13', 'le': '0.21', 'lle': '1.21', 'sei': '8.06'};CHEMBL3613446;;CHEMBL3613446;5.20;0;http://www.openphacts.org/units/Nanomolar;2499964;=;1;1;=;;Ki;nM;;6251.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.251
;;15707370;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CCC(C)(c2cccc(F)c2)CC1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '11.85', 'le': '0.22', 'lle': '1.63', 'sei': '8.32'};CHEMBL3613448;;CHEMBL3613448;5.37;0;http://www.openphacts.org/units/Nanomolar;2499966;=;1;1;=;;Ki;nM;;4237.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.237
;;15707371;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CCC(C)[C@@H](CN1CCC(C)(c2cccc(F)c2)CC1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '12.36', 'le': '0.23', 'lle': '1.65', 'sei': '8.94'};CHEMBL3613449;;CHEMBL3613449;5.78;0;http://www.openphacts.org/units/Nanomolar;2499967;=;1;1;=;;Ki;nM;;1666.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.666
;;15707372;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CCC(c2cccc(O)c2)CC1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '13.17', 'le': '0.25', 'lle': '2.63', 'sei': '6.79'};CHEMBL3613442;;CHEMBL3613442;5.76;0;http://www.openphacts.org/units/Nanomolar;2499958;=;1;1;=;;Ki;nM;;1732.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.732
;;15707373;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CCC(c2ccccc2)CC1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '14.49', 'le': '0.27', 'lle': '2.68', 'sei': '9.46'};CHEMBL3613444;;CHEMBL3613444;6.11;0;http://www.openphacts.org/units/Nanomolar;2499960;=;1;1;=;;Ki;nM;;777.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.777
;;15707374;[];CHEMBL3614618;Displacement of [3H]-astemizole from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)[C@@H](CN1CCC(c2cccc(F)c2)CC1)NC(=O)[C@H]1Cc2ccc(O)cc2CN1;;;CHEMBL3612054;Bioorg Med Chem;2015.0;{'bei': '14.47', 'le': '0.27', 'lle': '2.79', 'sei': '9.85'};CHEMBL3613443;;CHEMBL3613443;6.36;0;http://www.openphacts.org/units/Nanomolar;2499959;=;1;1;=;;Ki;nM;;436.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.436
;;16398142;[];CHEMBL3743004;Binding affinity to Kv11.1 channel (unknown origin);B;;;BAO_0000192;BAO_0000357;single protein format;O=C(COc1ccc2ccccc2c1Br)Nc1cccnc1;;;CHEMBL3739265;Eur J Med Chem;2015.0;{'bei': '23.29', 'le': '0.52', 'lle': '4.31', 'sei': '16.24'};CHEMBL1418045;;CHEMBL1418045;8.32;0;http://www.openphacts.org/units/Nanomolar;2738691;=;1;1;=;;Ki;nM;;4.8;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;4.8
;;16457089;[];CHEMBL3761681;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nc(NC(=O)c2cc(CNC(=O)C(C)C)cnc2C(F)F)[nH]c1-c1ccc(C(F)(F)F)cc1;;;CHEMBL3758174;J Med Chem;2016.0;{'bei': '8.85', 'le': '0.17', 'lle': '-0.88', 'sei': '4.39'};CHEMBL3342693;;CHEMBL3342693;4.38;0;http://www.openphacts.org/units/Nanomolar;2748450;=;1;1;=;;Ki;nM;;41300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;41.3
;;16480301;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '14.14', 'le': '0.26', 'lle': '1.36', 'sei': '8.98'};CHEMBL85606;;CHEMBL85606;6.20;0;http://www.openphacts.org/units/Nanomolar;2757600;=;1;1;=;;Ki;nM;;630.96;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.2
;;16480303;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(F)cc3)C2)n1C;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '13.17', 'le': '0.26', 'lle': '2.03', 'sei': '7.95'};CHEMBL3765754;;CHEMBL3765754;5.50;0;http://www.openphacts.org/units/Nanomolar;2757602;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;16480305;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '11.76', 'le': '0.23', 'lle': '1.15', 'sei': '7.95'};CHEMBL3764557;;CHEMBL3764557;5.50;0;http://www.openphacts.org/units/Nanomolar;2757604;=;1;1;=;;Ki;nM;;3162.28;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.5
;;16480307;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ncoc1-c1nnc(SCCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '11.63', 'le': '0.23', 'lle': '0.86', 'sei': '8.09'};CHEMBL3763418;;CHEMBL3763418;5.60;0;http://www.openphacts.org/units/Nanomolar;2757606;=;1;1;=;;Ki;nM;;2511.89;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.6
;;16480319;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '11.25', 'le': '0.22', 'lle': '2.15', 'sei': '5.75'};CHEMBL3764306;;CHEMBL3764306;5.70;0;http://www.openphacts.org/units/Nanomolar;2757378;=;1;1;=;;Ki;nM;;1995.26;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.7
;;16480321;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '10.48', 'le': '0.21', 'lle': '1.14', 'sei': '6.14'};CHEMBL3765426;;CHEMBL3765426;5.30;0;http://www.openphacts.org/units/Nanomolar;2757380;=;1;1;=;;Ki;nM;;5011.87;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.3
;;16480322;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '10.29', 'le': '0.20', 'lle': '1.04', 'sei': '6.03'};CHEMBL3765426;;CHEMBL3765426;5.20;0;http://www.openphacts.org/units/Nanomolar;2757381;=;1;1;=;;Ki;nM;;6309.57;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.2
;;16480328;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '11.33', 'le': '0.22', 'lle': '0.29', 'sei': '8.67'};CHEMBL3764143;;CHEMBL3764143;6.00;0;http://www.openphacts.org/units/Nanomolar;2757595;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;16480330;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '11.14', 'le': '0.22', 'lle': '0.19', 'sei': '8.52'};CHEMBL3764143;;CHEMBL3764143;5.90;0;http://www.openphacts.org/units/Nanomolar;2757597;=;1;1;=;;Ki;nM;;1258.93;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;5.9
;;16480334;[];CHEMBL3768210;Displacement of [3H]-dofetilide from human ERG potassium channel by scintillation proximity assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5noc(C)n5)cc4)n3C)CCO2)cc1;;;CHEMBL3763143;Bioorg Med Chem Lett;2016.0;{'bei': '12.23', 'le': '0.23', 'lle': '1.30', 'sei': '7.31'};CHEMBL3764246;;CHEMBL3764246;6.00;0;http://www.openphacts.org/units/Nanomolar;2757373;=;1;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;pKi;;UO_0000065;;6.0
;;16592941;[];CHEMBL3807756;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1;;;CHEMBL3804778;ACS Med Chem Lett;2016.0;{'bei': '17.35', 'le': '0.32', 'lle': '2.61', 'sei': '18.81'};CHEMBL296419;ASTEMIZOLE;CHEMBL296419;7.96;0;http://www.openphacts.org/units/Nanomolar;2778019;=;1;1;=;;Ki;nM;;11.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.011
;;16592942;[];CHEMBL3807756;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(=O)Nc1ccc2c3c(cccc13)C(=O)N(CCCCN1CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC1)C2=O;;;CHEMBL3804778;ACS Med Chem Lett;2016.0;{'bei': '11.13', 'le': '0.20', 'lle': '0.75', 'sei': '7.07'};CHEMBL3805335;;CHEMBL3805335;7.04;0;http://www.openphacts.org/units/Nanomolar;2778018;=;1;1;=;;Ki;nM;;91.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.091
;;16592943;[];CHEMBL3807756;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;O=[N+]([O-])c1ccc(NCCCCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)c2nonc12;;;CHEMBL3804778;ACS Med Chem Lett;2016.0;{'bei': '14.18', 'le': '0.26', 'lle': '2.48', 'sei': '6.23'};CHEMBL3805898;;CHEMBL3805898;7.92;0;http://www.openphacts.org/units/Nanomolar;2777903;=;1;1;=;;Ki;nM;;12.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.012
;;16592944;[];CHEMBL3807756;Displacement of [3H] dofetilide from human ERG channel expressed in HEK293 cell membranes incubated for 2 hrs by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CCN(CC)c1ccc2cc(C(=O)NCCCCN3CCC(Nc4nc5ccccc5n4Cc4ccc(F)cc4)CC3)c(=O)oc2c1;;;CHEMBL3804778;ACS Med Chem Lett;2016.0;{'bei': '10.43', 'le': '0.19', 'lle': '0.40', 'sei': '6.97'};CHEMBL3804918;;CHEMBL3804918;6.66;0;http://www.openphacts.org/units/Nanomolar;2777902;=;1;1;=;;Ki;nM;;217.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.217
;312541;17692741;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;Oc1ccc(OC[C@@H](O)CN2CCN(c3ccc(Cl)cc3)CC2)cc1;;;CHEMBL3639142;;2015.0;{'bei': '12.15', 'le': '0.24', 'lle': '1.80', 'sei': '7.85'};CHEMBL3683711;;CHEMBL3683711;4.41;0;http://www.openphacts.org/units/Nanomolar;2559872;=;37;1;=;;Ki;nM;;39000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;39000.0
;312542;17692742;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1[nH]c2ccc(OC[C@@H](O)CN3CCN(c4ccc(Cl)cc4)CC3)cc2o1;;;CHEMBL3639142;;2015.0;{'bei': '14.35', 'le': '0.28', 'lle': '3.46', 'sei': '7.07'};CHEMBL3688388;;CHEMBL3688388;5.80;0;http://www.openphacts.org/units/Nanomolar;2564781;=;37;1;=;;Ki;nM;;1600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1600.0
;312543;17692743;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;CS(=O)(=O)Nc1ccc(OC[C@@H](O)CN2CCN(c3ccc(Cl)cc3)CC2)cc1;;;CHEMBL3639142;;2015.0;{'bei': '14.22', 'le': '0.29', 'lle': '3.99', 'sei': '7.62'};CHEMBL3688389;;CHEMBL3688389;6.26;0;http://www.openphacts.org/units/Nanomolar;2564782;=;37;1;=;;Ki;nM;;553.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;553.0
;312544;17692744;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)Nc1ccc(OC[C@@H](O)CN2CCN(c3ccc(Cl)cc3)CC2)cc1;;;CHEMBL3639142;;2015.0;{'bei': '12.07', 'le': '0.24', 'lle': '2.50', 'sei': '5.37'};CHEMBL3688390;;CHEMBL3688390;4.89;0;http://www.openphacts.org/units/Nanomolar;2564783;=;37;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;13000.0
;312545;17692745;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O[C@H](COc1ccc2[nH]ncc2c1)CN1CCN(c2ccc(Cl)cc2)CC1;;;CHEMBL3639142;;2015.0;{'bei': '15.51', 'le': '0.30', 'lle': '3.22', 'sei': '9.29'};CHEMBL3688391;;CHEMBL3688391;6.00;0;http://www.openphacts.org/units/Nanomolar;2564784;=;37;1;=;;Ki;nM;;1000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1000.0
;312546;17692746;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1ccc2cc(OC[C@@H](O)CN3CCN(c4ccc(Cl)cc4)CC3)ccc2[nH]1;;;CHEMBL3639142;;2015.0;{'bei': '12.38', 'le': '0.24', 'lle': '2.38', 'sei': '7.45'};CHEMBL3688392;;CHEMBL3688392;5.12;0;http://www.openphacts.org/units/Nanomolar;2564785;=;37;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7500.0
;312547;17692747;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1[nH]c2ccc(OC[C@@H](O)CN3CCN(c4ccc(Cl)cc4)CC3)cc2[nH]1;;;CHEMBL3639142;;2015.0;{'bei': '12.72', 'le': '0.25', 'lle': '3.05', 'sei': '6.06'};CHEMBL3688393;;CHEMBL3688393;5.12;0;http://www.openphacts.org/units/Nanomolar;2564786;=;37;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7500.0
;312548;17692748;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1Cc2cc(OC[C@@H](O)CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1;;;CHEMBL3639142;;2015.0;{'bei': '12.44', 'le': '0.24', 'lle': '2.60', 'sei': '7.69'};CHEMBL3688394;;CHEMBL3688394;5.00;0;http://www.openphacts.org/units/Nanomolar;2564787;=;37;1;=;;Ki;nM;;10000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10000.0
;312549;17692749;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O[C@H](COc1ccc2[nH]c(=S)[nH]c2c1)CN1CCN(c2ccc(Cl)cc2)CC1;;;CHEMBL3639142;;2015.0;{'bei': '12.23', 'le': '0.25', 'lle': '1.68', 'sei': '7.59'};CHEMBL3688395;;CHEMBL3688395;5.12;0;http://www.openphacts.org/units/Nanomolar;2564788;=;37;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7500.0
;312550;17692750;[];CHEMBL3706371;"In Vitro Binding Assay: Compounds were evaluated for binding to the human ether-a-go-go potassium channel (hERG) expressed in HEK293 cells by displacement of 3[H]-astemizole according to the methods by Finlayson et al. (K. Finlayson., L. Turnbull, C. T. January, J. Sharkey, J. S. Kelly; [3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. 2001, 430, 147-148). Compounds were incubated at 1 or 10 M final concentration, in duplicate, and the amount of displaced 3[H]-astemizole determined by liquid scintillation spectroscopy. In some cases, a seven concentration (each concentration in duplicate) displacement curve was generated to determine an IC50.";B;;;BAO_0000192;BAO_0000219;cell-based format;O=C1CCc2cc(OC[C@@H](O)CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1;;;CHEMBL3639142;;2015.0;{'bei': '12.75', 'le': '0.25', 'lle': '2.51', 'sei': '8.15'};CHEMBL3688396;;CHEMBL3688396;5.30;0;http://www.openphacts.org/units/Nanomolar;2564789;=;37;1;=;;Ki;nM;;5000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;5000.0
;;18192391;[];CHEMBL4041928;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl;;;CHEMBL4041490;Eur J Med Chem;2017.0;{'bei': '17.52', 'le': '0.35', 'lle': '1.96', 'sei': '23.96'};CHEMBL1223749;;CHEMBL1223749;7.52;0;http://www.openphacts.org/units/Nanomolar;3018043;=;1;1;=;;Ki;nM;;30.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;30.0
;;18192392;[];CHEMBL4041928;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl;;;CHEMBL4041490;Eur J Med Chem;2017.0;{'bei': '18.63', 'le': '0.38', 'lle': '2.44', 'sei': '25.48'};CHEMBL1223683;;CHEMBL1223683;8.00;0;http://www.openphacts.org/units/Nanomolar;3018046;=;1;1;=;;Ki;nM;;10.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;10.0
;;18192393;[];CHEMBL4041928;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;c1ccc(C(OCCCc2c[nH]cn2)c2ccccc2)cc1;;;CHEMBL4041490;Eur J Med Chem;2017.0;{'bei': '21.55', 'le': '0.39', 'lle': '2.15', 'sei': '16.62'};CHEMBL1179089;;CHEMBL1179089;6.30;0;http://www.openphacts.org/units/Nanomolar;3018050;=;1;1;=;;Ki;nM;;500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;500.0
;;18300443;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(CCC(=O)N(c2nccc3ccccc23)[C@@H]2CCCNC2)cc1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '12.54', 'le': '0.23', 'lle': '0.93', 'sei': '8.97'};CHEMBL4128250;;CHEMBL4128250;4.89;0;http://www.openphacts.org/units/Nanomolar;3038039;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;18300444;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-c2ccccc2)cc1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '13.88', 'le': '0.25', 'lle': '0.36', 'sei': '12.51'};CHEMBL4129620;;CHEMBL4129620;5.66;0;http://www.openphacts.org/units/Nanomolar;3038040;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;18300446;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1cc(-c2ccc(C(=O)N(c3nccc4ccccc34)[C@@H]3CCCNC3)cc2)cn1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '11.65', 'le': '0.21', 'lle': '0.77', 'sei': '7.61'};CHEMBL4128388;;CHEMBL4128388;4.80;0;http://www.openphacts.org/units/Nanomolar;3038042;=;1;1;=;;Ki;nM;;16000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.0
;;18300447;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-c2cnn3cccnc23)cc1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '11.74', 'le': '0.21', 'lle': '0.93', 'sei': '6.98'};CHEMBL4130157;;CHEMBL4130157;5.27;0;http://www.openphacts.org/units/Nanomolar;3038043;=;1;1;=;;Ki;nM;;5400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.4
;;18300448;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '10.68', 'le': '0.19', 'lle': '1.04', 'sei': '5.41'};CHEMBL4126894;;CHEMBL4126894;4.80;0;http://www.openphacts.org/units/Nanomolar;3038044;=;1;1;=;;Ki;nM;;15800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;15.8
;;18300449;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-n2nnc3cccnc32)cc1)N(c1ncccc1Cl)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '10.93', 'le': '0.21', 'lle': '1.48', 'sei': '5.34'};CHEMBL4109308;;CHEMBL4109308;4.74;0;http://www.openphacts.org/units/Nanomolar;3038045;=;1;1;=;;Ki;nM;;18100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;18.1
;;18300450;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2nnn(-c3ccc(C(=O)N(c4ncccc4Cl)[C@@H]4CCCNC4)cc3)c2n1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '9.98', 'le': '0.19', 'lle': '0.90', 'sei': '5.03'};CHEMBL4126496;;CHEMBL4126496;4.47;0;http://www.openphacts.org/units/Nanomolar;3038047;=;1;1;=;;Ki;nM;;34000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;34.0
;;18300451;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cnc2c(c1)nnn2-c1ccc(C(=O)N(c2ncccc2Cl)[C@@H]2CCCNC2)cc1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '12.24', 'le': '0.23', 'lle': '1.91', 'sei': '6.17'};CHEMBL4114159;;CHEMBL4114159;5.48;0;http://www.openphacts.org/units/Nanomolar;3038048;=;1;1;=;;Ki;nM;;3300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.3
;;18300452;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-n2nnc3cccnc32)cn1)N(c1ncccc1Cl)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '10.44', 'le': '0.20', 'lle': '1.88', 'sei': '4.46'};CHEMBL4108338;;CHEMBL4108338;4.54;0;http://www.openphacts.org/units/Nanomolar;3038049;=;1;1;=;;Ki;nM;;28800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;28.8
;;18300453;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-n2nnc3cccnc32)nc1)N(c1ncccc1Cl)[C@@H]1CCCNC1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '11.26', 'le': '0.22', 'lle': '2.24', 'sei': '4.81'};CHEMBL4128560;;CHEMBL4128560;4.90;0;http://www.openphacts.org/units/Nanomolar;3038050;=;1;1;=;;Ki;nM;;12700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.7
;;18300454;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cnc2c(c1)nnn2-c1ccc(C(=O)N(c2ncccc2Cl)[C@@H]2CCCNC2)nc1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '11.65', 'le': '0.22', 'lle': '2.26', 'sei': '5.14'};CHEMBL4107559;;CHEMBL4107559;5.23;0;http://www.openphacts.org/units/Nanomolar;3038051;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.9
;;18300455;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;CN(C)c1cncc(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2)n1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '11.10', 'le': '0.21', 'lle': '1.19', 'sei': '6.53'};CHEMBL4127311;;CHEMBL4127311;4.85;0;http://www.openphacts.org/units/Nanomolar;3038052;=;1;1;=;;Ki;nM;;14100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;14.1
;;18300456;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cncc(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2)n1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '10.83', 'le': '0.21', 'lle': '0.52', 'sei': '6.22'};CHEMBL4127458;;CHEMBL4127458;4.42;0;http://www.openphacts.org/units/Nanomolar;3038053;=;1;1;=;;Ki;nM;;38200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;38.2
;;18300457;[];CHEMBL4124683;Inhibition of dofetilide binding to human ERG by fluorescence polarization assay;B;;;BAO_0000192;BAO_0000357;single protein format;CNc1cncc(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2)n1;;;CHEMBL4118248;J Med Chem;2018.0;{'bei': '10.44', 'le': '0.20', 'lle': '0.79', 'sei': '5.32'};CHEMBL4126072;;CHEMBL4126072;4.42;0;http://www.openphacts.org/units/Nanomolar;3038054;=;1;1;=;;Ki;nM;;38400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;38.4
;;18377470;[];CHEMBL4144996;Displacement of fluorescent-labelled dofetilide from human ERG expressed in HEK293 cell membrane homogenates;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(=O)NC(C)c2cnn(C)n2)cc1S(=O)(=O)Nc1ccc(Cl)cc1;;;CHEMBL4138303;ACS Med Chem Lett;2018.0;{'bei': '10.12', 'le': '0.21', 'lle': '1.78', 'sei': '3.95'};CHEMBL4159883;;CHEMBL4159883;4.55;0;http://www.openphacts.org/units/Nanomolar;3050339;=;1;1;=;;Ki;nM;;28000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;28.0
;;18458020;[];CHEMBL4179916;Displacement of [3H]Dofetilide from recombinant human ERG after 60 mins by scintillation counting method;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1cc(S(=O)(=O)Nc2ncns2)ccc1Oc1ccc(-c2cccc(C(F)(F)F)c2)cc1-c1ccnc(CNCCC2CCNCC2)c1;;;CHEMBL4177603;Bioorg Med Chem Lett;2017.0;{'bei': '8.28', 'le': '0.16', 'lle': '-1.27', 'sei': '4.20'};CHEMBL4217988;;CHEMBL4217988;5.96;0;http://www.openphacts.org/units/Nanomolar;3063234;=;1;1;=;;Ki;nM;;1091.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1091.0
;;18506827;[];CHEMBL4190649;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(NC[C@@H](Cc1ccccc1)N1CCC(O)(C(F)(F)F)CC1)C1(c2ccc(Cl)cc2)CCCC1;;;CHEMBL4190175;Medchemcomm;2016.0;{'bei': '9.02', 'le': '0.18', 'lle': '-0.68', 'sei': '8.73'};CHEMBL4208555;;CHEMBL4208555;4.59;0;http://www.openphacts.org/units/Nanomolar;3072563;=;1;1;=;;Ki;nM;;25700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;25700.0
;;18679221;[];CHEMBL4236263;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1;;;CHEMBL4229542;Bioorg Med Chem Lett;2018.0;{'bei': '13.53', 'le': '0.25', 'lle': '1.74', 'sei': '6.01'};CHEMBL1873475;IBRUTINIB;CHEMBL1873475;5.96;0;http://www.openphacts.org/units/Nanomolar;3102398;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;18679239;[];CHEMBL4236263;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;C=CC(=O)N1C[C@@H]2C[C@H]1CN2c1ccc(C(N)=O)c(Oc2ccc(Oc3ccccc3)cc2)n1;;;CHEMBL4229542;Bioorg Med Chem Lett;2018.0;{'bei': '12.39', 'le': '0.23', 'lle': '1.92', 'sei': '5.77'};CHEMBL4242598;;CHEMBL4242598;5.66;0;http://www.openphacts.org/units/Nanomolar;3102410;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;18916951;[];CHEMBL4322262;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by whole cell patch clamp method;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(F)cc2c(=O)[nH]c(-c3ccc(C4CCNCC4)cc3)nc12.Cl;;;CHEMBL4321794;J Med Chem;2019.0;{'bei': '15.32', 'le': '0.28', 'lle': '1.67', 'sei': '8.94'};CHEMBL4567515;;CHEMBL4595211;5.17;0;http://www.openphacts.org/units/Nanomolar;3155754;=;1;1;=;;Ki;nM;;6800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.8
;;18945011;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc(CCC(=O)N(c2nccc3ccccc23)[C@@H]2CCCNC2)cc1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.54', 'le': '0.23', 'lle': '0.93', 'sei': '8.97'};CHEMBL4128250;;CHEMBL4128250;4.89;1;http://www.openphacts.org/units/Nanomolar;3160455;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
;;18945012;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(CCc1ccc(-n2nnc3cccnc32)cc1)N(c1ncccc1Cl)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '10.27', 'le': '0.20', 'lle': '1.16', 'sei': '5.34'};CHEMBL4574496;;CHEMBL4574496;4.74;0;http://www.openphacts.org/units/Nanomolar;3160456;=;1;1;=;;Ki;nM;;18100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;18.1
;;18945013;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cnc2c(c1)nnn2-c1ccc(CCC(=O)N(c2ncccc2Cl)[C@@H]2CCCNC2)nc1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '10.96', 'le': '0.21', 'lle': '1.94', 'sei': '5.14'};CHEMBL4533299;;CHEMBL4533299;5.23;0;http://www.openphacts.org/units/Nanomolar;3160457;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.9
;;18945014;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(c1ccc(-c2ccccc2)cc1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '13.88', 'le': '0.25', 'lle': '0.36', 'sei': '12.51'};CHEMBL4129620;;CHEMBL4129620;5.66;1;http://www.openphacts.org/units/Nanomolar;3160458;=;1;1;=;;Ki;nM;;2200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.2
;;18945015;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N1CCC(c2ccccc2)CC1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '13.00', 'le': '0.24', 'lle': '0.60', 'sei': '11.11'};CHEMBL4534859;;CHEMBL4534859;5.39;0;http://www.openphacts.org/units/Nanomolar;3160459;=;1;1;=;;Ki;nM;;4100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.1
;;18945016;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N1CCC(c2ccccc2)CC1)N(c1ncccc1Cl)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.14', 'le': '0.24', 'lle': '0.55', 'sei': '10.00'};CHEMBL4446635;;CHEMBL4446635;4.84;0;http://www.openphacts.org/units/Nanomolar;3160460;=;1;1;=;;Ki;nM;;14300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;14.3
;;18945018;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1nccnc1N(C(=O)N1CCC(c2ccccc2)CC1)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.14', 'le': '0.22', 'lle': '1.27', 'sei': '7.51'};CHEMBL4469712;;CHEMBL4469712;4.61;0;http://www.openphacts.org/units/Nanomolar;3160462;=;1;1;=;;Ki;nM;;24800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;24.8
;;18945019;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cn1ccc2ccnc(N(C(=O)N3CCC(c4ccccc4)CC3)[C@@H]3CCCNC3)c21;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.56', 'le': '0.23', 'lle': '1.11', 'sei': '9.82'};CHEMBL4560206;;CHEMBL4560206;5.24;0;http://www.openphacts.org/units/Nanomolar;3160463;=;1;1;=;;Ki;nM;;5700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.7
;;18945020;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cccnc1N(C(=O)N1CCC(c2ccccc2F)CC1)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.63', 'le': '0.24', 'lle': '0.92', 'sei': '10.33'};CHEMBL4527910;;CHEMBL4527910;5.01;0;http://www.openphacts.org/units/Nanomolar;3160464;=;1;1;=;;Ki;nM;;9800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.8
;;18945022;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(N1CCN(c2ccccc2)CC1)N(c1nccc2ccccc12)[C@@H]1CCCNC1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.12', 'le': '0.22', 'lle': '1.30', 'sei': '9.74'};CHEMBL4456204;;CHEMBL4456204;5.04;0;http://www.openphacts.org/units/Nanomolar;3160467;=;1;1;=;;Ki;nM;;9200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.2
;;18945023;[];CHEMBL4329577;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1ccc2c(N3CCN(C(=O)N(c4nccc5ccccc45)[C@@H]4CCCNC4)CC3)noc2c1;;;CHEMBL4325911;Bioorg Med Chem Lett;2018.0;{'bei': '12.58', 'le': '0.23', 'lle': '1.73', 'sei': '7.62'};CHEMBL4525277;;CHEMBL4525277;5.92;0;http://www.openphacts.org/units/Nanomolar;3160468;=;1;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.2
;;18983926;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(CC(=O)N4CCC4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '17.12', 'le': '0.32', 'lle': '2.16', 'sei': '14.52'};CHEMBL4443868;;CHEMBL4443868;5.54;0;http://www.openphacts.org/units/Nanomolar;3166810;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;18983928;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(CC(=O)N4CC(F)C4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '16.22', 'le': '0.30', 'lle': '2.21', 'sei': '14.52'};CHEMBL4445829;;CHEMBL4445829;5.54;0;http://www.openphacts.org/units/Nanomolar;3166813;=;1;1;=;;Ki;nM;;2900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.9
;;18983929;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(CC(=O)N(C)C)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '16.79', 'le': '0.31', 'lle': '1.99', 'sei': '13.71'};CHEMBL4302264;;CHEMBL4302264;5.23;0;http://www.openphacts.org/units/Nanomolar;3166814;=;1;1;=;;Ki;nM;;5900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.9
;;18983930;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(Cc4ccccn4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '18.44', 'le': '0.33', 'lle': '1.26', 'sei': '19.06'};CHEMBL4539619;;CHEMBL4539619;5.85;0;http://www.openphacts.org/units/Nanomolar;3166815;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
;;18983933;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(Cc4ncco4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '19.67', 'le': '0.36', 'lle': '1.86', 'sei': '13.79'};CHEMBL4526512;;CHEMBL4526512;6.05;0;http://www.openphacts.org/units/Nanomolar;3166818;=;1;1;=;;Ki;nM;;900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.9
;;18983934;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(CC4CCOC4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '18.11', 'le': '0.33', 'lle': '1.43', 'sei': '20.78'};CHEMBL4446706;;CHEMBL4446706;5.62;0;http://www.openphacts.org/units/Nanomolar;3166819;=;1;1;=;;Ki;nM;;2400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.4
;;18983935;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(-c2cnc3ccn(CC4CCC4)c3c2)ccc1F;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '20.24', 'le': '0.37', 'lle': '1.01', 'sei': '33.44'};CHEMBL4537967;;CHEMBL4537967;5.96;0;http://www.openphacts.org/units/Nanomolar;3166820;=;1;1;=;;Ki;nM;;1100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.1
;;18983955;[];CHEMBL4339665;Displacement of [3H]dofetilide from recombinant human ERG expressed in HEK293 cell membranes measured after 80 mins by TopCount scintillation analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;O=C(Cn1ccc2ncc(-c3cccc(C(F)(F)F)c3)cc21)NC1CC1;;;CHEMBL4339196;ACS Med Chem Lett;2019.0;{'bei': '14.78', 'le': '0.28', 'lle': '1.31', 'sei': '11.32'};CHEMBL4475155;;CHEMBL4475155;5.31;0;http://www.openphacts.org/units/Nanomolar;3166842;=;1;1;=;;Ki;nM;;4900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.9
;;19133039;[];CHEMBL4375199;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by HPLC analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C=CC(=O)Nc1cccc(Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)c1;;;CHEMBL4373703;J Med Chem;2019.0;{'bei': '14.82', 'le': '0.27', 'lle': '0.89', 'sei': '6.14'};CHEMBL4554990;;CHEMBL4554990;6.28;0;http://www.openphacts.org/units/Nanomolar;3193398;=;1;1;=;;Ki;nM;;530.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;530.0
;;19133040;[];CHEMBL4375199;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by HPLC analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C=CC(=O)N[C@@H]1CCC[C@H](Nc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)C1;;;CHEMBL4373703;J Med Chem;2019.0;{'bei': '13.37', 'le': '0.25', 'lle': '1.20', 'sei': '5.62'};CHEMBL4469908;;CHEMBL4469908;5.75;0;http://www.openphacts.org/units/Nanomolar;3193399;=;1;1;=;;Ki;nM;;1800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1800.0
;;19133041;[];CHEMBL4375199;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by HPLC analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C=CC(=O)NC12CCC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)(C1)C2;;;CHEMBL4373703;J Med Chem;2019.0;{'bei': '13.77', 'le': '0.25', 'lle': '1.59', 'sei': '5.76'};CHEMBL4441219;;CHEMBL4441219;5.89;0;http://www.openphacts.org/units/Nanomolar;3193402;=;1;1;=;;Ki;nM;;1300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1300.0
;;19133042;[];CHEMBL4375199;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by HPLC analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C=CC(=O)N1CC2(CC(Nc3ncnc(N)c3-c3ccc(Oc4ccccc4)cc3)C2)C1;;;CHEMBL4373703;J Med Chem;2019.0;{'bei': '14.29', 'le': '0.26', 'lle': '2.00', 'sei': '6.54'};CHEMBL4515024;;CHEMBL4515024;6.11;0;http://www.openphacts.org/units/Nanomolar;3193406;=;1;1;=;;Ki;nM;;780.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;780.0
;;19133043;[];CHEMBL4375199;Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential by HPLC analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1;;;CHEMBL4373703;J Med Chem;2019.0;{'bei': '12.83', 'le': '0.24', 'lle': '1.16', 'sei': '5.90'};CHEMBL4072833;EVOBRUTINIB;CHEMBL4072833;5.51;0;http://www.openphacts.org/units/Nanomolar;3193408;=;1;1;=;;Ki;nM;;3100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;3100.0
;;19207463;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccccc4)cc3)nc2c1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '16.66', 'le': '0.31', 'lle': '-0.28', 'sei': '19.65'};CHEMBL4541477;;CHEMBL4541477;5.64;0;http://www.openphacts.org/units/Nanomolar;3205710;=;1;1;=;;Ki;nM;;2314.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2314.0
;;19207464;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4cccnc4)cc3)nc2c1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '17.23', 'le': '0.32', 'lle': '0.54', 'sei': '14.06'};CHEMBL4525823;;CHEMBL4525823;5.85;0;http://www.openphacts.org/units/Nanomolar;3205711;=;1;1;=;;Ki;nM;;1427.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1427.0
;;19207465;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cn1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '15.90', 'le': '0.30', 'lle': '0.63', 'sei': '9.14'};CHEMBL4443018;;CHEMBL4443018;5.65;0;http://www.openphacts.org/units/Nanomolar;3205712;=;1;1;=;;Ki;nM;;2250.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2250.0
;;19207466;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '17.09', 'le': '0.31', 'lle': '0.42', 'sei': '11.84'};CHEMBL4472207;;CHEMBL4472207;6.21;0;http://www.openphacts.org/units/Nanomolar;3205713;=;1;1;=;;Ki;nM;;616.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;616.0
;;19207468;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Oc1ccc(-c2ccc(-c3nc4cc(C(F)(F)F)ccc4[nH]3)cc2)cc1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '16.33', 'le': '0.30', 'lle': '0.16', 'sei': '11.83'};CHEMBL4575608;;CHEMBL4575608;5.79;0;http://www.openphacts.org/units/Nanomolar;3205715;=;1;1;=;;Ki;nM;;1641.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1641.0
;;19207469;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cc2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '13.94', 'le': '0.26', 'lle': '0.42', 'sei': '17.31'};CHEMBL4453601;;CHEMBL4453601;6.09;0;http://www.openphacts.org/units/Nanomolar;3205716;=;1;1;=;;Ki;nM;;820.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;820.0
;;19207470;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CN1CCN(c2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cc3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '14.56', 'le': '0.27', 'lle': '1.31', 'sei': '13.26'};CHEMBL4447657;;CHEMBL4447657;6.37;0;http://www.openphacts.org/units/Nanomolar;3205717;=;1;1;=;;Ki;nM;;426.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;426.0
;;19207471;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;FC(F)(F)c1ccc2[nH]c(-c3ccc(-c4ccc(N5CCOCC5)nc4)cc3)nc2c1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.51', 'le': '0.22', 'lle': '-0.27', 'sei': '9.04'};CHEMBL4574644;;CHEMBL4574644;4.88;0;http://www.openphacts.org/units/Nanomolar;3205718;=;1;1;=;;Ki;nM;;13040.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;13040.0
;;19207472;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC1(C(=O)O)CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.87', 'le': '0.23', 'lle': '0.29', 'sei': '5.60'};CHEMBL4476596;;CHEMBL4476596;5.32;0;http://www.openphacts.org/units/Nanomolar;3205719;=;1;1;=;;Ki;nM;;4800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.8
;;19207473;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1(CNc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.71', 'le': '0.22', 'lle': '0.30', 'sei': '4.74'};CHEMBL4534257;;CHEMBL4534257;4.92;0;http://www.openphacts.org/units/Nanomolar;3205720;=;1;1;=;;Ki;nM;;12120.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.12
;;19207474;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1CCCCC1Nc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.16', 'le': '0.23', 'lle': '0.05', 'sei': '5.25'};CHEMBL4554202;;CHEMBL4554202;5.45;0;http://www.openphacts.org/units/Nanomolar;3205721;=;1;1;=;;Ki;nM;;3560.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.56
;;19207475;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC1(C)CN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1CC(=O)O;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.10', 'le': '0.23', 'lle': '0.09', 'sei': '6.06'};CHEMBL4562424;;CHEMBL4562424;5.76;0;http://www.openphacts.org/units/Nanomolar;3205722;=;1;1;=;;Ki;nM;;1740.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.74
;;19207476;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC1(C(=O)O)CCCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.73', 'le': '0.24', 'lle': '0.67', 'sei': '6.00'};CHEMBL4516271;;CHEMBL4516271;5.70;0;http://www.openphacts.org/units/Nanomolar;3205723;=;1;1;=;;Ki;nM;;1980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.98
;;19207477;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1CCC(Nc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.11', 'le': '0.23', 'lle': '0.03', 'sei': '5.23'};CHEMBL4461413;;CHEMBL4461413;5.43;0;http://www.openphacts.org/units/Nanomolar;3205724;=;1;1;=;;Ki;nM;;3750.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.75
;;19207478;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)c1ccc(CNc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.80', 'le': '0.20', 'lle': '-0.73', 'sei': '4.74'};CHEMBL4577468;;CHEMBL4577468;4.92;0;http://www.openphacts.org/units/Nanomolar;3205725;=;1;1;=;;Ki;nM;;11890.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.89
;;19207479;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)CC1CCN(c2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.79', 'le': '0.23', 'lle': '0.25', 'sei': '5.56'};CHEMBL4450287;;CHEMBL4450287;5.28;0;http://www.openphacts.org/units/Nanomolar;3205726;=;1;1;=;;Ki;nM;;5220.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.22
;;19207481;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1)C(=O)O;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.04', 'le': '0.23', 'lle': '0.26', 'sei': '5.04'};CHEMBL4585408;;CHEMBL4585408;5.09;0;http://www.openphacts.org/units/Nanomolar;3205728;=;1;1;=;;Ki;nM;;8140.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.14
;;19207482;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)c1ccc(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)cc1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '13.25', 'le': '0.25', 'lle': '0.04', 'sei': '5.81'};CHEMBL4467163;;CHEMBL4467163;5.87;0;http://www.openphacts.org/units/Nanomolar;3205729;=;1;1;=;;Ki;nM;;1360.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.36
;;19207483;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.74', 'le': '0.22', 'lle': '-0.09', 'sei': '5.22'};CHEMBL2408632;;CHEMBL2408632;5.27;0;http://www.openphacts.org/units/Nanomolar;3205730;=;1;1;=;;Ki;nM;;5390.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.39
;;19207484;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CCC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.80', 'le': '0.21', 'lle': '-0.27', 'sei': '4.65'};CHEMBL4460750;;CHEMBL4460750;4.70;0;http://www.openphacts.org/units/Nanomolar;3205731;=;1;1;=;;Ki;nM;;20050.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;20.05
;;19207485;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)[C@H]1CC[C@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.15', 'le': '0.23', 'lle': '0.09', 'sei': '5.40'};CHEMBL2408633;;CHEMBL2408633;5.45;0;http://www.openphacts.org/units/Nanomolar;3205732;=;1;1;=;;Ki;nM;;3520.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.52
;;19207486;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.81', 'le': '0.23', 'lle': '0.39', 'sei': '4.92'};CHEMBL4461148;;CHEMBL4461148;4.97;0;http://www.openphacts.org/units/Nanomolar;3205733;=;1;1;=;;Ki;nM;;10750.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.75
;;19207487;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1CC(Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)C1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.15', 'le': '0.21', 'lle': '0.11', 'sei': '4.65'};CHEMBL4467830;;CHEMBL4467830;4.69;0;http://www.openphacts.org/units/Nanomolar;3205734;=;1;1;=;;Ki;nM;;20230.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;20.23
;;19207488;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1CC1COc1ccc(-c2ccc(-c3nc4cc(Cl)ccc4[nH]3)cn2)cn1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.22', 'le': '0.21', 'lle': '0.28', 'sei': '4.68'};CHEMBL4527253;;CHEMBL4527253;4.72;0;http://www.openphacts.org/units/Nanomolar;3205735;=;1;1;=;;Ki;nM;;18980.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;18.98
;;19207489;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C1(COc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)COC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.87', 'le': '0.23', 'lle': '1.36', 'sei': '4.70'};CHEMBL4527223;;CHEMBL4527223;5.18;0;http://www.openphacts.org/units/Nanomolar;3205736;=;1;1;=;;Ki;nM;;6540.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.54
;;19207490;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.93', 'le': '0.23', 'lle': '-0.23', 'sei': '5.47'};CHEMBL4453443;;CHEMBL4453443;5.52;0;http://www.openphacts.org/units/Nanomolar;3205737;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;19207491;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.85', 'le': '0.20', 'lle': '-0.73', 'sei': '5.33'};CHEMBL4452940;;CHEMBL4452940;5.39;0;http://www.openphacts.org/units/Nanomolar;3205738;=;1;1;=;;Ki;nM;;4100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.1
;;19207492;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.16', 'le': '0.19', 'lle': '-0.66', 'sei': '4.67'};CHEMBL4543944;;CHEMBL4543944;4.72;0;http://www.openphacts.org/units/Nanomolar;3205739;=;1;1;=;;Ki;nM;;19000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.0
;;19207493;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.67', 'le': '0.22', 'lle': '0.04', 'sei': '5.37'};CHEMBL4458847;;CHEMBL4458847;5.42;0;http://www.openphacts.org/units/Nanomolar;3205740;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
;;19207494;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(F)ccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.39', 'le': '0.21', 'lle': '-0.15', 'sei': '5.04'};CHEMBL4483357;;CHEMBL4483357;5.09;0;http://www.openphacts.org/units/Nanomolar;3205741;=;1;1;=;;Ki;nM;;8200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.2
;;19207495;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(Cl)cnc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.92', 'le': '0.21', 'lle': '-0.08', 'sei': '4.45'};CHEMBL4592144;;CHEMBL4592144;5.07;0;http://www.openphacts.org/units/Nanomolar;3205742;=;1;1;=;;Ki;nM;;8600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.6
;;19207496;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2c1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.28', 'le': '0.22', 'lle': '0.60', 'sei': '4.46'};CHEMBL4561313;;CHEMBL4561313;5.57;0;http://www.openphacts.org/units/Nanomolar;3205743;=;1;1;=;;Ki;nM;;2700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.7
;;19207497;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5ccccc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.67', 'le': '0.20', 'lle': '-0.53', 'sei': '4.53'};CHEMBL4443023;;CHEMBL4443023;4.57;0;http://www.openphacts.org/units/Nanomolar;3205744;=;1;1;=;;Ki;nM;;26900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;26.9
;;19207498;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@@H](Oc2ccc(-c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)cn2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '9.31', 'le': '0.18', 'lle': '-0.88', 'sei': '4.07'};CHEMBL4530290;;CHEMBL4530290;4.63;0;http://www.openphacts.org/units/Nanomolar;3205745;=;1;1;=;;Ki;nM;;23400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;23.4
;;19207499;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc2[nH]c(-c3ccc(-c4ccc(O[C@H]5CC[C@@H](CC(=O)O)CC5)nc4)nc3)nc2n1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '9.63', 'le': '0.18', 'lle': '-0.08', 'sei': '3.59'};CHEMBL4453213;;CHEMBL4453213;4.42;0;http://www.openphacts.org/units/Nanomolar;3205746;=;1;1;=;;Ki;nM;;37700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;37.7
;;19207501;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.57', 'le': '0.20', 'lle': '-0.35', 'sei': '5.81'};CHEMBL4572398;;CHEMBL4572398;5.31;0;http://www.openphacts.org/units/Nanomolar;3205748;=;1;1;=;;Ki;nM;;4900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.9
;;19207502;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(Cl)ccc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.40', 'le': '0.22', 'lle': '0.05', 'sei': '5.85'};CHEMBL4473500;;CHEMBL4473500;5.35;0;http://www.openphacts.org/units/Nanomolar;3205749;=;1;1;=;;Ki;nM;;4500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.5
;;19207503;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cc(F)cc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '11.45', 'le': '0.22', 'lle': '0.47', 'sei': '5.90'};CHEMBL4464262;;CHEMBL4464262;5.39;0;http://www.openphacts.org/units/Nanomolar;3205750;=;1;1;=;;Ki;nM;;4100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.1
;;19207504;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(F)c(F)cc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '9.33', 'le': '0.18', 'lle': '-0.53', 'sei': '4.81'};CHEMBL4592655;;CHEMBL4592655;4.39;0;http://www.openphacts.org/units/Nanomolar;3205751;=;1;1;=;;Ki;nM;;40700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;40.7
;;19207505;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5c(F)cccc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.98', 'le': '0.21', 'lle': '0.19', 'sei': '5.44'};CHEMBL4461166;;CHEMBL4461166;4.97;0;http://www.openphacts.org/units/Nanomolar;3205752;=;1;1;=;;Ki;nM;;10700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.7
;;19207506;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5ccccc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.56', 'le': '0.20', 'lle': '-0.05', 'sei': '5.03'};CHEMBL4469452;;CHEMBL4469452;4.59;0;http://www.openphacts.org/units/Nanomolar;3205753;=;1;1;=;;Ki;nM;;25700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;25.7
;;19207507;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=C(O)C[C@H]1CC[C@H](OC2CCN(c3ccc(-c4nc5cc(C(F)(F)F)cnc5[nH]4)cn3)CC2)CC1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '9.77', 'le': '0.19', 'lle': '-0.14', 'sei': '4.72'};CHEMBL4531344;;CHEMBL4531344;4.92;0;http://www.openphacts.org/units/Nanomolar;3205754;=;1;1;=;;Ki;nM;;12000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;12.0
;;19207508;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;N#Cc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2c1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '12.02', 'le': '0.22', 'lle': '1.00', 'sei': '4.80'};CHEMBL4452750;;CHEMBL4452750;5.52;0;http://www.openphacts.org/units/Nanomolar;3205755;=;1;1;=;;Ki;nM;;3000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.0
;;19207509;[];CHEMBL4392494;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;COc1ccc2[nH]c(-c3ccc(N4CCC(O[C@H]5CC[C@H](CC(=O)O)CC5)CC4)nc3)nc2n1;;;CHEMBL4390688;Bioorg Med Chem Lett;2019.0;{'bei': '10.07', 'le': '0.19', 'lle': '0.64', 'sei': '4.13'};CHEMBL4524803;;CHEMBL4524803;4.69;0;http://www.openphacts.org/units/Nanomolar;3205756;=;1;1;=;;Ki;nM;;20500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;20.5
;;19430773;[];CHEMBL4428885;Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells after 45 mins by scintillation counting analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;O=S(=O)(Nc1ncns1)c1ccc2c(-c3ccc(C(F)(F)F)c(Cl)c3)nccc2c1;;;CHEMBL4428053;J Med Chem;2016.0;{'bei': '12.10', 'le': '0.26', 'lle': '0.47', 'sei': '6.72'};CHEMBL3682663;;CHEMBL3682663;5.70;0;http://www.openphacts.org/units/Nanomolar;3245556;=;1;1;=;;Ki;nM;;2000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.0
;;19445387;[];CHEMBL4432469;Inhibition of [3H]dofetilide binding to human ERG expressed in HEK293 cell membranes after 60 mins by liquid scintillation spectrometric analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1[C@H](CCc2ccccc2)CCC[C@@H]1CC(=O)c1ccccc1;;;CHEMBL4431349;Bioorg Med Chem Lett;2016.0;{'bei': '20.60', 'le': '0.38', 'lle': '1.87', 'sei': '32.61'};CHEMBL122425;;CHEMBL122425;6.62;0;http://www.openphacts.org/units/Nanomolar;3248541;=;1;1;=;;Ki;nM;;238.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.238
;;19445388;[];CHEMBL4432469;Inhibition of [3H]dofetilide binding to human ERG expressed in HEK293 cell membranes after 60 mins by liquid scintillation spectrometric analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccccc1CCN1CCN(CCc2ccccc2OC)CC1.Cl.Cl;;;CHEMBL4431349;Bioorg Med Chem Lett;2016.0;{'bei': '16.90', 'le': '0.31', 'lle': '2.88', 'sei': '24.02'};CHEMBL4443407;;CHEMBL144393;5.99;0;http://www.openphacts.org/units/Nanomolar;3248543;=;1;1;=;;Ki;nM;;1020.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.02
;;19445389;[];CHEMBL4432469;Inhibition of [3H]dofetilide binding to human ERG expressed in HEK293 cell membranes after 60 mins by liquid scintillation spectrometric analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;Cl.Cl.Clc1ccccc1CCN1CCN(CCc2ccccc2Cl)CC1;;;CHEMBL4431349;Bioorg Med Chem Lett;2016.0;{'bei': '16.42', 'le': '0.34', 'lle': '1.57', 'sei': '92.08'};CHEMBL4442303;;CHEMBL4595039;5.97;0;http://www.openphacts.org/units/Nanomolar;3248546;=;1;1;=;;Ki;nM;;1080.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.08
;;19445390;[];CHEMBL4432469;Inhibition of [3H]dofetilide binding to human ERG expressed in HEK293 cell membranes after 60 mins by liquid scintillation spectrometric analysis;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccccc1CCN1CCN(CCc2ccccc2)CC1.Cl.Cl;;;CHEMBL4431349;Bioorg Med Chem Lett;2016.0;{'bei': '17.05', 'le': '0.31', 'lle': '2.43', 'sei': '35.21'};CHEMBL4519939;;CHEMBL4597762;5.53;0;http://www.openphacts.org/units/Nanomolar;3248548;=;1;1;=;;Ki;nM;;2940.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;2.94
;;19449106;[];CHEMBL4433274;Displacement of [3H]Dofetilide from human ERG human;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@@H]1CCCN1[C@H]1C[C@H](c2ccc(-c3ccc(C#N)cc3)cc2)C1;;;CHEMBL4433195;Bioorg Med Chem;2017.0;{'bei': '22.03', 'le': '0.40', 'lle': '2.01', 'sei': '25.79'};CHEMBL4516622;;CHEMBL4516622;6.97;0;http://www.openphacts.org/units/Nanomolar;3249486;=;1;1;=;;Ki;nM;;107.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;107.0
;;19449110;[];CHEMBL4433272;Displacement of [3H]Dofetilide from human ERG human expressed in HEK293 cells incubated for 45 mins;B;;;BAO_0000192;BAO_0000219;cell-based format;CN1C[C@H]2CCN(c3ccc(-c4ccc(-n5ncccc5=O)cc4)cc3)[C@H]2C1;;;CHEMBL4433195;Bioorg Med Chem;2017.0;{'bei': '13.57', 'le': '0.25', 'lle': '2.01', 'sei': '12.22'};CHEMBL4527011;;CHEMBL4527011;5.05;0;http://www.openphacts.org/units/Nanomolar;3249485;=;1;1;=;;Ki;nM;;8830.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;8830.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452701;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2ccnc(NC(=O)Cc3ccc(F)cc3F)c2)c2c(N)ncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '11.28', 'le': '0.21', 'lle': '1.40', 'sei': '4.39'};CHEMBL4748010;;CHEMBL4748010;5.08;0;http://www.openphacts.org/units/Nanomolar;3518965;=;1;1;=;;Ki;nM;;8300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.3
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452702;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2c(N)ncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '11.06', 'le': '0.21', 'lle': '0.91', 'sei': '4.29'};CHEMBL4790022;;CHEMBL4790022;4.97;0;http://www.openphacts.org/units/Nanomolar;3518966;=;1;1;=;;Ki;nM;;10800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;10.8
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452703;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '12.18', 'le': '0.23', 'lle': '0.81', 'sei': '5.89'};CHEMBL3661464;;CHEMBL3661464;5.28;0;http://www.openphacts.org/units/Nanomolar;3518967;=;1;1;=;;Ki;nM;;5200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;5.2
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452704;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(C#N)cc3)c2)c2cncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '12.13', 'le': '0.22', 'lle': '1.46', 'sei': '4.53'};CHEMBL3661466;;CHEMBL3661466;5.15;0;http://www.openphacts.org/units/Nanomolar;3518968;=;1;1;=;;Ki;nM;;7100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.1
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452705;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(C#N)cc3)c2)c2c(N)ncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '11.41', 'le': '0.21', 'lle': '1.74', 'sei': '3.59'};CHEMBL4794903;;CHEMBL4794903;5.01;0;http://www.openphacts.org/units/Nanomolar;3518969;=;1;1;=;;Ki;nM;;9700.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;9.7
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452706;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C(F)(F)F)n3)c2)c2cnccc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '12.83', 'le': '0.24', 'lle': '1.75', 'sei': '6.18'};CHEMBL3955023;;CHEMBL3955023;5.85;0;http://www.openphacts.org/units/Nanomolar;3518970;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452707;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cncnc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '11.47', 'le': '0.21', 'lle': '1.57', 'sei': '4.58'};CHEMBL3661485;;CHEMBL3661485;4.92;0;http://www.openphacts.org/units/Nanomolar;3518971;=;1;1;=;;Ki;nM;;11900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.9
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452708;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cnccc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '13.66', 'le': '0.25', 'lle': '1.89', 'sei': '6.18'};CHEMBL3942935;;CHEMBL3942935;5.85;0;http://www.openphacts.org/units/Nanomolar;3518972;=;1;1;=;;Ki;nM;;1400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;1.4
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452709;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cncc(F)c21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '11.08', 'le': '0.20', 'lle': '0.86', 'sei': '5.22'};CHEMBL3982112;;CHEMBL3982112;4.95;0;http://www.openphacts.org/units/Nanomolar;3518973;=;1;1;=;;Ki;nM;;11300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;11.3
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452710;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cn3ccc(C4CC4)n3)c2)c2cnc(N)nc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '9.92', 'le': '0.18', 'lle': '1.48', 'sei': '3.30'};CHEMBL3666257;;CHEMBL3666257;4.41;0;http://www.openphacts.org/units/Nanomolar;3518974;=;1;1;=;;Ki;nM;;38900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;38.9
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22452711;[];CHEMBL4681389;Inhibition of dofetilide binding to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)n1cc(C(=O)c2cncc(NC(=O)Cc3ccc(Cl)cc3)c2)c2cnc(N)nc21;;;CHEMBL4680090;J Med Chem;2016.0;{'bei': '10.63', 'le': '0.20', 'lle': '0.71', 'sei': '4.12'};CHEMBL3666254;;CHEMBL3666254;4.77;0;http://www.openphacts.org/units/Nanomolar;3518975;=;1;1;=;;Ki;nM;;16900.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;16.9
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22951112;[];CHEMBL4766286;Inhibition of human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;CC#C[C@@H](CC(=O)O)c1ccc(OCc2ccc(CN3CCC4(C=Cc5ccccc54)CC3)c(OC)c2)cc1;;;CHEMBL4765234;J Med Chem;2016.0;{'bei': '9.97', 'le': '0.18', 'lle': '-1.22', 'sei': '8.81'};CHEMBL4781604;;CHEMBL4781604;5.20;0;http://www.openphacts.org/units/Nanomolar;3564163;=;1;1;=;;Ki;nM;;6300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;6.3
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992017;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(C(N)=O)ccc2nc1N)c1cc(F)ccc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '11.80', 'le': '0.22', 'lle': '1.24', 'sei': '4.24'};CHEMBL4783261;;CHEMBL4783261;4.62;0;http://www.openphacts.org/units/Nanomolar;3570869;=;1;1;=;;Ki;nM;;24000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;24.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992018;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(C#N)ccc2nc1N)c1cc(F)c(F)cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '12.06', 'le': '0.22', 'lle': '0.43', 'sei': '5.26'};CHEMBL4778108;;CHEMBL4778108;4.72;0;http://www.openphacts.org/units/Nanomolar;3570870;=;1;1;=;;Ki;nM;;19000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;19.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992019;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(C(N)=O)ccc2nc1N)c1cc(F)c(F)cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '13.16', 'le': '0.25', 'lle': '1.87', 'sei': '4.94'};CHEMBL4794362;;CHEMBL4794362;5.39;0;http://www.openphacts.org/units/Nanomolar;3570871;=;1;1;=;;Ki;nM;;4100.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.1
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992020;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(F)ccc2nc1N)c1cc(F)c(F)cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '13.94', 'le': '0.26', 'lle': '0.80', 'sei': '8.12'};CHEMBL4784517;;CHEMBL4784517;5.36;0;http://www.openphacts.org/units/Nanomolar;3570872;=;1;1;=;;Ki;nM;;4400.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;4.4
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992021;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(C(N)=O)ccc2nc1N)c1cc2[nH]ncc2cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '11.82', 'le': '0.22', 'lle': '1.77', 'sei': '3.55'};CHEMBL4781765;;CHEMBL4781765;4.89;0;http://www.openphacts.org/units/Nanomolar;3570873;=;1;1;=;;Ki;nM;;13000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;13.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992022;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(C(N)=O)ccc2nc1N)c1ncc(F)cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '11.39', 'le': '0.21', 'lle': '1.69', 'sei': '3.66'};CHEMBL4797664;;CHEMBL4797664;4.47;0;http://www.openphacts.org/units/Nanomolar;3570874;=;1;1;=;;Ki;nM;;34000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;34.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992026;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(F)ccc2nc1N)c1cc2c(cnn2CCO)cc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '11.75', 'le': '0.22', 'lle': '1.46', 'sei': '4.89'};CHEMBL4778780;;CHEMBL4778780;5.08;0;http://www.openphacts.org/units/Nanomolar;3570878;=;1;1;=;;Ki;nM;;8300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;8.3
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992030;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(F)cc(F)c2nc1N)c1cc(C(=O)O)ccc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '10.72', 'le': '0.20', 'lle': '0.28', 'sei': '4.26'};CHEMBL4785484;;CHEMBL4785484;4.40;0;http://www.openphacts.org/units/Nanomolar;3570882;=;1;1;=;;Ki;nM;;40000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;40.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992032;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;C[C@H](Oc1cc2cc(F)cc(F)c2nc1N)c1[nH]c(=O)ccc1-n1cccn1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '10.96', 'le': '0.20', 'lle': '1.09', 'sei': '4.25'};CHEMBL4796436;;CHEMBL4796436;4.20;0;http://www.openphacts.org/units/Nanomolar;3570884;=;1;1;=;;Ki;nM;;63000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;63.0
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;22992033;[];CHEMBL4775388;Binding affinity to human ERG by dofetilide fluorescence polarization binding assay;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1n[nH]cc1-c1cnc(N)c(O[C@@H](C)c2cc(F)ccc2-n2cccn2)c1;;;CHEMBL4765473;J Med Chem;2021.0;{'bei': '14.32', 'le': '0.26', 'lle': '1.59', 'sei': '5.73'};CHEMBL4787096;;CHEMBL4787096;5.42;0;http://www.openphacts.org/units/Nanomolar;3570885;=;1;1;=;;Ki;nM;;3800.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;3.8
{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targeting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'};;23313249;[];CHEMBL4844548;Binding affinity to human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21;;;CHEMBL4842371;J Med Chem;2021.0;{'bei': '14.68', 'le': '0.28', 'lle': '3.05', 'sei': '8.96'};CHEMBL4867565;;CHEMBL4867565;6.03;0;http://www.openphacts.org/units/Nanomolar;3628453;=;1;1;=;;Ki;nM;;940.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;0.94
{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'};;24366881;[];CHEMBL5036234;Displacement of [3H]-dofetilide from human ERG;B;;;BAO_0000192;BAO_0000357;single protein format;Cc1cnc2c(-c3ccc(C(=O)N(c4ncccc4C)[C@@H]4CCCNC4)cc3F)cnn2c1;;;CHEMBL5034046;ACS Med Chem Lett;2022.0;{'bei': '11.57', 'le': '0.21', 'lle': '1.19', 'sei': '6.82'};CHEMBL5088467;;CHEMBL5088467;5.14;0;http://www.openphacts.org/units/Nanomolar;3775768;=;1;1;=;;Ki;nM;;7200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;uM;UO_0000065;;7.2
{'action_type': 'BINDING AGENT', 'description': 'Binds to a substance such as a cell surface antigen, targeting a drug to that location, but not necessarily affecting the functioning of the substance itself', 'parent_type': 'OTHER'};;24513609;[];CHEMBL5056440;Binding affinity to human ERG assessed as inhibition constant;B;;;BAO_0000192;BAO_0000357;single protein format;CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1;;;CHEMBL5055640;J Med Chem;2021.0;{'bei': '15.07', 'le': '0.28', 'lle': '0.66', 'sei': '16.27'};CHEMBL17157;TERFENADINE;CHEMBL17157;7.11;0;http://www.openphacts.org/units/Nanomolar;3838311;=;1;1;=;;Ki;nM;;78.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;78.0
;616128;27135653;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.39', 'le': '0.19', 'lle': '0.67', 'sei': '6.58'};CHEMBL6056182;;CHEMBL6056182;4.70;1;http://www.openphacts.org/units/Nanomolar;4239953;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616130;27135659;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1cncc(F)c1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.46', 'le': '0.20', 'lle': '0.36', 'sei': '6.87'};CHEMBL5759810;;CHEMBL5759810;4.90;1;http://www.openphacts.org/units/Nanomolar;4239954;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616136;27135677;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1[nH]ccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.84', 'le': '0.20', 'lle': '2.26', 'sei': '4.51'};CHEMBL6058376;;CHEMBL6058376;4.70;1;http://www.openphacts.org/units/Nanomolar;4239957;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616138;27135683;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nnc(Cl)cc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.50', 'le': '0.19', 'lle': '0.44', 'sei': '5.24'};CHEMBL5796119;;CHEMBL5796119;4.90;1;http://www.openphacts.org/units/Nanomolar;4239958;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616140;27135689;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5982671;;CHEMBL5982671;4.70;1;http://www.openphacts.org/units/Nanomolar;4239959;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616142;27135695;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cc(Cl)nnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.50', 'le': '0.19', 'lle': '0.44', 'sei': '5.24'};CHEMBL6019675;;CHEMBL6019675;4.90;1;http://www.openphacts.org/units/Nanomolar;4239960;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616148;27135713;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nnccc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.96', 'le': '0.20', 'lle': '1.75', 'sei': '5.24'};CHEMBL5900906;;CHEMBL5900906;4.90;1;http://www.openphacts.org/units/Nanomolar;4239963;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616150;27135719;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nnccc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5900906;;CHEMBL5900906;4.70;1;http://www.openphacts.org/units/Nanomolar;4239963;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616152;27135725;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C)(C)Oc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.02', 'le': '0.19', 'lle': '0.58', 'sei': '5.24'};CHEMBL6053796;;CHEMBL6053796;4.90;1;http://www.openphacts.org/units/Nanomolar;4239964;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616156;27135737;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5854342;;CHEMBL5854342;4.70;1;http://www.openphacts.org/units/Nanomolar;4239966;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616160;27135749;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(Cl)cncc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.10', 'le': '0.20', 'lle': '-0.16', 'sei': '6.87'};CHEMBL5842333;;CHEMBL5842333;4.90;1;http://www.openphacts.org/units/Nanomolar;4239967;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616162;27135755;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccnnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5761266;;CHEMBL5761266;4.70;1;http://www.openphacts.org/units/Nanomolar;4239968;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616174;27135791;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.26', 'le': '0.21', 'lle': '0.84', 'sei': '5.58'};CHEMBL5826481;;CHEMBL5826481;4.70;1;http://www.openphacts.org/units/Nanomolar;4239971;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616182;27135815;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5876088;;CHEMBL5876088;4.70;1;http://www.openphacts.org/units/Nanomolar;4239974;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616184;27135821;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5781609;;CHEMBL5781609;4.70;1;http://www.openphacts.org/units/Nanomolar;4239975;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616186;27135827;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5781609;;CHEMBL5781609;4.70;1;http://www.openphacts.org/units/Nanomolar;4239975;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616188;27135833;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Cl)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.20', 'le': '0.20', 'lle': '0.49', 'sei': '6.08'};CHEMBL5982773;;CHEMBL5982773;4.90;1;http://www.openphacts.org/units/Nanomolar;4239976;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616190;27135839;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1OC1COC1;;;CHEMBL5726098;;2019.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.78', 'sei': '4.57'};CHEMBL5900493;;CHEMBL5900493;4.70;1;http://www.openphacts.org/units/Nanomolar;4239977;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616194;27135851;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cnccn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5849363;;CHEMBL5849363;4.70;1;http://www.openphacts.org/units/Nanomolar;4239979;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616196;27135857;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nc(Cl)cnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.08', 'le': '0.20', 'lle': '0.45', 'sei': '5.82'};CHEMBL5798926;;CHEMBL5798926;4.90;1;http://www.openphacts.org/units/Nanomolar;4239980;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616200;27135869;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.71', 'le': '0.22', 'lle': '1.04', 'sei': '5.82'};CHEMBL5826481;;CHEMBL5826481;4.90;1;http://www.openphacts.org/units/Nanomolar;4239971;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616204;27135881;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccn2nccc2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.57', 'le': '0.18', 'lle': '0.65', 'sei': '5.30'};CHEMBL5896258;;CHEMBL5896258;4.70;1;http://www.openphacts.org/units/Nanomolar;4239982;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616206;27135887;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)c2ccncc12;;;CHEMBL5726098;;2019.0;{'bei': '9.20', 'le': '0.18', 'lle': '0.55', 'sei': '4.61'};CHEMBL6017954;;CHEMBL6017954;4.90;1;http://www.openphacts.org/units/Nanomolar;4239983;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616208;27135893;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(Cl)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.66', 'le': '0.19', 'lle': '0.25', 'sei': '5.58'};CHEMBL5883518;;CHEMBL5883518;4.70;1;http://www.openphacts.org/units/Nanomolar;4239984;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616210;27135899;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;1;http://www.openphacts.org/units/Nanomolar;4239985;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616214;27135911;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;1;http://www.openphacts.org/units/Nanomolar;4239987;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616216;27135917;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;1;http://www.openphacts.org/units/Nanomolar;4239987;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616218;27135923;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cnnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.09', 'le': '0.19', 'lle': '0.59', 'sei': '5.58'};CHEMBL5816995;;CHEMBL5816995;4.70;1;http://www.openphacts.org/units/Nanomolar;4239988;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616222;27135935;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.79', 'le': '0.20', 'lle': '1.42', 'sei': '5.58'};CHEMBL5846761;;CHEMBL5846761;4.70;1;http://www.openphacts.org/units/Nanomolar;4239989;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616228;27135953;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '9.90', 'le': '0.18', 'lle': '1.16', 'sei': '5.30'};CHEMBL5883008;;CHEMBL5883008;4.70;1;http://www.openphacts.org/units/Nanomolar;4239969;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616234;27135971;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5876088;;CHEMBL5876088;4.70;1;http://www.openphacts.org/units/Nanomolar;4239974;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616238;27135983;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;1;http://www.openphacts.org/units/Nanomolar;4239994;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616240;27135989;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;1;http://www.openphacts.org/units/Nanomolar;4239994;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616244;27136001;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;1;http://www.openphacts.org/units/Nanomolar;4239987;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616246;27136007;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)cn1;;;CHEMBL5726098;;2019.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5775380;;CHEMBL5775380;4.70;1;http://www.openphacts.org/units/Nanomolar;4239992;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616252;27136025;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;1;http://www.openphacts.org/units/Nanomolar;4239994;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616254;27136031;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.08', 'le': '0.20', 'lle': '0.45', 'sei': '5.82'};CHEMBL5799485;;CHEMBL5799485;4.90;1;http://www.openphacts.org/units/Nanomolar;4239998;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616280;27136109;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.46', 'le': '0.20', 'lle': '0.36', 'sei': '6.87'};CHEMBL6000039;;CHEMBL6000039;4.90;1;http://www.openphacts.org/units/Nanomolar;4240009;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616282;27136115;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;1;http://www.openphacts.org/units/Nanomolar;4240010;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616284;27136121;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOc1cnnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.18', 'le': '0.19', 'lle': '1.16', 'sei': '5.03'};CHEMBL5891111;;CHEMBL5891111;4.70;1;http://www.openphacts.org/units/Nanomolar;4240011;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616294;27136151;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1[C@H](O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.45', 'le': '0.19', 'lle': '1.11', 'sei': '5.58'};CHEMBL5896081;;CHEMBL5896081;4.70;0;http://www.openphacts.org/units/Nanomolar;4240016;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616296;27136157;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.45', 'le': '0.19', 'lle': '1.11', 'sei': '5.58'};CHEMBL5822977;;CHEMBL5822977;4.70;1;http://www.openphacts.org/units/Nanomolar;4240017;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616300;27136169;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cncnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL6040207;;CHEMBL6040207;4.70;1;http://www.openphacts.org/units/Nanomolar;4240018;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616302;27136175;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cnc(C)c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)n1;;;CHEMBL5726098;;2019.0;{'bei': '10.14', 'le': '0.19', 'lle': '0.80', 'sei': '5.58'};CHEMBL5787834;;CHEMBL5787834;4.70;1;http://www.openphacts.org/units/Nanomolar;4240019;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616304;27136181;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccsc12;;;CHEMBL5726098;;2019.0;{'bei': '10.01', 'le': '0.20', 'lle': '0.03', 'sei': '5.82'};CHEMBL5981733;;CHEMBL5981733;4.90;1;http://www.openphacts.org/units/Nanomolar;4240020;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616312;27136205;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.32', 'sei': '5.25'};CHEMBL6055613;;CHEMBL6055613;4.90;1;http://www.openphacts.org/units/Nanomolar;4240024;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616326;27136247;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(OC2COC2)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.36', 'le': '0.18', 'lle': '1.32', 'sei': '4.77'};CHEMBL5869725;;CHEMBL5869725;4.90;1;http://www.openphacts.org/units/Nanomolar;4240029;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616328;27136253;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.41', 'le': '0.18', 'lle': '0.81', 'sei': '4.18'};CHEMBL5926851;;CHEMBL5926851;4.90;1;http://www.openphacts.org/units/Nanomolar;4240030;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616330;27136259;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.02', 'le': '0.17', 'lle': '0.61', 'sei': '4.01'};CHEMBL5926851;;CHEMBL5926851;4.70;1;http://www.openphacts.org/units/Nanomolar;4240030;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616334;27136271;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.02', 'le': '0.17', 'lle': '0.61', 'sei': '4.01'};CHEMBL5926851;;CHEMBL5926851;4.70;1;http://www.openphacts.org/units/Nanomolar;4240030;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616338;27136283;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OCCNc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '9.86', 'le': '0.18', 'lle': '2.15', 'sei': '4.03'};CHEMBL5832128;;CHEMBL5832128;4.70;1;http://www.openphacts.org/units/Nanomolar;4240032;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616342;27136295;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CSc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.44', 'le': '0.19', 'lle': '0.18', 'sei': '5.58'};CHEMBL5746940;;CHEMBL5746940;4.70;1;http://www.openphacts.org/units/Nanomolar;4240034;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616346;27136307;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cc1C;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '0.79', 'sei': '5.24'};CHEMBL5929612;;CHEMBL5929612;4.90;1;http://www.openphacts.org/units/Nanomolar;4240036;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616350;27136319;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COCCOc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '8.93', 'le': '0.17', 'lle': '0.88', 'sei': '4.57'};CHEMBL5790750;;CHEMBL5790750;4.70;1;http://www.openphacts.org/units/Nanomolar;4240038;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616356;27136337;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(OCC(F)(F)F)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '8.92', 'le': '0.18', 'lle': '0.16', 'sei': '5.24'};CHEMBL6057597;;CHEMBL6057597;4.90;1;http://www.openphacts.org/units/Nanomolar;4240041;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616360;27136349;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Nc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.06', 'le': '0.19', 'lle': '1.32', 'sei': '4.26'};CHEMBL5849893;;CHEMBL5849893;4.70;1;http://www.openphacts.org/units/Nanomolar;4240043;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616362;27136355;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;N#Cc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.85', 'le': '0.19', 'lle': '1.03', 'sei': '4.35'};CHEMBL5992260;;CHEMBL5992260;4.70;1;http://www.openphacts.org/units/Nanomolar;4240044;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616364;27136361;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;N#CCOc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.27', 'le': '0.18', 'lle': '1.00', 'sei': '4.01'};CHEMBL5800793;;CHEMBL5800793;4.70;1;http://www.openphacts.org/units/Nanomolar;4240045;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616368;27136373;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ccc(OC(F)F)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.72', 'le': '0.18', 'lle': '0.95', 'sei': '5.03'};CHEMBL5805827;;CHEMBL5805827;4.70;1;http://www.openphacts.org/units/Nanomolar;4240047;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616370;27136379;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;C#CC(O)(c1ccc(OC)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.69', 'le': '0.19', 'lle': '1.31', 'sei': '5.24'};CHEMBL5761754;;CHEMBL5761754;4.90;1;http://www.openphacts.org/units/Nanomolar;4240048;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616376;27136397;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(C)(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.47', 'le': '0.18', 'lle': '0.72', 'sei': '5.03'};CHEMBL5881471;;CHEMBL5881471;4.70;1;http://www.openphacts.org/units/Nanomolar;4240051;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616378;27136403;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.05', 'le': '0.20', 'lle': '1.03', 'sei': '5.24'};CHEMBL5800084;;CHEMBL5800084;4.90;1;http://www.openphacts.org/units/Nanomolar;4240052;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616380;27136409;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.05', 'le': '0.20', 'lle': '1.03', 'sei': '5.24'};CHEMBL5800084;;CHEMBL5800084;4.90;1;http://www.openphacts.org/units/Nanomolar;4240052;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616382;27136415;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.63', 'le': '0.19', 'lle': '0.83', 'sei': '5.03'};CHEMBL5800084;;CHEMBL5800084;4.70;1;http://www.openphacts.org/units/Nanomolar;4240052;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616384;27136421;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5768114;;CHEMBL5768114;4.70;1;http://www.openphacts.org/units/Nanomolar;4240053;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616388;27136433;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.10', 'le': '0.19', 'lle': '1.41', 'sei': '5.03'};CHEMBL5981326;;CHEMBL5981326;4.70;1;http://www.openphacts.org/units/Nanomolar;4240054;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616394;27136451;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOc1ccc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.62', 'le': '0.20', 'lle': '1.36', 'sei': '5.24'};CHEMBL5749492;;CHEMBL5749492;4.90;1;http://www.openphacts.org/units/Nanomolar;4240057;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616400;27136469;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5768114;;CHEMBL5768114;4.90;1;http://www.openphacts.org/units/Nanomolar;4240053;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616402;27136475;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)(c1cncc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.20', 'le': '0.21', 'lle': '1.46', 'sei': '5.58'};CHEMBL5959053;;CHEMBL5959053;4.70;1;http://www.openphacts.org/units/Nanomolar;4240060;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616406;27136487;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ncc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.10', 'le': '0.21', 'lle': '1.49', 'sei': '5.58'};CHEMBL5889518;;CHEMBL5889518;4.70;1;http://www.openphacts.org/units/Nanomolar;4240062;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616408;27136493;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ncc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.63', 'le': '0.19', 'lle': '1.35', 'sei': '4.50'};CHEMBL5896422;;CHEMBL5896422;4.70;1;http://www.openphacts.org/units/Nanomolar;4240063;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616412;27136505;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.81', 'le': '0.20', 'lle': '0.72', 'sei': '5.88'};CHEMBL5860861;;CHEMBL5860861;4.90;1;http://www.openphacts.org/units/Nanomolar;4240065;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616414;27136511;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '10.97', 'le': '0.22', 'lle': '0.83', 'sei': '6.58'};CHEMBL6058437;;CHEMBL6058437;4.70;1;http://www.openphacts.org/units/Nanomolar;4240066;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616420;27136529;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(-c2ncnc3cc(N4CCOCC4)ccc23)s1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.94', 'le': '0.24', 'lle': '1.17', 'sei': '6.87'};CHEMBL5907528;;CHEMBL5907528;4.90;1;http://www.openphacts.org/units/Nanomolar;4240067;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616422;27136535;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '12.12', 'le': '0.23', 'lle': '1.23', 'sei': '6.87'};CHEMBL5763465;;CHEMBL5763465;4.90;1;http://www.openphacts.org/units/Nanomolar;4240068;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616432;27136565;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)(c1cccc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.23', 'le': '0.21', 'lle': '0.85', 'sei': '6.58'};CHEMBL5969254;;CHEMBL5969254;4.70;1;http://www.openphacts.org/units/Nanomolar;4240070;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616443;27136598;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.23', 'le': '0.22', 'lle': '0.92', 'sei': '6.87'};CHEMBL5942478;;CHEMBL5942478;4.90;1;http://www.openphacts.org/units/Nanomolar;4240075;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616477;27136700;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OCc1csc(C(O)c2cc(-c3ncnc4cc(N5C6CCC5COC6)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.16', 'le': '0.18', 'lle': '0.21', 'sei': '5.13'};CHEMBL6037677;;CHEMBL6037677;4.70;1;http://www.openphacts.org/units/Nanomolar;4240087;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616481;27136712;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cnc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '11.10', 'le': '0.21', 'lle': '1.49', 'sei': '5.58'};CHEMBL5831440;;CHEMBL5831440;4.70;1;http://www.openphacts.org/units/Nanomolar;4240082;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616483;27136718;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.14', 'le': '0.18', 'lle': '0.13', 'sei': '5.63'};CHEMBL5804021;;CHEMBL5804021;4.70;1;http://www.openphacts.org/units/Nanomolar;4240088;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616485;27136724;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.14', 'le': '0.18', 'lle': '0.13', 'sei': '5.63'};CHEMBL5804021;;CHEMBL5804021;4.70;1;http://www.openphacts.org/units/Nanomolar;4240088;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616489;27136736;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ncc34)cnc2F)sc1C;;;CHEMBL5726098;;2019.0;{'bei': '10.84', 'le': '0.21', 'lle': '1.68', 'sei': '5.05'};CHEMBL5991362;;CHEMBL5991362;4.90;1;http://www.openphacts.org/units/Nanomolar;4240090;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616493;27136748;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1csc(C(O)c2cnc(F)c(-c3ncnc4cc(N5CCOCC5)ncc34)c2)n1;;;CHEMBL5726098;;2019.0;{'bei': '10.72', 'le': '0.21', 'lle': '1.79', 'sei': '4.84'};CHEMBL6032229;;CHEMBL6032229;4.70;1;http://www.openphacts.org/units/Nanomolar;4240092;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616505;27136784;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CC(O)c1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726098;;2019.0;{'bei': '9.38', 'le': '0.19', 'lle': '0.18', 'sei': '5.13'};CHEMBL5864604;;CHEMBL5864604;4.70;1;http://www.openphacts.org/units/Nanomolar;4240098;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616507;27136790;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCn1cc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cn1;;;CHEMBL5726098;;2019.0;{'bei': '10.04', 'le': '0.19', 'lle': '0.48', 'sei': '6.16'};CHEMBL5742984;;CHEMBL5742984;4.70;1;http://www.openphacts.org/units/Nanomolar;4240099;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616511;27136802;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C(O)c2cnc(F)c(-c3ncnc4cc(N5CCOCC5)ncc34)c2)sc1C;;;CHEMBL5726098;;2019.0;{'bei': '10.84', 'le': '0.21', 'lle': '1.68', 'sei': '5.05'};CHEMBL6053505;;CHEMBL6053505;4.90;1;http://www.openphacts.org/units/Nanomolar;4240093;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616513;27136808;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)cnc2F)sc1C;;;CHEMBL5726098;;2019.0;{'bei': '10.86', 'le': '0.21', 'lle': '1.08', 'sei': '5.82'};CHEMBL5902129;;CHEMBL5902129;4.90;1;http://www.openphacts.org/units/Nanomolar;4240091;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616515;27136814;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)cnc2F)sc1C;;;CHEMBL5726098;;2019.0;{'bei': '10.41', 'le': '0.20', 'lle': '0.88', 'sei': '5.58'};CHEMBL5902129;;CHEMBL5902129;4.70;1;http://www.openphacts.org/units/Nanomolar;4240091;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616517;27136820;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)cc1C(O)c1nccs1;;;CHEMBL5726098;;2019.0;{'bei': '10.76', 'le': '0.21', 'lle': '0.58', 'sei': '6.58'};CHEMBL5801138;;CHEMBL5801138;4.70;1;http://www.openphacts.org/units/Nanomolar;4240100;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616531;27136862;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nccc1C(O)c1ccc(F)c(-c2nc(Cl)nc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.96', 'sei': '6.16'};CHEMBL5789812;;CHEMBL5789812;4.70;0;http://www.openphacts.org/units/Nanomolar;4240103;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616535;27136874;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;C#Cc1nc(-c2cc(C(O)c3nccs3)ccc2F)c2ccc(N3CCOCC3)cc2n1;;;CHEMBL5726098;;2019.0;{'bei': '10.98', 'le': '0.21', 'lle': '1.11', 'sei': '6.87'};CHEMBL5858570;;CHEMBL5858570;4.90;1;http://www.openphacts.org/units/Nanomolar;4240101;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616539;27136886;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccccn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.82', 'le': '0.20', 'lle': '0.81', 'sei': '6.58'};CHEMBL5798593;;CHEMBL5798593;4.70;1;http://www.openphacts.org/units/Nanomolar;4240105;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616541;27136892;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '10.10', 'le': '0.19', 'lle': '2.11', 'sei': '5.03'};CHEMBL5741788;;CHEMBL5741788;4.70;1;http://www.openphacts.org/units/Nanomolar;4240106;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616545;27136904;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)cn1;;;CHEMBL5726098;;2019.0;{'bei': '10.12', 'le': '0.19', 'lle': '0.80', 'sei': '5.83'};CHEMBL5980115;;CHEMBL5980115;4.70;1;http://www.openphacts.org/units/Nanomolar;4240108;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616551;27136922;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)nc1;;;CHEMBL5726098;;2019.0;{'bei': '10.12', 'le': '0.19', 'lle': '0.80', 'sei': '5.83'};CHEMBL5781489;;CHEMBL5781489;4.70;1;http://www.openphacts.org/units/Nanomolar;4240111;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616563;27136958;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CNC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.55', 'le': '0.18', 'lle': '0.50', 'sei': '5.86'};CHEMBL5981428;;CHEMBL5981428;4.70;1;http://www.openphacts.org/units/Nanomolar;4240114;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616577;27137000;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)cnc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '11.34', 'le': '0.21', 'lle': '2.05', 'sei': '5.05'};CHEMBL5970203;;CHEMBL5970203;4.90;1;http://www.openphacts.org/units/Nanomolar;4240120;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616579;27137006;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;1;http://www.openphacts.org/units/Nanomolar;4240010;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616581;27137012;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5768114;;CHEMBL5768114;4.70;1;http://www.openphacts.org/units/Nanomolar;4240053;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616585;27137024;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5977882;;CHEMBL5977882;4.90;1;http://www.openphacts.org/units/Nanomolar;4240122;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616587;27137030;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5977882;;CHEMBL5977882;4.70;1;http://www.openphacts.org/units/Nanomolar;4240122;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616589;27137036;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;1;http://www.openphacts.org/units/Nanomolar;4240010;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616591;27137042;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5768114;;CHEMBL5768114;4.70;1;http://www.openphacts.org/units/Nanomolar;4240053;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616597;27137060;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)cnc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.73', 'le': '0.19', 'lle': '1.50', 'sei': '4.42'};CHEMBL5992485;;CHEMBL5992485;4.70;1;http://www.openphacts.org/units/Nanomolar;4240115;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616625;27137144;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)cc(F)c23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '8.92', 'le': '0.17', 'lle': '1.22', 'sei': '4.04'};CHEMBL5927173;;CHEMBL5927173;4.70;1;http://www.openphacts.org/units/Nanomolar;4240130;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616661;27137252;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '9.39', 'le': '0.18', 'lle': '0.81', 'sei': '4.39'};CHEMBL6016532;;CHEMBL6016532;4.70;1;http://www.openphacts.org/units/Nanomolar;4240142;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616667;27137270;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.17', 'le': '0.18', 'lle': '0.11', 'sei': '4.99'};CHEMBL5848898;;CHEMBL5848898;4.70;1;http://www.openphacts.org/units/Nanomolar;4240144;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616683;27137318;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1cncc(Cl)c1)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.26', 'le': '0.20', 'lle': '0.96', 'sei': '5.20'};CHEMBL5795860;;CHEMBL5795860;4.90;1;http://www.openphacts.org/units/Nanomolar;4240152;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616695;27137354;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998261;;CHEMBL5998261;4.70;1;http://www.openphacts.org/units/Nanomolar;4240158;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616709;27137396;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(C(N)=O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.57', 'le': '0.18', 'lle': '1.50', 'sei': '4.04'};CHEMBL6022047;;CHEMBL6022047;4.70;1;http://www.openphacts.org/units/Nanomolar;4240165;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616715;27137414;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.83', 'le': '0.19', 'lle': '0.76', 'sei': '4.99'};CHEMBL5856476;;CHEMBL5856476;4.70;1;http://www.openphacts.org/units/Nanomolar;4240168;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616717;27137420;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1ncc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)nc1C;;;CHEMBL5726098;;2019.0;{'bei': '10.55', 'le': '0.19', 'lle': '0.94', 'sei': '5.58'};CHEMBL5781853;;CHEMBL5781853;4.70;1;http://www.openphacts.org/units/Nanomolar;4240169;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616719;27137426;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1nccnc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.90', 'le': '0.20', 'lle': '1.05', 'sei': '4.58'};CHEMBL6014328;;CHEMBL6014328;4.90;1;http://www.openphacts.org/units/Nanomolar;4240170;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616721;27137432;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F;;;CHEMBL5726098;;2019.0;{'bei': '9.90', 'le': '0.18', 'lle': '2.01', 'sei': '4.04'};CHEMBL5896712;;CHEMBL5896712;4.70;0;http://www.openphacts.org/units/Nanomolar;4240171;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616723;27137438;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1nc(C(C(N)=O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)ccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.90', 'le': '0.18', 'lle': '2.72', 'sei': '4.04'};CHEMBL5813635;;CHEMBL5813635;4.70;1;http://www.openphacts.org/units/Nanomolar;4240172;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616731;27137462;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1F;;;CHEMBL5726098;;2019.0;{'bei': '9.80', 'le': '0.18', 'lle': '1.14', 'sei': '4.99'};CHEMBL5935914;;CHEMBL5935914;4.70;1;http://www.openphacts.org/units/Nanomolar;4240176;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616733;27137468;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1cncc(F)c1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '0.82', 'sei': '5.20'};CHEMBL5944654;;CHEMBL5944654;4.90;1;http://www.openphacts.org/units/Nanomolar;4240177;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616735;27137474;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.07', 'le': '0.17', 'lle': '1.11', 'sei': '4.21'};CHEMBL5980137;;CHEMBL5980137;4.70;1;http://www.openphacts.org/units/Nanomolar;4240178;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616739;27137486;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(C(N)=O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '9.23', 'le': '0.18', 'lle': '1.36', 'sei': '4.04'};CHEMBL5770264;;CHEMBL5770264;4.70;1;http://www.openphacts.org/units/Nanomolar;4240180;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616753;27137528;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2ccsc12;;;CHEMBL5726098;;2019.0;{'bei': '9.92', 'le': '0.19', 'lle': '0.34', 'sei': '5.58'};CHEMBL5819507;;CHEMBL5819507;4.70;1;http://www.openphacts.org/units/Nanomolar;4240187;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616755;27137534;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '9.92', 'le': '0.19', 'lle': '0.34', 'sei': '5.58'};CHEMBL5842348;;CHEMBL5842348;4.70;1;http://www.openphacts.org/units/Nanomolar;4240188;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616763;27137558;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;O=c1[nH]nc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.05', 'sei': '4.51'};CHEMBL5880312;;CHEMBL5880312;4.70;1;http://www.openphacts.org/units/Nanomolar;4240192;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616771;27137582;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nncc2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '9.56', 'le': '0.18', 'lle': '0.20', 'sei': '5.58'};CHEMBL5800518;;CHEMBL5800518;4.70;1;http://www.openphacts.org/units/Nanomolar;4240196;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616775;27137594;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nnc2ccccn12;;;CHEMBL5726098;;2019.0;{'bei': '10.29', 'le': '0.19', 'lle': '1.30', 'sei': '5.30'};CHEMBL5808833;;CHEMBL5808833;4.70;1;http://www.openphacts.org/units/Nanomolar;4240198;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616781;27137612;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3F)ncnc21;;;CHEMBL5726098;;2019.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.53', 'sei': '4.60'};CHEMBL5777694;;CHEMBL5777694;4.70;1;http://www.openphacts.org/units/Nanomolar;4240200;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616785;27137624;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nncn2cccc12;;;CHEMBL5726098;;2019.0;{'bei': '9.78', 'le': '0.18', 'lle': '1.83', 'sei': '4.40'};CHEMBL5899195;;CHEMBL5899195;4.90;0;http://www.openphacts.org/units/Nanomolar;4240201;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616799;27137666;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)c(C)n1;;;CHEMBL5726098;;2019.0;{'bei': '10.14', 'le': '0.19', 'lle': '0.80', 'sei': '5.58'};CHEMBL5842038;;CHEMBL5842038;4.70;1;http://www.openphacts.org/units/Nanomolar;4240207;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616805;27137684;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccn2cccc12;;;CHEMBL5726098;;2019.0;{'bei': '10.36', 'le': '0.19', 'lle': '0.76', 'sei': '6.47'};CHEMBL6019177;;CHEMBL6019177;4.90;1;http://www.openphacts.org/units/Nanomolar;4240210;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616815;27137714;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)cccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '10.15', 'le': '0.19', 'lle': '1.13', 'sei': '5.84'};CHEMBL5962444;;CHEMBL5962444;4.70;1;http://www.openphacts.org/units/Nanomolar;4240215;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616827;27137750;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1nccn2ccnc12;;;CHEMBL5726098;;2019.0;{'bei': '9.94', 'le': '0.19', 'lle': '0.79', 'sei': '5.30'};CHEMBL5806887;;CHEMBL5806887;4.70;1;http://www.openphacts.org/units/Nanomolar;4240218;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616831;27137762;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1cnc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)ccc3Cl)ncnc21;;;CHEMBL5726098;;2019.0;{'bei': '10.05', 'le': '0.19', 'lle': '1.35', 'sei': '4.80'};CHEMBL6051468;;CHEMBL6051468;4.90;1;http://www.openphacts.org/units/Nanomolar;4240220;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616835;27137774;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1cccc2nncn12;;;CHEMBL5726098;;2019.0;{'bei': '10.29', 'le': '0.19', 'lle': '1.30', 'sei': '5.30'};CHEMBL5757448;;CHEMBL5757448;4.70;1;http://www.openphacts.org/units/Nanomolar;4240222;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616837;27137780;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '10.27', 'le': '0.19', 'lle': '0.81', 'sei': '4.82'};CHEMBL5789113;;CHEMBL5789113;4.70;1;http://www.openphacts.org/units/Nanomolar;4240223;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616843;27137798;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cncnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998631;;CHEMBL5998631;4.70;1;http://www.openphacts.org/units/Nanomolar;4240224;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616853;27137828;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '9.77', 'le': '0.19', 'lle': '0.99', 'sei': '5.84'};CHEMBL5979219;;CHEMBL5979219;4.70;1;http://www.openphacts.org/units/Nanomolar;4240227;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616863;27137858;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1ncnc2c1CCNC2;;;CHEMBL5726098;;2019.0;{'bei': '9.58', 'le': '0.18', 'lle': '1.77', 'sei': '4.88'};CHEMBL5956084;;CHEMBL5956084;4.70;1;http://www.openphacts.org/units/Nanomolar;4240230;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616865;27137864;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2c1CCNC2;;;CHEMBL5726098;;2019.0;{'bei': '10.38', 'le': '0.19', 'lle': '2.11', 'sei': '5.09'};CHEMBL5983762;;CHEMBL5983762;4.90;1;http://www.openphacts.org/units/Nanomolar;4240231;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616867;27137870;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.85', 'le': '0.21', 'lle': '1.10', 'sei': '5.82'};CHEMBL5857402;;CHEMBL5857402;4.90;1;http://www.openphacts.org/units/Nanomolar;4240232;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616869;27137876;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5857402;;CHEMBL5857402;4.70;1;http://www.openphacts.org/units/Nanomolar;4240232;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616871;27137882;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)ccc3F)ncnc21;;;CHEMBL5726098;;2019.0;{'bei': '9.97', 'le': '0.18', 'lle': '1.67', 'sei': '4.60'};CHEMBL5929065;;CHEMBL5929065;4.70;1;http://www.openphacts.org/units/Nanomolar;4240233;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616873;27137888;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL6059111;;CHEMBL6059111;4.70;1;http://www.openphacts.org/units/Nanomolar;4240234;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616875;27137894;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5789087;;CHEMBL5789087;4.70;1;http://www.openphacts.org/units/Nanomolar;4240235;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616879;27137906;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1nccn2ccnc12;;;CHEMBL5726098;;2019.0;{'bei': '9.57', 'le': '0.18', 'lle': '0.65', 'sei': '5.30'};CHEMBL5995294;;CHEMBL5995294;4.70;1;http://www.openphacts.org/units/Nanomolar;4240237;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616889;27137936;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)cccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '10.15', 'le': '0.19', 'lle': '1.13', 'sei': '5.84'};CHEMBL5962444;;CHEMBL5962444;4.70;1;http://www.openphacts.org/units/Nanomolar;4240215;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616891;27137942;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2F)cccc1=O;;;CHEMBL5726098;;2019.0;{'bei': '10.98', 'le': '0.20', 'lle': '1.85', 'sei': '6.09'};CHEMBL5803245;;CHEMBL5803245;4.90;1;http://www.openphacts.org/units/Nanomolar;4240216;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616893;27137948;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3Cl)ncnc21;;;CHEMBL5726098;;2019.0;{'bei': '9.29', 'le': '0.18', 'lle': '1.02', 'sei': '4.60'};CHEMBL5836101;;CHEMBL5836101;4.70;1;http://www.openphacts.org/units/Nanomolar;4240239;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616895;27137954;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3F)ncnc21;;;CHEMBL5726098;;2019.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.53', 'sei': '4.60'};CHEMBL5831533;;CHEMBL5831533;4.70;1;http://www.openphacts.org/units/Nanomolar;4240240;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616901;27137972;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1ncnc2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL5866182;;CHEMBL5866182;4.90;1;http://www.openphacts.org/units/Nanomolar;4240243;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616903;27137978;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cncnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998631;;CHEMBL5998631;4.70;1;http://www.openphacts.org/units/Nanomolar;4240224;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616905;27137984;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL6055346;;CHEMBL6055346;4.90;1;http://www.openphacts.org/units/Nanomolar;4240244;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616911;27138002;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5744600;;CHEMBL5744600;4.90;1;http://www.openphacts.org/units/Nanomolar;4240245;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616913;27138008;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5857402;;CHEMBL5857402;4.70;1;http://www.openphacts.org/units/Nanomolar;4240232;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616915;27138014;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.13', 'le': '0.19', 'lle': '1.03', 'sei': '5.03'};CHEMBL6055346;;CHEMBL6055346;4.70;1;http://www.openphacts.org/units/Nanomolar;4240244;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616917;27138020;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;1;http://www.openphacts.org/units/Nanomolar;4240246;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616919;27138026;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;1;http://www.openphacts.org/units/Nanomolar;4240246;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616921;27138032;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2occc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL5828867;;CHEMBL5828867;4.90;1;http://www.openphacts.org/units/Nanomolar;4240247;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616923;27138038;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5822629;;CHEMBL5822629;4.70;1;http://www.openphacts.org/units/Nanomolar;4240248;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616927;27138050;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5822629;;CHEMBL5822629;4.70;1;http://www.openphacts.org/units/Nanomolar;4240248;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616933;27138068;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5744600;;CHEMBL5744600;4.90;1;http://www.openphacts.org/units/Nanomolar;4240245;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616943;27138098;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5895768;;CHEMBL5895768;4.70;1;http://www.openphacts.org/units/Nanomolar;4240253;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616945;27138104;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.95', 'le': '0.21', 'lle': '0.93', 'sei': '5.82'};CHEMBL5895768;;CHEMBL5895768;4.90;1;http://www.openphacts.org/units/Nanomolar;4240253;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616953;27138128;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;1;http://www.openphacts.org/units/Nanomolar;4240246;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616963;27138158;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2sccc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL6039429;;CHEMBL6039429;4.90;1;http://www.openphacts.org/units/Nanomolar;4240258;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616965;27138164;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2ccsc12;;;CHEMBL5726098;;2019.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL6012455;;CHEMBL6012455;4.90;1;http://www.openphacts.org/units/Nanomolar;4240259;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616967;27138170;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1ncnc2ccsc12;;;CHEMBL5726098;;2019.0;{'bei': '9.98', 'le': '0.19', 'lle': '0.40', 'sei': '5.82'};CHEMBL5972912;;CHEMBL5972912;4.90;1;http://www.openphacts.org/units/Nanomolar;4240260;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616969;27138176;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '9.55', 'le': '0.18', 'lle': '0.16', 'sei': '4.82'};CHEMBL5804401;;CHEMBL5804401;4.70;1;http://www.openphacts.org/units/Nanomolar;4240261;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616971;27138182;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '9.97', 'le': '0.19', 'lle': '0.36', 'sei': '5.03'};CHEMBL5804401;;CHEMBL5804401;4.90;1;http://www.openphacts.org/units/Nanomolar;4240261;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616983;27138218;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5815339;;CHEMBL5815339;4.90;1;http://www.openphacts.org/units/Nanomolar;4240264;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616985;27138224;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.53', 'le': '0.20', 'lle': '1.61', 'sei': '5.24'};CHEMBL6006289;;CHEMBL6006289;4.90;1;http://www.openphacts.org/units/Nanomolar;4240265;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616989;27138236;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccnc1OC(F)F;;;CHEMBL5726098;;2019.0;{'bei': '9.37', 'le': '0.18', 'lle': '0.82', 'sei': '5.03'};CHEMBL5787148;;CHEMBL5787148;4.70;1;http://www.openphacts.org/units/Nanomolar;4240266;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616991;27138242;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccnc1OC(F)F;;;CHEMBL5726098;;2019.0;{'bei': '9.37', 'le': '0.18', 'lle': '0.82', 'sei': '5.03'};CHEMBL5787148;;CHEMBL5787148;4.70;1;http://www.openphacts.org/units/Nanomolar;4240266;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;616993;27138248;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726098;;2019.0;{'bei': '9.97', 'le': '0.19', 'lle': '0.36', 'sei': '5.03'};CHEMBL5804401;;CHEMBL5804401;4.90;1;http://www.openphacts.org/units/Nanomolar;4240261;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616995;27138254;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.53', 'le': '0.20', 'lle': '1.61', 'sei': '5.24'};CHEMBL5967736;;CHEMBL5967736;4.90;1;http://www.openphacts.org/units/Nanomolar;4240267;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;616999;27138266;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1[C@H](O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.10', 'le': '0.19', 'lle': '1.41', 'sei': '5.03'};CHEMBL5751337;;CHEMBL5751337;4.70;0;http://www.openphacts.org/units/Nanomolar;4240268;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617001;27138272;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1[C@@H](O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.53', 'le': '0.20', 'lle': '1.61', 'sei': '5.24'};CHEMBL6040614;;CHEMBL6040614;4.90;0;http://www.openphacts.org/units/Nanomolar;4240269;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;617005;27138284;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)nn1;;;CHEMBL5726098;;2019.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5947717;;CHEMBL5947717;4.90;1;http://www.openphacts.org/units/Nanomolar;4240271;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;617013;27138308;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.55', 'le': '0.19', 'lle': '0.99', 'sei': '5.58'};CHEMBL5975635;;CHEMBL5975635;4.70;1;http://www.openphacts.org/units/Nanomolar;4240273;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617015;27138314;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;CCOc1cccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726098;;2019.0;{'bei': '10.20', 'le': '0.19', 'lle': '0.55', 'sei': '5.83'};CHEMBL5993979;;CHEMBL5993979;4.70;1;http://www.openphacts.org/units/Nanomolar;4240274;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617017;27138320;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1OC(F)F;;;CHEMBL5726098;;2019.0;{'bei': '9.72', 'le': '0.18', 'lle': '0.95', 'sei': '5.03'};CHEMBL6054325;;CHEMBL6054325;4.70;1;http://www.openphacts.org/units/Nanomolar;4240275;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617019;27138326;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;1;http://www.openphacts.org/units/Nanomolar;4239985;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617021;27138332;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;1;http://www.openphacts.org/units/Nanomolar;4239985;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617025;27138344;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5977882;;CHEMBL5977882;4.70;1;http://www.openphacts.org/units/Nanomolar;4240122;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617027;27138350;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '11.30', 'le': '0.22', 'lle': '1.24', 'sei': '5.82'};CHEMBL5887376;;CHEMBL5887376;4.90;1;http://www.openphacts.org/units/Nanomolar;4240276;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;617035;27138374;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Br)c1;;;CHEMBL5726098;;2019.0;{'bei': '8.94', 'le': '0.19', 'lle': '0.18', 'sei': '5.83'};CHEMBL5890288;;CHEMBL5890288;4.70;1;http://www.openphacts.org/units/Nanomolar;4240278;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617037;27138380;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cn2ccsc2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726098;;2019.0;{'bei': '10.23', 'le': '0.20', 'lle': '0.70', 'sei': '6.47'};CHEMBL5744383;;CHEMBL5744383;4.90;1;http://www.openphacts.org/units/Nanomolar;4240279;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;617039;27138386;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1OC(F)(F)F;;;CHEMBL5726098;;2019.0;{'bei': '9.39', 'le': '0.18', 'lle': '0.05', 'sei': '5.83'};CHEMBL5872585;;CHEMBL5872585;4.70;1;http://www.openphacts.org/units/Nanomolar;4240280;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;617045;27138404;[];CHEMBL5732052;Kv11.1 (hERG) ION CHANNEL ACTIVITY (Patch Clamp Assay): Method for the detection and characterisation of test substances which interfere with the Kv11.1 (hERG) channel: Kv11.1 (hERG, human ether a-go-go related gene) is a potassium channel which plays a central role for repolarisation of the cells in the ventricular cardiomyocytes.The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of 80 mV. For measurement of substancepromoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/80 mV, 500 ms/+40 mV, 500 ms/40 mV, 200 ms/80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.If the measurement result of a test substance at an initial concentration of 10 M was smaller than ()50% effect (threshold value) (for example ()60% effect), the test substance was, in order to determine a dose/action relationship, added cumulatively in increasing concentration, where each concentration was measured for 5 min.The reference substance used was the Kv11.1 (hERG) ion channel blocker quinidine. The effects of test substances and quinidine were standardised to the associated vehicle control. The effect on the Kv11.1 (hERG) channel activity was assessed from the potassium current at 40 mV. For the calculation, the current was evaluated for the respective final trace. A test-substance-induced inhibition of the Kv11.1(hERG) channel was standardised to the vehicle control (0.1% of DMSO).During the measurement, an aliquot of the test substance was taken for concentration determination. The sample was measured immediately by HPLC, and the final concentration was determined from a calibration curve.;B;;;BAO_0000192;BAO_0000219;cell-based format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726098;;2019.0;{'bei': '10.83', 'le': '0.21', 'lle': '1.04', 'sei': '5.58'};CHEMBL5887376;;CHEMBL5887376;4.70;1;http://www.openphacts.org/units/Nanomolar;4240276;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659318;27262142;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.39', 'le': '0.19', 'lle': '0.67', 'sei': '6.58'};CHEMBL6056182;;CHEMBL6056182;4.70;0;http://www.openphacts.org/units/Nanomolar;4266565;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659320;27262148;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1cncc(F)c1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.46', 'le': '0.20', 'lle': '0.36', 'sei': '6.87'};CHEMBL5759810;;CHEMBL5759810;4.90;0;http://www.openphacts.org/units/Nanomolar;4266566;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659326;27262166;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;O=c1[nH]ccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.84', 'le': '0.20', 'lle': '2.26', 'sei': '4.51'};CHEMBL6058376;;CHEMBL6058376;4.70;0;http://www.openphacts.org/units/Nanomolar;4266569;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659328;27262172;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nnc(Cl)cc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.50', 'le': '0.19', 'lle': '0.44', 'sei': '5.24'};CHEMBL5796119;;CHEMBL5796119;4.90;0;http://www.openphacts.org/units/Nanomolar;4266570;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659330;27262178;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5982671;;CHEMBL5982671;4.70;0;http://www.openphacts.org/units/Nanomolar;4266571;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659332;27262184;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cc(Cl)nnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.50', 'le': '0.19', 'lle': '0.44', 'sei': '5.24'};CHEMBL6019675;;CHEMBL6019675;4.90;0;http://www.openphacts.org/units/Nanomolar;4266572;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659338;27262202;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nnccc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.96', 'le': '0.20', 'lle': '1.75', 'sei': '5.24'};CHEMBL5900906;;CHEMBL5900906;4.90;0;http://www.openphacts.org/units/Nanomolar;4266575;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659340;27262208;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nnccc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5900906;;CHEMBL5900906;4.70;0;http://www.openphacts.org/units/Nanomolar;4266575;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659342;27262214;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(C)(C)Oc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.02', 'le': '0.19', 'lle': '0.58', 'sei': '5.24'};CHEMBL6053796;;CHEMBL6053796;4.90;0;http://www.openphacts.org/units/Nanomolar;4266576;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659346;27262226;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5854342;;CHEMBL5854342;4.70;0;http://www.openphacts.org/units/Nanomolar;4266578;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659350;27262238;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(Cl)cncc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.10', 'le': '0.20', 'lle': '-0.16', 'sei': '6.87'};CHEMBL5842333;;CHEMBL5842333;4.90;0;http://www.openphacts.org/units/Nanomolar;4266579;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659352;27262244;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccnnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5761266;;CHEMBL5761266;4.70;0;http://www.openphacts.org/units/Nanomolar;4266580;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659364;27262280;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.26', 'le': '0.21', 'lle': '0.84', 'sei': '5.58'};CHEMBL5826481;;CHEMBL5826481;4.70;0;http://www.openphacts.org/units/Nanomolar;4266583;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659372;27262304;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;O[C@@H](c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5876441;;CHEMBL5876441;4.70;0;http://www.openphacts.org/units/Nanomolar;4266587;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659374;27262310;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5781609;;CHEMBL5781609;4.70;0;http://www.openphacts.org/units/Nanomolar;4266588;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659376;27262316;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5781609;;CHEMBL5781609;4.70;0;http://www.openphacts.org/units/Nanomolar;4266588;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659378;27262322;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Cl)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.20', 'le': '0.20', 'lle': '0.49', 'sei': '6.08'};CHEMBL5982773;;CHEMBL5982773;4.90;0;http://www.openphacts.org/units/Nanomolar;4266589;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659380;27262328;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1OC1COC1;;;CHEMBL5726336;;2017.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.78', 'sei': '4.57'};CHEMBL5900493;;CHEMBL5900493;4.70;0;http://www.openphacts.org/units/Nanomolar;4266590;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659384;27262340;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cnccn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5849363;;CHEMBL5849363;4.70;0;http://www.openphacts.org/units/Nanomolar;4266592;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659386;27262346;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nc(Cl)cnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.08', 'le': '0.20', 'lle': '0.45', 'sei': '5.82'};CHEMBL5798926;;CHEMBL5798926;4.90;0;http://www.openphacts.org/units/Nanomolar;4266593;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659390;27262358;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.71', 'le': '0.22', 'lle': '1.04', 'sei': '5.82'};CHEMBL5826481;;CHEMBL5826481;4.90;0;http://www.openphacts.org/units/Nanomolar;4266583;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659394;27262370;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccn2nccc2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.57', 'le': '0.18', 'lle': '0.65', 'sei': '5.30'};CHEMBL5896258;;CHEMBL5896258;4.70;0;http://www.openphacts.org/units/Nanomolar;4266595;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659396;27262376;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)c2ccncc12;;;CHEMBL5726336;;2017.0;{'bei': '9.20', 'le': '0.18', 'lle': '0.55', 'sei': '4.61'};CHEMBL6017954;;CHEMBL6017954;4.90;0;http://www.openphacts.org/units/Nanomolar;4266596;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659398;27262382;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(Cl)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.66', 'le': '0.19', 'lle': '0.25', 'sei': '5.58'};CHEMBL5883518;;CHEMBL5883518;4.70;0;http://www.openphacts.org/units/Nanomolar;4266597;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659400;27262388;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;0;http://www.openphacts.org/units/Nanomolar;4266598;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659404;27262400;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;0;http://www.openphacts.org/units/Nanomolar;4266600;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659406;27262406;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;0;http://www.openphacts.org/units/Nanomolar;4266600;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659408;27262412;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cnnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.09', 'le': '0.19', 'lle': '0.59', 'sei': '5.58'};CHEMBL5816995;;CHEMBL5816995;4.70;0;http://www.openphacts.org/units/Nanomolar;4266601;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659412;27262424;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.79', 'le': '0.20', 'lle': '1.42', 'sei': '5.58'};CHEMBL5846761;;CHEMBL5846761;4.70;0;http://www.openphacts.org/units/Nanomolar;4266602;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659418;27262442;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '9.90', 'le': '0.18', 'lle': '1.16', 'sei': '5.30'};CHEMBL5883008;;CHEMBL5883008;4.70;0;http://www.openphacts.org/units/Nanomolar;4266581;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659424;27262460;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5876088;;CHEMBL5876088;4.70;0;http://www.openphacts.org/units/Nanomolar;4266606;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659428;27262472;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;0;http://www.openphacts.org/units/Nanomolar;4266608;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659430;27262478;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;0;http://www.openphacts.org/units/Nanomolar;4266608;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659434;27262490;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '1.60', 'sei': '5.03'};CHEMBL5971496;;CHEMBL5971496;4.70;0;http://www.openphacts.org/units/Nanomolar;4266600;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659436;27262496;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)cn1;;;CHEMBL5726336;;2017.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL5775380;;CHEMBL5775380;4.70;0;http://www.openphacts.org/units/Nanomolar;4266605;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659442;27262514;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.99', 'le': '0.19', 'lle': '0.85', 'sei': '5.53'};CHEMBL5755271;;CHEMBL5755271;4.90;0;http://www.openphacts.org/units/Nanomolar;4266608;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659444;27262520;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.08', 'le': '0.20', 'lle': '0.45', 'sei': '5.82'};CHEMBL5799485;;CHEMBL5799485;4.90;0;http://www.openphacts.org/units/Nanomolar;4266612;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659470;27262598;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.46', 'le': '0.20', 'lle': '0.36', 'sei': '6.87'};CHEMBL6000039;;CHEMBL6000039;4.90;0;http://www.openphacts.org/units/Nanomolar;4266623;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659472;27262604;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;0;http://www.openphacts.org/units/Nanomolar;4266624;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659474;27262610;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCOc1cnnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.18', 'le': '0.19', 'lle': '1.16', 'sei': '5.03'};CHEMBL5891111;;CHEMBL5891111;4.70;0;http://www.openphacts.org/units/Nanomolar;4266625;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659484;27262640;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.45', 'le': '0.19', 'lle': '1.11', 'sei': '5.58'};CHEMBL5822977;;CHEMBL5822977;4.70;0;http://www.openphacts.org/units/Nanomolar;4266630;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659486;27262646;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.45', 'le': '0.19', 'lle': '1.11', 'sei': '5.58'};CHEMBL5822977;;CHEMBL5822977;4.70;0;http://www.openphacts.org/units/Nanomolar;4266630;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659490;27262658;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cncnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.50', 'le': '0.19', 'lle': '1.55', 'sei': '5.03'};CHEMBL6040207;;CHEMBL6040207;4.70;0;http://www.openphacts.org/units/Nanomolar;4266631;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659492;27262664;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cnc(C)c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)n1;;;CHEMBL5726336;;2017.0;{'bei': '10.14', 'le': '0.19', 'lle': '0.80', 'sei': '5.58'};CHEMBL5787834;;CHEMBL5787834;4.70;0;http://www.openphacts.org/units/Nanomolar;4266632;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659494;27262670;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccsc12;;;CHEMBL5726336;;2017.0;{'bei': '10.01', 'le': '0.20', 'lle': '0.03', 'sei': '5.82'};CHEMBL5981733;;CHEMBL5981733;4.90;0;http://www.openphacts.org/units/Nanomolar;4266633;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659502;27262694;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.32', 'sei': '5.25'};CHEMBL6055613;;CHEMBL6055613;4.90;0;http://www.openphacts.org/units/Nanomolar;4266637;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659516;27262736;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(OC2COC2)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.36', 'le': '0.18', 'lle': '1.32', 'sei': '4.77'};CHEMBL5869725;;CHEMBL5869725;4.90;0;http://www.openphacts.org/units/Nanomolar;4266642;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659518;27262742;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.41', 'le': '0.18', 'lle': '0.81', 'sei': '4.18'};CHEMBL5926851;;CHEMBL5926851;4.90;0;http://www.openphacts.org/units/Nanomolar;4266643;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659520;27262748;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.02', 'le': '0.17', 'lle': '0.61', 'sei': '4.01'};CHEMBL5926851;;CHEMBL5926851;4.70;0;http://www.openphacts.org/units/Nanomolar;4266643;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659524;27262760;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(C#N)Oc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.02', 'le': '0.17', 'lle': '0.61', 'sei': '4.01'};CHEMBL5926851;;CHEMBL5926851;4.70;0;http://www.openphacts.org/units/Nanomolar;4266643;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659528;27262772;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OCCNc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '9.86', 'le': '0.18', 'lle': '2.15', 'sei': '4.03'};CHEMBL5832128;;CHEMBL5832128;4.70;0;http://www.openphacts.org/units/Nanomolar;4266645;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659532;27262784;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CSc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.44', 'le': '0.19', 'lle': '0.18', 'sei': '5.58'};CHEMBL5746940;;CHEMBL5746940;4.70;0;http://www.openphacts.org/units/Nanomolar;4266647;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659536;27262796;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cc1C;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '0.79', 'sei': '5.24'};CHEMBL5929612;;CHEMBL5929612;4.90;0;http://www.openphacts.org/units/Nanomolar;4266649;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659540;27262808;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COCCOc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '8.93', 'le': '0.17', 'lle': '0.88', 'sei': '4.57'};CHEMBL5790750;;CHEMBL5790750;4.70;0;http://www.openphacts.org/units/Nanomolar;4266651;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659546;27262826;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(OCC(F)(F)F)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '8.92', 'le': '0.18', 'lle': '0.16', 'sei': '5.24'};CHEMBL6057597;;CHEMBL6057597;4.90;0;http://www.openphacts.org/units/Nanomolar;4266654;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659550;27262838;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Nc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.06', 'le': '0.19', 'lle': '1.32', 'sei': '4.26'};CHEMBL5849893;;CHEMBL5849893;4.70;0;http://www.openphacts.org/units/Nanomolar;4266656;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659552;27262844;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;N#Cc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.85', 'le': '0.19', 'lle': '1.03', 'sei': '4.35'};CHEMBL5992260;;CHEMBL5992260;4.70;0;http://www.openphacts.org/units/Nanomolar;4266657;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659554;27262850;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;N#CCOc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.27', 'le': '0.18', 'lle': '1.00', 'sei': '4.01'};CHEMBL5800793;;CHEMBL5800793;4.70;0;http://www.openphacts.org/units/Nanomolar;4266658;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659558;27262862;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ccc(OC(F)F)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.72', 'le': '0.18', 'lle': '0.95', 'sei': '5.03'};CHEMBL5805827;;CHEMBL5805827;4.70;0;http://www.openphacts.org/units/Nanomolar;4266660;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659560;27262868;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;C#CC(O)(c1ccc(OC)nn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.69', 'le': '0.19', 'lle': '1.31', 'sei': '5.24'};CHEMBL5761754;;CHEMBL5761754;4.90;0;http://www.openphacts.org/units/Nanomolar;4266661;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659566;27262886;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(C)(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.47', 'le': '0.18', 'lle': '0.72', 'sei': '5.03'};CHEMBL5881471;;CHEMBL5881471;4.70;0;http://www.openphacts.org/units/Nanomolar;4266664;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659568;27262892;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.05', 'le': '0.20', 'lle': '1.03', 'sei': '5.24'};CHEMBL5800084;;CHEMBL5800084;4.90;0;http://www.openphacts.org/units/Nanomolar;4266665;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659570;27262898;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.05', 'le': '0.20', 'lle': '1.03', 'sei': '5.24'};CHEMBL5800084;;CHEMBL5800084;4.90;0;http://www.openphacts.org/units/Nanomolar;4266665;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659572;27262904;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)sc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.63', 'le': '0.19', 'lle': '0.83', 'sei': '5.03'};CHEMBL5800084;;CHEMBL5800084;4.70;0;http://www.openphacts.org/units/Nanomolar;4266665;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659574;27262910;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.10', 'le': '0.19', 'lle': '1.41', 'sei': '5.03'};CHEMBL5981326;;CHEMBL5981326;4.70;0;http://www.openphacts.org/units/Nanomolar;4266666;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659578;27262922;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.10', 'le': '0.19', 'lle': '1.41', 'sei': '5.03'};CHEMBL5981326;;CHEMBL5981326;4.70;0;http://www.openphacts.org/units/Nanomolar;4266666;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659584;27262940;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCOc1ccc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.62', 'le': '0.20', 'lle': '1.36', 'sei': '5.24'};CHEMBL5749492;;CHEMBL5749492;4.90;0;http://www.openphacts.org/units/Nanomolar;4266669;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659590;27262958;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5768114;;CHEMBL5768114;4.90;0;http://www.openphacts.org/units/Nanomolar;4266672;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659592;27262964;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(O)(c1cncc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.20', 'le': '0.21', 'lle': '1.46', 'sei': '5.58'};CHEMBL5959053;;CHEMBL5959053;4.70;0;http://www.openphacts.org/units/Nanomolar;4266673;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659596;27262976;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ncc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.10', 'le': '0.21', 'lle': '1.49', 'sei': '5.58'};CHEMBL5889518;;CHEMBL5889518;4.70;0;http://www.openphacts.org/units/Nanomolar;4266675;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659598;27262982;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ncc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.63', 'le': '0.19', 'lle': '1.35', 'sei': '4.50'};CHEMBL5896422;;CHEMBL5896422;4.70;0;http://www.openphacts.org/units/Nanomolar;4266676;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659602;27262994;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.81', 'le': '0.20', 'lle': '0.72', 'sei': '5.88'};CHEMBL5860861;;CHEMBL5860861;4.90;0;http://www.openphacts.org/units/Nanomolar;4266678;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659604;27263000;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)sc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '10.97', 'le': '0.22', 'lle': '0.83', 'sei': '6.58'};CHEMBL6058437;;CHEMBL6058437;4.70;0;http://www.openphacts.org/units/Nanomolar;4266679;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659610;27263018;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(-c2ncnc3cc(N4CCOCC4)ccc23)s1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.94', 'le': '0.24', 'lle': '1.17', 'sei': '6.87'};CHEMBL5907528;;CHEMBL5907528;4.90;0;http://www.openphacts.org/units/Nanomolar;4266680;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659612;27263024;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '12.12', 'le': '0.23', 'lle': '1.23', 'sei': '6.87'};CHEMBL5763465;;CHEMBL5763465;4.90;0;http://www.openphacts.org/units/Nanomolar;4266681;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659620;27263048;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(O)(c1cccc(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.23', 'le': '0.21', 'lle': '0.85', 'sei': '6.58'};CHEMBL5969254;;CHEMBL5969254;4.70;0;http://www.openphacts.org/units/Nanomolar;4266682;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659624;27263060;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(O)(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.23', 'le': '0.22', 'lle': '0.92', 'sei': '6.87'};CHEMBL5942478;;CHEMBL5942478;4.90;0;http://www.openphacts.org/units/Nanomolar;4266684;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659649;27263135;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OCc1csc(C(O)c2cc(-c3ncnc4cc(N5C6CCC5COC6)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.16', 'le': '0.18', 'lle': '0.21', 'sei': '5.13'};CHEMBL6037677;;CHEMBL6037677;4.70;0;http://www.openphacts.org/units/Nanomolar;4266695;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659653;27263147;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cnc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '11.10', 'le': '0.21', 'lle': '1.49', 'sei': '5.58'};CHEMBL5831440;;CHEMBL5831440;4.70;0;http://www.openphacts.org/units/Nanomolar;4266690;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659655;27263153;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.14', 'le': '0.18', 'lle': '0.13', 'sei': '5.63'};CHEMBL5804021;;CHEMBL5804021;4.70;0;http://www.openphacts.org/units/Nanomolar;4266696;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659657;27263159;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCNCc1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.14', 'le': '0.18', 'lle': '0.13', 'sei': '5.63'};CHEMBL5804021;;CHEMBL5804021;4.70;0;http://www.openphacts.org/units/Nanomolar;4266696;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659661;27263171;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ncc34)cnc2F)sc1C;;;CHEMBL5726336;;2017.0;{'bei': '10.84', 'le': '0.21', 'lle': '1.68', 'sei': '5.05'};CHEMBL5991362;;CHEMBL5991362;4.90;0;http://www.openphacts.org/units/Nanomolar;4266698;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659665;27263183;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1csc(C(O)c2cnc(F)c(-c3ncnc4cc(N5CCOCC5)ncc34)c2)n1;;;CHEMBL5726336;;2017.0;{'bei': '10.72', 'le': '0.21', 'lle': '1.79', 'sei': '4.84'};CHEMBL6032229;;CHEMBL6032229;4.70;0;http://www.openphacts.org/units/Nanomolar;4266700;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659677;27263219;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CC(O)c1csc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)n1;;;CHEMBL5726336;;2017.0;{'bei': '9.38', 'le': '0.19', 'lle': '0.18', 'sei': '5.13'};CHEMBL5864604;;CHEMBL5864604;4.70;0;http://www.openphacts.org/units/Nanomolar;4266706;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659679;27263225;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCn1cc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cn1;;;CHEMBL5726336;;2017.0;{'bei': '10.04', 'le': '0.19', 'lle': '0.48', 'sei': '6.16'};CHEMBL5742984;;CHEMBL5742984;4.70;0;http://www.openphacts.org/units/Nanomolar;4266707;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659683;27263237;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nc(C(O)c2cnc(F)c(-c3ncnc4cc(N5CCOCC5)ncc34)c2)sc1C;;;CHEMBL5726336;;2017.0;{'bei': '10.84', 'le': '0.21', 'lle': '1.68', 'sei': '5.05'};CHEMBL6053505;;CHEMBL6053505;4.90;0;http://www.openphacts.org/units/Nanomolar;4266701;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659685;27263243;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)cnc2F)sc1C;;;CHEMBL5726336;;2017.0;{'bei': '10.86', 'le': '0.21', 'lle': '1.08', 'sei': '5.82'};CHEMBL5902129;;CHEMBL5902129;4.90;0;http://www.openphacts.org/units/Nanomolar;4266699;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659687;27263249;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)cnc2F)sc1C;;;CHEMBL5726336;;2017.0;{'bei': '10.41', 'le': '0.20', 'lle': '0.88', 'sei': '5.58'};CHEMBL5902129;;CHEMBL5902129;4.70;0;http://www.openphacts.org/units/Nanomolar;4266699;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659689;27263255;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)cc1C(O)c1nccs1;;;CHEMBL5726336;;2017.0;{'bei': '10.76', 'le': '0.21', 'lle': '0.58', 'sei': '6.58'};CHEMBL5801138;;CHEMBL5801138;4.70;0;http://www.openphacts.org/units/Nanomolar;4266708;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659703;27263297;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1ccnc1C(O)c1ccc(F)c(-c2nc(Cl)nc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.96', 'sei': '6.16'};CHEMBL5973977;;CHEMBL5973977;4.70;0;http://www.openphacts.org/units/Nanomolar;4266711;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659707;27263309;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;C#Cc1nc(-c2cc(C(O)c3nccs3)ccc2F)c2ccc(N3CCOCC3)cc2n1;;;CHEMBL5726336;;2017.0;{'bei': '10.98', 'le': '0.21', 'lle': '1.11', 'sei': '6.87'};CHEMBL5858570;;CHEMBL5858570;4.90;0;http://www.openphacts.org/units/Nanomolar;4266709;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659711;27263321;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccccn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.82', 'le': '0.20', 'lle': '0.81', 'sei': '6.58'};CHEMBL5798593;;CHEMBL5798593;4.70;0;http://www.openphacts.org/units/Nanomolar;4266713;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659713;27263327;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1nc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '10.10', 'le': '0.19', 'lle': '2.11', 'sei': '5.03'};CHEMBL5741788;;CHEMBL5741788;4.70;0;http://www.openphacts.org/units/Nanomolar;4266714;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659717;27263339;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)cn1;;;CHEMBL5726336;;2017.0;{'bei': '10.12', 'le': '0.19', 'lle': '0.80', 'sei': '5.83'};CHEMBL5980115;;CHEMBL5980115;4.70;0;http://www.openphacts.org/units/Nanomolar;4266716;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659723;27263357;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)nc1;;;CHEMBL5726336;;2017.0;{'bei': '10.12', 'le': '0.19', 'lle': '0.80', 'sei': '5.83'};CHEMBL5781489;;CHEMBL5781489;4.70;0;http://www.openphacts.org/units/Nanomolar;4266719;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659735;27263393;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CNC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.55', 'le': '0.18', 'lle': '0.50', 'sei': '5.86'};CHEMBL5981428;;CHEMBL5981428;4.70;0;http://www.openphacts.org/units/Nanomolar;4266722;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659749;27263435;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)cnc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '11.34', 'le': '0.21', 'lle': '2.05', 'sei': '5.05'};CHEMBL5970203;;CHEMBL5970203;4.90;0;http://www.openphacts.org/units/Nanomolar;4266728;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659751;27263441;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;0;http://www.openphacts.org/units/Nanomolar;4266624;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659753;27263447;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5768114;;CHEMBL5768114;4.70;0;http://www.openphacts.org/units/Nanomolar;4266672;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659757;27263459;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5977882;;CHEMBL5977882;4.90;0;http://www.openphacts.org/units/Nanomolar;4266730;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659759;27263465;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5977882;;CHEMBL5977882;4.70;0;http://www.openphacts.org/units/Nanomolar;4266730;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659761;27263471;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5781990;;CHEMBL5781990;4.70;0;http://www.openphacts.org/units/Nanomolar;4266624;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659763;27263477;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cc1;;;CHEMBL5726336;;2017.0;{'bei': '9.79', 'le': '0.19', 'lle': '-0.32', 'sei': '6.94'};CHEMBL5901567;;CHEMBL5901567;4.70;0;http://www.openphacts.org/units/Nanomolar;4266731;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659769;27263495;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)cnc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.73', 'le': '0.19', 'lle': '1.50', 'sei': '4.42'};CHEMBL5992485;;CHEMBL5992485;4.70;0;http://www.openphacts.org/units/Nanomolar;4266723;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659797;27263579;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)cc(F)c23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '8.92', 'le': '0.17', 'lle': '1.22', 'sei': '4.04'};CHEMBL5927173;;CHEMBL5927173;4.70;0;http://www.openphacts.org/units/Nanomolar;4266739;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659833;27263687;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '9.39', 'le': '0.18', 'lle': '0.81', 'sei': '4.39'};CHEMBL6016532;;CHEMBL6016532;4.70;0;http://www.openphacts.org/units/Nanomolar;4266751;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659839;27263705;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.17', 'le': '0.18', 'lle': '0.11', 'sei': '4.99'};CHEMBL5848898;;CHEMBL5848898;4.70;0;http://www.openphacts.org/units/Nanomolar;4266753;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659855;27263753;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1cncc(Cl)c1)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.26', 'le': '0.20', 'lle': '0.96', 'sei': '5.20'};CHEMBL5795860;;CHEMBL5795860;4.90;0;http://www.openphacts.org/units/Nanomolar;4266761;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659867;27263789;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998261;;CHEMBL5998261;4.70;0;http://www.openphacts.org/units/Nanomolar;4266767;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659881;27263831;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(C(N)=O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.57', 'le': '0.18', 'lle': '1.50', 'sei': '4.04'};CHEMBL6022047;;CHEMBL6022047;4.70;0;http://www.openphacts.org/units/Nanomolar;4266774;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659887;27263849;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.83', 'le': '0.19', 'lle': '0.76', 'sei': '4.99'};CHEMBL5856476;;CHEMBL5856476;4.70;0;http://www.openphacts.org/units/Nanomolar;4266777;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659889;27263855;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1ncc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)nc1C;;;CHEMBL5726336;;2017.0;{'bei': '10.55', 'le': '0.19', 'lle': '0.94', 'sei': '5.58'};CHEMBL5781853;;CHEMBL5781853;4.70;0;http://www.openphacts.org/units/Nanomolar;4266778;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659891;27263861;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1nccnc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.90', 'le': '0.20', 'lle': '1.05', 'sei': '4.58'};CHEMBL6014328;;CHEMBL6014328;4.90;0;http://www.openphacts.org/units/Nanomolar;4266779;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659893;27263867;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '9.54', 'le': '0.18', 'lle': '1.87', 'sei': '4.04'};CHEMBL5989068;;CHEMBL5989068;4.70;0;http://www.openphacts.org/units/Nanomolar;4266780;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659895;27263873;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1nc(C(C(N)=O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)ccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.90', 'le': '0.18', 'lle': '2.72', 'sei': '4.04'};CHEMBL5813635;;CHEMBL5813635;4.70;0;http://www.openphacts.org/units/Nanomolar;4266781;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659903;27263897;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1c(F)cncc1F;;;CHEMBL5726336;;2017.0;{'bei': '9.80', 'le': '0.18', 'lle': '1.14', 'sei': '4.99'};CHEMBL5935914;;CHEMBL5935914;4.70;0;http://www.openphacts.org/units/Nanomolar;4266784;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659905;27263903;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1cncc(F)c1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '0.82', 'sei': '5.20'};CHEMBL5944654;;CHEMBL5944654;4.90;0;http://www.openphacts.org/units/Nanomolar;4266785;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659907;27263909;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1ccc2nccn2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.07', 'le': '0.17', 'lle': '1.11', 'sei': '4.21'};CHEMBL5980137;;CHEMBL5980137;4.70;0;http://www.openphacts.org/units/Nanomolar;4266786;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659911;27263921;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(C(N)=O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '9.23', 'le': '0.18', 'lle': '1.36', 'sei': '4.04'};CHEMBL5770264;;CHEMBL5770264;4.70;0;http://www.openphacts.org/units/Nanomolar;4266788;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659925;27263963;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2ccsc12;;;CHEMBL5726336;;2017.0;{'bei': '9.92', 'le': '0.19', 'lle': '0.34', 'sei': '5.58'};CHEMBL5819507;;CHEMBL5819507;4.70;0;http://www.openphacts.org/units/Nanomolar;4266795;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659927;27263969;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nncc2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '9.92', 'le': '0.19', 'lle': '0.34', 'sei': '5.58'};CHEMBL5842348;;CHEMBL5842348;4.70;0;http://www.openphacts.org/units/Nanomolar;4266796;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659935;27263993;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;O=c1[nH]nc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.05', 'sei': '4.51'};CHEMBL5880312;;CHEMBL5880312;4.70;0;http://www.openphacts.org/units/Nanomolar;4266800;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659943;27264017;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nncc2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '9.56', 'le': '0.18', 'lle': '0.20', 'sei': '5.58'};CHEMBL5800518;;CHEMBL5800518;4.70;0;http://www.openphacts.org/units/Nanomolar;4266804;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659947;27264029;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nnc2ccccn12;;;CHEMBL5726336;;2017.0;{'bei': '10.29', 'le': '0.19', 'lle': '1.30', 'sei': '5.30'};CHEMBL5808833;;CHEMBL5808833;4.70;0;http://www.openphacts.org/units/Nanomolar;4266806;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659953;27264047;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1cnc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3F)ncnc21;;;CHEMBL5726336;;2017.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.53', 'sei': '4.60'};CHEMBL5777694;;CHEMBL5777694;4.70;0;http://www.openphacts.org/units/Nanomolar;4266808;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659957;27264059;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;NC(=O)C(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccn2cccc12;;;CHEMBL5726336;;2017.0;{'bei': '9.80', 'le': '0.18', 'lle': '1.22', 'sei': '4.97'};CHEMBL5900529;;CHEMBL5900529;4.90;0;http://www.openphacts.org/units/Nanomolar;4266809;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659971;27264101;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cnc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2F)c(C)n1;;;CHEMBL5726336;;2017.0;{'bei': '10.14', 'le': '0.19', 'lle': '0.80', 'sei': '5.58'};CHEMBL5842038;;CHEMBL5842038;4.70;0;http://www.openphacts.org/units/Nanomolar;4266815;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659977;27264119;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccn2cccc12;;;CHEMBL5726336;;2017.0;{'bei': '10.36', 'le': '0.19', 'lle': '0.76', 'sei': '6.47'};CHEMBL6019177;;CHEMBL6019177;4.90;0;http://www.openphacts.org/units/Nanomolar;4266818;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;659987;27264149;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)cccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '10.15', 'le': '0.19', 'lle': '1.13', 'sei': '5.84'};CHEMBL5962444;;CHEMBL5962444;4.70;0;http://www.openphacts.org/units/Nanomolar;4266823;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;659999;27264185;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1nccn2ccnc12;;;CHEMBL5726336;;2017.0;{'bei': '9.94', 'le': '0.19', 'lle': '0.79', 'sei': '5.30'};CHEMBL5806887;;CHEMBL5806887;4.70;0;http://www.openphacts.org/units/Nanomolar;4266826;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660003;27264197;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1cnc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)ccc3Cl)ncnc21;;;CHEMBL5726336;;2017.0;{'bei': '10.05', 'le': '0.19', 'lle': '1.35', 'sei': '4.80'};CHEMBL6051468;;CHEMBL6051468;4.90;0;http://www.openphacts.org/units/Nanomolar;4266828;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660007;27264209;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1cccc2nncn12;;;CHEMBL5726336;;2017.0;{'bei': '10.29', 'le': '0.19', 'lle': '1.30', 'sei': '5.30'};CHEMBL5757448;;CHEMBL5757448;4.70;0;http://www.openphacts.org/units/Nanomolar;4266830;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660009;27264215;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '10.27', 'le': '0.19', 'lle': '0.81', 'sei': '4.82'};CHEMBL5789113;;CHEMBL5789113;4.70;0;http://www.openphacts.org/units/Nanomolar;4266831;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660015;27264233;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cncnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998631;;CHEMBL5998631;4.70;0;http://www.openphacts.org/units/Nanomolar;4266832;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660025;27264263;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)c(F)cc2Cl)cccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '9.77', 'le': '0.19', 'lle': '0.99', 'sei': '5.84'};CHEMBL5979219;;CHEMBL5979219;4.70;0;http://www.openphacts.org/units/Nanomolar;4266835;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660035;27264293;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1ncnc2c1CCNC2;;;CHEMBL5726336;;2017.0;{'bei': '9.58', 'le': '0.18', 'lle': '1.77', 'sei': '4.88'};CHEMBL5956084;;CHEMBL5956084;4.70;0;http://www.openphacts.org/units/Nanomolar;4266838;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660037;27264299;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2c1CCNC2;;;CHEMBL5726336;;2017.0;{'bei': '10.38', 'le': '0.19', 'lle': '2.11', 'sei': '5.09'};CHEMBL5983762;;CHEMBL5983762;4.90;0;http://www.openphacts.org/units/Nanomolar;4266839;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660039;27264305;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.85', 'le': '0.21', 'lle': '1.10', 'sei': '5.82'};CHEMBL5857402;;CHEMBL5857402;4.90;0;http://www.openphacts.org/units/Nanomolar;4266840;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660041;27264311;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5857402;;CHEMBL5857402;4.70;0;http://www.openphacts.org/units/Nanomolar;4266840;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660043;27264317;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)ccc3F)ncnc21;;;CHEMBL5726336;;2017.0;{'bei': '9.97', 'le': '0.18', 'lle': '1.67', 'sei': '4.60'};CHEMBL5929065;;CHEMBL5929065;4.70;0;http://www.openphacts.org/units/Nanomolar;4266841;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660045;27264323;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL6059111;;CHEMBL6059111;4.70;0;http://www.openphacts.org/units/Nanomolar;4266842;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660047;27264329;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.89', 'le': '0.20', 'lle': '1.25', 'sei': '5.58'};CHEMBL5789087;;CHEMBL5789087;4.70;0;http://www.openphacts.org/units/Nanomolar;4266843;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660051;27264341;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1nccn2ccnc12;;;CHEMBL5726336;;2017.0;{'bei': '9.57', 'le': '0.18', 'lle': '0.65', 'sei': '5.30'};CHEMBL5995294;;CHEMBL5995294;4.70;0;http://www.openphacts.org/units/Nanomolar;4266845;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660061;27264371;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)cccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '10.15', 'le': '0.19', 'lle': '1.13', 'sei': '5.84'};CHEMBL5962444;;CHEMBL5962444;4.70;0;http://www.openphacts.org/units/Nanomolar;4266823;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660063;27264377;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1c(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2F)cccc1=O;;;CHEMBL5726336;;2017.0;{'bei': '10.98', 'le': '0.20', 'lle': '1.85', 'sei': '6.09'};CHEMBL5803245;;CHEMBL5803245;4.90;0;http://www.openphacts.org/units/Nanomolar;4266824;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660065;27264383;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3Cl)ncnc21;;;CHEMBL5726336;;2017.0;{'bei': '9.29', 'le': '0.18', 'lle': '1.02', 'sei': '4.60'};CHEMBL5836101;;CHEMBL5836101;4.70;0;http://www.openphacts.org/units/Nanomolar;4266847;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660067;27264389;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cn1ncc2c(C(O)c3cc(-c4ncnc5cc(N6CCOCC6)ccc45)c(F)cc3F)ncnc21;;;CHEMBL5726336;;2017.0;{'bei': '9.60', 'le': '0.18', 'lle': '1.53', 'sei': '4.60'};CHEMBL5831533;;CHEMBL5831533;4.70;0;http://www.openphacts.org/units/Nanomolar;4266848;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660073;27264407;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1F)c1ncnc2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL5866182;;CHEMBL5866182;4.90;0;http://www.openphacts.org/units/Nanomolar;4266851;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660075;27264413;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cncnc1C(C(N)=O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.89', 'le': '0.19', 'lle': '1.20', 'sei': '4.39'};CHEMBL5998631;;CHEMBL5998631;4.70;0;http://www.openphacts.org/units/Nanomolar;4266832;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660077;27264419;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL6055346;;CHEMBL6055346;4.90;0;http://www.openphacts.org/units/Nanomolar;4266852;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660083;27264437;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5744600;;CHEMBL5744600;4.90;0;http://www.openphacts.org/units/Nanomolar;4266853;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660085;27264443;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncncc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.40', 'le': '0.20', 'lle': '0.90', 'sei': '5.58'};CHEMBL5857402;;CHEMBL5857402;4.70;0;http://www.openphacts.org/units/Nanomolar;4266840;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660087;27264449;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.13', 'le': '0.19', 'lle': '1.03', 'sei': '5.03'};CHEMBL6055346;;CHEMBL6055346;4.70;0;http://www.openphacts.org/units/Nanomolar;4266852;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660089;27264455;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;0;http://www.openphacts.org/units/Nanomolar;4266854;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660091;27264461;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;0;http://www.openphacts.org/units/Nanomolar;4266854;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660093;27264467;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2occc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL5828867;;CHEMBL5828867;4.90;0;http://www.openphacts.org/units/Nanomolar;4266855;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660095;27264473;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5822629;;CHEMBL5822629;4.70;0;http://www.openphacts.org/units/Nanomolar;4266856;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660099;27264485;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5822629;;CHEMBL5822629;4.70;0;http://www.openphacts.org/units/Nanomolar;4266856;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660105;27264503;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5744600;;CHEMBL5744600;4.90;0;http://www.openphacts.org/units/Nanomolar;4266853;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660115;27264533;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.49', 'le': '0.20', 'lle': '0.73', 'sei': '5.58'};CHEMBL5895768;;CHEMBL5895768;4.70;0;http://www.openphacts.org/units/Nanomolar;4266861;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660117;27264539;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.95', 'le': '0.21', 'lle': '0.93', 'sei': '5.82'};CHEMBL5895768;;CHEMBL5895768;4.90;0;http://www.openphacts.org/units/Nanomolar;4266861;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660125;27264563;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.50', 'sei': '5.03'};CHEMBL6050666;;CHEMBL6050666;4.90;0;http://www.openphacts.org/units/Nanomolar;4266854;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660135;27264593;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2sccc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL6039429;;CHEMBL6039429;4.90;0;http://www.openphacts.org/units/Nanomolar;4266866;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660137;27264599;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncnc2ccsc12;;;CHEMBL5726336;;2017.0;{'bei': '10.35', 'le': '0.20', 'lle': '0.54', 'sei': '5.82'};CHEMBL6012455;;CHEMBL6012455;4.90;0;http://www.openphacts.org/units/Nanomolar;4266867;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660139;27264605;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1ncnc2ccsc12;;;CHEMBL5726336;;2017.0;{'bei': '9.98', 'le': '0.19', 'lle': '0.40', 'sei': '5.82'};CHEMBL5972912;;CHEMBL5972912;4.90;0;http://www.openphacts.org/units/Nanomolar;4266868;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660141;27264611;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '9.55', 'le': '0.18', 'lle': '0.16', 'sei': '4.82'};CHEMBL5804401;;CHEMBL5804401;4.70;0;http://www.openphacts.org/units/Nanomolar;4266869;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660143;27264617;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '9.97', 'le': '0.19', 'lle': '0.36', 'sei': '5.03'};CHEMBL5804401;;CHEMBL5804401;4.90;0;http://www.openphacts.org/units/Nanomolar;4266869;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660155;27264653;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL5815339;;CHEMBL5815339;4.90;0;http://www.openphacts.org/units/Nanomolar;4266872;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660157;27264659;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cncnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.53', 'le': '0.20', 'lle': '1.61', 'sei': '5.24'};CHEMBL6006289;;CHEMBL6006289;4.90;0;http://www.openphacts.org/units/Nanomolar;4266873;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660161;27264671;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccnc1OC(F)F;;;CHEMBL5726336;;2017.0;{'bei': '9.37', 'le': '0.18', 'lle': '0.82', 'sei': '5.03'};CHEMBL5787148;;CHEMBL5787148;4.70;0;http://www.openphacts.org/units/Nanomolar;4266874;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660163;27264677;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F)c1nccnc1OC(F)F;;;CHEMBL5726336;;2017.0;{'bei': '9.37', 'le': '0.18', 'lle': '0.82', 'sei': '5.03'};CHEMBL5787148;;CHEMBL5787148;4.70;0;http://www.openphacts.org/units/Nanomolar;4266874;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660165;27264683;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl)c1ncnc2ccoc12;;;CHEMBL5726336;;2017.0;{'bei': '9.97', 'le': '0.19', 'lle': '0.36', 'sei': '5.03'};CHEMBL5804401;;CHEMBL5804401;4.90;0;http://www.openphacts.org/units/Nanomolar;4266869;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660167;27264689;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.53', 'le': '0.20', 'lle': '1.61', 'sei': '5.24'};CHEMBL5967736;;CHEMBL5967736;4.90;0;http://www.openphacts.org/units/Nanomolar;4266875;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660171;27264701;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1[C@H](O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5934134;;CHEMBL5934134;4.70;0;http://www.openphacts.org/units/Nanomolar;4266876;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660173;27264707;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1[C@@H](O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.17', 'le': '0.20', 'lle': '1.09', 'sei': '5.24'};CHEMBL6005452;;CHEMBL6005452;4.90;0;http://www.openphacts.org/units/Nanomolar;4266877;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660177;27264719;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1ccc(C(O)c2cc(-c3ncnc4cc(N5CCOCC5)ccc34)ccc2Cl)nn1;;;CHEMBL5726336;;2017.0;{'bei': '10.57', 'le': '0.20', 'lle': '1.23', 'sei': '5.24'};CHEMBL5947717;;CHEMBL5947717;4.90;0;http://www.openphacts.org/units/Nanomolar;4266879;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660185;27264743;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCc1nccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.55', 'le': '0.19', 'lle': '0.99', 'sei': '5.58'};CHEMBL5975635;;CHEMBL5975635;4.70;0;http://www.openphacts.org/units/Nanomolar;4266881;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660187;27264749;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;CCOc1cccnc1C(O)c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1;;;CHEMBL5726336;;2017.0;{'bei': '10.20', 'le': '0.19', 'lle': '0.55', 'sei': '5.83'};CHEMBL5993979;;CHEMBL5993979;4.70;0;http://www.openphacts.org/units/Nanomolar;4266882;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660189;27264755;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1nccnc1OC(F)F;;;CHEMBL5726336;;2017.0;{'bei': '9.72', 'le': '0.18', 'lle': '0.95', 'sei': '5.03'};CHEMBL6054325;;CHEMBL6054325;4.70;0;http://www.openphacts.org/units/Nanomolar;4266883;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660191;27264761;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;0;http://www.openphacts.org/units/Nanomolar;4266598;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660193;27264767;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.42', 'le': '0.20', 'lle': '0.30', 'sei': '6.58'};CHEMBL5954562;;CHEMBL5954562;4.70;0;http://www.openphacts.org/units/Nanomolar;4266598;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660197;27264779;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1nccnc1C(O)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '9.75', 'le': '0.19', 'lle': '0.89', 'sei': '5.03'};CHEMBL5977882;;CHEMBL5977882;4.70;0;http://www.openphacts.org/units/Nanomolar;4266730;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660199;27264785;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '11.30', 'le': '0.22', 'lle': '1.24', 'sei': '5.82'};CHEMBL5887376;;CHEMBL5887376;4.90;0;http://www.openphacts.org/units/Nanomolar;4266884;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660207;27264809;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;COc1cnc(C(O)c2ccc(F)c(-c3ncnc4cc(N5CCOCC5)ccc34)c2)c(Br)c1;;;CHEMBL5726336;;2017.0;{'bei': '8.94', 'le': '0.19', 'lle': '0.18', 'sei': '5.83'};CHEMBL5890288;;CHEMBL5890288;4.70;0;http://www.openphacts.org/units/Nanomolar;4266886;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660209;27264815;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cn2ccsc2n1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)c(F)cc1F;;;CHEMBL5726336;;2017.0;{'bei': '10.23', 'le': '0.20', 'lle': '0.70', 'sei': '6.47'};CHEMBL5744383;;CHEMBL5744383;4.90;0;http://www.openphacts.org/units/Nanomolar;4266887;=;37;1;=;;Ki;nM;;12500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;12500.0
;660211;27264821;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1ccc(F)c(-c2ncnc3cc(N4CCOCC4)ccc23)c1)c1ncccc1OC(F)(F)F;;;CHEMBL5726336;;2017.0;{'bei': '9.39', 'le': '0.18', 'lle': '0.05', 'sei': '5.83'};CHEMBL5872585;;CHEMBL5872585;4.70;0;http://www.openphacts.org/units/Nanomolar;4266888;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;660217;27264839;[];CHEMBL5732504;Patch Clamp Assay: The patch-clamp measurement was carried out at room temperature in whole-cell configuration on human embryonic kidney cells (HEK293) which have been transfected in a stable manner with the hERG gene.The whole-cell configurations were carried out using an automated patch clamp device (Patchliner, Nanion Technologies, Munich). This is a glass chip-based system with which automated whole-cell measurements on up to 8 cells simultaneously are possible. The glass chip has a hole of defined size to which the cell is transferred into the Gigaseal by application of a reduced pressure and brought into the whole-cell configuration. Buffer, cell suspension and test substances were added to microchannels of the chip using a Teflon-coated pipette. The cells were clamped to a holding potential of -80 mV. For measurement of substance-promoted inhibition of the Kv11.1 channel, the following voltage protocol was applied at 10-second intervals: 51 ms/-80 mV, 500 ms/+40 mV, 500 ms/-40 mV, 200 ms/-80 mV. The leakage current is subtracted by means of the P4 method. The cells were resuspended in extracellular buffer (EC) and applied to the chip. After the cell had been collected, the seal was improved by addition of a seal enhancer buffer. As soon as the whole-cell configuration had been reached, the seal enhancer buffer was washed out and replaced by extracellular buffer. The measurement started in EC for 1.5 min. DMSO (vehicle control, 0.1% of DMSO) was then applied, and the control current was recorded for 3 min. The test substance was subsequently added twice in the same concentration, and the potassium current was measured for 3.5 min in each case.;B;;;BAO_0000192;BAO_0000019;assay format;OC(c1cccnn1)c1cc(-c2ncnc3cc(N4CCOCC4)ccc23)ccc1Cl;;;CHEMBL5726336;;2017.0;{'bei': '10.83', 'le': '0.21', 'lle': '1.04', 'sei': '5.58'};CHEMBL5887376;;CHEMBL5887376;4.70;0;http://www.openphacts.org/units/Nanomolar;4266884;=;37;1;=;;Ki;nM;;20000.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;20000.0
;1294628;29049398;[];CHEMBL5739517;In-Vitro Safety Profile-Testing the Selectivity Over hErg: Inhibition of the ion channel hErg (or Kv11.1) current causes QT interval prolongation resulting in potentially fatal ventricular tachyarrhythmia called Torsade de Pointes. This is one of the major causes of cardiotoxicity and hErg channel activity is usually evaluated early in the drug development process to mitigate cardiotoxicity risk.hERG ion channel activity was assessed using a patch clamp technique in stable Kv11.1 (hERG) transfected human embryonic kidney cell line (HEK293). Whole cell recordings were carried out with an automated patch clamp device Patchliner from Nanion Technologies, Munich following manufacturer recommendation. Different concentrations of the test compound or reference, quinidine, were applied to whole cells suspension and current was measured using a pulse pattern with fixed amplitudes. The effect on Kv11.1 (hERG) ion channel activity was judged from the tail current amplitude and Changes in Kv11.1 (hERG) ion channel activity between control value (defined as 100%) and test compound and reported as percent change of control value of COI.;B;;;BAO_0000192;BAO_0000019;assay format;CC1(N)CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1;;;CHEMBL5729803;;2023.0;{'bei': '18.52', 'le': '0.39', 'lle': '3.17', 'sei': '8.05'};CHEMBL4060033;;CHEMBL4060033;6.52;0;http://www.openphacts.org/units/Nanomolar;4646882;=;37;1;=;;Ki;nM;;300.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;300.0
;1294630;29049404;[];CHEMBL5739517;In-Vitro Safety Profile-Testing the Selectivity Over hErg: Inhibition of the ion channel hErg (or Kv11.1) current causes QT interval prolongation resulting in potentially fatal ventricular tachyarrhythmia called Torsade de Pointes. This is one of the major causes of cardiotoxicity and hErg channel activity is usually evaluated early in the drug development process to mitigate cardiotoxicity risk.hERG ion channel activity was assessed using a patch clamp technique in stable Kv11.1 (hERG) transfected human embryonic kidney cell line (HEK293). Whole cell recordings were carried out with an automated patch clamp device Patchliner from Nanion Technologies, Munich following manufacturer recommendation. Different concentrations of the test compound or reference, quinidine, were applied to whole cells suspension and current was measured using a pulse pattern with fixed amplitudes. The effect on Kv11.1 (hERG) ion channel activity was judged from the tail current amplitude and Changes in Kv11.1 (hERG) ion channel activity between control value (defined as 100%) and test compound and reported as percent change of control value of COI.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1nc(N2CCC3(CC2)CO[C@@H](C)[C@H]3N)c(CO)nc1-c1cccc(Cl)c1Cl;;;CHEMBL5729803;;2023.0;{'bei': '14.23', 'le': '0.29', 'lle': '2.64', 'sei': '7.36'};CHEMBL4752026;;CHEMBL4752026;6.22;0;http://www.openphacts.org/units/Nanomolar;4646883;=;37;1;=;;Ki;nM;;600.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;600.0
;1294632;29049410;[];CHEMBL5739517;In-Vitro Safety Profile-Testing the Selectivity Over hErg: Inhibition of the ion channel hErg (or Kv11.1) current causes QT interval prolongation resulting in potentially fatal ventricular tachyarrhythmia called Torsade de Pointes. This is one of the major causes of cardiotoxicity and hErg channel activity is usually evaluated early in the drug development process to mitigate cardiotoxicity risk.hERG ion channel activity was assessed using a patch clamp technique in stable Kv11.1 (hERG) transfected human embryonic kidney cell line (HEK293). Whole cell recordings were carried out with an automated patch clamp device Patchliner from Nanion Technologies, Munich following manufacturer recommendation. Different concentrations of the test compound or reference, quinidine, were applied to whole cells suspension and current was measured using a pulse pattern with fixed amplitudes. The effect on Kv11.1 (hERG) ion channel activity was judged from the tail current amplitude and Changes in Kv11.1 (hERG) ion channel activity between control value (defined as 100%) and test compound and reported as percent change of control value of COI.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1c(N2CCC3(CC2)Cc2ccccc2[C@H]3N)nc(C)n(-c2cccc(Cl)c2Cl)c1=O;;;CHEMBL5729803;;2023.0;{'bei': '12.61', 'le': '0.25', 'lle': '0.92', 'sei': '9.23'};CHEMBL4797428;;CHEMBL4797428;5.92;0;http://www.openphacts.org/units/Nanomolar;4646826;=;37;1;=;;Ki;nM;;1200.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;1200.0
;1294633;29049413;[];CHEMBL5739517;In-Vitro Safety Profile-Testing the Selectivity Over hErg: Inhibition of the ion channel hErg (or Kv11.1) current causes QT interval prolongation resulting in potentially fatal ventricular tachyarrhythmia called Torsade de Pointes. This is one of the major causes of cardiotoxicity and hErg channel activity is usually evaluated early in the drug development process to mitigate cardiotoxicity risk.hERG ion channel activity was assessed using a patch clamp technique in stable Kv11.1 (hERG) transfected human embryonic kidney cell line (HEK293). Whole cell recordings were carried out with an automated patch clamp device Patchliner from Nanion Technologies, Munich following manufacturer recommendation. Different concentrations of the test compound or reference, quinidine, were applied to whole cells suspension and current was measured using a pulse pattern with fixed amplitudes. The effect on Kv11.1 (hERG) ion channel activity was judged from the tail current amplitude and Changes in Kv11.1 (hERG) ion channel activity between control value (defined as 100%) and test compound and reported as percent change of control value of COI.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1c(N2CCC3(CC2)Cc2ncccc2[C@@H]3N)nc(C)n(-c2cccc(Cl)c2Cl)c1=O;;;CHEMBL5729803;;2023.0;{'bei': '10.89', 'le': '0.22', 'lle': '0.73', 'sei': '6.65'};CHEMBL4794480;;CHEMBL4794480;5.12;0;http://www.openphacts.org/units/Nanomolar;4646816;=;37;1;=;;Ki;nM;;7500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;7500.0
;1294634;29049416;[];CHEMBL5739517;In-Vitro Safety Profile-Testing the Selectivity Over hErg: Inhibition of the ion channel hErg (or Kv11.1) current causes QT interval prolongation resulting in potentially fatal ventricular tachyarrhythmia called Torsade de Pointes. This is one of the major causes of cardiotoxicity and hErg channel activity is usually evaluated early in the drug development process to mitigate cardiotoxicity risk.hERG ion channel activity was assessed using a patch clamp technique in stable Kv11.1 (hERG) transfected human embryonic kidney cell line (HEK293). Whole cell recordings were carried out with an automated patch clamp device Patchliner from Nanion Technologies, Munich following manufacturer recommendation. Different concentrations of the test compound or reference, quinidine, were applied to whole cells suspension and current was measured using a pulse pattern with fixed amplitudes. The effect on Kv11.1 (hERG) ion channel activity was judged from the tail current amplitude and Changes in Kv11.1 (hERG) ion channel activity between control value (defined as 100%) and test compound and reported as percent change of control value of COI.;B;;;BAO_0000192;BAO_0000019;assay format;Cc1c(N2CCC3(CC2)Cc2ccccc2[C@H]3N)nc(N)n(-c2cccc(Cl)c2Cl)c1=O;;;CHEMBL5729803;;2023.0;{'bei': '11.91', 'le': '0.24', 'lle': '1.33', 'sei': '6.21'};CHEMBL5805825;;CHEMBL5805825;5.60;0;http://www.openphacts.org/units/Nanomolar;4646878;=;37;1;=;;Ki;nM;;2500.0;CHEMBL240;Homo sapiens;Voltage-gated inwardly rectifying potassium channel KCNH2;9606;;;Ki;nM;UO_0000065;;2500.0
